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Abstract 
Low back pain (LBP) is a chronic condition that leads to disability and work absence. It 
affects patients’ lives regardless of their age, gender, social status, level of education or 
culture. After the common cold, LBP is the second condition that results in health seeking 
behaviour and has a consequential social burden, as well as a global burden, on the health 
economy. Limitations in physical functioning arising from LBP affect other dimensions 
of quality of life, such as mental and social functioning. Therefore, LBP is considered a 
multidimensional problem.  
Targeted physiotherapy interventions are used to improve functional outcomes in 
individuals with LBP. However, a number of problems exist on the measurement of the 
effectiveness and efficiency of these complex interventions in a clinical context. A valid, 
reliable and responsive outcome measure that is underpinned by theoretical and clinical 
knowledge is required to address these issues. 
The aim of this thesis is to develop a clinical measure suitable for research and for 
implementation in the Jordanian healthcare system for the measurement of functional 
outcomes in people with LBP. The research process involved three phases, namely, 
conceptualisation of the problems, development of the measurement tool and clinical 
testing of the measurement tool. 
Different research methods were used in this research programme to achieve the 
objectives. In the conceptualisation phase, a systematic review of the global prevalence 
of LBP was conducted to compare the prevalence of LBP in different countries with that 
in Jordan. This process was followed by a meta-synthesis of qualitative studies that 
investigated the impact of LBP on people’s lives, as well as of critical reviews of 
management models of LBP, theory of measuring scales and scaling methods. These 
reviews resulted in the development of a theoretical framework to measure functional 
status in individuals with LBP and the identification of measurement standards in a 
clinical context. This framework was used at the end of the conceptualisation phase to 
critically review six of the most commonly used LBP outcome measures. After the 
conceptualisation phase, a new outcome measure of functional performance in 
individuals with LBP was determined to be necessary. 
  
VI 
 
A mixed-methods approach was used in the development of the measurement tool phase. 
The Treatment Evaluation by LE Roux (TELER) method of measurement was utilised in 
the development and validation of a new outcome measure of functional performance, in 
which rigorous and extensive qualitative methods, such as in-depth interviews and 
nominal group techniques, were used. 
In the clinical testing phase, the TELER LBP indicators were tested in Jordanian 
physiotherapy clinics. This testing provided evidence of the clinical utility of the TELER 
LBP indicators in generating informative data appropriate to inform clinical decision-
making. This thesis has contributed to the development of measurement in the 
musculoskeletal field by providing a new clinical tool that is underpinned by sound 
theoretical, clinical and empirical knowledge. The tool is appropriate for use in clinical 
evaluation and has potential use in research. This thesis provides a solid base upon which 
further new knowledge can be developed in the future.  
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Overview of the thesis 
The 2010 Global Burden of Disease study suggested that the prevalence of chronic 
disorders is escalating (1,2). Chronic conditions, such as low back pain (LBP), present an 
economic burden on any healthcare system because they affect many individuals 
regardless of age, gender or social status (3). Studies showed that LBP as a symptom also 
has a social burden because it affects almost all people at some point in their lives (4), 
and it is the leading cause of disability and work absence (1,2). LBP affects many 
dimensions of one’s quality of life, such as physical functioning, mood and social 
functioning (5), which in turn result in complex cases.  
Mounting evidence supports the view that such a multidimensional disorder requires 
targeted multidimensional physiotherapy interventions (6). The delivery of these 
physiotherapy interventions occurs in clinical, community and home settings (7). The 
overall aim of physiotherapy is to reduce the impact of pain and improve the functional 
status of individual patients (8).  
Many measurement tools have been developed to evaluate the effectiveness and 
efficiency of physiotherapy interventions (9). These measurement tools were originally 
created for research and audit purposes, but they were recently used by clinicians to 
measure outcomes in a clinical context often called a service evaluation (10). The 
measures used to inform research and audit involve the data collected, aggregated and 
analysed at the group level (11,12). Different studies indicated that measurement tools, 
which possess adequate psychometric properties at the group level and perform 
satisfactorily in the measurement of outcomes in clinical trials, are not necessarily suitable 
for the evaluation of clinical outcomes at the level of the individual in a clinical context 
(13-16). Data collection in research aims mainly to generate generalisable findings, and 
in the clinical context, data collection aims to inform individual care (10,17,18).  
In addition to this concern, the majority of measurement tools were developed in English-
speaking countries, and they were cross-culturally adapted to other languages. A recent 
review of these cross-cultural adaptations of measures showed that only two tools were 
translated into the Arabic language (9). This factor may be one of the reasons why an 
evidence-based culture is almost non-existent in other countries, such as Jordan. A recent 
study conducted in Jordan (19) suggested that evidence-based practice (EBP) is not 
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implemented in Jordan for many reasons, such as lack of resources, lack of time because 
of patient overload, inadequate research skills and lack of outcome measures. Such 
outcome measures should be appropriate to the context and the population within which 
it will be implemented.  
This thesis proposes that an appropriate measurement tool that measures what is 
important to Jordanian individuals with LBP improves the quality of care delivered to the 
individual patient, enhances the care experience, facilitates clinical decision-making and 
ultimately improves the effectiveness and efficiency of the care provided to whole groups 
of patients. 
Therefore, this research programme seeks to respond to both of the aforesaid concerns 
and develop a clinical tool for the measurement of outcomes that are important to a patient 
during physiotherapy. This thesis suggests that an appropriate outcome measure in a 
clinical context should be valid, reliable and responsive to change or the lack of change. 
The data collected can inform clinical decision-making at the individual level and can be 
aggregated to provide information at the group level for managers, policymakers or 
commissioners about the quality of healthcare services provided to patients. The 
overarching purpose of this thesis is to stimulate and promote an EBP paradigm in the 
physiotherapy field in Jordan through the development of an appropriate LBP outcome 
measure. The overarching aim of this thesis is in line with the current ongoing significant 
reforms in the Jordanian healthcare system to implement EBP in clinical decision-making 
(20-22). The purpose of these reforms in the healthcare sector in Jordan is to provide 
high-quality and cost-effective care for individuals with chronic conditions, such as LBP. 
The premise for the first section in the first phase of this thesis is that understanding the 
trajectory of LBP, the impact of LBP on individuals’ quality of life, the management 
models used and the constructs that are often measured after therapy is the key to the 
development of an appropriate LBP measurement tool (23,24). This information ensures 
clarity about what should be measured and how it should be measured (23,24). 
The theory of measuring scales, scaling methods and the quality criteria required by a 
measurement scale in order to have clinical utility were reviewed in the second section in 
the first phase. These reviews were conducted to synthesise current literature into a 
framework for the specifications of an appropriate outcome measure for implementation 
in a clinical context. This new theoretical framework constitutes an integral component 
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upon which current LBP outcome measures were critically reviewed in Chapter 7. The 
purpose of these critical reviews was to determine whether current measures meet the 
requirements of measurement in a clinical context. Chapter 7 identified a number of issues 
in current LBP outcome measures, such as the use of double-barrelled questions, lack of 
responsiveness, and floor and ceiling effects. None of the instruments reviewed showed 
that they had the required characteristics to be used in a clinical context nor the ability to 
detect change over time. 
Based on the findings of the first phase, a new outcome measure was developed in the 
second phase. The development phase involved selecting an appropriate method of 
measurement that met the specifications of measurement in a clinical context and the 
qualitative exploration of Jordanian patients’ experience of living with their problem. The 
TELER method of measurement was selected in this thesis to develop the new 
measurement tool because it conformed to the specifications of the construct functional 
performance, the rules of the levels of measurement and the standards of measurement in 
a clinical context. Patients’ narratives were used to develop the first draft of TELER LBP 
indicators. This process was followed by the validation and calibration of the new 
outcome measure with the use of a nominal group technique, which utilised clinicians’ 
clinical knowledge in calibrating the TELER codes to represent, as closely as possible, 
recovery patterns. 
The clinical testing phase involved testing the indicators in Jordanian physiotherapy 
clinics. The purpose of this phase was to examine the measurement properties and clinical 
utility of the TELER LBP questionnaire in a Jordanian clinical context. Figure (1.A) 
shows the structure of this thesis.  
A mixed-methods approach that used a triangulation of qualitative and quantitative 
methods was utilised to achieve the different objectives in this research programme (see 
Figure 1.B). Further objectives (see Figure 8.1) are integrated within each chapter in the 
second and the third phases. The method sections were distributed and integrated within 
each chapter in this thesis.
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Figure 1.A: Overview of the structure of this thesis 
 
 Section 1: Knowledge underpinning LBP and physiotherapy interventions 
 Chapter 1: Knowledge underpinning LBP 
 Chapter 2: Impact of LBP on individuals’ quality of life 
 Chapter 3: LBP management models 
 Chapter 4: Pain and functioning: Definition and analytical framework 
Section 2: The theoretical underpinning of measurement 
 Chapter 5: A review of the theory of measuring scale and scaling methods 
 Chapter 6: A critical review of the quality criteria required in a measurement scale in order to have clinical utility 
 Chapter 7: A critical review of existing LBP outcome measures 
Phase one: Conceptualisation of the problems 
 
 Chapter 8: Selection of a method of measurement: Treatment Evaluation by LE Roux method (TELER) 
 Chapter 9: Determining the desired outcome: A qualitative study to explore patients’ perspective of living with LBP 
 Chapter 10: Combining outcome components into one measure: Generating TELER codes from patients’ narratives 
 Chapter 11: Item calibration and validation of TELER LBP indicators: Expert validation 
 
Phase two: Development of the measurement tool 
 
 Chapter 12: Determining of the usefulness of TELER LBP indicators: Pilot testing the TELER LBP questionnaire 
 Chapter 13: Overall discussion 
 
Phase three: Clinical testing of the measurement tool 
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Figure 1.B: Overview of the objectives and methods of the first phase 
 
Chapter 1: Knowledge underpinning LBP Method: A systematic review of 
epidemiological studies 
Objective: To gain an in-depth understanding of LBP and its prevalence and to identify personal and 
environmental factors that influence its clinical course. This objective is important in this thesis to 
define the targeted population and to compare the prevalence of LBP in Jordan with those in other 
countries 
 
Chapter 2: Impact of LBP on individuals’ quality of life Method: A meta-synthesis of 
qualitative studies 
Objective: To explore the impact of LBP on the different dimensions of individuals’ quality of life. This 
objective is important to identify the constructs that are affected by LBP and are frequently measured 
after physiotherapy 
 
Chapter 3: LBP management models Method: A critical review of LBP 
management models 
Objective: To understand the models of healthcare used in the management of LBP in a clinical 
context. The selection of any of these models will determine the measurement characteristics of the 
LBP outcome measure 
 
Chapter 4: Pain and functioning: Definition and analytical 
framework 
Method: A literature review of 
health service research 
Objective: To identify the different components of the constructs (pain and functional status) that are 
often measured after physiotherapy interventions 
 
Chapter 5: A review of the theory of measuring scales and 
scaling methods 
Method: A literature review of 
health service research 
Objective: To identify the rules that govern the measurement of the desired outcomes in a clinical 
context. The achievement of this objective is important to develop a theoretical framework of 
measurement in a clinical context 
 
Chapter 6: A critical review of the quality criteria required in a 
measurement tool for clinical utility 
Method: A critical review of health 
service research 
Objective: To identify the key characteristics required in a measurement tool in order to have clinical 
utility. The achievement of this objective is important in this thesis for the development of a theoretical 
framework of measurement in a clinical context for use later in the following chapter to either identify 
an appropriate measurement tool for cross-cultural adaptation or guide the development of a new LBP 
outcome measure 
 
Chapter 7: A critical review of existing LBP outcome measures Method: A critical review of health 
service research 
Objective: To examine the measurement properties, feasibility, acceptability and suitability of current 
LBP outcome measures for implementation in the Jordanian clinical context 
Further objectives are displayed in Figure 8.1  
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Phase 1: Conceptualisation of the problems 
Section 1: Knowledge underpinning LBP and physiotherapy interventions 
Chapter 1: Knowledge underpinning low back pain 
Chapter 2: Impact of LBP on individuals’ quality of life 
Chapter 3: LBP Management models 
Chapter 4: Pain and functioning: Definition and analytical framework 
 
Section 2: The theoretical underpinning of measurement 
Chapter 5: A review of the theory of measuring scale and scaling methods 
Chapter 6: A critical review of the quality criteria required in a measurement tool for clinical utility 
Chapter 7: A critical review of existing LBP outcome measures 
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Overview of phase 1: Conceptualisation of the problems 
Little is known about the prevalence of LBP in Jordan. The first chapter in the 
conceptualisation of the problems phase responded to this gap in the literature through 
the conduct of a systematic review of the global prevalence of LBP. The prevalence of 
LBP in Jordan was compared against that in other countries. This systematic review was 
important in this thesis because it also identified the characteristics of the targeted 
population, as well as the personal and environmental factors that influence the trajectory 
of LBP. These factors were considered during the planning of the subsequent phases in 
this thesis.  
This step was followed by a report on the findings of a recent meta-synthesis of qualitative 
studies that explored the impact of LBP on individuals’ quality of life. Such a report was 
important in this thesis to identify any qualitative study conducted in Jordan that explored 
the impact of LBP on individuals’ quality of life. The second chapter in this thesis 
indicated that no qualitative study has been conducted in Jordan on the impact of this 
problem on the Jordanian population. Therefore, this thesis responded to this gap in the 
literature during the development of the measurement tool phase by conducting a rigorous 
qualitative study that explored the Jordanian people’s perspective of living with LBP.  
The third chapter in this thesis reviewed LBP management models. The purpose of the 
critical review was to identify the role of LBP management models in the development 
of outcome measures. Chapter 4 in this thesis reviewed the different dimensions that are 
frequently measured after physiotherapy. The findings of this chapter were important in 
this thesis to determine what should be measured after physiotherapy. The findings of 
Chapter 4 suggested that compared with the impact of the other dimensions of pain, that 
of pain on one’s functional status can be observed by a clinician and reported by a patient; 
therefore, this construct was considered during the development of the measurement tool 
phase. 
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The purpose of the second section in the conceptualisation of the problems phase was to 
develop a theoretical framework of measurement in a clinical context. This new 
framework was used to critically appraise current and most commonly used LBP outcome 
measures in order to select an appropriate measurement tool for use in a clinical context 
in Jordan. A critical review of the literature indicated that an appropriate LBP clinical 
measurement tool does not exist in the musculoskeletal literature. This thesis responded 
to this gap in the literature by developing a new, appropriate outcome measure suitable 
for implementation in a clinical setting. Critical reviews of the theory of measuring scales 
and scaling methods were conducted to develop this theoretical framework (Chapter 5). 
This process was followed by a critical review of the health services research literature to 
identify the theoretical principles of measurement in a clinical context (Chapter 6). 
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Chapter 1: Knowledge underpinning low back pain 
Key points in Chapter 1: 
- LBP is a prevalent condition (point prevalence = 25%–47.7%) that affects 
individuals regardless of age, gender or socio-economic status. The reported 
recurrence rates of LBP are high (40%–50%), so LBP is one of the costliest 
health problems. Little is known about the prevalence of LBP in Jordan and the 
impact of this condition on the Jordanian population. Therefore, this thesis aims 
to explore the impact of LBP on the Jordanian population. 
- The systematic review of the global prevalence of LBP in this thesis indicated 
that the majority of epidemiological studies did not use valid and reliable tools 
in the measurement of the prevalence of LBP, which is a clear gap in the current 
knowledge on LBP. The use of these invalid tools might distort the current 
understanding of LBP. 
1.1 Introduction on the low back pain problem 
Musculoskeletal pain is a problem that affects people globally; the prevalence of this pain 
increases with age (3,4,25), and it has an impact on individuals’ quality of life (4,26-29). 
The World Health Organization (WHO) initiated Bone and Joint Decades 2000–2020 
(BJD 2000–2020) in recognition of the significant burden posed by musculoskeletal 
disorders (30). BJD 2000–2020 is the only international initiative that brings together 
relevant stakeholders to focus on musculoskeletal problems and raise awareness of these 
conditions at the global, regional and state levels. The primary mission of this 
international movement is to decrease the burden of musculoskeletal problems on 
individuals, healthcare systems and society through (31): 
1- “Raising the priority for musculoskeletal conditions on the global and national health 
agenda. 
2- Raising awareness of public and policymakers of the burden of musculoskeletal 
conditions and what can be achieved by implementing effective prevention and treatment. 
3- Increasing knowledge of the suffering and cost to society associated with musculoskeletal 
conditions. 
4- Empowering people to gain priority for their own care. 
5- Improving access to cost-effective prevention and treatment. 
6- Increasing research that will advance understanding of musculoskeletal disorders and 
improve prevention and treatment”. 
Disorders of the spine are the most prevalent problems within the musculoskeletal field 
(32-41). Furthermore, LBP1 is the most reported spinal complaint (26,28,33,34,42-53). 
Interestingly, LBP as a symptom affects many people around the world regardless of age, 
gender, socio-demographic characteristics or behaviour (3,4,54,55).  
                                                 
1 Unless otherwise stated in the text, the abbreviation ‘LBP’ refers to non-specific chronic LBP. 
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Any abnormalities within the anatomical structures, such as the bones, blood vessels, 
neural or ligamentous structures, muscles, joints or inter-vertebral discs, may or may not 
be associated with the development of a new episode of LBP. Many studies indicated the 
poor association between diagnostic imaging, which shows degenerative changes within 
the spinal column, and reporting pain in the lower back (55-57). However, approximately 
5%–15% of causes, such as fractures, degeneration or inflammation, can be directly 
related as an origin of LBP, whereas the remaining 85%–95% of cases are diagnosed as 
non-specific(2) LBP or LBP of an unknown cause (55,58-60). 
Many epidemiological studies report that more than 80% of individuals around the world 
suffer from LBP at a certain point in their lives (4,42,55,61,62). Furthermore, LBP is an 
economic burden on any healthcare system, and a huge amount of money is being spent 
each year on the management of LBP (63-65).  
Dagenais et al. (65) reported in a systematic review of 14 studies conducted in different 
countries that physiotherapy accounts for an average of 17% of the overall direct amount 
spent on the management of LBP (Figure 1.1). Furthermore, studies that investigated the 
healthcare cost in different countries reported that LBP is a problem that leads to huge 
economic burden (64,66,67). For example, the direct costs (healthcare services) of LBP 
were estimated at €2.6 billion and the direct medical costs at 6.1% of the total healthcare 
expenditure in Switzerland. Indirect costs (productivity losses) were estimated at €4.1 
billion. The total economic burden of LBP to Swiss society was between 1.6% and 2.3% 
of the gross domestic product (67). Another study conducted in the Netherlands on the 
cost of LBP in 2007 reported direct and indirect costs of €3.5 billion (68). Both studies 
indicate that the indirect costs of LBP, such as production losses because of limitations 
in physical activities, represented approximately two-thirds of the overall economic 
burden of LBP. 
Dagenais et al. (65) reported that the majority of studies investigating the economic 
burden of LBP were conducted in developed and high-income countries, such as the UK, 
US, Australia and Japan. By contrast, little is known about the economic burden of LBP 
in developing countries, such as Jordan, in terms of disability, work absence or medical 
healthcare costs. 
 
                                                 
2 Non-specific LBP is defined as ‘LBP [that is] not attributable to a recognisable, known specific pathology’ (55), p. 482. 
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Figure 1.1: Overall costs of management of LBP 
 
Dagenais et al. (65) reported that physiotherapy services account for a significant 
proportion of the money spent on the management of LBP. Despite the fact that LBP 
affects many individuals, different studies (69-71) indicated that a small but significant 
group of people with severe disability arising from LBP account for the majority of the 
economic burden. Regardless of their disability level, many individuals seek 
physiotherapy services for their LBP (65). Nearly one physiotherapist is allocated in 
Jordan for every 10,000 people (72). Generally, health professionals in Jordan rarely 
search for evidenced-based interventions to use in their practice because of a variety of 
reasons, including patient overload, limited resources and absence of suitable outcome 
measures (19). Valid, reliable, responsive and culturally sensitive outcome measures are 
required to collect data that inform practice and decision-making (73,74). The impact of 
LBP on the Jordanian people is unclear. Furthermore, because of the lack of suitable 
outcome measures, other health professionals, such as medical doctors, attribute changes 
in patient health status to their interventions and not to physiotherapy interventions. 
Therefore, Jordanian physiotherapists may be in urgent need to conduct research and 
demonstrate their achievements by using scientific outcome measures and appropriate 
research designs.  
The Science Council (75) in the UK defines science as “the pursuit of knowledge and 
understanding of the natural and social world following a systematic methodology based 
on evidence”. The current study aimed to stimulate or enhance the EBP paradigm in 
Jordan by developing an appropriate outcome measure. The word ‘appropriate’ is defined 
in the Cambridge dictionary as “suitable or right for a particular situation or occasion”. 
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This definition implies that to achieve the overall goal of this thesis, this research should 
identify the targeted population within which the outcome measure will be implemented, 
as well as identify the theoretical underpinning of measurement in a clinical context (76). 
The characteristics of the targeted population will be discussed in further detail in the 
following subsections. However, discussing first the concept of EBP at this stage is 
important.  
1.2 Evidence-based practice 
Sackett (77), p. 71, defines EBP as “the conscientious, explicit and judicious use of 
current best evidence in making decisions about the care of the individual patient. It 
means integrating individual clinical expertise with the best available external clinical 
evidence from systematic research”. The previous definition indicates that EBP is the 
incorporation of the best research evidence, clinical expertise and patient goals into the 
clinical decision-making process. EBP has become the acceptable practice among 
healthcare professions across the world (78), including physiotherapy (73). EBP indicates 
that research and evidence, not solely therapist preference, should guide treatments and 
clinical decisions. Furthermore, high-quality research is needed to provide valid evidence, 
based upon which a therapeutic intervention can be evaluated and prescribed (12,79).  
Physiotherapists in Jordan do not possess the means that empower them to prove the 
effectiveness and efficiency of their interventions through scientific evidence. This 
phenomenon can be attributed to a long tradition of research that does not exist in Jordan 
and to a critical mass of clinical knowledge that is still emerging in some areas of clinical 
practice, such as nursing (80), and not existing at all in others, such as physiotherapy. 
Furthermore, the profession of physiotherapy in Jordan is still residing under the auspices 
and protection of the medical profession, a factor that has led to its lack of professional 
autonomy (81). Physiotherapists in Jordan are obligated to practice their profession under 
physicians’ orders. Therefore, the use of research findings in Jordan to inform the choice 
of techniques is limited. The factors that Jordanian physiotherapists use to select 
interventions include their professional education, attendance of continuing professional 
development (CPD) courses, previous experiences with a patient or following peer 
recommendations. No obligation that involves the profession of physiotherapy exists to 
demonstrate the effectiveness and efficiency of an intervention before its inclusion in an 
undergraduate course or in the area of CPD (82). This situation may be one of the reasons 
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that have led to the inconsistency in the provision of physiotherapy services. The absence 
of appropriate measurement tools in the Arabic language presents a challenge in 
providing evidence that supports the effectiveness of physiotherapy interventions. 
Variations do exist in physiotherapy practice (83); individuals who present with very 
similar symptoms may be treated in different ways depending on the treating clinician 
and the clinical context they are treated in (55,84). This reality might suggest the 
importance of treating people with LBP through evidence-based interventions rather than 
through therapists’ preference, habits or traditions (83,85,86). 
Physiotherapists are keen to establish the clinical effectiveness(3) of the various 
interventions they use in their clinical practice (73,79,87). Healthcare providers, 
managers and commissioners are encouraged to base their decisions on evidence-based 
interventions or clinical guidelines. For example, the guideline developed by the National 
Institute for Health and Care Excellence for the management of non-specific LBP (88) 
include both expert opinions and evidence of the effectiveness or efficiency of various 
types of complex physiotherapy interventions (84).  
In the healthcare field, information and evidence can be generated from three types of 
data collection activities, which are clinical audit, research and service evaluation (79). 
Table (1.1) defines these activities and shows the purpose of conducting each of these 
data collection activities. 
Information is achieved through a clinical audit. The aim of a clinical audit is to ensure 
that the effectiveness of healthcare services meets the agreed high-quality standards. A 
clinical audit is considered a continuous cycle of measurements that help policymakers 
take actions to bring practice in line with these high-quality standards and thus enhance 
the quality of care and health outcomes (89). The second type of evidence is achieved 
through empirical studies. These studies generate new knowledge that helps in practice 
development or guides future research.  
                                                 
3 Mawson defines effectiveness as ‘The ability of the healthcare practitioner, multidisciplinary team or organisation to 
produce results or outcome, i.e. extent to which the recovery potential is achieved’ (87). 
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Table 1.1 Comparisons between different data collection activities  
Data collection activity Purpose 
Clinical audit 
Measures existing practice against evidence-based clinical standards. This typically 
involves measuring both process and outcomes at the same time. 
Research 
Generates new knowledge where there is no or limited research evidence available 
and which has the potential to be generalisable or transferable 
Service review 
Service/practice evaluation: Evaluates the effectiveness or efficiency of an existing 
or new service/practice that is evidence based, with the intention of generating 
information to inform local decision-making. 
Service/practice development: Introduces a change in service delivery or practice 
for which there is evidence derived from research or from other health/social care 
settings that have already introduced and evaluated the change. 
Adapted from Brain et al.(89) 
The third data collection activity is service review, which incorporates both service 
evaluation and service development. Service evaluation is used to evaluate current 
practice. Both research and service development might lead to the development of 
healthcare services (79). However, research is frequently used to investigate the effect of 
a new treatment on a specific group of patients. In research, a group of individuals with 
specific characteristics is recruited to be randomised later into at least two groups. The 
randomisation element in research is important to establish the causal relationship 
between the effect of a particular treatment and the pre-specified outcome. Furthermore, 
research tests a hypothesis mathematically to determine the probability of the change in 
a patient’s outcome being a random event or a result of the new treatment (89). The 
research results might be generalisable and transferable to other healthcare settings. On 
the other hand, service development uses rigorous methods to provide evidence of the 
effectiveness or efficiency of the treatment in a clinical context. Service development 
aims to investigate individuals’ response to therapeutic intervention in a real clinical 
situation (89). Compared with research, service review does not aim to establish causality; 
it aims to establish the best treatment. Both types of studies are important in decision-
making to provide evidence for therapy effectiveness and efficiency.  
As mentioned earlier in this section, a long tradition of research does not exist in Jordan 
because of a number of factors, such as difficulties in designing studies and the lack of 
appropriate measurement tools. Therefore, commencing the research through an 
evaluation of the current healthcare services provided by physiotherapists in Jordan for 
individuals with LBP is appropriate. This research programme aims to respond to this 
shortcoming in the Jordanian healthcare system by developing an appropriate outcome 
measure that can be used in both research and clinical practice to provide information to 
inform clinical decision-making. 
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1.2.1 Outcome measures in physiotherapy 
In physiotherapy, two types of outcome measures are used, namely, generic and 
condition-specific outcome measures. Binkley et al. (90), p. 372, defines generic 
measurement tools as measures that “assess overall health, including social, emotional, 
and physical health status, and are intended to be applicable across a broad spectrum of 
diseases, interventions, and demographic and cultural subgroups”. Condition-specific 
measures, also called ‘disease-specific measures’, are designed to “assess attributes that 
are most relevant to the disease or condition of interest. Ideally, disease-specific 
measures are composed of items that are frequently affected by the condition of interest 
and that are likely to demonstrate clinically important change” (90), p. 372. Compared 
with condition-specific measures, generic measures do not focus on issues of particular 
interest to individuals with a specific condition (91). Therefore, condition-specific 
measurement tools have a greater utility in clinical practice at the individual level to 
inform clinical decision-making than do generic instruments because condition-specific 
measurement tools are designed to capture clinically important changes.  
Individualised measurement tools are required because individual patient preferences 
significantly vary, and consequently, patient goals are idiosyncratic. Thereby, capturing 
what individual patients perceive as important might be valuable in the design of pertinent 
outcome measures (91). 
In the examination of LBP within the Jordanian context, a number of studies indicated 
that LBP is a major problem in Jordan that leads to physical and psychological problems 
(92-95). The burden of the problem suggests the importance of further research within 
the Jordanian clinical context to understand the impact of LBP on individuals and monitor 
changes in their health status after physiotherapy interventions. The generation of 
appropriate evidence on the effectiveness of physiotherapy practice in Jordan requires the 
implementation of appropriate outcome measures (96).  
Therefore, the research process presented in this thesis covered the two main approaches 
that will enable the achievement of the overarching aim of this thesis. The first approach 
requires critically appraising current LBP outcome measures to select an appropriate 
measurement tool for cross-cultural adaptation into Arabic language and then testing it in 
a Jordanian clinical context. The second approach will require, in the instance of the 
absence of a suitable current LBP measurement tool [Chapter 7], the utilisation of a 
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mixed-methods approach that will enable the development of a new LBP outcome 
measure and its clinical testing it in a clinical context. However, before the critical 
appraisal of current LBP outcome measures, understanding LBP [Chapter 1], the impact 
of LBP on individuals’ quality of life [Chapter 2], the healthcare models used in the 
management of LBP [Chapter 3] and the dimensions that are often measured after 
physiotherapy is equally important [Chapter 4]. These aspects play a key role in the 
development of outcome measures. 
The next subsection will explore the epidemiology of LBP within the Jordanian context 
and compare the data gathered from different population-based epidemiological studies 
conducted worldwide and in Jordan. This is important in this thesis because little is known 
about the epidemiology of LBP in Jordan. 
1.3 Epidemiology of LBP 
1.3.1 Background 
To fill this gap in the literature, the following subsection aims to define the targeted 
population, explore the prevalence of LBP and determine the personal and environmental 
factors that affect the clinical course of LBP. Doing so is important to understand the 
similarity and differences between the Jordanian context and that of the rest of the world.  
Epidemiology is defined as “the study of the distribution and determinants of health-
related states or events in specified populations, and the application of this study to the 
control of health problems” (97). To obtain a general understanding of LBP 
epidemiology, this subsection covered LBP topography, prevalence and clinical course. 
A systematic search was used to identify the studies that were conducted in Jordan and 
worldwide on the prevalence of LBP in the general population.  
Hoy et al. (3) conducted a systematic review by using Cochrane and meta-analysis of 
observational studies in epidemiology (MOOSE) guidelines. The research was conducted 
by the first author, and the findings were reviewed for thoroughness and accuracy by an 
independent researcher according to pre-set eligibility criteria. The search strategy was 
well illustrated, so replicating and tracing the search process is easy (98).  
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In Hoy’s review, publications from 1980 to 2009 were searched in several appropriate 
databases, such as MEDLINE, EMBase and CINAHL. A scoping review identified that 
many epidemiological studies were published subsequent to the last systematic review of 
Hoy (3). These more recent epidemiological studies reported the prevalence of LBP and 
the associated personal and environmental factors in different regions around the world, 
including low- and middle-income countries. The last systematic review of the global 
prevalence of LBP did not include any study that reported the prevalence rates of LBP in 
Jordan. To examine the LBP prevalence rates in Jordan, this research programme updated 
the systematic review of Hoy et al. (3), replicated the methods used and applied the 
MOOSE and Cochrane Collaboration recommendations (99,100). Doing so is important 
to critically review publications on LBP prevalence between January 2009 and May 2014. 
The next subsections will present the search strategy and the findings of the new 
systematic review. 
1.3.2 Method 
This systematic review was conducted with the use of a predetermined protocol in 
accordance with the Cochrane Collaboration recommendation (101) and the PRISMA 
statement (102).  
1.3.2.1 Data sources and search strategy 
CINAHL Plus, CINAHL complete, Health Source: Nursing/Academic Edition, 
MEDLINE, Scopus, EmBase and different combinations of MeSH keywords and 
Boolean logic were used (Table 1.2). The electronic search was complemented by hand 
through a search of the reference lists of the studies found. This process was undertaken 
by TA and verified by a second reviewer (AA4). 
Table 1.2: MeSH keywords 
Condition (AND) Epidemiological parameter (AND) Targeted population (AND) 
back pain (OR) lower back pain 
(OR) back ache (OR) backache 
(OR) lumbago 
Prevalence (OR) incidence (OR) 
frequency (OR) occurrence (OR) 
surveillance 
general population (OR) 
community (OR) population-based 
(OR) dwellings 
MeSH: Medical Subject Headings 
  
                                                 
4 Mr. Ahmed Adem is a musculoskeletal physiotherapist who is doing a PhD in Sheffield Hallam University in the LBP 
field. 
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1.3.2.2 Study selection 
Epidemiological studies needed to meet the following criteria to be included: 
1.3.2.2.1 Participants 
Studies on adult individuals (>18 years old) presenting with signs and symptoms 
suggestive of LBP, defined as activity-limiting LBP (with/without pain referred into one 
or both lower limbs) that lasts for at least 1 day were considered for inclusion. If the 
studies did not specify episode duration but did specify the anatomical location of the 
pain, these studies were included. This review aims to explore the prevalence of LBP in 
the working population; therefore, studies that recruited individuals who are older than 
18 years were included. Those studies that estimated the prevalence of LBP in a specific 
population, such as nurses, were excluded. This step is important to ensure the 
generalisability of the results. Non-population-based studies were excluded because they 
were not representative of the national population, and they might limit any attempt to 
describe disorder patterns in a country. Studies that reported only pain from feverish 
illness/menstruation or were limited to a subset of individuals with LBP were excluded. 
1.3.2.2.2 Study design 
All population-based cross-sectional or longitudinal cohort studies published between 
January 2009 and May 2014 in which the prevalence of LBP was reported were 
considered for inclusion. 
1.3.2.2.3 Language 
The author of this thesis has a good command of both the English and Arabic languages. 
Articles written in other languages were therefore excluded. 
Two reviewers (TA/AA) independently assessed the titles and abstracts of all retrieved 
references to identify the studies that appeared to meet the inclusion criteria. The 
reviewers later agreed upon the studies that should be retrieved for full-text review. In the 
case of disagreement, a third reviewer (CL5) was available to arbitrate; however, this was 
not needed. 
                                                 
5 Dr. Chris Littlewood is a musculoskeletal physiotherapist and a research follow at Sheffield University 
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1.3.2.3 Data extraction and management 
The current review followed the same data extraction protocol used by Hoy et al. (3). The 
relevant study information was extracted (by TA) into a Microsoft Excel database. The 
extracted information included the following: region, country, year of publication, study 
type, sample size, case definition (anatomic/minimum episode duration/activity 
limitation), recall period, urbanicity, age, gender, prevalence and each item from the risk-
of-bias tool (Table 1.3). Double entry of data was undertaken (by AA) for a randomly 
selected sample of studies (10 studies), and it indicated a high level of accuracy. 
1.3.2.4 Assessment of the risk of bias 
One reviewer (TA) assessed the risk of bias in each of the retrieved articles by using the 
same assessment tool developed and validated by Hoy et al. (103). The list included 10 
items addressing four domains of bias, namely, selection, nonresponse, measurement and 
analysis bias (Table 1.3). 
Table 1.3 Assessment tool for the risk of bias 
Items Low Moderate High 
1- Was the study’s target population a close representation of the national 
population in relation to relevant variables? 
   
2- Was the sampling frame a true or close representation of the target 
population? 
   
3- Was some form of random selection used to select the sample, OR was a 
census undertaken? 
   
4- Was the likelihood of nonresponse bias minimal?    
5- Were data collected directly from the subjects (as opposed to a proxy)?    
6- Was an acceptable case definition used in the study?    
7- Was the study instrument that measured the parameter of interest shown to 
have validity and reliability? 
   
8- Was the same mode of data collection used for all subjects?    
9- Was the length of the shortest prevalence period for the parameter of 
interest appropriate? 
   
10- Were the numerator(s) and denominator(s) for the parameter of interest 
appropriate? 
   
11- Summary item on the overall risk of study bias    
The response choices for each item were either high risk or low risk of bias. The tool also 
included a summary assessment indicator that evaluates the overall risk of study bias. The 
summary indicator was divided into three categories, namely, high risk of bias (scores 0–
3), moderate risk of bias (scores 4–7) and low risk of bias (8–10). Hoy et al. (103) checked 
the validity and reliability of the assessment tool and indicated that it is reliable and valid 
to examine observational studies in the LBP field. A second reviewer (AA) assessed the 
risk of bias on a sample of eight studies (17%) to ensure that the criteria were applied 
consistently, and agreement could be reached. The overall level of agreement between 
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the two reviewers (TA and AA) was moderate (K = 0.69). Kappa statistics was calculated 
with SPSS® 22.  
Differences relating to the interpretation of the criteria in the checklist were resolved 
through discussion. In the majority of instances, the initial assessment by TA was verified 
through a consensus. The quality of the overall evidence from the systematic review was 
summarised with the Grading of Recommendations Assessment, Development and 
Evaluations system (101), which has the following categories: 
 High quality: Further research is very unlikely to change our confidence in the estimate. 
 Moderate quality: Further research is likely to have an important impact on our 
confidence in the estimate and may change the estimate. 
 Low quality: Further research is very likely to have an important impact on our 
confidence in the estimate and is likely to change the estimate. 
 Very low quality: Any estimate is very uncertain. 
1.3.2.5 Assessment of the impact of case definition on the LBP prevalence range 
One of the important criteria in designing an observational study is the case definition 
because if different studies define LBP in different ways, reviewers may not be able to 
obtain accurate figures of prevalence across countries in a consistent manner (3,104). The 
case definition of LBP has two components, namely, topography and temporality. 
Topography refers to the anatomical location of the pain, and temporality refers to the 
recall period or episode duration (104).  
Hoy et al. (104) indicated that the majority of studies used three topographical categories, 
namely, back pain, LBP and pain in the area between the inferior margin of the 12th rib 
and the inferior gluteal fold (104). The category of back pain refers to any pain in the 
whole spinal segmental levels (cervical, thoracic, lumbar, sacral or coccyx). LBP might 
only include patients who have pain in the lumbar or sacral region, and this is more 
specific than the previous category. The last topographical category of LBP is more 
specific than back pain and LBP. Different recall periods were also used. Point 
prevalence, 1 month and 1 year are examples of the recall periods used. 
1.3.2.6 Subgroup analysis 
One reviewer (TA) conducted the subgroup analysis. Methodologic heterogeneity 
between observational studies in the field of LBP is well known (104) and has a clear 
impact on the ability to synthesise findings in the current review (105). Therefore, a 
narrative approach was undertaken to synthesise the findings on the environmental and 
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personal factors associated with the high prevalence of LBP. The prevalence estimates 
associated with different age groups, genders, marital statuses, educational levels, 
occupations, body weights, psychological factors and physical activities reported in the 
included studies were extracted and inserted in separate spreadsheets. These factors were 
determined prior to conducting the systematic review; new factors identified during data 
abstraction were added to the Excel database. Subgroup analysis was performed to 
examine the relationships between different environmental or personal factors and high 
LBP prevalence rates. The findings of this review were compared with those of the last 
systematic review of the global prevalence of LBP. Prevalence rates were combined 
according to the case definition and recall period. 
Figure 1.2: Study selection process 
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1.3.3 Results 
1.3.3.1 Prevalence of LBP 
The initial systematic search returned 2606 articles published between January 2009 and 
April 2014 (Figure 1.2). Only 47 articles (Table 1.4) were included. The systematic search 
identified three studies that explored the one-year prevalence in Jordan. However, these 
were excluded because they reported the prevalence of LBP in a restricted population and 
not in the general population. This current systematic review suggests that the LBP point 
prevalence ranges from 25% to 47.7%, the one-year prevalence ranges from 7.9% to 49 
% and the lifetime prevalence ranges from 7% to 83.4%.  
The LBP recurrence rates over a one-year period in the current systematic review reported 
in this thesis ranged from 62.4% to 72% (35,106). The pattern of pain reporting over one 
year was relatively similar to the recurrence pattern. This result might also support the 
notion that individuals who have previous LBP episodes early on in their life are likely 
to continue to experience LBP in the future.  
1.3.3.2 Quality of overall evidence 
The majority of the studies (38 studies) were of a moderate quality, so the overall quality 
of evidence in the current review was considered moderate as well. This finding suggests 
that future research is likely to have an important impact on the level of confidence in the 
estimate and might change the estimate of LBP (103). Figure1.3 shows the different 
aspects related to the assessment of risk of bias. The findings suggested that the majority 
of studies included in the current review used less precise case definitions, long recall 
periods and invalid measurement instruments. These flaws might reduce the confidence 
in the reported prevalence rates and ultimately distort the current understanding of LBP. 
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 Table 1.4: Prevalence of LBP around the world 
No Authors § Country Design Anatomical definition Recall period Age group Prevalence 
rates 
Sample 
size 
Attrition % Risk of 
bias 
1 Abegunde et al. 
(44) 
Nigeria Cross-sectional LBP 3 months 60 to 110 40.16 630 1.56 Moderate 
2 Akinpelu et al. 
(107) 
Nigeria Cross-sectional LBP 1 year ≥18 47 1262 Not clear Moderate 
3 El-Sayed et al. 
(32) 
Ethiopia Cross-sectional BP 1 week Not clear 16.7 900 18 Moderate 
4 Igumbor et al. 
(33) 
South Africa Cross-sectional BP 1 year ≥18 38.27 473 4.6 Moderate 
5 Miszkurka et al. 
(45) 
Burkina Faso Cross-sectional BP 1 year ≥18 24 [21.5-26.6] 4822 2 Moderate 
6 Baek et al. (26) Korea Cross-sectional LBP 24 hours ≥65 72.6 714 36.14 Moderate 
7 Biglarian et al.  
(108)  
Iran Cross-sectional LBP 1 month 20-65 29.9 E 25307 Not clear High 
8 Bihari et al. (28) India Cross-sectional LBP 24 hours 10 to 70 8.2 2086 10 Low 
9 Cho et al. (109) Korea Cross-sectional Area below the 12th rib 
and above the gluteal 
fold 
Point 
6 months 
Lifetime 
40 to 79 (rural 
community) 
Point: 33.4 [32-
34.9] 
6 months: 48 
[46.5-49.5] 
Lifetime: 61.3 
[59.8-62.7] 
4181 10.2 Moderate 
10 Choi et al. (34) Korea Cross-sectional BP 1 year ≥18 19.5 1576 Not clear Moderate 
11 Chou et al. (110) Taiwan Cross-sectional LBP 3 months ≥15 25.7 32,660 Not clear Low 
 
 
 
 
36 
 
   
12 Davatchi et al. 
(111) 
Iran Cross-sectional LBP 1 week ≥15 Dorsolumbar: 
41.9 
1565 13.73 Moderate 
13 Fujii et al. (112) Japan Cross-sectional Area below the 12th rib 
and above the gluteal 
fold 
1 month 
Lifetime 
20 to 79 1 month: 35.7 
Lifetime: 83.4 
65,496 Not clear Moderate 
14 Jackson et al. 
(113) 
China Cross-sectional BP 6 months Not clear 17.56 1003 67.04 High 
15 Lu et al. (47) Philippine Cross-sectional LBP 1 year 18 to 85 21 11,000 Not clear Moderate 
16 Ono et al. (27) Japan Cross-sectional LBP 1 month 18 to 75 28.4 2,358 32.18 Low 
17 Sandoughi et al. 
(50) 
Iran Cross-sectional Area below the 12th rib 
and above the gluteal 
fold 
1 week ≥15 28.83 [26.90 to 
30.77] 
2100 22.22 Moderate 
18 Subramaniam et 
al. (114) 
Singapore Cross-sectional BP Life time ≥18 7 6616 24.1 Moderate 
19 Teraguchi et al. 
(115) 
Japan Cross-sectional LBP 1 month 21 to 97 43 975 39.33 High 
20 van Oostrom et 
al. (39) 
Netherland Longitudinal cohort LBP 1 year 1993-1997: : 
25 to 65 
1993-1997: 
20.6 
1998-2002: 
18.1 
2003-2007: 
20.6 
t1: 6118 
t2: 4917 
t3: 4520 
48.42 Moderate 
21 Wong et al. (116) Hong Kong/ 
China 
Cross-sectional BP 3 months ≥18 28.5 5001 41.56 Moderate 
22 Woo et al. (117) Hong Kong/ 
China 
Longitudinal cohort BP 1 year >65 48 4000 21.18 High 
23 Yamada et al. 
(49) 
Japan Cross-sectional Area below the 12th rib 
and above the gluteal 
fold 
1 month 20 to 79 25.2 20044 0.09 Moderate 
24 Yeo et al. (118) Singapore Cross-sectional LBP 6 months 18 to 85 19 4141 56.4 Moderate 
25 Yoshimura et al. 
(119) 
Japan Longitudinal cohort BP 1 month Not clear 37.7 9046 Not clear High 
26 Björnsdóttir et al. 
(51) 
Iceland Cross-sectional CLBP 1 year 18 to 79 18 5756 39.7 Moderate 
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27 Fernández-de-
las-Peñas et al. 
(35) 
Spain Cross-sectional LBP 1 year ≥16 19.9 29,478 Not clear Moderate 
28 Fernndez-de-las-
Pe~nas et al. 
(120) 
Spain Cross-sectional LBP 1 year ≥16 7.9 [7.4–8.3] 22,188 Not clear Moderate 
29 Gerhardt et al. 
(121) 
Germany Cross-sectional BP 3 months 18 to 74 17.73 2408 38.24 Moderate 
30 Halla-aho et al. 
(122) 
Finland Cross-sectional BP 2009: 2 weeks 2009: 75, 80, 
85, 90, 95 
2009: 18.1 2009: 
1610 
2009: 38.85 Moderate 
31 Jiménez-
Sánchez et al. 
(36) 
Spain 
(Madrid) 
Cross-sectional LBP 1 year ≥16 22.6 12190 Not clear Moderate 
32 Klemenc-Ketiš et 
al. (53) 
Slovenia Cross-sectional BP 1 month 20 to 80 42.58 937 Not clear Moderate 
33 Kolb et al. (106) Switzerland         
34 Korovessis et al. 
(123) 
Greece Longitudinal cohort BP 1 year Not clear 1999: 33.2 
2000:38.5 
2001:37.4 
2002: 38.0 
2003: 37.0 
3881 50.2 Moderate 
35 Langley et al. (37) Spain Cross-sectional Area below the 12th rib 
and above the gluteal 
fold 
6 months ≥20 39.5 674 Not clear Moderate 
36 Leboeuf-Yde et 
al. (124) 
Denmark Cross-sectional BP 1 month ≥18 60.53 5039 Not clear Moderate 
37 Neva et al. (125) Finland Cross-sectional LBP 1 year 20 to 71 Lifetime:  57 
1 year: 43 
34,902 53.36 Moderate 
38 Pedisic et al. (38) Croatia Cross-sectional BP 1 year 21 to 64 25 1491 25.45 Moderate 
39 Schmidt et al. 
(126) 
Germany Cross-sectional BP not clear ≥15 66.3 1030 Not clear Moderate 
40 Sterud et al. (127) Norway Cross-sectional BP 3 months 18 to 75 63.7 8756 44.41 Moderate 
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§ Studies were ordered according to continent and then arranged alphabetically according to the surname of the first author in each of these continents 
BP: back pain; LBP: low back pain; p: prevalence 
Risk of bias was examined with the assessment tool developed by Hoy et al. (103) 
High = 0–3; Moderate = 4–7; Low = 8–10 
 
41 Alkherayf et al. 
(128) 
Canada Longitudinal cohort LBP 1 month 18 to 66 12.8 6745 32.81 Moderate 
42 Freburger et al. 
(129) 
USA (North 
Carolina) 
Cross-sectional LBP 6 months 20 to 59 20.91 73,507 44.71 Moderate 
43 Johannes et al. 
(130) 
USA Cross-sectional BP 3 months ≥21 10.16 837 84.38 High 
44 Ohayon et al. 
(131) 
USA 
California 
Cross-sectional CLBP point ≥18 47.71 27,035 73.91 Moderate 
45 Ferriera et al. 
(132) 
Brazil Cross-sectional CBP point 18 to 94 25 3243 14.36 Moderate 
46 Meucci et al. 
(133) 
Brazil Cross-sectional LBP 1 year 20 to 69 40 972 Not clear Moderate 
47 Peláez-Ballestas 
et al. (52) 
MEXICO Cross-sectional Area below the 12th rib 
and above the gluteal 
fold 
3 months ≥20 2002: 4.2  
2010:9.6 
2002: 
3182 
2010: 
2732 
t1: 5.6 
t2: 10.4 
Moderate 
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1.3.3.3 Examining the impact of different case definitions on LBP estimates 
This review involved inadequate studies to fully examine the impact of different case 
definitions on the LBP estimates. For example, only three studies in this review used the 
temporal parameter ‘point prevalence’, whereas only six used the topographical 
parameter ‘pain in the area between the inferior margin of the 12th rib and the inferior 
gluteal fold’. This systematic review followed the same search strategy used in the last 
global review; therefore, combining the data extracted from the observational studies 
included in the previous review of Hoy et al. (3) with those retrieved by this current 
review is acceptable. Doing so gave the opportunity to extract different case definitions 
and prevalence rates from 212 studies (Table 1.5). 
Figure 1.3: Assessment of risk of bias 
 
 
Table 1.5 shows that the range of LBP estimates tends to increase when researchers used 
a less precise case definition; however, this was not always the case with long prevalence 
periods (e.g. 3 months). This inconsistency might also be due to the small number of 
studies that used a particular case definition and recall period. For example, the range of 
LBP ‘point’ estimates increase with generic anatomical definitions, such as ‘back pain’.  
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Table 1.5: Updating the last systematic review 
Recall Period Back pain (n=107) LBP (n=151) 
Area below the 12th rib 
and above gluteal fold 
(n=20) 
Point (n=56) 
M: 20.7 (n=23) 
R: [1.2-49.7] 
M: 22.7 (n=30) 
R: [1.0-49] 
M: 15.5 (n=3) 
R: [4.2-33.4] 
1 week (n=26) 
M: 26.6 (n=5) 
R: [8.1-35.7] 
M: 16.3 (n=14) 
R: [5.1-41.9] 
M: 15.9 (n=7) 
R: [5.5-28.83] 
2 weeks (n=4) 
M: 20.4 (n=2) 
R: [18.1-22.7] 
M: 43.3 (n=2) 
R: [41.2-45.4] 
M: N/A 
R: N/A 
1 month (n=32) 
M: 34.3 (n=12) 
R: [18.9-60.5] 
M: 29.4 (n=18) 
R: [7.5-52.7] 
M: 30.5 (n=2) 
R: [25.2-35.7] 
3 months (n=15) 
M: 34 (n=6) 
R: [10.2-63.7] 
M: 35.7 (n=7) 
R: [24.1-52.1] 
M: 6.9 (n=2) 
R: [4.2-9.6] 
6 months (n=13) 
M: 39.7 (n=5) 
R: [17.6-59.7] 
M: 45 (n=6) 
R: [15.6-71.4] 
M: 43.8 (n=2) 
R: [39.5-48] 
1-year (n=89) 
M: 32.9 (n=42) 
R: [8.9-76] 
M: 37.9 (n=44) 
R: [7-72.4] 
M: 20.9 (n=3) 
R: [11.6-28.2] 
Lifetime (n=45) 
M: 43.7 (n=12) 
R: [3.9-85.5] 
M: 42.4 (n=30) 
R: [1.6-84] 
M: 52.1 (n=3) 
R: [1.6-83.4] 
n is the number of estimates, M is the mean and R is the range. 
With regard to the influence of different recall periods on LBP estimates, this review 
cannot identify a clear and consistent pattern that suggests an association between long 
recall periods and a wide range of LBP estimates. For example, the lifetime LBP 
prevalence range was similar across different case definitions. This result might be due 
to selection, recall and measurement biases, which can indicate that the identification of 
a specific anatomical area within the case definition is important (3). 
1.3.3.4 Subgroup analysis of the personal and environmental factors associated with 
high prevalence rates 
Exploring the global prevalence of LBP in this review with the use of different 
populations and settings, as well as within the context of different countries, enabled the 
current review to examine the association between some of the environmental and 
personal factors and the high prevalence of LBP. Despite the methodologic heterogeneity 
between the studies included in the current review, this review combined only the 
prevalence rates of studies that used the same case definition and recall periods. It 
reviewed some of these factors associated with high prevalence rates, such as age, gender, 
educational level, body mass index and physical activity. 
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1.3.3.4.1 Age 
Figure 1.4 shows the median prevalence of LBP according to age group. The evidence in 
the current systematic review with regard to the idea that LBP is prevalent in old age is 
conflicting. In this review, 10 studies suggest that age is one of these factors, whereas the 
overall LBP prevalence continues to increase with age until the mid-60s and then slowly 
declines (34,51,53,110,114,123,127,133-135). On the other hand, five studies reported 
that the LBP prevalence rates are relatively similar across different age groups 
(49,116,128,130,132). 
Figure 1.4: Median prevalence of LBP, with interquartile range, according to age group 
 
1.3.3.4.2 Gender 
Table 1.6 shows the LBP prevalence according to gender. In this paper, 24 studies 
indicated that LBP is more prevalent in females than in males (26,28,32,34,35,38,39,50-
53,106,108-110,112,115,121,123,125,127,129,132,133). Furthermore, one study 
reported that women are more likely to develop chronic LBP or take sick leaves as a result 
of LBP (116). However, four studies in this review reported no significant differences in 
prevalence between genders (114,120,128,130). 
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Table 1.6: Comparison of the prevalence of LBP according to gender 
 
Recall 
period 
 
Gender 
Anatomical location of pain 
Back pain 
Low back 
pain 
R12 to 
lower GF§ 
Point 
prevalence 
Male - - 23.8 
Female - - 41.2 
1 day 
Male - 32.2 - 
Female - 46.4 - 
1 week 
Male 37.4 - 18.9 
Female 62.6 - 39 
1 month 
Male 35.2 19.2 43.3 
Female 40.6 26.8 42.6 
3 months 
Male 20.3 21.5 4.8 
Female 22.4 30 8.5 
6 months 
Male - - 36.4 
Female - - 49.1 
1 year 
Male 14.7 21.5 - 
Female 23.2 29.2 - 
Lifetime 
Male 7.2 - 68.1 
Female 6.8 - 75.9 
1.3.3.4.3 Marital status 
Ten studies indicated that unmarried individuals reported significantly less LBP than their 
married, divorced and widowed counterparts (35,36,51,108,110,114,120,121,123,132). 
1.3.3.4.4 Place of residence 
Conflicting evidence exists with regard to the place of residence as one of the 
environmental factors that influence the development of LBP. Four studies indicated that 
individuals who are living in rural areas are likely to complain more about LBP than those 
who live in urban areas (50,107,108,123). Only one study (51) found no difference in 
LBP prevalence between different residence places. However, two studies (44,111) 
indicated that LBP is more prevalent in urban areas than in rural ones. 
1.3.3.4.5 Educational level 
People with high educational level (e.g. university degree) were reported in 14 studies to 
have a lower prevalence of LBP than those with low educational level (e.g. school 
education) (34-36,51,108,110,114,120,121,123,127,129,133,136). 
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1.3.3.4.6 Occupation 
Six studies indicated that individuals who are unemployed or retired reported higher LBP 
prevalence rates than do white-collar workers (35,51,110,114,120,129). Two studies 
indicated that blue-collar workers complain about LBP more than do white-collar workers 
(34,127).  
1.3.3.4.7 Body weight 
Ten studies included in the updated review indicated that overweight and obesity are 
associated with increased prevalence of LBP (34-36,51,108,110,120,128,132,133). 
1.3.3.4.8 Physical activity 
Six studies in this review indicated that those individuals who are physically active 
reported a less significant LBP compared with those who live a sedentary lifestyle 
(34,35,40,110,120,128). 
1.3.4 Discussion 
The findings of this review suggested that LBP continues to be a major problem 
throughout the world and is most common among females and people aged 40–65 years 
old, do manual work, have a high body mass index and have low levels of education or 
physical activities. The current updated review indicated that the majority of the studies 
used a vague case definition. Furthermore, nearly two-third of the studies were at risk of 
recall bias, and 76% of the studies did not use a valid and reliable measurement tool, so 
the risk of measurement bias was increased. The findings of this review were similar to 
those of the last systematic review of the global prevalence of LBP (3). 
The findings of the current review suggested that LBP prevalence continues to increase 
with age until the mid-60s, and then it decreases. The prevalence values for people over 
60 years might have been missed because of under-reporting, or perhaps individuals 
already suffer from other comorbidities, such as osteoporosis or hip fracture, which may 
affect their lives more than LBP does (137). 
Many recent international studies indicated that LBP is a long-term or lifelong condition 
(3,4,41,138) and that the study of pain should be over the course of one’s life and not at 
an individual point in time. These studies argue that LBP is highly prevalent in 
adolescents and in children. This result can mean that individuals who are affected by 
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LBP at a young age will continue to have episodes of LBP throughout their whole life. 
Therefore, LBP is considered a recurrent condition, such as asthma, which has episodes 
of exacerbations and remissions (4,41,55).  
The study of the trajectory of LBP is important to the development of an outcome measure 
in this thesis because compared with other chronic health conditions, such as chronic 
obstructive pulmonary disease, the clinical course of LBP fluctuates over time, and 
consequently, the measurement of LBP should be over time and not at an individual point 
in time. This review also suggests that LBP outcome measures should possess the ability 
to reflect three patterns of changes, namely, improvements, deteriorations or lack of 
change. These patterns of changes were reported in a recent study by Leboeuf-Yde et al. 
(138), who examined the absence of LBP in the general population over one year. The 
participants received an automated text (SMS) message every two weeks. They were 
asked to report their number of days with LBP in the preceding fortnight. Approximately 
11% of the respondents reported continuous LBP over a period of one year, 83% had at 
least one month without LBP and 52% reported two months’ interval without feeling 
LBP.  
1.3.4.1 Comparison between the Jordanian studies and the international studies 
The systematic search showed that no studies investigated the prevalence of LBP in the 
general population in Jordan; however, a number of institutionalised studies that describe 
the prevalence of LBP were identified in the literature. These studies have a moderate 
(92,93) to high risk of bias (94). The cross-sectional studies conducted in Jordan found 
that the LBP prevalence ranges from 56% to 81%. 
Such discrepancies between international studies and those in Jordan may be attributed 
to the different research methods used or may be caused by the specific nature of the 
Jordanian society, which certainly differs from those of other cultures. Reporting pain for 
Muslims, for example, is somewhat related to the acceptance of the idea that pain is from 
Allah (the creator), and it is a test of human patience (95). Reporting pain for males may 
be culturally unacceptable in Jordan and may be considered a sign of weakness, and this 
may be the cause behind the low figures of reporting pain among males (95). Taking into 
consideration culture and ethnicity may be of great importance to identify what is 
important to measure in people with LBP. The same issue was reported in a study that 
used the Oswestry Disability Index; in this research, the majority of Japanese females 
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who were suffering from LBP did not answer questions related to their sexual activities 
because of cultural reasons (139,140). 
The Jordanian studies and the international ones had similarities and differences in the 
methods they used. Jordanian authors used the international case definition of LBP. Doing 
so helped in pooling findings from different studies to draw the Jordanian profile 
compared with that of the international community. All Jordanian studies selected the 
cross-sectional method as the most convenient and pragmatic method to overcome the 
high cost and dropout rate encountered in the conduct of longitudinal prospective cohort 
studies. 
Arguably, the findings of the Jordanian studies may have been affected by recall biases 
because the participants were asked to remember if they suffered from LBP within the 
past year. Other studies limited the recall period to one month to control recall biases and 
hence increase confidence in the accuracy of their findings. Moreover, the random 
sampling methods employed by the non-Jordanian studies can increase external validity 
and aid generalisability.  
Finally, a critical comparison between the instruments used indicated that the non-
Jordanian studies might have been able to target the specific domains relevant to LBP by 
using condition-specific tools rather than less pertinent generic tools, such as the 
Middlesex hospital questionnaire (141). 
The current systematic review showed a gap in the literature. The findings of the review 
suggested the lack of valid measurement tools in Jordan, specifically within the LBP field, 
and this finding supports the aim of this thesis to design a suitable outcome measure to 
be used within the Jordanian healthcare system. Furthermore, the review showed that LBP 
is a widespread and common problem, so the development of valid and reliable outcome 
measures might help evaluate and develop current treatment strategies in the Jordanian 
context. 
1.3.4.2 Limitations 
This review has a number of limitations. Firstly, only studies written in English were 
included, so the risk of excluding important studies existed. However, the author of this 
thesis only identified one study (142) written in the French language. Secondly, the 
majority of this work was conducted by one reviewer only. This might introduce the 
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possibility of reviewer bias (143). However, there is a trend in the field of systematic 
review methodology headed for an appreciation of rapid reviews. Commonly such 
reviews utilise one reviewer at the various stages for pragmatic reasons and despite the 
acknowledgment that the potential error is higher, it is generally proposed that most errors 
or omission do not lead to significant change in any conclusion (144). 
1.3.5 Conclusion 
This review supports the findings of the previous global review of Hoy et al.(3). This 
systematic review is important to this thesis because it showed that old age, being a 
female, being married, doing manual work, being obese and having a low level of 
education were some of the factors that might be associated with high LBP prevalence 
rates. This review encourages future epidemiological studies to use precise case 
definitions, short recall periods and valid and reliable measurement tools suitable to be 
used on individuals with LBP to enhance the overall quality of the research design. This 
chapter has identified the knowledge underpinning the condition, and it indicates that the 
measurement of change in individuals with LBP should be over time and not at an 
individual point in time. The next chapter reviewed the impact of LBP on individuals’ 
quality of life.  
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Chapter 2: Impact of LBP on individuals’ quality of life 
Key point in Chapter 2: 
- The pain experience is multidimensional, so many aspects of individuals’ quality 
of life are affected by LBP. LBP might cause many limitations in people’s 
activity levels, which consequently have an impact on their physical, social, 
emotional and cognitive functioning. This chapter provides an in-depth 
understanding of the impact of LBP on the different dimensions of individuals’ 
quality of life. However, no studies have been conducted in Jordan to explore 
the impact of LBP on Jordanian individuals. This chapter demonstrated the need 
to undertake a qualitative study to explore the perspective of Jordanian 
individuals with LBP about the impact of this condition on their life. 
2.1 Introduction 
The systematic review in the previous chapter showed that LBP affects societies 
regardless of geographical location; however, exploring the impact of LBP on 
individuals’ quality of life is equally important in this thesis. Currently, what the impact 
of LBP is on Jordanian individuals is unclear. Therefore, another scoping review of the 
healthcare literature was needed to identify any study that investigated the impact of LBP 
on the quality of life of Jordanians. Doing so is important to identify the dimensions of 
quality of life that are affected by LBP and determine later on in this research programme 
whether the current LBP outcome measures address these affected dimensions. The 
following section aims to explore the experience of living with non-specific LBP at the 
individual level. 
2.2 Meta-synthesis study of qualitative papers that investigated the impact of 
LBP on individuals’ lives 
Froud et al. (5) conducted a recent meta-synthesis of qualitative studies that investigated 
the impact of LBP on people’s lives. The authors searched different databases to identify 
studies that explore people’s experiences of living with non-specific LBP. The authors 
took into consideration that qualitative research can be one part in a clinical trial; 
therefore, they also searched the PEDro database for nested qualitative studies within 
clinical trials. Meta-ethnographic and meta-synthesis approaches were used to 
thematically code abstracted data. These methods were used to identify concepts from 
different individual studies to synthesise a whole picture on the impact of LBP on 
people’s lives. Furthermore, these methods helped develop a comparative understanding 
of LBP (145). Froud et al. (5) modified a meta-ethnographic approach developed by 
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Britten et al. (146) for qualitative data synthesis (Figure 2.1). Terms developed from the 
Cochrane back review search strategy, scoping search and team discussions were used 
(147). The search strategy was well illustrated, and it can help replicate and trace the 
search process (98).  
Figure 2.1: Seven steps of meta-ethnography  
  
Cited in Britten et al. (146) 
2.3 Findings 
A scoping search of the literature identified no studies conducted in Jordan on the impact 
of LBP on individuals’ life. This research programme responded to this gap in health 
services research by conducting a qualitative study in the development of the 
measurement tool phase to explore the perspective of Jordanian individuals with LBP 
about the impact of this condition on their life. The findings reported in this chapter were 
compared with those of Jordanian qualitative studies [Chapter 9]. Doing so enabled 
identifying the similarities and differences between the themes generated in the Jordanian 
studies and those reported in this chapter. 
The systematic searched identified 49 articles describing 42 original studies. Five themes 
were identified from participant-level data. These major themes in the meta-analysis 
study were activities, relationships, work, stigma and changing outlook (5). LBP seems 
to negatively affect individuals’ ability to perform activities of daily living because of 
impairment associated with the condition.  
 “Things like [cleaning the] bathroom and shower and stuff, because you have to get right in 
and you’re bending over when you’re scrubbing.” (Angela, 35, cited in (5)) 
This loss of function also undermined family’s activities, which seemed to affect 
relationships, especially with those closest to the individual with LBP. People with LBP 
also described a paradoxical need for support from those closest to them, but at the same 
time, they avoided social interactions because of intense episodes of LBP. 
1
• Geting started
2
• Deciding what is relevant to the initial interest
3
• Reading the studies
4
• Determining how the studies are related
5
• Translating the studies into one another
6
• Synthesising translations
7
• Expressing the synthesis
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 “…we won’t go anywhere now because of that [being boring with little to talk about except 
pain]. I get too embarrassed and I just hate being in company and you always get onto that 
subject [pain]. And if you’re out for a social evening the last thing people want to hear is what 
your misery, so I just, that’s why we don’t go out often.” (Becky, cited in (5)) 
Sufferers isolate themselves from those closest to them to avoid spoiling the experiences 
of their loved ones. This loss of functional ability might lead to feelings of isolation, 
dependence, cohabitation difficulties and issues involving sexual relationships. 
 “I don’t go out, I don’t answer the phone, I live at the back of the house and I dread it when the 
postman comes. … I don’t know what to say, or anything, I just feel embarrassed. You just think 
‘what do they think of me?” (Kevin, cited in (5)) 
Individuals with LBP described how they modified their work tasks to avoid losing their 
jobs and facilitate function. Allowing some time to recover was one example of these 
modifications. 
 “I don’t look sick, I don’t limp, I don’t have a cane, I’m not in a wheelchair, I don’t look 
terrible … I look good. So [the people I work with] could have the perception that she’s not 
really sick, she’s just taking days off” (Participant 14, cited in (5)) 
 Different age groups reacted differently to the presence of LBP. For example, young 
individuals worried most about loss of employment because of LBP. They perceived LBP 
as a threat to their career, whereas older people who were closer to retirement seemed to 
find asking for help easier. 
“I can’t go off-sick. I can’t afford to go on half-pay [incapacity]. So … so that’s a real dilemma 
and then I think: God, I have to work until I’m 65! I’ve got a mortgage to pay. How am I going 
to cope? … You start thinking: what if it never goes, right? What if it gets worse? What am I 
going to do?” (Anon, cited in (5)) 
“If I am having a bad day they’re [the clients] perfectly happy just for me to sit there and have 
a cup of tea with them and keep them company . . . I make it up to them . . . On a good day I’ll 
flip the damn mattress, but on a bad day I am sitting!” [Female, 57 years old, home aide for the 
elderly (148)]. 
Individuals with LBP also described how they forced themselves to engage in activities 
they thought would likely exacerbate their symptoms simply to maintain social 
relationships or perform tasks at their work despite their pain. Their participation in social 
events, the performance of certain activities at work and the lack of acceptable diagnosis 
might undermine the credibility, legitimacy and validity of their LBP. This situation 
might include not being believed by family, friends, co-workers, employers and 
healthcare providers. 
 “I remember at my sickness interview - you can see the disbelief in the manager’s eyes, and I’m 
thinking OK well …” (male, aged 37, cited in (5)) 
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Some individuals with non-specific LBP managed to adapt to and cope with LBP. Others 
who received a diagnosis for their LBP seemed empowered and accepting of their 
problem, especially if the diagnosis was in the form of radiographic evidence.  
 “I got quite a lot of sympathy from any medical profession because I had an X-Ray and it could 
show the damage, and I certainly...in the rehab programs that I was involved in there were a lot 
of people with non-speciﬁc lower back pain who were...who felt angry at the world, and angry 
at the system, and angry at the health professionals, and I really believe that because I had 
really obviously hurt my back that I did in some ways have it easier.” Lynne, cited in (149)) 
However, some patients doubted the validity of their diagnosis. Individuals with LBP 
expressed their anger, frustration and depression if they received a second diagnosis that 
contradicted their initial diagnosis, especially, if the initial diagnosis implied a 
psychosomatic origin.  
 “the doctors say oh, it’s stress or it’s anxiety and they (put) you on anti-depressants. Then you 
get the surgeons who only look at one line and that’s to cut and they won’t give you an option of 
massage or physiotherapy”. Marjorie, cited in (149)) 
Individuals with LBP described different psychological and emotional statuses, including 
experiencing anxiety, hopelessness, shame, embarrassment, fear of pathology, fear of 
movement, feeling imprisoned, determination, identity threats and uselessness. 
 “I mean, I’ve had days and weeks where I’ve just got depressed over it, and I think, well, I 
can’t be bothered, there’s no point, it’s not getting better… I felt like a wasp with a very tiny 
waist. Just imagine! Such a waist may snap anytime! It was horrible, I just couldn’t move! I 
didn’t think I’d make it.” (Anon, cited in (5)). 
2.4 Summary 
This chapter identified a significant lack of knowledge of the impact of LBP on Jordanian 
individuals. Whether this impact on Jordanians is different from that experienced by other 
nationalities is also unclear. This research programme identified this gap in the healthcare 
literature, and a qualitative study was needed to explore the perspective of living with 
LBP [Chapter 9]. Even if LBP is not a life-threatening condition (104,150), it does affect 
individuals’ quality of life (5). Because of the inability to identify a cause in the majority 
of cases diagnosed with non-specific LBP, healthcare professionals are shifting their 
focus from identifying the cause of LBP to examining the impact of LBP on people’s life 
(5,55). This initiative has resulted in a movement away from a biomedical model to a bio-
psychosocial one for the management of LBP. An understanding of the management 
models of LBP is important in this thesis because these models form the theoretical basis 
of current physiotherapy practice. Biomedical and biopsychosocial models are therefore 
reviewed in the next chapter. 
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Chapter 3: LBP Management models  
Key points in Chapter 3: 
- The bio-psychosocial model is considered the appropriate model for the 
management of LBP. This model seems to address the different dimensions 
related to the impact of LBP on people’s life. 
 
- The WHO used the bio-psychosocial model to develop the International 
Classification of Function, Disability and Health (ICF). The ICF was developed 
as a universal framework to help healthcare professionals understand complex 
conditions, including LBP.  
 
- The WHO encourages healthcare systems to use a new integrated healthcare 
model that places patients at the centre of healthcare. 
3.1 Introduction 
The previous chapters identified the knowledge underpinning LBP. LBP is a chronic and 
costly condition leading to functional limitations that follow a fluctuating trajectory. 
These limitations in physical functioning affect other dimensions of individuals’ quality 
of life, such as mental and social functioning. They also sometimes create complex cases 
requiring multidimensional interventions (6). This chapter aims to identify the knowledge 
underpinning these complex interventions used in the management of LBP and the 
contribution of physiotherapy to the integrated care6 of individuals with LBP. This goal 
is important to improve the understanding on the potential outcomes of the management 
approaches in musculoskeletal physiotherapy and how these outcomes should be 
measured (152). 
Management models have the potential to influence the way health professionals evaluate 
and look after patients. Glanz et al. (153), p. 26, suggested that, “Health behaviour and 
the guiding concepts for influencing it are far too complex to be explained by a single, 
unified theory. Models draw on a number of theories to help understand a specific 
problem in a particular setting or context. They are often informed by more than one 
theory, as well as by empirical findings”. The following subsections aim to assess the 
importance, strengths and weaknesses inherent in the selection of the biomedical or bio-
psychosocial models in the management of LBP. Both models were selected because they 
are two of the most commonly used approaches in spine care (6,154). 
                                                 
6 The WHO defines integrated care as ‘a concept bringing together inputs, delivery, management, and organization of 
services related to diagnosis, treatment, care, rehabilitation, and health promotion’ (151), p. 7. 
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3.2 The biomedical model (also known as the disease model) 
Texts that describe the use of the biomedical model of illness within Western healthcare 
pre-date the 19th century (155,156). Prior to the development of the biopsychosocial 
model in the late 1970s, the majority of clinicians assumed that pain was the consequence 
of a pathological process in the bones, joints, muscles, nerves or connective tissues (157). 
The biomedical model assumes that tissue pathology is directly proportionate to the level 
of pain and disability (158). The model strictly looks at patients’ current condition from 
pathoanatomic or pathophysiologic perspectives and does not recognise the importance 
of psychological, environmental and social influences (154,159,160). In the biomedical 
model, disease can be conceived outside of its embodiment in certain patients and is 
envisioned as an entity unto itself (154). This argument mean that the disease itself can 
be studied independently, with the goal of developing chemical treatments to stop, reverse 
or prevent the pathological process or using mechanical treatment that reconstructs or 
excises the affected structure.  
The objective study of the underlying pathoanatomy and pathophysiology has 
significantly improved the medical profession (154). However, regardless of the success 
in the treatment of many illnesses, some complex and important health conditions have 
proven resistance to the biomedical approach. The biomedical model indicates that health 
is the absence of pain, illness or defect. In this model, any illness has an underlying cause, 
and once that cause is eliminated, the patient will be cured and become healthy again (6). 
The assumptions of the biomedical model were found inadequate in the management of 
many conditions, such as non-specific LBP, which has an unclear cause and 
psychological and social implications that might affect the outcomes of treatment 
(154,161).  
Conditions, such as non-specific LBP, are important because they are common and costly. 
However, the link between clinical assessment, pathological diagnosis, treatment and 
outcomes is lacking. Some issues relating to the management of LBP using the 
biomedical model exist. Firstly, LBP is a self-limiting condition, and people can deal with 
it themselves most of the time, so this symptom can be regarded as a subjective health 
complaint rather than a serious tissue injury (104). In addition, because of current 
limitations in knowledge, healthcare providers cannot identify any affected anatomical 
structures most of the time (>80%) (56). 
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Secondly, the biomedical model explains pain as a tissue injury. This model does not 
consider all the factors that have an impact on people’s quality of life. Biological factors, 
as well as psychological and social factors, should all be considered when a diagnosis is 
made. For example, Carragee (162) suggested that persistent LBP develops frequently in 
patients who, at the time of initial assessment, have a high level of fear avoidance, 
psychological distress, disputed compensation claims and job dissatisfaction. Excluding 
these psychosocial factors when planning spine care correlates strongly with treatment 
failure (163). Hence, the complexity and multidimensional nature of LBP does not lend 
itself to the reductionist approach of the biomedical model. 
Thirdly, this model fails to explain many clinical observations, such as asymptomatic 
patients with disc prolapse (56). Patients who complain of symptoms that have no clear 
cause might be dismissed as not being ill despite the impact of their symptoms on their 
daily life (158). 
Finally, as concluded from the previous chapters in this thesis (epidemiology, pathology 
and natural history of LBP), people clearly react differently to the back pain experience; 
the way patients think and feel have an influence on their disability, pain, illness 
behaviour and clinical progress (161). Social, environmental and contextual issues 
considerably affect disability and illness behaviour (60,72). Individuals with LBP will 
react and modify their behaviour and beliefs according to the surrounding socio-cultural 
environment (164). These issues highlight the limitations of the biomedical model and 
have led to the development of the biopsychosocial model of illness. The biopsychosocial 
model does not only address psychological and biomedical factors but also suggests that 
social factors, such as relationships and role in society, play an important role in the 
management of patients with LBP (104,165). 
3.3 The biopsychosocial model 
The biopsychosocial model is considered an advancement of the biomedical model (154). 
Over recent years, the pathoanatomic and pathophysiologic grounded ‘disease’ within the 
biomedical model has shifted to the contextual grounded ‘disorder’ within the 
biopsychosocial model. This shift was significant because of its impact on the ways 
clinicians evaluate outcomes and the ways these measured outcomes have been utilised 
to guide patient care (154). 
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The biopsychosocial model has received widespread recognition within the spine care 
community, and its implementation has an important impact on the ways in which 
physiotherapy services are delivered and measured (154,166). Compared with the 
biomedical model, the biopsychosocial model suggests that patients’ unique biological, 
psychological and social factors must carry equal weight at the time of evaluation. 
Presentations, such as spinal pain, disability, capability to return to work, patient 
satisfaction, and spine biomechanics, can only be understood and examined through this 
model (167).  
Figure 3.1 suggests that management models affect the level of measurement and the 
implementation of different measurement tools within spine care. The theory of 
measuring scale and scaling methods were discussed in detail in Section 2 in the 
conceptualisation of the problems phase. Figure 3.1 suggests that the biomedical model 
is pointing to an underlying pathoanatomy or pathophysiology in isolation of 
psychosocial factors. Diagnostic radiological imaging, blood tests and range of motion 
measures are a few examples of pathoanatomic measurement tools developed according 
to the biomedical model. On the other hand, the biopsychosocial model recognises the 
different dimensions that are affected by LBP. This understanding has led to the 
development of many patient-oriented outcome measures, such as pain scales and back-
disability scales. Many key elements are built in the biopsychosocial model (158). Table 
3.1 identifies these elements and the factors that influence them.
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Figure 3.1: Use of different management models to determine the use of different outcome measures.  
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Table 3.1: Clinical elements of the biopsychosocial model 
Adopted and modified form Waddell (161) 
Components Depend on Causes 
Physical dysfunction Dysfunction relies on a number of factors; the degree of stress and 
the demand required, with the ability of the musculoskeletal 
system to create balance between both forces. It is said that if a 
functional disturbance has caused back pain then there is always 
a hope for potential recovery. 
Might occur in structurally normal tissues 
A primary dysfunction arising in response to abnormal forces imposed on or generated within the 
musculoskeletal system 
Abnormal patterns of muscle function, abnormal forces acting on musculoskeletal structures, 
abnormal posture or abnormal joint movement may all produce pain 
Segmental soft tissue changes; neurophysiologic and psychophysiologic changes 
Beliefs and coping Expecting pain with much anxiety and attention. The 
understanding of pain influences of previous experiences in 
addition to the power of suggestion or placebos. Such beliefs can 
partially represent the backs’ actual condition, and rather show 
what individuals perceive of their back conditions 
Beliefs Beliefs about damage and disease 
Fear of hurt and harming 
Fear-avoidance beliefs 
Personal responsibility, control, and self-efficacy 
Beliefs and expectations about treatment 
Coping Active or passive 
Catastrophising 
Beliefs affect healthcare: healthcare affect beliefs 
Distress Pain is often associated with a psychological state of arousal and 
distress, which sensitizes the body to pain intensity and lowers the 
pain threshold and tolerance. Thus, LBP patients become 
preoccupied with their back problems and seek medical help. 
Anxiety 
Increased bodily awareness 
Fear and uncertainty 
Depressive symptoms 
Anger and hostility 
Illness behaviour Patient’s attitudes towards pain reflect their emotional processing 
rather than the causative problem. These attitudes are influenced 
by personal beliefs around pain, and individual coping or 
management skills. 
Observations of illness behaviour: 
Pain drawing Help with personal care 
Pain adjectives and description Non-anatomic or behavioural description of symptoms 
Overt of pain behaviour Non-organic or behavioural responses to examination 
Down-time Use of walking aids 
Social interaction The effects of family, vocational, social lives on influence beliefs 
and coping skills cannot be denied. 
Family Litigation Social class/occupation/ education 
Culture Unemployment Job satisfaction and psychological aspects 
of work 
Social security Early retirement Workers’ compensation 
 57 
A growing concern with the biopsychosocial model represents its scientific status as a 
key element for scientific theories, with the ability to test and falsify it (168,169). The 
biomedical model might suggest that tissue injury in the spine is the primary cause of 
LBP; this can be tested scientifically (falsified) and rejected by the medical scientific 
community. Whether the biopsychosocial model can allow such an empirical testing is 
unclear because of the complex and multidimensional nature involved in this model. In 
this stage, recognising the complex synthesis of biological, psychological, cognitive and 
social factors, which might lead to different ‘kinds’ of possibilities, is important; 
understanding the effect of each of these factors on the current condition, i.e. ‘which 
component will affect the patient and when?’ (154), poses a challenge. This issue might 
be highlighted by the fact that philosophers spent more than a millennia exploring the 
relationship between the mind and body (170,171). 
Despite these limitations in the biopsychosocial model, its implementation within spine 
care is clear. The WHO designed the ICF according to the conceptual framework in the 
biopsychosocial model of illness (172). This classification will be discussed in detail in 
the following subsection.  
3.3.1 The International Classification of Function, Disability and Health (ICF) 
The ICF was reviewed in this thesis for two main reasons. Firstly, the ICF provides a 
current, comprehensive model of standardised assessment of functioning and disability. 
Secondly, the ICF can be used as a guideline or reference for the development of 
standardised measurement tools under a framework that integrates the biological, medical 
and social models of healthcare (173,174). Understanding the relationship between LBP 
outcome measure and the ICF is therefore important. Therapists can better understand 
and examine the content of current LBP outcome measures by referencing them to ICF 
categorised standards. This thesis has compared the content of existing LBP outcome 
measures, the findings of the qualitative study [Chapter 9] and the TELER LBP indicators 
[Chapter 12] with the ICF LBP core set (175). This step was important to determine 
whether such content is comparable to the ICF categories. 
After an extensive global examination involving individuals with various kinds of 
disabilities, as well as healthcare professionals from various disciplines, in 2001, the 
World Health Assembly approved the ICF for use (176). The biopsychosocial model 
formed the basis of the development of ICF categories (177), especially for creating 
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specific sets of core categories for health conditions, such as LBP (175). The ICF 
represents a conceptual framework and classification system that organises and describes 
information related to functioning and disability. The framework was designed to provide 
a universal standard language and conceptual basis for the definition and measurement of 
health through the examination of functioning and disability.  
The WHO integrated the major models of disability to develop this classification of 
functioning. The ICF successfully placed all health conditions on an equal footing by 
shifting the focus from health conditions to functioning (178).  
One of the important characteristics of the ICF is the neutrality of language used. Domain 
definitions are worded in neutral language to allow the recording of both positive and 
negative aspects of functioning and disability. The classification system is therefore 
suitable for all individuals whether they have disability or not. This feature also helps 
prevent the stigma induced by some health problems. This characteristic is particularly 
relevant to individuals with LBP in which the stigma of the self-inflected disease and 
avoidance behaviour are two of the main factors that limit participation (5). Another 
characteristic is that the ICF reflects on individuality by recognising the role of 
environmental factors that affect functioning, as well as associated health conditions and 
their effect on people’s quality of life. Environmental factors range from physical factors, 
such as building design and climate, to social factors, such as laws and institutions. 
The ICF is a multidimensional classification system developed to serve different 
disciplines and sectors across various countries and cultures; therefore, it helps enhance 
communication among different users, such as individuals with disabilities, health 
professionals, researchers and policymakers (176). The standard language in this 
classification system also facilitates and enhances data comparison across healthcare 
disciplines, time and countries. Therefore, the ICF is directly relevant to this thesis. 
3.3.1.1 Component of the ICF 
The classification system has two parts (176). Part 1 represents functioning and disability, 
and part 2 represents contextual factors. Each part has two components (Figure 3.2). 
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Figure 3.2: Components of the ICF 
 
 
 
 
 
 
Figure 3.3 shows the dynamic interaction between all ICF components. The components 
of functioning and disability indicate the presence or absence of health problems, such as 
impairments, activity limitations and participation restrictions. This characteristic of the 
ICF enables identification of the aspects of functioning influenced by health problems. 
Doing so is important in conditions, such as LBP, which simultaneously affect different 
dimensions of people’s quality of life (5). 
In the ICF classification system, each component contains hierarchically ordered 
domains; these are sets of related physiological functions, anatomical structures, activities 
and external influences. The ICF provides a classification of functioning for each 
individual regardless of whether this individual is suffering from a health condition or 
not. The classification highlights the individualised nature of the classification system 
and its usefulness in guiding the development of outcome measures that measure 
functioning at the level of the individual. This issue is relevant to this thesis because 
individuals with LBP have different functional profiles as a result itself of the 
multidimensional nature of the condition. Furthermore, contextual factors and 
environmental factors obviously affect functioning in the ICF. These points are also 
relevant to this thesis. The studies in Chapter 2 reported the impact of environmental 
factors, such as workplace, on the ability to work, as well as that of personal factors, such 
as avoidance behaviour and depression, on functional outcomes. 
  
 
The International classification of Function, Disability and Health 
Components of functioning and disability Components of contextual factors 
 
Body components 
(Body system and 
body structures) 
Activities and 
participation 
component 
Environmental 
factors 
Other contextual 
factors 
 60 
Figure 3.3:  The ICF model of functioning and disability 
 
 
 
Definitions in the context of health: 
 
1- Body Structures are anatomical parts of the body such as organs, limbs and their components.  
2- Body Functions are physiological functions of body systems (including psychological functions).  
3- Impairments are problems in body function or structure such as a significant deviation or loss. 
4- Activity is the execution of a task or action by an individual. 
5- Activity Limitations are difficulties an individual may have in executing activities. 
6- Participation is involvement in a life situation. 
7- Participation Restrictions are problems an individual may experience in involvement in life situations. 
8- Environmental factors make up the physical, social and attitudinal environment in which people live and 
conduct their lives. 
9- Personal factors are the individual’s inherent characteristics, psychological assets and behavioural features 
which are highly variable and individualised in nature (i.e. age, gender, race, fitness, self-efficacy). 
10- Functioning is an umbrella term for body function, body structures, activities and participation. It denotes the 
positive or neutral aspects of the interaction between a person’s health condition(s) and that individual’s 
contextual factors (environmental and personal factors).  
11- Disability is an umbrella term for impairments, activity limitations and participation restrictions. It denotes the 
negative aspects of the interaction between a person’s health condition(s) and that individual’s contextual 
factors (environmental and personal factors). 
3.3.1.2 Use of the ICF in physiotherapy clinical practice and management of LBP 
The World Confederation for Physical Therapy (WCPT) encourages physiotherapists to 
use the ICF as a conceptual framework to guide the delivery of physiotherapy care, 
allocation of resources, patient referral and rehabilitation management (179). Regardless 
of the WHO’s and WCPT’s recommendations, the classification system is rarely used in 
physiotherapy practice (177), which may be attributed to its highly complex 
categorisation (Table 3.2) for daily use in clinical practice (180). The ICF encompasses a 
list of 1,454 categories. Each category constitutes units of classification, which are 
hierarchically ordered. The classification system lacks the ability to provide 
physiotherapists with meaningful information that can inform their clinical decision-
making or for patients. 
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Table 3.2: Example of ICF categories for LBP 
First/chapter 
level 
b2 Sensory functions and pain 
Second level b28 Sensation of pain 
Third level b2800 Generalised pain 
Fourth level b28013 Pain in back 
A growing body of evidence suggests that radiological imaging and examination of the 
spinal structure do not provide both patients and health professionals clear answers on the 
origin of pain (56,181-184). Despite this evidence, individuals with LBP continue to be 
provided with biomedical diagnoses, and according to these beliefs, they are prescribed 
with stabilisation exercises, pelvic belts, supportive vests, spinal injections or stabilisation 
surgery (184-186). These interventions might lead to negative consequences, such as fear 
of movement, avoidance behaviour, hypervigilance and disability, which only serve to 
fuel the vicious cycle of pain (187). Furthermore, the findings of clinical trials testing 
commonly prescribed physiotherapy interventions for LBP suggest that no management 
approaches are clearly superior (188-192). 
The ICF indicates that physiotherapists are encouraged to focus less on treating the 
structure or signs and symptoms of LBP and more on targeting the different combinations 
of beliefs, cognitive, lifestyle and physical abilities that underline and drive LBP (6). 
Implementation of the ICF in physiotherapy practice might require a paradigm shift in 
the ‘beliefs’ of physiotherapists and patients in terms of how they understand and deal 
with LBP. Current knowledge suggests that LBP should be considered within a 
multidimensional biopsychosocial framework. This shift in beliefs might require 
abandoning ineffective practices, learning new skills, and using and integrating new 
approaches (6). For example, mounting evidence supports the view that targeted 
multidimensional interventions are more effective than a single intervention to manage 
LBP in primary care settings (6). Asenlof et al. (193,194) showed that individually 
tailored behavioural treatments targeting activity levels, cognition and motor behaviour 
demonstrate superior outcomes compared with exercise therapy alone. Another study also 
showed that a patient-centred multidimensional behavioural approach that targets 
maladaptive cognitive, lifestyle, pain and movement factors is more effective (greater 
effect size) than manual therapy and exercise for LBP (195). Despite this evidence, recent 
research suggested that healthcare providers dealing with LBP have difficulty correctly 
identifying psychosocial risks in individuals with LBP in a clinical context. Furthermore, 
Butler and Moseley (196) suggested that many individuals, including health 
professionals, do not have a modern understanding of pain mechanisms, which might lead 
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to delayed recovery. A modern understanding of pain and specific training in the 
behavioural aspects of patient presentation are seemingly important to enable 
physiotherapists to identify risk indicators from clinical examination (196,197). Hill et al. 
(198) emphasised the importance of targeted and timely initiated interventions in patients 
at risk for chronic LBP to induce recovery and reduce healthcare costs. 
3.4 Summary 
The biopsychosocial model is widely accepted within the spinal community. It plays a 
central role in how health professionals provide care for people with LBP and helps 
determine future management. The biomedical model allowed significant medical 
advances through the objective study of the pathoanatomic/pathophysiologic aspects of a 
disease; similarly, the biopsychosocial model achieved advances by emphasising illness 
as experienced within different dimensions. Examining individuals with LBP through 
these dimensions is the strength of this model because people who suffer from LBP and 
live in a difficult social condition will be more complex than similar people who are not 
suffering from the same. This model motivates health professionals to consider patients’ 
psychosocial status before care is implemented and changes in the outcomes of therapy 
are made. The ICF was used in this thesis because it offers a framework on how 
‘management’ might be prescribed and how ‘outcomes’ are measured. In accordance with 
the identification of the theoretical basis of current physiotherapy practice, defining the 
different dimensions of the outcomes of physiotherapy is important. The following 
section will review the different dimensions of outcomes that are commonly measured 
following the management of LBP. Then, a critical review of the theory of measurement 
and measuring scales follows. These reviews are important in this thesis to determine 
whether the cross-cultural adaptation of one of the existing LBP outcome measures or the 
development of a new outcome measure for implementation in the Jordanian healthcare 
system is needed. 
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Chapter 4: Pain and functioning: Definition and analytical framework 
Key points in Chapter 4: 
- Pain is a sophisticated protective mechanism that alerts the body when there is 
danger. Tissue injury is neither sufficient nor necessary to generate pain. Pain 
depends on how much danger the brain ‘thinks’ the body structures are in, not 
how much danger the body structures are ‘actually’ in. Identifying the different 
dimensions of pain is important in this thesis in order to measure pain 
appropriately. 
 
- There are four dimensions of pain. These include intensity, impact, quality and 
location. In comparison to the other pain dimensions, pain impact can be 
observed by physiotherapists and reported by individuals with LBP. This thesis 
proposes that Jordanian physiotherapists should observe and measure the impact 
of LBP on functioning rather than on pain itself. 
4.1 Introduction 
Chapter 3 of this thesis indicates that the biopsychosocial model plays a significant role 
in how physiotherapists provide care for individuals with LBP and how they determine 
outcomes that are important to their patients. The purpose of physiotherapy interventions 
is to restore lost functions (88). Clinical trials suggest that physiotherapy interventions 
are more effective in the management of LBP when they are tailored to the individualised 
needs of patients (193-195). 
To demonstrate the effectiveness of physiotherapy in the management of LBP, 
physiotherapists use different measurement tools. These tools aim to measure different 
aspects of health-related quality of life; more specifically, they aim to measure pain and 
function (88,199,200). A recent systematic review that investigated the impact of LBP on 
adult populations indicate that pain and disability are associated with catastrophisation7, 
which leads to delayed recovery (202). Many international guidelines concerning the 
management of LBP suggest physiotherapy interventions for LBP. They also recommend 
areas of evaluation that reflect aspects related to pain and function (88,203,204). 
However, there are new concerns that the current and commonly used measurement tools 
in the clinical trials of LBP management do not satisfy the theory of measurement (205-
211) and that the core sets might not adequately address what is important to individuals 
with LBP (212-214). Understanding these concepts in the conceptualisation phase is 
                                                 
7 Catastrophizing is ‘‘an exaggerated negative mental set brought to bear during actual or anticipated painful 
experience’’ (201). 
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important in this thesis because this research programme aims to develop an appropriate 
measurement tool that adheres to the theory of measurement [Chapter 5] and measures 
changes in a construct that is important to individuals with LBP in the clinical contexts 
in Jordan. The first step in the development of an outcome measure is a theoretically 
sound definition of the construct of interest (215). This includes identifying the 
dimensions and the factors influencing them (216,217). The following subsections will 
utilise relevant theoretical backgrounds and clinical knowledge to achieve an adequate 
understanding of pain as a phenomenon and the impact of pain on the construct of 
function. The following subsection reviews the definitions and the dimensions of each 
construct, as well as the factors related to these constructs. Understanding these constructs 
from a theoretical perspective is important in this thesis because it will later enable a 
critical review of the commonly used LBP outcome measures [Chapter 7]. 
4.2 Pain 
4.2.1 Introduction 
There is much debate about the definition and measurement of pain (218). It is well 
established today that pain is a multifactorial subjective sensory experience, which is 
dynamic, as individual perception of pain changes between different points of time 
(161,218,219). The purpose of this subsection is to define pain and identify its 
dimensions. 
4.2.2 Definitions of pain 
The International Association for the Study of Pain defines pain as “an unpleasant 
sensory and emotional experience associated with actual or potential tissue damage, or 
described in terms of such damage” (220). This definition indicates that pain is not always 
associated with tissue-based injury and that pain experience might or might not occur as 
a result of tissue damage. It seems that pain happens when the body’s alarm system alerts 
the brain to real or probable tissue damage (196). 
There are many misconceptions about pain. These misconceptions might exist because 
some individuals, including health professionals, do not have a contemporary 
understanding of pain (196). Motor and sensory elements are closely related to each other 
at each level within the central nervous system (CNS) (221). Many studies of functional 
brain imaging confirm that different cortical regions are active during the occurrence of 
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painful experiences (222). This could generally mean that pain is the final product of 
responses taking place within the brain’s neural matrix (161,223).  
It seems that the CNS is not a rigid neural matrix, but rather plastic in nature (161,218). 
This network of nerve cells and surrounding structures is subject to injury and recovery. 
However, radiological imaging studies demonstrated little evidence regarding structural 
nerve damage in the majority of LBP cases. This might add weight to the agreement 
among health professionals to avoid unnecessary examination and overtreatment by 
treating symptomatically, along with the persuading individuals with LBP to stay active 
for LBP management (56,161,224). Despite recent advances in this field, 
neurophysiology cannot fully explain pain. Butler and Moseley (196) suggest that pain is 
not in the CNS or specifically in the human cerebrum; pain is an output of the brain 
(psychology, emotion, environment, social and religion), making it difficult to be defined, 
expressed or measured. Health professionals might have the impression that they can 
understand pain and measure it in a reliable manner. However, in reality, this is not the 
case (207,208,225,226). Many clinical studies have reported that the perception of pain 
is different among individuals (196,219). For example, Waddell (161) suggested that 
people with different types of LBP in Oman are significantly under-reporting their pain 
as compared to their counterparts in the UK. This is because people in Oman accept being 
in pain for religious reasons. Horn and Munafo (219) suggest that people who have similar 
injuries might react to pain in different ways. For example, a military officer who has a 
knee injury in a battlefield and a solicitor who happens to have the same injury in an 
office might describe pain and report it in a different way due to the differences in contexts 
(196). These factors make any comparison of pain perception between individuals near 
to impossible, calling into question the validity of the current pain measures used in 
clinical contexts. Despite this, health professionals, including physiotherapists, continue 
to measure pain using different scales [Chapter 7] that aim to measure different 
dimensions of pain. The following subsection will review these dimensions in more 
details. Understanding of these dimensions of pain is important in this thesis to critically 
review the pain scales in Chapter 7. 
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4.2.3 Dimensions of pain 
There are four dimensions of pain; intensity, impact, quality and location (218). Pain 
intensity refers to how much an individual hurts. Pain impact is another dimension that is 
related to pain experience. It is considered to be more complex compared to the other 
dimensions. For example, Chapter 2 in this thesis reviewed the impact of LBP on quality 
of life. Jensen and Karoly (227), p. 19, define pain impact as “the degree of emotional 
arousal or the changes in action readiness caused by the sensory experience of pain”. 
The previous definition used the term degree, which suggests that pain affect can be 
quantified. The same definition also implies the existence of equal intervals between 
categories, which is not the case in reality. The definition indicates that fear of pain or 
avoidance behaviours can lead to limitations in physical activity, alterations to regulatory 
efficiency or ordinary modes of response. It seems that pain affect is a mental state 
activated by an implicit or explicit review of risks. For example, the fear-avoidance model 
is a theoretical model that describes how psychological factors impact the confidence to 
move and affect the experience of pain influence the development of persistent pain and 
disability (201). In this model, negative beliefs about pain and negative information about 
the condition lead to exaggerated negative mental set in which individuals with LBP 
imagine the worst possible outcome. This catastrophisation leads to fear of movement 
and avoidance behaviours. This sequence of events strengthens the original negative 
review of risks in a deleterious cycle.  Similarly, positive beliefs about pain and modern 
understanding of LBP encourage patients to confront their pain problems and be active in 
the coping process. The fear-avoidance model will be discussed in more details in Chapter 
9. 
Pain quality is the physical sensation related to pain sensory experience. Terms, such as 
sharp or shooting pain, are some of the common expressions used by patients when 
describing pain quality (227). Pain quality is often documented on a body chart that shows 
the pain location. Pain location means the direct description of where the perceived pain 
is. 
In clinical trials, pain intensity is frequently measured more than the other dimensions of 
pain. This is worthy of further investigation (208,225,227). A critical review of pain 
intensity scales is conducted in Chapter 7. It is important to note that at this stage, 
therapists cannot observe pain intensity, quality and location. Consequently, they have to 
rely on patients reports concerning these dimensions. However, pain impact on functional 
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status might be observed by therapists and reported by patients. This chapter suggests that 
the measurement of pain impact as an outcome of LBP management, is far more important 
than other pain dimensions. The purpose of the following subsection is to understand the 
theoretical underpinnings of the construct functional status. The following subsection is 
important in this thesis because it will enable an in-depth critical review of back disability 
scales [Chapter 7]. It will also facilitate the process of outcome measure development in 
the second phase. 
4.3 Function 
4.3.1 Definition of the construct function 
A standardised definition of the construct ‘functional status’ or ‘function’ is not included 
in any of the major LBP management guidelines (88,203,204,228). Furthermore, the wide 
range of linguistic expressions used in research to refer to aspects related to ‘functioning’ 
might indicate that research in the area of LBP management lacks a consensus on the 
definition of the term ‘function’. The term ‘function’ is defined in the Oxford dictionary 
as “an activity or purpose natural to or intended for a person or thing” (229), p. 575. This 
definition has three important elements. Firstly, the term ‘activity’ indicates the “degree 
to which something displays its characteristic property or behaviour” (229), p. 13. 
Secondly, the term ‘natural’ suggests that it is socially accepted. Thirdly, ‘intended for a 
person’ implies that engagement and involvement in this activity is valued and socially 
important to fulfil a role.  Table 4.1 shows some examples of definitions published in the 
healthcare literature. 
Leidy (216) suggested that the term functional status represents the whole domain of 
functioning. Each of the definitions in Table 4.1 refers to activities, roles or behaviours 
that individuals engage in during their day-to-day life.  
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Box 4.1: Definitions of ‘Functional status’ published in the literature 
Bowling (230), p. 6: “Functional status can be defined as the degree to which an individual 
is able to perform socially allocated roles free of physically (or mentally in the case of mental 
illness) limitations. There is a clear distinction from general health status. Functional status 
is directly related to the ability to perform social roles, which a measure of health status need 
not take into account. Functional status is just one component of health – it is a measure of 
the effects of disease rather than the disease itself”. 
Meyboom-De Jong and Smith (231), p. 128: “Level of actual performance or capacity to 
perform, both in the sense of self-care and in the sense of being able to fulfill a task or role in 
a given moment or during a given period”. 
Patrick and Erickson (232), p. 418: “An individual’s effective performance or ability to 
perform those roles, tasks, or activities that are valued, e.g., going to work, playing sports, 
maintaining the house. Most often functional status is divided into psychological, emotional, 
mental and social domains, although much finer distinctions are possible. Deviations from 
usual performance or ability indicate dysfunction”. 
Ware et al. (233), Glossary 3: “Functional status: the extent to which individuals currently 
perform their normal or usual behaviors and activities without limitations due to health 
problems; often used to refer to a variety of concepts of behavioral functioning and well-
being”. 
Leidy (216), p. 197: “…it is proposed that functional status be defined as a multidimensional 
concept characterizing one’s ability to provide for the necessities or life; that is, those 
activities people do in the normal course of their lives to meet basic needs, fills usual roles, 
and maintain their health and well-being. Necessities include, but are not limited to, Physical, 
psychological, social, and spiritual needs. There are four dimensions of functional status: 
Capacity, performance, reserve, and capacity utilization”. 
The definitions provided by Bowling (230) and Meyboom-De Jong and Smith (231) 
suggest the existence of different functional statuses, which might be ranked on a 
continuum. In addition, Bowling’s (230) definition distinguished general health status 
from functional status. Patrick and Erickson (232) suggest that functional status is a 
multidimensional concept that represents physical, role, psychological and cognitive 
functioning. 
Leidy (216) argued that the previous definitions and models of functioning had problems. 
For example, the Meyboom-De Jong and Smith (231) definition failed to demonstrate a 
significant distinction between functional performance and capacity. Consequently, their 
definition was considered too broad, and to lack the ability to inform or guide treatment 
planning, study designing or outcome measures development. Another definition of 
functional status developed by Folta and Metzger (234) provided a conceptual model that 
addressed the concept of functional capacity from a physiological perspective. Their 
approach to define function was considered too constrained because it did not show how 
physiological improvements translate into improvements in day-to-day performance 
(216).  
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Ware (215), p. 473, stated that “definition is the blueprint underlying the construction of 
health measures”. Therefore, it is important in this thesis to define the construct 
‘functioning’ on a sound theoretical background and on relevant clinical knowledge. This 
is important to guide the process of developing the new outcome measure later in this 
thesis [Chapter 10 and 11]. Leidy (216) developed an analytical framework that shows 
the different dimensions of the construct ‘functioning’. Other analytical frameworks of 
the construct ‘functioning’ could not be located; therefore, this research programme 
adopted the framework developed by Leidy in this thesis. The analytical framework was 
adopted because it appeared to be comprehensive and suggested that a complete analysis 
of the construct ‘functioning’ required a concurrent consideration of all dimensions. 
Leidy’s (216) approach is also consistent with Duncan and Velozo’s (235) view that a 
full evaluation of rehabilitation outcomes mandates the utilisation of a battery of outcome 
measures. Each of these tools is designed for the purpose of measuring one dimension at 
a time. The separate measurement of each dimension is important to eliminate confusions 
of what exactly is being measured. 
4.3.2 Defining the dimensions of function 
Leidy (216) proposed four units of analysis for the construct functioning. These are 
capacity, performance, reserve and capacity utilisation. Figure 4.2 shows that these 
dimensions are interrelated. Leidy’s analytical framework was developed for the purpose 
of analysing and measuring one dimension at a time (216). 
Figure 4.1: The four dimensions of functioning  
 
 
(Adapted from Leidy (216); p.198).  
4.3.2.1 Functional capacity 
Functional capacity is defined as ‘one's maximum potential to perform those activities 
people do in the normal course of their lives to meet basic needs, fulfil usual roles, and 
maintain their health and wellbeing. The term refers to potential in any domain, including 
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physical, cognitive, psychological, spiritual, and sociodemographic’ (Leidy (216), p. 
198). In exercise physiology, functional capacity refers to the maximum physical effort 
that a person can attain under the conditions of maximal exertion (236). Functional 
capacity is a function of muscle strength, endurance, coordination and balance (216). The 
ability to maintain high intensity tasks for a long period of time is dependent on one’s 
functional capacity and on the resources available (216). Treadmill and grip strength tests 
are two examples of functional capacity measures that are used frequently in 
physiotherapy (237,238). 
Leidy (216) pointed out that functional capacity does not translate into functional 
performance. Individuals with certain potential to perform physical tasks might not 
perform these tasks up to the maximum functional capacity. Functional performance is 
constrained by functional capacity and by the interaction of multiple factors, including 
physical, psychological, social, cognitive and spiritual demands and constrictions (Figure 
4.2). 
4.3.2.2 Functional performance 
Functional performance is defined as “the physical, psychological, social, occupational, 
and spiritual activities that people do in the normal course of their lives to meet basic 
needs, fulfil usual roles and maintain their health and wellbeing” (Leidy (216), p. 198). 
In comparison to functional capacity, functional performance is the observable outcome 
of individual choice to do or perform an activity to fulfil a biological, psychological, 
social or spiritual role. The actual level of performance is influenced by contextual 
factors, such as body structures, or support from others, which enable or inhibit 
performance.  
The empirical and clinical relationship between functional capacity and performance can 
be explained through the concept of exertion8. The closer an individual performs to the 
limits of functional capacity, the more exertion is required to achieve the next unit of 
performance (216). The LBP physical functioning indicators developed later on in this 
thesis belong to and represent this dimension of ‘functional status’. 
4.3.2.3 Functional reserve 
Functional reserve is defined as “the difference between capacity and performance, one's 
functional latency and dormant abilities that can be called upon in time of perceived 
                                                 
8 Exertion is “the cost of moving to the next level of performance and this must be weighed against the benefits”. 
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need” (Leidy (216), p. 199). The size of the difference between functional capacity and 
performance naturally varies from one individual to another (216). According to Leidy’s 
(216) definition, functional reserve is called upon only in times of need where high levels 
of exertion are necessary in uncommon circumstances. For example, athletes tend to have 
higher physiologic functional reserve than non-athletic people, who in turn have more 
reserve than individuals with acute or chronic health conditions (216). 
4.3.2.4 Functional capacity utilisation 
Functional capacity utilisation is defined as “the extent to which functional potential is 
called upon in the selected level of performance” (Leidy (216), p. 199). Leidy (216) 
suggested that this concept refers to the extent to which individuals recognise their 
potential, and that it is inversely related to reserve (Figure 4.2). According to Leidy’s 
(216) model of functioning, when functional capacity utilisation increases, it in turn 
increases the level of exertion. When functional performance increases, approach 
capacity, which means functional reserve, will also decrease. This analytical model 
proposes that health interventions should be directed and designed to improve functional 
capacity utilisation in an attempt to enhance performance and augment life quality. The 
response choices in each of the TELER LBP indicator developed in this thesis [Chapter 
11] represents the functional capacity utilisation of each daily activity identified as 
important by Jordanian individuals with LBP in a qualitative study [Chapter 9]. 
4.4 Summary 
This chapter suggests that pain is an individualised experience. Pain is a complex 
symptom; other factors, such as human behaviour, psychology, patient expectations and 
attitudes, beliefs and the surrounding environment, should be considered when managing 
pain. Pain experience and the previously mentioned factors cannot be separated, as they 
are dynamically interacting and are not the final product of a linear sensory transmission 
system. 
In comparison to the other dimensions of pain, pain impact can be observed by clinicians 
and reported by patients. This thesis proposes that Jordanian physiotherapists should 
observe and measure the impact of LBP on functioning rather than on pain itself. 
Following the identification of what should be measured, it is important to determine how 
it should be measured. This requires the critical review of the theory of measuring scale 
and scaling methods to develop a theoretical framework of measurement in a clinical 
context. 
 72 
The purpose of the next section is to develop this theoretical framework of measurement 
in a clinical context. The development of this framework might make it possible to 
critically review pain and back-disability measurement tools used frequently in the field 
of LBP. These tools will be critically reviewed according to their content, their adherence 
to the theory of measurement and the criteria of measurement in clinical context. 
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Phase 1: Conceptualisation of the problems 
Section 1: Knowledge underpinning LBP and physiotherapy interventions 
Chapter 1: Knowledge underpinning low back pain 
Chapter 2: Impact of LBP on individuals’ quality of life 
Chapter 3: LBP Management models 
Chapter 4: Pain and functioning: Definition and analytical framework 
 
Section 2: The theoretical underpinning of measurement 
Chapter 5: A review of the theory of measuring scale and scaling methods 
Chapter 6: A critical review of the quality criteria required in a measurement tool for 
clinical utility 
Chapter 7: A critical review of existing LBP outcome measures 
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Chapter 5: A review of the theory of measuring scales and scaling 
methods 
Key points in Chapter 5: 
- Measuring the outcome of healthcare is a key element in determining therapeutic 
effectiveness and, consequently, the delivery of evidence-based healthcare. This 
chapter suggests that the measurement of ‘functional status’ can be used for both 
physical examinations in the initial assessment sessions and as an outcome 
measure in follow-up sessions. 
 
- The majority of LBP scales are ordinal in nature because they are used to measure 
constructs, such as symptom status and functional status.  
 
- Different scaling methods were used to construct the current LBP scales. The 
critical review in this thesis revealed that the Guttman scaling approach is capable 
of converting observations into quantifiable data. 
5.1 Introduction 
In the first phase, Section 1 suggested that targeted-physiotherapy interventions helped to 
reduce the negative impact of pain on an individual’s quality of life, restore lost functions 
or both simultaneously; however, the effectiveness and the efficiency of most 
physiotherapy interventions have not been established, and there is often weak evidence 
supporting physiotherapy interventions (239-247). The difficulties in measuring the 
effectiveness of therapeutic interventions are partly related to the complex, 
multidimensional and subjective nature of the constructs, namely pain and function 
(216,218,248). 
Outcome measures are essential to successful clinical practices, especially regarding the 
current efforts to enhance healthcare quality and the successful evaluation of the 
effectiveness and efficiency of therapeutic interventions (24). Several LBP outcome 
measures have been developed to measure pain and function before and after 
physiotherapy interventions in both clinical trials and in clinical contexts 
(88,199,200,203,204); however, little is known about their development and their 
appropriateness for use in clinical practices (249-252). Therefore, Chapter 5 will begin 
by examining a conceptual model that identifies the clinical variables that influence the 
process of measurement during the different stages of healthcare. This conceptual 
framework will be slightly modified to translate the findings of the first section in Phase 
1, to demonstrate how therapists shifted their focus from establishing diagnoses to 
 76 
measuring patient outcomes, to demonstrate the transition from developing clinician-
based measurement tools to the development of a patient-specific outcome measure and 
from measuring the effectiveness of unidimensional treatment to multidimensional 
management. This will be followed by a critical review of the theory of measuring scales 
and scaling methods and the quality criteria required for a measurement scale for clinical 
utility. These critical reviews are important later in this thesis to develop a theoretical 
framework of measurements in a clinical context that will enable critically reviewing six 
of the most commonly used outcome measures in the LBP field. This new theoretical 
framework will also guide the development of a new LBP outcome measure in the second 
phase of this research programme. 
5.2 Exploring a conceptual model of patient outcomes 
Measuring the outcomes of healthcare is a key element in determining therapeutic 
effectiveness and, consequently, the delivery of evidence-based healthcare (23,24). The 
quantification of therapy outcomes has become imperative in musculoskeletal 
rehabilitation for two primary reasons. The first reason is that healthcare professionals 
have continually attempted to find a way to provide clinical information that answers 
questions related to the effectiveness of therapy. The second reason is related to the 
continuous development of a theoretical basis for physiotherapy practices in 
musculoskeletal rehabilitation (73,253).  
Conceptual models play a key role in how observers9 identify constructs that are 
important to measure in research and clinical practice (23). Wilson and Cleary (254) 
developed a conceptual model (Figure 5.1) that shows the different stages of the 
evaluation of medical care and the different factors that influence the measurement of 
outcomes. 
In this model, arrows indicate the important flows of influence. The authors of this model 
acknowledged that there may be reciprocal relationships (24). For example, in different 
qualitative studies, individuals with LBP (symptom status) reported that fear of movement 
(symptom amplification) led to functional limitations (functional status), which led to 
depression (general health perception) and poor quality of life (5). 
                                                 
9 The person who undertakes the measurement will be called the ‘observer’ in this thesis.  
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5.2.1 From establishing a diagnosis to an outcome measurement 
According to the Wilson and Cleary (254) model, when diagnosing LBP, the focus of 
clinicians and therapists is on the left-hand side of the model, while for the examination 
of outcomes of health problems or therapeutic interventions, the levels on the right-hand 
side are more relevant. Usually, when physiotherapists manage a complex condition, such 
as LBP, they consider the functional status to be both a diagnosis and an outcome of 
physiotherapy interventions. This indicates that the outcomes of LBP are assessed at 
different levels, ranging from the pathophysiological parameters to the health-related 
quality of life (HRQL). 
Figure 5.1: Relationships between measures of patient outcomes in a health-related quality of life 
conceptual model 
 
Adapted from Wilson and Cleary (254), p. 60. 
5.2.2 From clinician-based assessments to self-reported patient-based 
measurements 
There are variables in the Wilson and Cleary (254) model that can be directly observed, 
such as disc degeneration via radiological imaging, which are referred to as clinician-
based assessments. Other variables that cannot be directly observed, such as an 
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individual’s perception of the overall level of QOL, require self-reported measures or 
patient-reported outcome measures (PROMS). The clinician-based assessment tools are 
usually located on the left-hand side of the model, and the patients’ self-reported measures 
are located on the right-hand side (24); however, the functional status is examined through 
either self-reported questionnaires or observations by clinicians. For example, 
physiotherapists frequently ask patients to perform certain physical activities during the 
initial assessment sessions to assess the impact of LBP on functional status. 
Physiotherapists also use standardised questionnaires, such as the Quebec Back Pain 
Questionnaire (QBPDS), to examine physical functions following physiotherapy.  
5.2.3 Objective and subjective measurements 
Any involvement of personal judgment in the process of measurement will determine 
whether the measurement tool is objective, including measuring bone density using 
radiological imaging or subjective measurements, such as measuring back-disability 
using the Oswestry Disability Index (ODI). Hypothetically, objective measurements do 
not involve any personal judgment; however, the assumption is that the person who is 
doing the measurement possesses adequate knowledge regarding how to use the tool. 
Furthermore, the interpretation of these objective measurements may be subjective in 
nature. For example, health professionals may disagree about what should be considered 
a ‘normal’ bone density. Therefore, health professionals currently focus less on the 
terminologies ‘objective’ and ‘subjective’ and replace them with ‘history’ and ‘physical 
examination’ (248). 
Due to the current lack of knowledge regarding the identification of a cause for the 
majority of LBP cases, clinicians heavily rely on the measurement of symptoms, such as 
pain and functional status. The existing measures that examine the symptoms of LBP are 
often subjective in nature. Therefore, the majority of LBP outcome measures are located 
on the right-hand side of Figure 5.1. Six of the most commonly used LBP outcome 
measures will be reviewed in more detail in Chapter 7. 
5.2.4 Unidimensional to multidimensional characteristics 
On the left-hand side of Figure 5.1, there are many examples of unidimensional 
constructs, such as range of movement and bone density. The characteristics on the left-
hand side of the model represent only one aspect of a disorder. On the right-hand side of 
Figure 5.1, the perceived health status, or HRQL, represents more complex 
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characteristics. Multidimensional constructs, such as functioning, encompass not only the 
physical aspects but also the psychological and social aspects of health. For example, in 
Chapter 2, the systematic review showed that individuals with LBP (with limitations in 
functional status) tend to avoid social occasions (social functioning) because they feel 
embarrassed (mental functioning) about discussing their pain (symptoms status).  
After exploring the clinical variables that influence the process of measurement during 
the different stages of healthcare, knowledge of the theory underlying the measurement 
is required to critically review the existing LBP outcome measures, or, if necessary, to 
develop an appropriate outcome measure for use in the clinical context (255). The theory 
of measuring scales will be discussed in more detail in the following subsection. 
5.3 The theory of measuring scales 
The term ‘measurement’ has been defined by a number of authors. For example, Stevens 
(171), whom many considered the author of the scales of measurement, defined 
measurement as the “assignment of numerals to objects or events according to rules, any 
rule” (Stevens (171), p. 19). In his definition, Stevens clarified that the measurement 
process involves a systematic allocation of numerals to observations according to a priori 
rules of measurement. A numeral is a numeric label that has no value (256). This 
definition, therefore, ignores the problem of quantifying the label. Perhaps the definition 
that is most appropriate in the context of this thesis is that of Michels, who suggested that 
“measurement is the act of converting observations into data, and includes classifying, 
counting, ranking, and quantifying” (Michels (257), p. 210). Michels’ definition is more 
relevant to this thesis because it implies that quantification is an integral part of the 
measurement process. 
As section 1 in the first phase outlined, if the measurement of the impact of LBP on 
functional status is an integral part of any study on the effectiveness of physiotherapy, it 
may be argued that Michels’ definition of measurement supports the use of functional 
status if this construct could be converted into quantifiable data. These data might provide 
evidence of effective practice if the measurement is carried out in a clinical context by 
physiotherapists for LBP patients (258). 
Measurement theory underpins the development of measurement tools because it 
provides the rules and conditions that control the process of transforming observations 
into units of measurement (258). It is concerned with how the scores generated by a 
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scale’s items represent the construct to be measured (259). It is important to understand 
that to perform measurements according to the measurement theory, the items of a scale 
must measure one construct (e.g., physical functioning) at a time (216) despite the fact 
that the health problem might affect different dimensions of quality of life at the same 
time (5). The measurement of one concept at a time is important to prevent any confusion 
regarding what exactly is being measured (216). The measurement tool should measure 
all aspects of the construct of interest (e.g., functional performance) simultaneously; 
otherwise, it will generate meaningless statements and conclusions (216,260). This is 
important because health conditions, such as LBP, tend to change over time. Thus, scales 
directed to measure attributes, such as pain impact or limitations in functional 
performance, must be able to capture these changes, thereby informing clinical decisions 
in a timely manner. This will be further discussed in Chapter 6 of this thesis. 
The measurement of a construct such as pain is possible if the measurement systems 
satisfy certain conditions and are able to measure this construct indirectly using multiple 
observable items. For example, in Figure 5.1, constructs such as functional status can be 
observed by clinicians and reported by patients. Therefore, functional status is often used 
in research and clinical practices to measure the effectiveness of physiotherapy 
interventions in the management of LBP. 
The theory developed for the study of the rules and conditions underpinning measurement 
is the theory of measuring scales, and these rules are the subject matter of the theoretical 
investigations in the following subsections.  
5.3.1 Levels of measurement 
Stevens (261) proposed in his publication On The Theory Of Scales Of Measurement that 
measurement exists in a variety of forms and can be categorised into certain specific 
classes. These classes are nominal, ordinal, interval and ratio. The understanding of these 
levels of measurement is very important later in this thesis to guide the critical appraisal 
in Chapter 7 and to determine the appropriate level of measurement to represent the 
outcome of interest for Jordanian individuals with LBP. It is also necessary to determine 
the appropriate statistical operations to analyse the information obtained by the new 
measurement tool. The aim of this subsection is to discuss the criteria that distinguish 
between the different levels of measurements to understand the specific characteristics of 
each level.  
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5.3.1.1 The nominal scale 
The operation of differentiating is the only feature of this level; clinicians can divide 
variables into dichotomous answers, such as ‘male’ or ‘female’. Numerals are assigned 
to each category according to the rule Nˈ= s (N), which is that the new numerals (Nˈ) 
might be any direct substitution for the original numerals. Stevens’s rule for the nominal 
scale is “two classes which are different with respect to the variable or quality being 
measured shall not bear the same name; two individual objects which are the same with 
respect to this quality shall not be placed in classes bearing different names” (Senders 
(256), p. 52).  
If numbers are selected to represent responses within the nominal scale, researchers 
should be aware that the formal arithmetic rules that apply to numbers do not apply to the 
entities that are represented by the numbers in a nominal scale. Only basic arithmetic 
operations (i.e., counting) can be applied to these numerals. For example, if a 
questionnaire was distributed with the answers ‘yes’, ‘no’ and ‘uncertain’, the frequency 
of these responses could be calculated. 
5.3.1.2 The ordinal scale 
After determining that two things are either different or alike, it may be possible to find 
out whether one has more or less attributes of a particular quality than another. For 
example, if four tennis players are categorised in order, Smith might beat John, Peter and 
Glen all of the time; Peter can beat John and Glen but not Smith all of the time; John can 
beat Glen, but he cannot beat Peter and Smith all of the time; and Glen is beaten by the 
other players all of the time. Number ‘1’ might be assigned to Smith, ‘2’ to Peter, ‘3’ to 
John and ‘4’ to Glen. Basic arithmetic operations, such as addition, are not permitted in 
calculating the results obtained by the ordinal scale. For instance, when the game involves 
two players against two, we assume that 1+4 = 2+3 (Smith and Glen play against Peter 
and John). This might not be the observed result in reality as Smith, Peter and John might 
be Olympic champions and Glen by chance have just seen a racket for the first time. If 
‘4’ is assigned to him, the other players should have six digit numbers. 
When numerals are allocated to classes on an ordinal scale, the order in relation to the 
numerals is important, but their absolute values are not; the differences in the quantity of 
any two adjacent classes within the ordinal scale are not equal. 
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Three different roles must be applied as a minimum requirement to consider a 
measurement an ordinal scale. The first role is connectedness, which simply means if A 
≠ B, then either A > B or A < B. In other words, if A is different from B, then it may be 
that A has more of the quality than B or that A has less of the quality than B. 
The second role is transitivity, which means if A has more of the quality than B and B 
has more of the quality than C, then A has more of the quality than C (A > B and B > C 
then A > C). The third role is asymmetry, and this simply means that if A has more of the 
quality than B, then B does not have more of the quality than A (A > B then B ≯ A). It is 
important to mention that the majority of the scales developed within the LBP field are 
ordinal scales (73,262,263). This will be further discussed in Chapter 7 of this thesis. 
5.3.1.3 Interval scale 
Interval scales have clear and equal units of measurement (e.g., one Celsius degree); 
however, the interval scale does not have an absolute zero, which limits the arithmetic 
operation to only addition and subtraction. It is possible to perform these arithmetic 
operations if equality, symmetry and transitivity are present as three characteristics of the 
interval scale. Senders (256) indicated that the relationship of equality is reflexive (A = 
A), symmetrical (if A = B then B = A) and transitive (if A = B and B = C then A = C). 
5.3.1.4 Ratio scales 
The ratio scale is the last level of measurement. It is quite similar to the interval scale, but 
it has an absolute zero. Thus, it is possible to perform different arithmetic operations, such 
as addition, subtraction, multiplication and division (256). Levels of measurement are 
important for the development of new scales, especially for the scaling method. This will 
be discussed in detail in the next subsections. 
5.4 Scaling methods 
The mathematical structure (i.e., level of measurement) to measure a clinical phenomenon 
is dependent on the hypothetical structure of that phenomenon (i.e., functional status) 
under scrutiny (264). Hinds (265), p. 346, stated: 
 “The selection of the method by which the phenomenon is measured, depends 
upon the clinical meaning of the measured phenomenon and the clinical 
interpretability of the resulting score”. 
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Scaling methods are central to the construction of outcome measures (266). Simultaneous 
with the identification of what is to be measured is the identification of a method of 
scaling that is suitable for detecting changes or a lack of changes before and after 
therapeutic interventions in a clinical context (23,76).  
To ensure that the clinical meaning is preserved during the process of measurement, the 
chosen method should conform to the specifications of the construct under scrutiny 
(Chapter 4 and Subsection 5.2), the rules of the levels of measurement (Subsection 5.3) 
and the standards of measurement in a clinical context (Chapter 6). The fulfilment of these 
requirements ensures the construction of a valid, reliable and responsive outcome 
measure for individuals with LBP attending physiotherapy in a clinical context (76,267). 
The continuous scrutiny of these requirements will also ensure the construction of a 
useful, informative and meaningful outcome measure later in this thesis (267). 
The complex and multidimensional nature of LBP dictates the design of multidisciplinary 
and individualised interventions to target the outcomes of interest for the patients 
(198,268,269). Many outcome measures were developed to trace changes in the various 
dimensions of the LBP experience (9,208,270). 
Typically, outcome measures are composed of three elements: a stimulus element (the 
item stem), a response part (the response choices) and the scaling methods (266). The 
stimulus element is usually a short sentence or phrase that describes one attribute of 
quality of life, such as social functioning or physical functioning. The item stem should 
contain one concept, and the different items in a scale should belong to one dimension. 
Any item in a scale aiming to measure more than one concept in one indicator would be 
problematic for the respondent. For example, section seven in the ODI aims to measure 
activity and participation, body functions and environmental components simultaneously. 
These double or triple direct questions in one item, which simultaneously touch upon 
more than one concept, would be a source of confusion for the respondents who are rating 
themselves due to a lack of clarity and uncertainty over what exactly is being measured 
(210). 
The second element in constructing a measurement scale is the response choices. 
Different formats of response choices were used previously in HRQOL outcome 
measures (91). For example, many measures used the Visual Analogue Scale (VAS) 
format in the measurement of pain intensity. Other measures, such as the Quebec Back 
Pain Disability Scale (QBPDS), used a Likert format (See Table 5.1). The response 
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choices for each of the methods of measurement varied in both their underlying levels 
and units of measurement (23,266,271). The definition of the unit of measurement also 
varied. For example, indicators that test patient satisfaction could be associated with a 
binary response format, such as ‘agree’ or ‘disagree’. Similarly, indicators that measure 
a construct such as physical function could be associated with a ranking response system 
that reflects respondents’ abilities to perform various functional movements. The 
response choices differ in the number of scale points (or codes) given to the respondents, 
and they usually range from 2 to 5 scale points (266). Some of these scale points are 
anchored using words or phrases (Table 5.1). 
Table 5.1: Different formats of response choices used in HRQOL outcome measures 
Type Description Example 
Visual analogue scale 
(VAS) 
A horizontal or vertical line of fixed length (usually 100 
mm) with words that anchor the scale at the extreme ends 
and no words describing intermediate positions. Subjects 
are instructed to place a mark on the line corresponding 
to their perceived state. 
How would you rate your pain, today? 
 
 
 No pain                                                 Unbearable pain 
Anchored or 
categorized VAS 
A VAS that has the horizontal or vertical line of fixed length 
(usually 100 mm) with words that anchor the scale at the 
extreme ends and words describing intermediate 
positions. 
How would you rate your pain, today? 
 
 
 No pain     Slight          Moderate         Extreme    Unbearable pain 
Likert scale An ordered set of discrete terms or statements from which 
subjects are asked to choose the response that best 
describes their state or experience. 
How would you rate your overall quality 
of life, today? 
 
Poor            Fair             Good            Very good        Excellent 
Rating scale A set of numerical categories from which subjects are 
asked to choose a category that best describes their state 
or experience. The ends of the rating scales are anchored 
with words but the intermediate categories do not have 
descriptive labels. 
How would you rate your overall quality 
of life, today? 
 
 
   0          1          2          3           4  
   Poor             Fair             Good        Very good        Excellent 
Checklist Checklists provide a simple choice between a limited set 
of response options such as Yes, No, and Don’t know. 
Today would you rate your overall 
quality of life as good? 
 
 
 Yes                No           Don’t know 
Binary format The simplest checklist with only two responses options 
such as yes or no. 
Today would you rate your overall 
quality of life as good? 
 
 Yes             No   
From Walters (91). 
The next subsection will critically review the three scaling methods that were used in the 
construction of measurement tools in the field of healthcare (266), which are the 
Thurstone, Likert and Guttman methods. These are the most common scaling methods 
used in the construction of outcome measures (266). 
5.4.1 Thurstone method 
The Thurstone method was originally developed by Louis Thurstone in 1929 (272). This 
scaling method aimed to develop a format for generating groups of indicators of a 
construct of interest that have at least one empirical structure between them (266,271). 
For example, a group of judges, such as individuals with LBP, are asked to assess a large 
number of items that are thought to be indicators of a construct of interest. The approach 
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for constructing a scale using the Thurstone method is described in Table 5.2, which also 
shows the assumptions’ advantages and disadvantages. 
The responsibility of each judge is to rate each statement on a 1-11 point scale in terms 
of how much it indicates a favourable representation of the construct of interest. For 
example, if the construct of interest is the impact of LBP on an individual’s physical 
activities, the judges will be asked to assign a score of 1 to the very weakest and a score 
of 11 to the very strongest indicators. Intermediate scores will be assigned to the 
statements felt to be somewhere in between. Once the judges complete this step, the 
researcher examines all scores and decides which items have generated the greatest 
agreement between the judges. The items in which the judges disagreed largely would be 
excluded as ambiguous. 
Among the indicators that produce a general agreement in scoring, one or more would be 
allocated to represent each scale score between 1 and 11. However, the process of 
constructing a scale using the Thurstone method is not commonly used in research 
(266,271) for many reasons, including the unclear units of measurement and the 
requirement of a large amount of time and resources (Table 5.2). Still, it was used in the 
development of the response choices (273) of the Sickness Impact Profile (SIP). Twenty-
four items were selected from the SIP to develop the Roland Morris Disability 
Questionnaire (RMDQ) in 1983 (274). The RMDQ has been identified in this research 
programme as one of the most commonly used outcome measures for people with LBP 
following physiotherapy interventions. 
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Table 5.2: Summary comparison between different scaling methods 
Scaling 
method 
Assumptions Scale construction  Advantages Disadvantages 
Thurstone 
(Equal-
appearing 
interval)  
 Concepts are assumed to be unidimensional. 
 The description of concept should be as clear 
as possible. 
 Judges have a clear idea about the concept 
that been measured. 
1. Developing the focus for the scaling 
project. 
2. Generating a large set of potential scale 
items that describe specific construct of 
interest. 
3. Ambiguous items will be removed. 
4. Judges will independently assess items 
and rate each statement on 1-to-11 scale 
in terms of their representativeness of the 
phenomenon under examination. 
5. Computing scale score values for each 
scale item. 
6. Visual inspection of items for 
inconsistency 
7. Average value for retained items will be 
estimated. 
8. Select items that are at equal intervals 
across the range of medians. 
 Role of external experts.  Unclear unit of measurement. 
 Violate the specifications and rules of the 
theory of measurement. 
 Representativeness of judges. Judges could 
mistakenly reflect on their beliefs about the 
construct of interest under examination, 
instead of rating representativeness of items 
on scale points such as 1 = strongly 
disagree and 11 = strongly agree). 
 Judges perspective towards the phenomena 
under examination could change with time. 
 The quality of judgments is dependent on 
the judges’ experience with the construct. 
 Scales generated in one clinical context 
cannot be transferred to other settings. 
 Requires a large amount of time and 
resources. 
 Persons with identical scores may have 
different traits. 
 The assumption that data collected are 
continuous where in reality is a subjective 
ordinal ranking. 
Likert 
(Summated)  
 Concepts are assumed to be unidimensional. 
 Items reflect the variable under consideration. 
 Items provide a good measure of the variable. 
 Scoring of items is uniformed. 
1. The researcher assembles a large number 
of statements concerning the dimension 
need to be measured. 
2. Each of the test items is classified by the 
researcher as generally “favourable” or 
“unfavourable” with regard to the construct 
under study. No attempt is made to scale 
the items; however, a pre-test is conducted 
that involves the full set of statements. 
Ideally, the initial classification should be 
checked across several judges. 
3. In the pre-test the respondent indicates 
approval (or not) with every item. 
4. Each response is given a numerical weight 
(e.g., +2, +1, 0, −1, −2).  
 Easy to construct. 
 Subjects/respondents used to 
them. 
 Lend themselves to ordinal 
levels of measurement. 
 Use common measurement 
format. 
 Unclear unit of measurement. 
 Violate the specifications and rules of the 
theory of measurement. 
 Extra efforts are needed to interpret scores 
obtained in a clinical context. 
 Assumes each item has an identical weight. 
 Persons with identical scores may have very 
different traits. 
 Problem of validity. 
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5. The individual’s total-attitude score is 
represented by the algebraic summation of 
weights associated with the items 
checked. 
6. On the basis of the results of the pre-test, 
the analyst selects only those items that 
appear to discriminate well between high 
and low total scorers. 
7. The 20 to 25 items finally selected are 
those that have discriminated “best” (i.e., 
exhibited the greatest differences in mean 
values) between high versus low total 
scorers in the pre-test. 
Guttman 
(Cumulative)  
 The purpose of Guttman scaling is to establish 
a one dimensional continuum for a construct 
under measurement. 
 The Guttman scaling is used to predict item 
responses perfectly knowing only the total 
score for the respondent. For example, if a 
respondent have a score of four in ten items 
scale then this respondent agree on the first 
four statements. 
 The Guttman scale should conform with a 
perfect linear pattern. 
 Define the focus of the scale. 
 Develop a sample of items. 
 A group of judges will rate the items. 
 Subject item responses to scalogram 
analysis 
 Eliminate errors 
 Develop the Cumulative scale. 
 Administrating the scale. 
 Uni-dimensional 
 Highly reliable 
 Lend themselves to ordinal 
levels of measurement 
 Violate the specifications and rules of the 
theory of measurement. 
 Little guidance for the selection of items 
 Problem of validity 
 Unequal intervals. 
 Poor definition of the unit of measurement. 
 Individuals who did not fit with the pattern are 
excluded from the study. 
 Scales generated in one clinical context 
cannot be transferred to other settings. 
 The perfect pattern of the Guttman scaling is 
highly problematic in clinical contexts. 
Babbie (271,275), p. 178-183.
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5.4.2 Likert method 
The Likert method was developed by Rensis Likert in 1932 (276). It is one of the most 
commonly used subject-centred scaling methods in the construction of measurement tools 
(271). This method was developed in an attempt to enhance the levels of measurement in 
social research through the use of standardised response choices in questionnaires to 
determine the relative intensity for different indicators (271). The steps for constructing 
a Likert scale are described in Table 5.2.  Even though the majority of studies within the 
HRQOL literature do not report which method of measurement is used in the construction 
of scales, many scales, such as QBPDS, use a Likert response format (277-279). 
5.4.3 Guttman method 
The aim of the Guttman method is to establish a unidimensional continuum of statements 
that summarise several discrete observations (280). Guttman developed the scalogram 
technique to ascertain unidimensionality (266,271). This method of scaling allows for the 
possibility of predicting item responses perfectly by knowing only the overall score of 
the respondent. The Guttman method aims to identify a list of indicators that conform to 
a consecutive pattern. The assumptions, advantages and disadvantages of the Guttman 
scaling method are illustrated in Table 5.2. 
The focus of this method is the property of unidimensionality in a scale (280). This 
unidimensional scale, according to the Guttman method, and the knowledge of the 
respondent score should allow researchers to reproduce the respondents’ item score 
patterns (266). In a unidimensional scale, items are organised in order of endorsement or 
descriptiveness in a logical manner so that a positive response to an item should imply a 
positive response to all other items lower on the scale, and vice versa, if a negative 
response has been given (Table 5.3). 
Table 5.3: An example of a walking ability scale with the responses of six patients 
Walking ability Patients 
Items A B C D E F 
I am unable to walk. 1 1 1 1 1 1 
I am able to walk with assistance of a walker. 1 1 1 1 1 0 
I am able to walk with the assistance of a crutch. 1 1 1 1 0 0 
I am able to walk with the assistance of a cane. 1 1 1 0 0 0 
I am able to walk under supervision. 1 1 0 0 0 0 
I am able to walk independently. 1 0 0 0 0 0 
1  = (yes) and 0 = (no) 
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5.5 Discussion 
This chapter suggested that within the context of spine care, many outcome measures 
have been developed to measure symptoms and functional status. Physical functioning, 
in particular were one of these constructs that can be observed by clinicians and reported 
by patients. 
The majority of LBP outcome measures have an ordinal level of measurement 
(206,207,262,270,281). This may be due to the characteristics of functional status, per se 
[Chapter 4]. There are no clear units in functional status; however, the performance of 
different activities can be ordered in a logical sequence of events. For example, no 
individual can walk without first being able to stand up, and the ability to walk is one of 
the most important requirements before being able to run. According to Chapter 4 of this 
thesis, functioning meets the characteristics of an ordinal level of measurement. It is 
possible to rank physical abilities on a Guttman scale according to the roles of the ordinal 
levels of measurement. This will be important later in this thesis in the development phase 
when selecting an appropriate measurement system that conform to the characteristics of 
functioning and the assumptions of the theory of measuring scales. 
To ensure that the clinical meaning is preserved during the process of measurement, the 
chosen method should conform to the specifications of the construct under scrutiny 
[Subsection 5.2], the rules of the theory of measuring scales [Subsection 5.3] and scaling 
methods [Subsection 5.4]. It is equally important to meet the criteria required in a 
measurement tool to use it in a clinical context. These criteria will be reviewed in Chapter 
6.  
5.6 Conclusion 
The fulfilment of the rules of the theory of measuring scales and the requirements of 
scaling methods ensures the construction of a valid, reliable and responsive outcome 
measure for individuals with LBP attending physiotherapy. The continuous scrutiny of 
these requirements during this research will also ensure the construction of a useful, 
informative and meaningful outcome measure later in this thesis that measures the 
effectiveness of physiotherapy interventions. 
The following chapter will review the criteria required in a measurement tool to use it in 
a clinical context, and in Chapter 7, a critical review of commonly used LBP outcome 
measures used in clinical practice will be presented. 
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Chapter 6: A critical review of the quality criteria required in a 
measurement tool for clinical utility 
Key points in Chapter 6: 
- This chapter suggests that the majority of outcome measures developed for 
research are not suitable for use in clinical contexts. This chapter proposes that 
outcome measures developed for use in clinical contexts might be suitable for use 
in research. 
 
- Most studies on the psychometric properties of scales focus on providing 
compelling evidence for validity and reliability; however, less attention is directed 
towards responsiveness. 
6.1 Introduction 
The first section in the conceptualisation phase examined the prevalence, personal and 
environmental factors and the impact of LBP on people’s lives. The first section provided 
an in-depth understanding of the burden of the problem on society, the healthcare system 
and the individual. The first section also reviewed the management models of LBP and 
the definition of pain and functional status. These reviews provided a conceptual 
understanding of the constructs that are affected by LBP and the modern models used to 
manage this disorder. The second section discussed the theory of measuring scales and 
scaling methods. The second part in the conceptualisation phase is very important because 
the aim of this thesis is to develop a clinical measurement tool for use in the Jordanian 
healthcare system. Therefore, the purpose of the current chapter is to support the idea that 
outcome measures should be developed in the frame of the application (i.e., clinical 
context). 
It is important to begin this chapter by pointing out that there is an international demand 
for the delivery of high-quality effective, efficient and patient-centred care (282). One of 
the barriers in implementing EBP in Jordan in the clinical context is the lack of 
appropriate outcome measures (19). Measuring the outcomes of interventions using a 
suitable measurement tool that reflects the quality of care is crucial in addressing this 
demand.  
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Pertinent outcome measures might provide useful information about various aspects of 
care, such as (16): 
 A description of the natural history of the disorder and the impact of it on an individual. 
This is achieved through the measurement of relevant outcomes over time. These 
longitudinal measurements of outcomes might provide information regarding the LBP 
clinical course and consequently enhance the current understanding of LBP. 
 The evaluation of therapeutic interventions in clinical trials to determine their 
effectiveness. 
 Scrutiny of clinical judgment, including initial assessment and treatment planning. This 
is achieved through the longitudinal monitoring of outcomes. 
Chapter 1 suggested that our current understanding of the causes of LBP is rudimentary. 
The evidence-based paradigm is not embedded in the health services culture (19). In such 
circumstances, the primary determinants of the best clinical decisions are the clinician’s 
judgment, which is guided by clinical experience, limited scientific evidence and patient 
preferences (283). This experiential knowledge is one important aspect of EBP (284); 
however, research findings and patient preferences are equally important to experiential 
knowledge, and EBP requires the integration of all of these components simultaneously. 
This further highlights the urgent need to examine Jordanian individuals’ experiences of 
living with LBP and to develop a suitable outcome measure that is appropriate for service 
evaluations in a clinical context.  
In the context of this thesis, an appropriate outcome measure is needed to serve as a 
feedback tool for physiotherapists to assist informed clinical decisions regarding whether 
or not to continue musculoskeletal rehabilitation, stop therapy and refer the patient to 
other services or other interventions to induce recovery and consequently improve the 
patients’ experiences of care. When combined with an appropriate documentation system, 
measurement provides legal credentials that explain the practice and assist in the process 
of clinical reasoning (74). Moreover, a comprehensive documentation of relevant clinical 
outcomes can guide clinical reasoning and provide transparent reviews for auditing 
purposes. The following subsections will discuss the similarities and differences between 
the properties required in an outcome measure for use in research and in clinical practices. 
The understanding of these requirements is important in this thesis to ensure the 
development of a measurement tool that is dynamic enough to meet the requirements of 
both the clinical context and the research. 
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6.2 A comparison between patient reported outcome measures (PROMs) that 
are developed for research and clinical practices 
Due to the lack of suitable PROMs in the Jordanian healthcare system, the National 
Health Services (NHS) in the UK will be used as an example in this subsection to 
demonstrate the different uses of PROMs in research and clinical practices. In the UK, 
there is a demand to transform healthcare services to assist patients and clinicians in 
making better decisions and to offer comparisons of providers’ performances to stimulate 
improvements in healthcare services (285). In response to these demands, PROMs were 
developed to stimulate these changes in how healthcare is organised and delivered to 
improve healthcare quality (10). 
PROMs were originally developed for research and audit purposes; however, PROMs 
were adopted and used in a clinical context to inform clinical decision-making (10). 
Measures used to inform research and audits involve data being collected, aggregated and 
analysed on a group level (11,12). Different studies indicated that PROMs, which possess 
adequate psychometric properties at the group level and perform satisfactorily in the 
measurement of outcomes in clinical trials, are not necessarily suitable for the evaluation 
of clinical outcomes on the level of the individual in a clinical context (13-16). This is 
because data collection in research mainly aims to generate generalisable findings, while 
data collection in clinical contexts aims to inform individual’s care (10,17,18). 
This conflict between the two aims and the widespread mandatory implementation of 
PROMs in the NHS without adequate training in how to use them might cause harm rather 
than help an individual patient’s care. The primary motivation behind developing PROMs 
was to improve patient care; however, the process of how researchers undertook this task 
and developed the current PROMs was found inadequate in achieving this goal (18). The 
clinicians who use PROMs in clinical practices might not know the answers to the 
following questions (286):  
 What a particular PROMs score means (e.g., what a VAS score of 6/10 mean,)? 
 How clinicians can safely interpret and report data? 
 How much change is enough? 
 How often to use these data in clinical practice? 
 When not to use PROMs in a clinical context? 
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The attention on the process of quantification in research has moved the focus of the 
research community from developing PROMs that facilitate clinical reasoning and 
promoting partnerships between individuals and health professionals to the focus on 
developing rigorous studies designed for research purposes with significantly less 
attention on the appropriateness for use in clinical, home or community settings (287-
292). This shift in attention might have occurred as a result of the belief created by the 
dominant scientific perspective that considers health records and all types of qualitative 
clinical data as ‘soft’ and insufficient to fulfil the requirements of scientific evidence 
(293). 
The research environment is different from a clinical environment (294). The purpose of 
outcome measurements in clinical trials is to compare groups of patients, usually over a 
relatively short period of time, thus potentially missing variations in responses that can 
occur over longer periods of time (295). Until recently, clinical trials were usually 
conducted in highly-selected populations of patients with few comorbidities to meet the 
often meticulous prerequisites of research protocols, which might not resemble clinical 
practices (283). Measurements in clinical trials would be undertaken at 2 or 3 intervals, 
and the cross-sectional variation between the groups on each of these scales would be 
correlated (76). To overcome some of the limitations of current research designs, a new 
framework was developed by the Medical Research Council to recognise and adopt 
appropriate methods for the evaluation of a variety of complex interventions (296). This 
framework suggested alternatives to theory-driven evaluation methods, such as cluster 
randomisation, a stepped-wedge design and a realist evaluation (296). However, the 
measurement tools designed for research purposes are highly likely to continue to be 
directed towards the measurement of the disease or the effectiveness of interventions 
rather than what is important to the patient (297). 
In contrast to the research environment, the majority of healthcare providers in a clinical 
context interact with patients who have multiple comorbidities and who are of various 
ages, genders, levels of education or social statuses (298). In a clinical context, clinicians 
are more interested in examining the longitudinal within-subject changes in a singular 
dimension of interest (76). Usually, it is a partnership, communication or a mutual 
agreement between a clinician’s experience/expertise and a patient’s 
expectations/preferences that will determine the outcomes to be measured in a clinical 
context. 
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Clinicians in a research setting are more interested in developing measurement tools that 
examine overall changes between patients (294). When performing a measurement on a 
group level, it is common in a research setting to randomise patients into different groups 
and average the results to reduce the systematic bias and random errors that are associated 
with the process of measurement. This is not attainable when using the same measurement 
tool on the individual level (299). In contrast, clinicians in a clinical context are more 
interested in the within-patient changes over time (289,294,297,299).   
Measurements in clinical contexts are often on an individual level, while in research, 
group measurements are usually needed. Measurements on the individual level (i.e., a 
sample of 1) require a higher level of specificity, sensitivity and responsiveness to 
overcome measurement errors, which could affect a scale’s validity and lead to low scale 
reliability (289,300,301). Studies have also shown that some clinicians might struggle to 
apply research-designed measures to clinical practice due to limited knowledge and 
expertise in the field of measurement theories (283,302).  
There are at least four important properties that should be fulfilled in a scale to ensure 
that it is suitable to translate clinical observations into meaningful scientific data that 
would ultimately contribute to solving clinical problems and providing EBP in clinical 
contexts (76,289). Firstly, a scale should produce the same results when repeated in the 
same population (reliable). Secondly, a scale must be able to measure what it is intended 
to measure (valid). Thirdly, a scale must be able to detect an important change, even if 
that change is small (sensitivity/responsive). Fourthly, the intended audience must be able 
to comprehend the magnitude of the effect (interpretable). This research programme 
proposes that satisfying these requirements of a theory-driven measurement tool that 
measures constructs important to individuals with LBP will ensure the collection of data 
that inform clinical decisions in a clinical context at the individual level and that it be 
aggregated to inform decisions on the group level (i.e., managers, policymakers or 
commissioners). These measurement properties will be discussed in detail in the 
following subsections. 
 6.2.1 A scale should produce the same results when repeated in the same 
population 
The process of measurement might be associated with systematic and random errors 
(303). The nature of the pain or functional status makes the processes of measurement 
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rarely perfectly reliable. In reality, it is difficult to calculate errors associated with the 
measurement of pain or function because they are unstable subjective phenomena; 
therefore, the measurement of both constructs and the associated measurement errors are 
difficult and rarely reliable. 
In a research environment, measuring changes on a group level will significantly reduce 
random errors by averaging the test scores, assuming that random errors are normally 
distributed and would eventually cancel each other out, making the average score a good 
estimate of the true score. However, this is not the case if the same measurement is 
performed at the individual level. A physiotherapist working in a clinical context would 
deal with one patient at a time, and instead of performing cross-sectional measurements 
on a group of patients, he/she would perform longitudinal measurements on the same 
patient. This might eliminate systematic errors; however, random errors would have a 
significant impact on the scores if the scale was poorly developed (304,305). 
The usefulness of measurements in clinical contexts depends on the extent to which 
healthcare providers can rely on scores as accurate and meaningful indicators of pain or 
function. A scale that is highly inconsistent cannot generate meaningful measurements 
(295). A reliable scale should produce relatively consistent responses over time given the 
subjectivity and instability of the attribute being measured, providing it remains 
consistent. This first characteristic is fundamental to all other aspects of measurement 
(295). This is because without it, clinicians cannot have confidence in the data collected 
and would be unable to make rational conclusions from the data or clinical decisions 
regarding whether or not to continue therapy or to stop physiotherapy and refer the patient 
to other services or interventions that might induce recovery. An appropriate scaling 
method, such as the Guttman scaling method [Subsection 5.4.3], might help to minimise 
the impact of errors on the process of the measurement at the individual level and might 
enhance the reliability (271,306). 
6.2.2 A scale must be able to measure what it is intended to measure 
Scales that are intended for use in clinical contexts must contain questions that are 
relevant to the context (288). It is not logical to ask people about the effort required to 
climb hills where there are no hills. If a scale is able to measure what is intended to be 
measured, then it is considered a valid scale. Validity implies that a scale is relatively free 
from measurement errors or has a small margin of measurement errors (295). The 
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presence of any measurement errors might cause a scale’s scores to be invalid 
representations of the attribute being measured. This characteristic is fundamental in 
drawing inferences from collected data and determining how scores of a scale can be used 
in clinical contexts and in the decision-making process (295). 
As indicated in Chapter 4, pain intensity is a subjective experience that can only be 
quantified through self-reporting, which presents a different set of issues. For example, 
patients may be asked to rate their pain by placing a mark on a 10 centimetre straight line 
over a page of paper, so different respondents place different marks to show how much 
pain they are experiencing at a particular time. The line itself in this type of scale does 
not specifically represent any of the different dimensions of pain [Chapter 4]. Participants 
might feel confused and rate the pain impact on their life, report only the pain intensity 
or any combination of these different dimensions of pain. Clinicians cannot guarantee 
that these marks actually represent any of the dimensions of pain. In other words, the 
problems are that the clinician cannot falsify patients’ ratings nor can they verify that this 
pain scale actually reflects the different dimensions of pain.  
Additional problems will also appear in the longitudinal measurement of pain. This is 
because there are no clear units of the measurement of pain to reflect upon if a patient’s 
symptoms have actually improved, did not change or have deteriorated. It is well-
documented that pain is not a fixed phenomenon, which means the same patient might 
report different pain intensities or pain impact throughout the day; therefore, the timing 
of the measurement will play a major role in the measurement process. In comparison to 
pain, for physical functioning, which is an observable construct and is affected by LBP, 
patients can report their problems, and physiotherapists can observe the problems. 
Therefore, this thesis supports the adoption of this construct in the measurement of the 
impact of LBP.  
6.2.3 A scale must be able to detect an important change even if that change is 
small 
As mentioned previously, clinicians in a research environment may be more interested in 
calculating the difference between groups. Thus, the scores generated from clinical trial 
measures are often presented as means. While this may be helpful in testing one 
intervention against another in groups of patients, it is of less value in clinical 
environments (294). It is difficult to evaluate the effectiveness of physiotherapy at the 
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individual level using means because the point in time in which the patient’s health status 
changed cannot be identified. A clinical trial is the best-known approach to examine 
whether an intervention works, but it is debatably the worst approach to examine who 
benefits from an intervention (307). 
To clarify the confusion involving the interpretation of means in clinical trials, 
significance testing through the use of a p-value cut-off point of 0.05 was introduced by 
statisticians (308). This resulted in studies’ scores being either statistically significant or 
insignificant. Even though this cut-off point objectified clinical trials’ outcomes, adhering 
to such a rigid p-value can lead to serious consequences. Firstly, a potentially important 
clinical difference observed in trials can be represented as insignificant and therefore be 
unfairly disregarded as a result of having a small sample size (type 2 error). Secondly, a 
trivial difference in measurements can be proved statistically significant by increasing the 
number of individuals in a trial. Such a small difference may be irrelevant to patients or 
clinicians. Therefore, a statistically significant difference does not necessarily infer a 
clinical significance. To examine clinical significance, the concept of a minimal clinically 
important difference (MCID) was proposed by Kirshner and Guyatt (76) in 1985. The 
MCID is defined as “the smallest difference in a score of a domain of interest that patients 
perceive to be beneficial and that would mandate a change in their management in the 
absence of troublesome side effects and excessive costs” (309), p. 408.  
It is clear from this definition that MCID offers a threshold above which an outcome is 
deemed as important by the patient. This threshold must also exceed the errors threshold 
of measurement to consider it a true change in the patient’s health status and not the result 
of a measurement error (267,289). 
There are three well-known techniques to calculate or estimate the MCID, which are 
distribution-based methods, anchor-based methods and the nominal group technique 
(289). The distribution-based methods are derived from statistical measures of the spread 
of data, such as standard deviation, standard error of the mean and effect size, which is 
based on standard deviation (289). These methods have two major limitations. Firstly, 
estimates of variability will differ from one study to another (289). For example, if a 
clinician selected the between-patient standard deviation, they have to confront its 
dependence on the heterogeneity of the sample under study. If an extremely 
heterogeneous sample (which is typical in clinical contexts) is enrolled in a trial, the 
significant effect may be small in terms of the between-individual standard deviation and 
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therefore judged trivial. However, the same effect size in an extremely homogeneous 
sample (which is typical in a research environment) in a trial may be large in terms of the 
between-individual standard deviation and therefore considered as significantly 
important. The real impact of the change stays the same, but the interpretation varies 
drastically. This leads to the second limitation in deciding whether or not the magnitude 
of the intervention effect is worth the risks and costs. A clinician who knows that the 
effect is a 0.4 standard deviation unit will be unable to use this number to inform clinical 
decisions. The unit does not carry any intuitive meaning to clinicians. Furthermore, 
methods based on the effect size assume that all patients change in the same direction. 
This might lead to imprecision if individuals who did not improve are included in the 
summary statistics (290). 
The anchor based method establishes whether or not the patient has changed after 
treatment compared to the baseline according to the patient’s own experiences. The 
anchor method is not suitable for conditions in which most patients will improve and few 
will remain unchanged, such as individuals with LBP (308).  
The nominal group technique relies on a panel of experts who possess scientific or clinical 
knowledge to reach a consensus regarding the MCID. The expert panel is asked to provide 
their best estimate of the MCID. The opinion of the majority is considered during the 
period of the scale construction (310-312). Currently, there is no consensus on one right 
method to determine the MCID. It is important to note that MCID varies according to the 
health conditions and the starting states. The perception of change in a state, such as 
physical functioning, derives its significance and meaning in comparison to the starting 
state as much as any other referent (290). For instance, an individual who started at a low 
level of function on a scale and experienced a degree of change along the dimensions 
being measured might perceive the change as clinically significant. However, another 
individual who started with much higher physical abilities might view the same size 
change as a trivial improvement and would need a much larger change to consider it 
clinically significant. Therefore, the sensitivity or responsiveness of the scale still 
mandates asking the question of whether the same amount of change in an underlying 
dimension is clinically significant at all levels or a function of the level at which a person 
starts. 
MCID is significantly important to determine whether or not a measurement tool is 
sensitive or responsive to change. Clinicians should be cautious not to confuse sensitivity 
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with responsiveness. Sensitivity refers to “the ability of an instrument to measure change 
in a state regardless of whether it is relevant or meaningful to the decision maker. A test 
may be sensitive to a state or a diagnosis, but whether it is meaningful or important 
cannot be deduced from this property alone” (290), p. 1185. However, responsiveness 
refers to “the ability of an instrument to measure a meaningful or clinically important 
change in a clinical state” (290), p. 1185. This difference between the two terminologies 
will be addressed in more detail in the next subsection. Clinical knowledge may be more 
suitable to determine the MCID than the statistical tests because statistical tests provide 
data that requires further interpretations and analyses to transform these data into 
information. On the other hand, clinical knowledge provides direct information about the 
pattern of recovery and the various stages of recovery. Therefore, this thesis supports the 
use of the nominal group technique to determine the MCID in outcome measures 
developed for use in a clinical context. 
6.2.4 Intended audience must be able to comprehend the magnitude of the 
treatment effect 
In the last century, the scientific community argued that the question to which clinicians 
must find an answer is not ‘should it work’ but ‘does it work’ (307). In 2015, clinicians 
have to advance one step further and ask ‘does it work for this patient’ instead of ‘does it 
work for most patients’. Therapists need a responsive system to explore what works for 
whom. Unfortunately, many measurement tools are ‘sensitive’ to changes but not 
‘responsive’. It is unclear whether these scales (generic or condition-specific) capture 
meaningful changes at the individual level. This research programme identified a number 
of factors that might affect a clinician’s ability to understand the magnitude of a treatment 
effect.  
Firstly, the high variability in individual perceptions and the qualitative nature of both 
pain and function implies that presenting only the mean value is both meaningless and 
unscientific (292). In other words, mean values do not reflect the health status of any 
individual in the group. 
Secondly, clinicians need to consider that two individuals with the same injury who are 
treated in the same way might see changes in their health status in different ways (267). 
Therefore, a desired outcome, such as restoring physical function or pain reduction, may 
be perceived differently by different patients based on their personal and disease-related 
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characteristics as well as their health-concerned beliefs, attitudes and expectations.  
Thirdly, clinicians rarely consider that individuals with health conditions are affected by 
their social environment (289). Therefore, clinicians working in clinical contexts must 
consider the complexity of social problems within which clinical problems arise and must 
be solved. Measurement tools should assist clinicians in interpreting personally unique 
patterns of illness instead of recognising generalised patterns of disease. This can be 
achieved by understanding the different dimensions of a patient’s disease-related quality 
of life and their perceived state of well-being. This holistic bio-psychosocial approach 
views patients as people instead of cases, which can empower people to live with 
incurable illnesses, such as LBP.  
Fourthly, clinicians should understand that the path from scientific law to scientific 
measurement can rarely be travelled in the reverse direction (313), which suggests that 
clinical and theoretical knowledge as well as measurement theories and scaling methods 
are preliminaries in measurements that are scientifically useful. It also implies that 
therapists may not be able to generate/build concrete theories/laws about the attribute 
being measured from individual measurements taken during clinical practices. 
As discussed previously, many scales in the field of physiotherapy are nominal and 
ordinal level scales. The assignment of numerals to categories produces problems because 
clinicians might assume that such numerals represent numbers or magnitudes instead of 
orders. This is important because data generated by nominal and ordinal scales cannot be 
manipulated with any of the fundamental operations of algebra (257). 
Fifthly, adherence to the theoretical conditions of numerical assignment will ensure that 
scores generated by a measurement tool are informative in clinical contexts. These 
assumptions and conditions were discussed in detail in the previous section; however, a 
short list will be presented in Box 6.1. The points in Box 6.1 were extracted from a study 
by Michels (257) addressing the theoretical requirements of a measurement in the 
physiotherapy field. 
Finally, most studies on the psychometric properties of scales focused on providing 
compelling evidence for validity and reliability; however, less attention is directed 
towards responsiveness (314). 
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Box 6.1: The theoretical conditions of numerical assignments to observations 
1. There is a rule for making numerical assignments. 
2. The rule is determinative in the sense that the same numerals would always be 
assigned to the same things under the same conditions. 
3. The rule is non-degenerate in the sense that it allows for the possibility of 
assigning different numerals to different things or to the same things under 
different conditions.  
4. Categories or units on the scale are mutually exclusive and exhaustive. 
5. Any object that occurs in the order of the quantity represented on the scale 
must be measurable by the procedure for measuring on that scale. 
6. Any object that is measurable on the scale must occur in the order of the 
quantity represented on that scale. 
7. Objects measurable on the scale that are arranged in the order of their 
numerical assignments are thereby arranged in the order of the quantity. 
6.3 Summary 
This section proposes that a valid, reliable and responsive outcome measure will not only 
influence clinical decisions but will also help in allocating scarce health resources without 
compromising patients’ care. In a clinical context, it is important to relate clinical 
significance to the goal of therapy and the construct that the clinical significance reflects. 
The theoretical knowledge generated from previous chapters will be used in a critical 
review of six of the most commonly used scales in the management of LBP in the next 
chapter. 
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Chapter 7: A critical review of existing LBP outcome measures 
Key point in Chapter 7: 
- There are major issues in the current most commonly used LBP outcome 
measures, such as a lack of conceptual models, double and triple direct questions, 
the absence of a clear unit of measurement, a lack of coverage of goals important 
to individuals with LBP and floor and ceiling effects. Therefore, a new 
measurement tool capable of measuring patient-centred changes at the individual 
level in clinical contexts and the group level in research contexts might be a useful 
addition. 
7.1 Introduction 
This chapter aims to answer the following question: are current pain and back-disability 
measures appropriate and adequate for the measurement of changes in individuals with 
LBP in clinical practices, or is a new measurement tool required? Answering this requires 
critically appraising current measures with an appropriate evaluation checklist. The 
Consensus-based Standards for the selection of the health status Measurement 
Instruments (COSMIN) checklist (315) was used to evaluate the measurement properties 
of six LBP scales (Figure 7.1). The outcome measures reviewed in this chapter were 
selected because they are the most commonly used in the LBP field (209,210,225,316) 
and the only ones translated into the Arabic language (9). This consensus-based checklist 
was specifically developed by healthcare experts to evaluate the methodological quality 
of studies on measurement properties. 
Figure 7.1: COSMIN taxonomy of the relationships of measurement properties 
 
From Mokkink et al. (315), HR-PRO: Health-Related Patient Reported Outcome measure 
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Box 7.1 shows six questions that were extracted from the findings of the previous chapters 
of this thesis. These novel questions were added to the checklist because the COSMIN 
checklist was designed to evaluate the measurement properties, but it did not include 
questions related to the process of their development; therefore, the questions in Box 7.1 
are an important addition to the COSMIN checklist. 
Box 7.1: List of questions to guide the critical appraisal of LBP outcome measures 
1) What is the dimension of interest in this scale? 
2) What is the purpose of this scale? 
3) Have the logical requirements of the measurement theory been satisfied? 
4) What is the scale of measurement? 
5) What is the rule for making numerical assignments? 
6) What is the unit of measurement in this scale? 
The measurement tools in the healthcare context are divided into generic and condition-
specific outcome measures. Condition-specific outcome measures pertaining to LBP are 
mainly used to examine the symptoms and the impact of LBP on individuals’ lives (317). 
The preference to use one type of measures or a combination depends on the purpose of 
the measurement and the period of evaluation (318). Researchers interested in comparing 
the impact of different conditions on peoples’ lives might opt to use a generic outcome 
measure, such as the Short Form-36 (319), for a policy directive perspective (11); 
however, generic measures include items that do not necessarily reflect what is important 
to different patients with a specific condition in a clinical context. Patients might choose 
not to complete questions that are not relevant to them. This might limit the use of generic 
measures in a clinical context. In contrast to generic measures, condition-specific 
measures directly relate to what patients consider important to them, such as restoring 
function, reducing pain intensity, or improving social interaction (211,320). Thus, the 
purposes of the following sub-sections are: 
1. Review the concepts within six of the most commonly used condition-specific 
questionnaires that examine back-specific disability (321) and pain intensity (225,322). 
2. Critically appraise the development of each of these questionnaires based on the 
measurement theory.  
3. To examine the ability to understand and interpret scores or percentages obtained by each 
of these patient-oriented scales. 
7.2 Pain scales 
7.2.1 The visual analogue scale 
The visual analogue scale (VAS) is a measure that uses a 100 millimetre line to enable 
respondents to rate their pain intensity (323). This scale is frequently marked on one end 
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as no pain and the other end as pain as bad as it could possibly be (226,324). The VAS 
is easy to administer and has many response categories (227). Therapists’ might ask 
patients to place a mark on this line to represent their current perception of a particular 
phenomenon regarding pain intensity or pain impact on a physical activity, and then 
therapists measure the length between the ‘no pain’s’ mark to the patient’s mark in 
millimetres using a ruler (226). However, the process of the interpretation of scores is not 
simple. Many studies report various limitations associated with the administration and 
interpretation of the VAS (225,226,324-330). For example, the VAS lacks a theoretical 
foundation that relates units of measurement to clinical meanings (325,326).  Due to this 
lack of clarity in the units of measurement, the patients (and therapists) are obligated to 
guess the meaning of the mark on the VAS. 
The graphic rating scale is another form of the VAS that assigns marks, such as mild, 
moderate or severe, to specific intervals of 20 mm, for instance (226,281,331). Placing 
these marks at equal distances may not be appropriate for all patients because patients 
usually express pain in different ways while rating their pain using these marks on the 
VAS (332). Furthermore, a 20 mm change that is close to the lower end of the scale may 
not be the same as a 20 mm change that is close to the upper end of the scale (331). Scott 
and Huskisson (323) and Aicher (281) showed that the scores’ distributions are affected 
by the allocation of markers on the VAS; if these markers were spread through the entire 
length of the line, it might produce a more uniform data distribution compared to placing 
markers on even intervals on the VAS. 
The graphic line orientation can also be one of the VAS’s limitations during the 
administration process. Ogon (205) showed that data obtained using the VAS in the 
horizontal graphic orientation was normally distributed, but when the same scale was 
administered using the vertical graphic orientation, such as in the EQ-5D-5L (333), the 
data obtained was not normally distributed. This might mean that graphic orientations can 
lead to changes in the distribution of ratings obtained using the VAS; however, a Chinese 
study showed less error using the vertical graphic orientation of the VAS scale compared 
to the horizontal scale (334). Another study by Scott and Huskisson (335) found a 7% 
disagreement between two sets of scores when researchers presented the VAS in a vertical 
orientation compared to the horizontal graphic orientation. This disagreement occurred 
because the ratings obtained using the horizontal scale tended to be slightly lower than 
the vertically obtained results from the same subjects at the same time. The reason for 
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this may be cultural, as the Chinese population usually reads symbols in a vertically, while 
the English population reads from left to right. However, Herr and Mobily (336) reported 
that elderly individuals prefer to report pain intensity levels using the vertical VAS. The 
authors suggested that elderly people find it easier to understand; however, findings 
obtained from the previous studies may not be generalisable as participants within this 
study were purposively recruited and were highly educated, which might indicate 
selection bias. Regardless of the aforementioned limitations, it is highly recommended to 
keep the graphical orientation constant for any scale during testing and follow ups. This 
is important to induce a degree of consistency and to potentially control orientation related 
errors. 
It is also important to examine the data distribution because this will determine the 
statistical tests employed (226). Many studies hypothesized that the VAS has ratio 
properties, and the data obtained are normally distributed to allow the use of parametric 
tests, though this may not always be the case, especially with a small sample (226). 
Studies showed that data obtained from patients who have psychological problems 
associated with their health conditions or data obtained from individuals with severe pain 
might produce responses that are not normally distributed, which requires non-parametric 
tests (205,208). Furthermore, it was reported that old people have more difficulties in 
understanding the concept of the VAS, which may be due to difficulties in quantifying a 
subjective latent phenomenon as pain (208). 
Although studies have suggested that the VAS is a valid and reliable measure in a research 
setting, evidence is lacking regarding the examination of psychometric properties in a 
clinical context. Rosier (337) suggested that if a constant stimulation, such as a visual 
stimulation, was applied to a group of patients on different occasions to avoid the 
summation effect of repeated measurement, the ratings obtained using the VAS should 
be the same on all occasions. However, this study showed that the pain ratings varied over 
time despite the fact that the physical stimuli were consistent.  
The VAS does not have a clear unit of measurement that represents the perceived pain 
intensity. There is no evidence to suggest that patients will interpret the same amount of 
change at any point on the scale in the same way (331). This lack of clarity and precision 
of what exactly is being measured may be a source of measurement errors. Therefore, 
there is no evidence to support the use of the VAS for decision-making in a clinical 
context. Table 7.1 presents a summary of the critical appraisal of three pain scales.
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Table 7.1: A summary for the critical review of the measurement properties of the Visual Analogue Scale (VAS), Verbal Rating Scale (VRS) and Numeric Rating Scale (NRS)  
Quality criteria Visual analogue scale Verbal rating scale Numeric rating scale 
What is the dimension of interest in this scale? Multiple uses including pain intensity Multiple uses including pain intensity Multiple uses including pain intensity 
What is the purpose of this scale? VAS is not discriminative, predictive or 
evaluation instrument; however, this scale is 
frequently used to quantify pain intensity. 
VRS is not discriminative, predictive or 
evaluation instrument; however, this scale is 
frequently used to quantify pain intensity 
NRS is not discriminative, predictive or 
evaluation instrument; however, this scale is 
frequently used to quantify pain intensity 
Are the logical requirements of measurement theory 
satisfied? 
No, VAS has unclear unit of measurement 
and the same score could be assigned to 
different pain traits. 
No, VRS has unclear unit of measurement 
and the same response choice could be 
assigned to different pain traits. 
No, NRS has unclear unit of measurement 
and the same score could be assigned to 
different pain traits. 
What is the scale of measurement? Ratio (Not valid) Ordinal Ratio (Not valid) 
What is the rule for making numerical assignments? Unclear, an individual with LBP places a mark 
on a 100 mm line to represent their perception 
of pain intensity; however, the score cannot 
be falsified 
Unclear, an individual with LBP selects one of 
the available response choices; however, the 
score cannot be falsified 
Unclear, an individual with LBP selects one of 
the available response choices (0 -10); 
however, the score cannot be falsified 
What is the unit of measurement in this scale? 1 millimetre; however, a one unit of change 
does not represent neither a statistical nor a 
clinical significant change 
1 response choice; however, a one unit of 
change does not represent neither a statistical 
nor a clinical significant change 
1 response choice; however, a one unit of 
change does not represent neither a statistical 
nor a clinical significant change 
Reliability  Inter-rater: k = 0.61 § 
 Intra-rater: k = 0.70 § 
 Inter-rater: k = 0.54 § 
 Intra-rater: k =0.65 § 
 Inter-rater: k = 0.48 § 
 Intra-rater: k = 0.59 § 
Internal consistency N/A N/A N/A  
Measurement error Standard Error: 15mm ¥ N/A Standard Error: 1.02 point Ж 
Content validity No, the response system is not an adequate 
reflection of the construct to be measured 
No, the response system is not an adequate 
reflection of the construct to be measured 
No, the response system is not an adequate 
reflection of the construct to be measured 
Face validity No, the VAS does not look as an adequate 
reflection of the construct to be measured 
Yes (but depends on wording) No, the VAS does not look as an adequate 
reflection of the construct to be measured 
Construct validity r = 0.84 - 0.93 (NRS) Ѫ Lack of information about the slope of the 
regression line of changes in pain perception 
means that the degree of agreement between 
the VRS and other pain scales cannot be 
established. 
r = 0.84 - 0.93 (VAS) Ѫ 
  
 108  
 
 
 
 
   
Structural validity No, the VAS represents an arithmetic curve 
and the perception of pain intensity follow an 
exponential curve ѱ 
 No, the NRS represents an arithmetic curve 
and pain intensity follow an exponential curve 
Cross-cultural validity Not established in the Arabic language Not established in the Arabic language Not established in the Arabic language 
Criterion validity N/A N/A N/A 
Sensitivity ES: 0.77 Ф 
MDC: 18-19 mm ¥ 
ES: 0.76 Ф 
AUC: 0.61 Ω 
ES: 0.86 Ф 
MDC: 2 points Ж 
AUC: 0.72 (0.62, 0.81) and 0.92 (0.86, 0.97); 
1 and 4-week follow-up, respectively Ж 
MCID: 2.2 and 1.5 points, respectively Ж 
Interpretability No guidance of how to interpret scores No guidance of how to interpret scores No guidance of how to interpret scores 
The information in Table 7.1 were extracted mainly from Williamson et al. (208) 
ICC: Interclass coefficient, r: Spearman’s r coefficient, k: Kappa coefficient, N/A: Not applicable, MDC: Minimum Detectable Change, ES: Effect size, AUC: Area Under the Curve, 
MCID: Minimum Clinically Important Difference 
§ From Lara-Mun˜oz et al. (328) ¥ From Hagg et al. (211) Ж From Childs et al. (338) Ѫ From Sindhu et al. (339) ѱ From Fechner (170)   
Ф From Bolton and Wilkinson (340)  Ω  From Chien et al. (341) 
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Despite the fact that the scaling method used in the VAS generates ratio level data, the 
translating medium in the VAS is the patient perception of pain, which can be described 
using ordinal level data because the mind is known to convert the intensity of pain to a 
logarithm of the intensity of the pain (170) according to the following equation: 
Equation 7.1: Weber–Fechner law 
Perceived pain intensity (S) = k log (actual intensity (R)) + Fechner constant (c) 
Figure 7.2 shows a simple representation of the relationship between actual, transformed 
and perceived pain intensity.  
Figure 7.2: A representation of the Weber–Fechner law 
 
According to the Weber–Fechner law (170), a mark on a 100 mm scale is not a valid 
measurement of pain because the properties of the translating medium are ignored (342). 
Furthermore, the millimetres on the VAS have not been defined as units of actual pain 
intensity. 
7.2.2 The verbal rating scale 
The verbal rating scale (VRS) is a set of adjectives used in a hierarchical order to represent 
pain intensity levels (328). Most commonly, this scale is represented in four categories 
using the words ‘no pain at all’, ‘mild pain’, ‘moderate pain’ and ‘severe pain’ (227). 
Many studies report the ease of administration and scoring of this scale, and it can be 
administered in many formats and through different methods, such as verbally via a phone 
call or printed on paper (208,225,227,281). However, issues associated with this scale 
have been reported (208,225).  
Actual intensity 
Transformed intensity 
Units of perceived 
intensity (100 mm scale) 
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This scale is an ordinal scale, and it should follow the ordinal level of measurement 
devised by Steven (343). This means that mathematical operations, such as summation 
and subtraction, cannot be applied to ratings obtained using this scale despite assigning 
patients’ responses to different numbers because the intervals between responses are not 
equal (208). This is important to understand at this stage because it has been suggested 
that parametric tests should not be used to test the psychometric properties of this scale if 
it measures qualitative attributes (227). It is also important to note that this scale limits 
patients’ abilities to express pain from a personal perspective because the patient has to 
choose from the limited given options, which may be less representative of his/her own 
pain intensity level. This is important because many studies indicated that pain itself is a 
personal experience for each individual [Chapter 4]. Clinicians rely on patients to self-
report their pain intensity levels, and by limiting the choices or categories on a measure, 
the report might not adequately reflect the individual patient’s experience. 
7.2.3 The numeric rating scale 
The numeric rating scale (NRS) is an 11, 21 or 101 point scale in which one end of the 
scale may be marked as ‘no pain at all’ and the other end may be marked as ‘pain as bad 
as it could be’ (344). This scale could be administered graphically printed on paper or 
verbally via the phone (208,225). 
The NRS is easy to administer and score (208,227); however, many studies report issues 
associated with the NRS, and a limited number of studies investigated the scale’s 
psychometric properties (225). Thus, there is no adequate information regarding the data 
distribution, the minimal clinical change or the error of data obtained using the NRS 
(208,225). Many researchers consider the level of measurement in the NRS to be a ratio 
scale when it is in fact an ordinal scale because patients are assigning their perceptions of 
pain (a psychological phenomenon) to numerals and not to numbers (227). The process 
of the measurement of pain is subjective and qualitative in its nature rather than an 
arithmetic calculation. There are differences between patients regarding their perception 
of their problems, and the same numeral cannot be generalised or assumed to mean the 
same for different subjects (256). The NRS is affected by the same major limitations as 
the VAS. Therefore, the NRS is not a valid measurement of pain intensity. 
The measurement units of the VAS, VRS and NRS are unclear (340). For example, the 
standard error of measurement of the VAS was reported to be 15 mm (211), and studies, 
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such as Landorfa and Radford (345), showed that the MCID in the VAS (9 mm) is inside 
the standard error of the measurement range. The answer to this question is important for 
the interpretation of scores and later on in the process of clinical decision-making (340). 
This is important because if the MCID is within the range of measurement errors, then it 
will be difficult to determine if this change is an important clinical change or the result of 
measurement errors. Clinicians must be cautious when interpreting VAS scores because 
it is well-documented in many studies that a change from 90 mm to 80 mm is not equal 
to a change from 20 mm to 10 mm (281).  
7.3 Back-disability scales 
There are many back-disability scales that examine the impact of LBP on people’s 
abilities to carry out various activities (321). However, the Roland-Morris disability 
questionnaire (RMDQ), the Oswestry disability index (ODI) and the Quebec back pain 
disability scale (QBPDS) are three questionnaires most commonly used in clinical 
research and clinical settings to examine disabilities caused by LBP 
(209,210,321,346,347). These instruments have been researched extensively, and a 
summary of the psychometric properties for these tools is presented in Table 7.2. 
7.3.1 Roland-Morris disability questionnaire 
The developer of the RMDQ selected twenty-four items out of 136 items belonging to the 
Sickness Impact Profile to generate the RMDQ (274). There are different versions of the 
RMDQ (321). However, only the original version is recommended because different 
studies indicate that the original version of the RMDQ is valid, reliable and sensitive to 
changes in people with LBP (209,321). The RMDQ is considered to be short and simple 
to administer and is widely used to examine patients’ levels of physical disabilities (270). 
The RMDQ includes items that represent the execution of functions and physical 
activities that may be affected by LBP. Activities such as housework, sleeping and 
mobility, dressing and getting help, appetite, irritability and pain severity are covered in 
the original RMDQ. The authors of the RMDQ likely selected these items because they 
describe activities affected by LBP. This was confirmed later in a study by Wang (210) 
in which items in this scale were linked to the ICF (Table 7.3). It can be clearly observed 
in Table 7.3 that the concepts in the RMDQ, ODI and QBPDS show some of the daily 
activities that are affected by LBP. 
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Table 7.2: A summary for the critical review of RMDQ, ODI and QBPDS 
Quality criteria Roland-Morris disability questionnaire Oswestry disability index Quebec back pain disability scale 
What is the dimension of interest in this scale? Social functioning, personal care, body 
functions, pain intensity and fear-avoidance 
behaviours  Ж 
Pain intensity, personal care, social 
functioning and physical functioning Ж 
Physical functioning Ж 
What is the purpose of this scale? Evaluation instrument Evaluation instrument Evaluation instrument 
What is the scale of measurement? Nominal Ordinal Ordinal 
What is the rule for making numerical assignments? An individual with LBP selects (Yes/No) for 
each statement in the questionnaire 
An individual with LBP selects one of the 
available response choices for each item in 
the scale 
An individual with LBP selects one of the 
available response choices; however, the 
score cannot be falsified 
What is the unit of measurement in this scale? 1 response choice; however, a one unit 
change does not represent neither a statistical 
nor a clinical significant change 
1 response choice; however, a one unit 
change does not represent neither a statistical 
nor a clinical significant change 
1 response choice; however, a one unit 
change does not represent neither a statistical 
nor a clinical significant change 
Reliability Intra-rater: ICC = .91 Same day test-retest † Intra-rater: ICC= 0.94 (0.89 - 0.97); 95%$ Intra-rater: ICC= 0.92; 95% Ѫ 
Internal consistency 0.83 ѱ 0.83 $ 0.96 Ѫ 
Measurement error SEM (95% CI) = 5.2 (4.1-6.4) † SEM (95% CI) = 9 (7-12) † SEM (95% CI) = 13.08 (10.54–17.47) ‡ 
Content validity No Ѫ No Ѫ Yes Ѫ 
Face validity No Ѫ No Ѫ Yes Ѫ 
Construct validity RMDQ and the SIP (r = .85) Ф 
RMDQ and QBPDS (r= 0.77) Ѫ 
ODI and EQ5D baseline scores (r = 0.58) £ RMDQ and QBPDS (r= 0.77) Ѫ 
Structural validity No (Subsection 7.3.1) No (Subsection 7.3.2) No (Subsection 7.3.3) 
Cross-cultural validity Cross-culturally adapted to Arabic ¥ Cross-culturally adapted to Arabic β Cross-culturally adapted to Arabic € 
Criterion validity N/A N/A N/A 
Sensitivity SRM = 0.55 (95% CI = -0.54 to 1.64) † 
ROC = 0.77 (95% CI = 0.68 to 0.87) † 
MDC (95% CI) = 8.6 (6.7–10.6) † 
MCID = 6.56 points Ω 
SRM = 0.52 (95% CI = - 0.51 to 1.56) † 
ROC = 0.78 (95% CI = 0.69 to 0.87) † 
MDC (95% CI) = 15 (11–19) † 
MCID = 12.8 (2.92 - 15.36) § 
SRM = 0.49 (95% CI = - 0.47 to 1.44) † 
ROC = 0.74 (95% CI = 0.64 to 0.84) † 
MDC (95% CI) = 19 (14–24) † 
MCID = 15 points (sensitivity=82% [95% 
CI=70%–93%], specificity=83% [95% 
CI=67%–98%]). 
Interpretability No guidance of how to interpret scores No guidance of how to interpret scores No guidance of how to interpret scores 
Ж Longo et al. (321)  † Davidson and Keating (270)  ѱ Mousavi et al. (348) Ф Deyo (349)  Ѫ Kopec et al. (279)           Ω Jordan et al. (350)  
§ Copay et al. (351) $ Grotle et al. (352)  £ Johnsen et al. (353) ¥ Bejia et al. (354)   β Algarni et al. (355)  € Altaim and Littlewood (96) 
‡  Fritz and Irrgang (356)       SEM: Standard Error of Measurement  SRM: Standard Response Mean ROC: Receiver Operating Characteristic  
MDC: Minimal Detectable Change     N/A: Not applicable
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Table 7.3: Linking concepts in the ODI, RMDQ and QBPDS to the ICF 
Scale ODI RMDQ QBPDS 
ICFDH 
codes 
b134 (Sleep function)*,  
b280 (Sensation of Pain), 
d230 (Carrying out daily 
routine)**, 
d4153 (Maintaining a sitting 
position)**, 
d4154 (Maintaining a standing 
position)*, 
d430 (Lifting and carrying 
objects)**, 
d4500 (Walking short 
distances)*, 
d4501 (Walking long 
distances)**, 
d5 (Self-care), 
d7702 (Sexual relationship), 
d9 (Community, social and civic 
life), 
d920 (Recreation and leisure), 
e1101 (Drugs), 
e1150 (General products and 
technology for personal use in 
daily living), 
e1201 (Assistive products and 
technology for personal indoor 
and outdoor mobility and 
transportation), 
b1302 (Appetite), 
b134 (Sleep function)*, 
b152 (Emotional function), 
b28013 (Pain in back), 
d230 (Carrying out daily 
routine)**, 
d410 (Changing basic body 
position)**, 
d4102 (Kneeling), 
d4105 (Bending)**, 
d4106 (Shifting the body’s 
centre of gravity), 
d4154 (Maintaining a standing 
position)*, 
d450 (Walking), 
d4500 (Walking short 
distances)*, 
d4551 (Climbing)**, 
d465 (Moving around using 
equipment), 
d540 (Dressing), 
d5402 (Putting on footwear)**, 
d570 (Looking after one’s 
health), 
d845 (Acquiring, keeping and 
terminating a job), 
d850 (Remunerative 
employment), 
e3 (Support and relationship), 
b134 (Sleep function)*, 
d2100 (Undertaking a simple 
tasks), 
d410 (Changing basic body 
position)**, 
d4105 (Bending)**, 
d4153 (Maintaining a sitting 
position)**, 
d4154 (Maintaining a standing 
position)*, 
d430 (Lifting and carrying 
objects)**, 
d4450 (Pulling), 
d4451 (Pushing), 
d4454 (Throwing), 
d4500 (Walking short 
distances)*, 
d4501 (Walking long 
distances)**, 
d4551 (Climbing)**, 
d4552 (Running), 
d470 (Using transportation), 
d5402 (Putting on footwear)**, 
d640 (Doing housework), 
 
Adapted from Wang (210)  
ODI: Oswestry disability index; RMDQ: Roland-Morris disability questionnaire; QBPDS: Quebec back 
pain disability scale; ICF: international classification of function, disability and health; ICC: Interclass 
correlation coefficient; AUC: Area under curve.  
*: The ICF code is shared between the ODI, RMDQ and QDBS. 
**: ICF code is shared between at least two scales 
7.3.2 Oswestry disability index 
The ODI was developed by clinicians (357). It is unclear how the questions in the ODI 
were selected or generated to be tested on people who suffer from LBP; however, Kopec 
et al. (279) suggested that clinicians used a ‘common sense’ approach for item selection 
based on intuition rather than on the empirical analysis of a large sample of potential 
items. It does not appear that any qualitative study was undertaken to develop the ODI, 
which suggests that questions were selected from different questionnaires that assessed 
the impact of LBP on the activities of daily living (321). The original ODI included ten 
sections of questions that covered twenty-four concepts (210). These concepts belong to 
three ICF categories (Table 7.3): body function, activity and participation and 
environmental factors (210). These sections include concepts related to pain intensity, 
sleeping, sitting and standing, walking, lifting, social and sexual abilities, personal care 
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and travelling (321). Each section includes six statements that range from the best to worst 
scenarios. However, the process of calculating the overall score is inappropriate because 
it violates the rules of the ordinal level of measurement [Chapter 5]. The numerals from 
each section are added to give a total percentage of disability using the following equation 
(Equation 7.1):  
Equation 7.2: Calculating the Oswestry disability index overall disability percentage 
Overall disability level= ((patient’s score) / (number of sections completed X 5)) X 100 
Thus, an incomplete section is omitted from the calculation, and the implication is that 
the sensitivity of the scale could be compromised (295). Patients are classified on the ODI 
as minimally disabled (0-20%), moderately disabled (21-40%), severely disabled (41-
60%) and crippled (61-80%). Patients with a score between 81-100% are considered to 
be either bed-bound or exaggerating their symptoms, which may or may not be true from 
a patient’s reality or viewpoint (357). 
There are different versions of the ODI, and some studies have removed the sex life 
section and replaced it with either a changing degree of pain section or an 
employment/homemaking section (321). Furthermore, one version of the ODI modified 
by the American Academy of Orthopaedic Surgeons completely omits sections 1, 8 and 
9 (358). Moreover, statements in each section within each version of the ODI have also 
been changed (321). It is not clear whether or not omitting sections of the ODI might alter 
its psychometric properties or decrease its sensitivity. However, the different versions of 
the ODI aim to measure the same concepts but with different wording. Only version 2.0 
specifies the recall period as ‘today’. It is logical to assume that longer periods of recall 
might lead to recall bias given the instability of the attributes being measured over time 
(321). 
7.3.3 Quebec back pain disability scale 
Studies describing the development and reporting of the psychometric characteristics of 
the QBPDS were published by Kopec et al. in 1996 and 1995, respectively (278,279). 
Some amendments were made in relation to the scale’s format and the wording of some 
of the indicators to produce the final version of the scale (279). The QBPDS includes 
twenty items that were selected out of more than forty-eight items identified by patients 
and healthcare professionals who participated in a qualitative study (278,279). This 
approach to the development of an outcome measure can make the scale relevant to the 
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intended population or suitable for clinical practice (23,24). However, the qualitative 
study was one part in a doctoral thesis, and the developer of the QBPDS did not publish 
this qualitative study in a peer-reviewed journal (274). 
Twenty items were selected from a pool of data using a factor analysis to be tested with 
ambulatory LBP patients with different disability levels (356). These items represent 
basic daily tasks that patients with LBP might perceive as challenging to perform (209).  
Patients are instructed to rate the difficulty they face in performing the activities on the 
same day they visited the clinic (209). A 6-point Likert scale ranging from 0 to 5 was 
used with each indicator in the QBPDS to indicate the level of difficulty. It is not clear 
why the authors of the QBPDS selected this response system. Physical functioning is 
considered to be an observable phenomenon. However, the response choices in the Likert 
scale are unobservable and consequently unfalsifiable, which make them difficult to 
understand or to be applied to clinical decisions (359). Furthermore, the authors of this 
scale indicated that the assumptions of the Item Response Theory were followed; 
however, it is not clear how the different choices in the response system met the 
requirements of the Guttman scale [Chapter 5]. 
The RMDQ, ODI and QDS are freely available and permission is not required to use them 
in clinical practice or to reproduce them for clinical research (209,270,346). Furthermore, 
these three scales can be completed within ten minutes with no more than five minutes 
required to calculate the overall score for LBP back-related disability (270). However, 
there are issues associated with the content of these scales (Table 7.2). Studies have 
reported that the ODI contains items that are challenging to use with patients who are 
severely affected by LBP (209,270). This is known as the floor effect, and it makes the 
ODI more sensitive for use with people who are mildly or moderately affected by LBP 
(270,346). Compared with the ODI, the RMDQ has a ceiling effect, which makes it more 
sensitive for patients with more persistent and severe disabilities and less sensitive to mild 
conditions (209,270,360). Patients tend to leave some sections in the ODI and the RMDQ 
incomplete, especially those related to their sexual lives (139,209,270). Incomplete 
sections might reduce the sensitivity level of the scale. Scoring the RMDQ does not 
include an abstinence option (209). Thus, if patients choose not to answer an item that is 
irrelevant to them, clinicians might not notice this omission and assume that the patient 
does not have any problem that is related to this item and continue to fix the denominator 
as twenty-four [24 questions in the scale] (321). This might lead later on to a problem in 
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interpreting the overall score of disability level (209). 
Regarding the ICF, studies show that the concepts within these scales are fully linked to 
the ICF (210). The ODI and the RMDQ include different dimensions, such as pain impact 
and physical disability (Table 7.3). However, there are many issues associated with the 
measurement of these concepts. For example, each question within the ODI aims to 
measure concepts from the body function, activity and participation components at the 
same time; this problem is known as a double question (210,321). This is a problem 
because a double question forces the respondent to rate two independent concepts on one 
response system, which might cause confusion. Furthermore, section seven in the ODI 
aims to measure activity and participation, body functions and environmental components 
simultaneously. These double or triple direct questions that simultaneously touch upon 
more than one concept can be a source of confusion for patients who are rating themselves 
due to a lack of clarity and uncertainty of what exactly is being measured (321). This lack 
of understanding of what exactly is being measured might lead to a user error, a problem 
also reported in the RMDQ (361). These double or triple direct questions can be a source 
of an overlap of concepts in a self-reported questionnaire and might lead to an 
unnecessarily lengthy questionnaire that asks patients to rate the same concept many 
times.  Therefore, therapists and researchers might misunderstand this overlap in the ODI 
or the RMDQ, which hinders the appropriate use of these tools and adversely affects their 
validity. 
Conversely, the QBPDS contains questions that measure concepts related to activity and 
participation in more detail (210). The questions in the QBPDS focus on examining 
various aspects of mobility (209,210). However, some patients indicated that some items 
in the QBPDS lack precision and that the choice between response 0 and 1 and between 
4 and 5 is sometimes difficult (209). Furthermore, some patients said that items, such as 
‘throwing a ball’, were not relevant to them (209). 
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Although many healthcare providers recognise the importance of these measurement 
tools, they face many difficulties in interpreting the changes in scores that occur following 
therapy (211,361,362). Clinicians need to interpret this information for service 
improvement and to make clinical decisions (320). Many studies show that back-specific 
disability instruments include items that are sensitive to change (209,270,321). However, 
interpreting these changes is a totally separate concept that requires close attention and 
sometimes caution (209). This problem may be related to the fact that the response system 
in these questionnaires does not represent a recovery pattern, and the changes between 
the response choices do not represent a clinically significant change. Items in these back-
specific disability scales are not weighted equally, and the total score is calculated by 
adding the scores of all sections. There are no specific instructions in the case of omission 
or failure to answer irrelevant questions (209,321). This might significantly affect the 
clinicians’ abilities to use these scales in clinical settings due to the difficulties that they 
face in interpreting the scores. 
The same overall score of a disability level can be interpreted in many ways. This kind of 
uncertainty can be challenging and might lead to misunderstanding and confusion for 
both patients and clinicians. For example, a 10 unit reduction in a QBPDS score might 
mean a clinically significant change in a patient’s health status. However, this might not 
always be the case as these ten units could be the result of a one-unit change (a trivial 
change) in ten questions that measures the same concept, such as a patient’s ability to 
move the upper limbs while holding the trunk bent forward (211). Another interpretation 
could be that patients have five units of change in two different activities (a significant 
change), which are important to the patient, such as sitting down or standing for a long 
period of time. Hagg et al. (211) showed that the ODI and other scales indicated an overall 
improvement in patients’ physical ability following different surgical treatments. There 
was no statistically significant difference between the different groups who underwent 
different surgical procedures. However, a close examination of individual items revealed 
that following surgical intervention, improvements were noted in pain intensity, sexual 
function, ability to sleep and psychological irritability. Major pre-treatment problems, 
such as the ability to sit, stand or lift weights, did not improve more than other functions, 
which indicates noticeable disabilities in these physical activities even after surgical 
intervention. 
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7.4 Summary 
Pain and back-disability measurement tools are two types of condition-specific 
instruments that are well-researched and widely used in the literature of spine care. 
However, there are issues associated with the current most commonly used measurement 
tools. Firstly, it is unclear how items included within some of these questionnaires have 
been selected or developed to be tested with patients, such as individuals with LBP. 
Furthermore, it seems that the condition-specific instruments reviewed in this section do 
not adhere to the rules of the measurement theory discussed in Chapter 5 of this thesis. 
Different studies showed that some of these instruments include valid indicators or 
questions that reflect what is important to those who suffer from LBP. However, many 
research papers report that the response systems in these questionnaires are problematic.  
This critical review showed that some of the questions in the current LBP pain or back-
disability scales aim to measure more than one concept simultaneously. This leads to 
misunderstanding and confusion regarding what is actually being measured. Although 
each question in the QBPDS aims to measure one concept, there is an imbalance between 
the activities included in the scale. It appears that ten questions in the QBPDS examine 
patients’ abilities to move their upper limbs while they bend their trunk forward, which 
could lead to overrepresentation bias as there is more emphasis on certain activities than 
others important to people with LBP, such as lifting and maintaining a sitting or standing 
position. This would suggest that a new measurement tool capable of measuring patient-
centred changes at the level of the individual in clinical and research contexts would be a 
useful addition. The following chapter in the second phase discusses a method identified 
in the healthcare literature that was used to develop appropriate outcome measures that 
are suitable for implementation in both clinical and research settings.
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Phase 2: Development of physical functioning indicators 
Chapter 8: The selection of a method of measurement: Treatment Evaluation by A LE Roux's 
method (TELER) 
Chapter 9: Determining the desired outcome: A qualitative study to explore patients’ 
perspective of living with LBP 
Chapter 10: Combining outcome components into one measure: Generating TELER codes from 
patients’ narrative 
Chapter 11: Item calibration and validation of TELER LBP indicators: Expert validation 
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Overview of phase 2: Development  
 
A critical review of pain and back disability scales was conducted in the first phase of 
this thesis identified major problems in the development and application of six of the most 
commonly used LBP outcome measures. The critical review in Chapter 7 concluded by 
suggesting that current commonly used LBP scales might not be suitable for use in 
clinical setting. This is confirmed in a recent study that explored the content of the current 
LBP outcome measure that physiotherapists used in their clinical practice (363). Gardner 
et al. (363), p. 1035, suggested that current “clinical outcome measures may not be 
providing accurate information about the success of treatments that are meaningful to 
the patient”.  This lack of suitable LBP scales in the field of physiotherapy requires 
developing a new measurement tool that adhere to the logical requirements of 
measurement, scientific standards and qualifiers of measurement. These criteria will be 
further explained in the following subsections. 
Costa et al. (9) conducted a literature review of LBP back-disability scales that were 
cross-culturally adapted from their original languages into other languages. None of the 
measurement tools were originally designed for individuals who speak Arabic. 
Furthermore, only two out of forty back disability scales were cross-culturally adapted 
from their original language into the Arabic language. However, these two translated 
scales were not cross-culturally adapted specifically for the Jordanian population 
(354,364). This might limits their use in the Jordanian physiotherapy clinics due to the 
differences in the accents or words’ appropriateness. For example, the RMDQ was cross-
culturally adapted to the Arabic language to be used in Tunisia (354). The authors selected 
words that are relevant to the Tunisian society, such as ‘اشرب’ and ‘شاب’, and not to the 
Jordanian society. Thus, the aim of the second phase of this research programme is not to 
cross-culturally adapt one of the current LBP scales but instead to develop a new outcome 
measure that is capable of evaluating clinically important changes in outcomes important 
to Jordanian individuals with LBP following physiotherapy interventions. 
There are many guidelines and recommendations in the healthcare literature that aid the 
process of developing a new measurement tool, such as the framework devised by 
Kirshner and Guyatt (76) or the recommendations of the Physician Consortium for 
Performance Improvement (365). There are two common features that are shared between 
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these guidelines; these are the selection of an appropriate method of measurement that 
guide the designing of the new measurement tool and defining the desired outcome for 
the targeted population (23,76,365). Chapter 8 in this thesis addresses the first point, 
which is related to the selection of a suitable method of measurement. This has been 
achieved through a literature review. Chapter 9 addresses the second point, which is 
identifying the desired outcome for the Jordanian individual with LBP. This has been 
through a qualitative study that explored outcomes that are important to Jordanian 
individuals with LBP. 
The selected method for developing the new measure should ensure that the measurement 
tool is practical and scores generated are meaningful and useful in either clinical or 
research settings (249,251,300). According to the findings of the first phase in this thesis, 
the selected method of measurement should fulfil the following criteria: 
1. Logical requirement of measurement [discussed extensively in Chapter 4]. 
 
 Defining the desired outcome and the factors influencing it. 
 Identifying whether the construct is quantitative, such as bone density, or qualitative, 
such as physical functioning. 
 Exclusive and exhaustive definition of dimensions of the selected outcome. 
 
2. Scientific standards of measurement [discussed extensively in Chapter 5]. 
 
 The rules for assigning a numeral to an attribute should be made explicit. 
 Identifying the level of measurement and the mathematical properties of the resulting 
measurement tool. 
 The use of appropriate mathematical and statistical operations according to the 
characteristics of the phenomenon under scrutiny. 
 
3. Qualifiers of measurement [discussed extensively in Chapter 6]. 
 
 Ensuring validity, reliability, responsiveness and meaningfulness. 
 Defining a clear unit of measurement that possess a singular meaning. 
 Appropriate use of numerals or numbers on the scale depending on the level of 
measurement. 
These criteria are important for three reasons. Firstly, to ensure the development of a 
measurement tool that is able to monitor changes at the individual level as well as group 
level. Secondly, to ensure that the new measurement tool is able to provide useful and 
meaningful information that guides decision-making process to interested stakeholders, 
such as patients, clinicians, managers or commissioners. Thirdly, to ensure that patients 
are at the centre of their care and who determining what is to be measured within the 
frame of what physiotherapy services can help them to achieve. 
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The following objectives were linked in the process of constructing a new LBP 
measurement tool (76,366): 
1. Selection of a method of measurement [Chapter 8]. 
2. Identification of clinically significant outcomes and factors influencing them [Chapter 9]. 
3. Selection of the items pool and item reduction [Chapter 10]. 
4. Review of the initial items by experts for categorisation and calibration [Chapter 11]. 
5. Determination of usefulness [Chapter 12]. 
Kirshner and Guyatt (76) suggested that reliability, validity, responsiveness should be 
considered during the process of development. These measurement properties were tested 
in Chapter 12. 
Figure 8.1 provides an overview of the process of constructing the new measurement tool 
and the methods used in each stage. The following chapters will provide a detailed 
overview of the methods used in each of these steps. 
Figure 8.1 A diagram representing the stages of development of new outcome measure 
 
 
  
 
(Adapted from Okasheh (366)). 
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Chapter 8: The selection of an appropriate method of measurement 
– Treatment Evaluation by A LE Roux's method (TELER) 
Key point in Chapter 8: 
- The TELER method adheres to the rules of levels of measurement and the 
requirements of measurement in a clinical context; therefore, this method was 
chosen in this research programme to construct the new LBP measurement tool. 
8.1 Introduction 
Babbie (271) suggested that science, in general, is standing on two pillars, which are 
observation and measurement. The Science Council in the UK also supported this opinion 
in their proposed definition of ‘science’ (75). Phase 1 in this thesis indicated that physical 
functioning is an observable phenomenon; however, it is not clear up to this stage in this 
research programme whether or not Jordanian individuals with LBP consider it to be their 
desired outcome following physiotherapy. Thus, in order to develop the new LBP 
measurement tool, a mixed-method design was required (Table 8.1). Mixed-method 
approaches are used by pragmatic researchers who employ the most appropriate methods 
or techniques used in qualitative and quantitative methodologies and apply them within 
one study (367). Table 8.1 shows examples of four mixed-method designs in the 
healthcare literature. It seems that design 1 in Table 8.1 is suitable to guide the 
development of the new measurement tool.  Thus, a complementary qualitative 
methodology has been used in Chapter 9 in this thesis to explore the impact of LBP on 
individuals’ lives and identify the concepts required to develop the new measurement tool 
later in Chapters 10 and 11. Following the development phase, a quantitative method has 
been used in Chapter 12 to investigate the clinical utility and the psychometric properties 
of the new outcome measure. 
It is important at this stage before identifying the ‘desired outcome’ to select a suitable 
method of measurement. This method should generate quantifiable data that inform 
clinical decisions at the level of the group but not at the expense of clinically important 
individual results.  
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Table 8.1: Priority-sequence model in mixed-method approach 
 Priority decision 
Principal method: Quantitative Principal method: Qualitative 
Sequence 
decision 
Complementary 
method: 
Preliminary 
Design 1 
qual              QUANT 
e.g. to generate hypotheses, 
develop questionnaires 
Design 2 
quant               QUAL 
e.g. to guide purposive 
sampling, identify areas to 
pursue in depth 
Complementary 
method: 
Follow-up 
Design 3 
QUANT              qual 
e.g. help to interpret poorly 
understood results, help 
explain divergent findings 
Design 4 
QUAL               quant 
e.g. to generalise results to 
other settings, test elements 
of emergent theories 
Adapted from Morgan’s Priority-Sequence Model cited in Simons and Lathlean (367). 
Mawson (368-371) and Okasheh (366) suggested the Treatment Evaluation by Le Roux 
(TELER) method as a suitable method of measurement in the healthcare field. In order to 
ensure rigour and avoid bias within this thesis, the author undertook a literature review to 
search for any suitable methods of measurement other than TELER which are appropriate 
for the purpose of measurement of change in a clinical context. The literature review used 
different combinations of relevant keywords (Table 8.2) and databases CINAHL, Health 
Source: Nursing/Academic Edition, MEDLINE, Scopus and PubMed. The initial search 
retrieved 22 studies; however, after reading the abstracts of these studies, this research 
programme could not identify methods of measurement other than TELER published in 
the healthcare literature.  
Table 8.2: Keywords used in the literature search for a suitable method of measurement 
Keyword 1 Keyword 2 Keyword 3 
method 
approach 
develop 
design 
generate 
questionnaire 
index 
scale 
measurement tool 
Table 8.3 suggests that the TELER method was utilised by many healthcare professions 
in both research and clinical contexts. For instance, Mawson (368-370,372) developed 
sets of functional and component indicators that measure the impact of stroke on people’s 
lives. Grocott et al. (373-376) developed sets of functional, component and quiz-style 
indicators to measure the effectiveness and quality of wound care, Okasheh (366) 
developed a set of functional indicators to measure changes in people with chronic 
obstructive pulmonary disease, and Bidmead (377) developed sets of quiz-style indicators 
to measure parent/health visitor relationships in community settings. A shared 
characteristic of these clinical areas is the complexity of the conditions and the 
interventions used within each of these fields.  
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Grocott et al. (375) indicated that TELER indicators could be applied to different 
conditions or ranges of activities, clinical or non-clinical, where the outcomes of 
interventions need to be measured over time. 
Table 8.3: Examples of research institutes and clinics that use the TELER method in their work 
Research institutes / clinics Location Field 
Glasgow Royal Infirmary UK Every-day clinical use (Stroke recovery) 
MoreRehab UK Every-day clinical use (General physiotherapy) 
North East Lincolnshire Clinical 
Commissioning Group 
UK Every-day clinical use (Wound care) 
Liverpool Clinical 
Commissioning Group 
UK Every-day clinical use 
Kings College London UK The Glove Project 
Wound care in Palliative Care 
Parent/health visitor relationship 
Guys and St Thomas’s  UK GLOVE project, developing a Hand Therapy Online System based 
on TELER for every-day clinical use Great Ormond Street Hospital 
for Children 
UK 
The University of Sheffield UK Neurological rehabilitation 
Musculoskeletal rehabilitation 
Sheffield Hallam University UK Pulmonary rehabilitation 
Iberwounds of Lisbon Portugal Every-day clinical use (Wound Care) 
Istituto Nazionale Tumori Italy Measurement of palliative care (breast cancer) 
University of Jordan Jordan Measurement of pulmonary rehabilitation effectiveness 
SpineCare Jordan Jordan Every-day clinical use (General Physiotherapy) 
From LongHand data (December 2014). 
8.2 Background 
The TELER method was developed during the 1980s by A. A. Le Roux (378). The 
TELER method is considered unique because it has a clear structure for making, 
collecting and presenting clinical notes for a patient who is receiving healthcare and to a 
manager who is assessing the quality of rehabilitation services (275). This method of 
measurement supports the development of different types of clinical indicators that aim 
to trace clinically significant changes in functional performance in a patient (342). The 
ability to monitor such changes or the lack of changes is important in order to support the 
process of clinical decision-making in a timely manner, ensuring that action is taken to 
alter the care plan for a particular patient without undue delay.  
The TELER method has already been used in physiotherapy clinical settings in the 
measurement of functional performance in individuals with stroke (369) and chronic 
obstructive pulmonary disease (366). It therefore, might be feasible to use the TELER 
method in the construction of indicators to measure either pain impact or physical 
functioning in individuals with LBP following physiotherapy interventions in Jordan.  
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8.3 The assumptions of TELER 
The TELER concept is derived from a series of assumptions (cited in Mawson (258)). 
These assumptions are as follows: 
 The essential purpose of treatment is to promote change and prevent deteriorations. 
 Effective treatment is patient-centred and patient-oriented. 
 Effective treatment is grounded in theory. 
 Change occurs in clinically significant steps over clinically significant periods of time. 
 Change occurs naturally, spontaneously, and the model for spontaneous change is a 
constrained random walk (recovery pattern). 
 Change, or the lack of change, which is unlikely to have occurred spontaneously or by 
chance was induced by something. 
 The effect of clinically significant changes is not necessarily measureable on an interval 
or ratio scale, but are observable. 
It seems that the TELER method conforms to the requirement of the theory of measuring 
scales. TELER also fulfils the standards of measurement in a clinical context (342). These 
criteria are significantly important to ensure the construction of a useful, informative and 
meaningful measurement tool. The TELER method acknowledges the imperfect nature 
of measurement, especially the measurement of a subjective phenomenon, such as pain 
and function. The precision of measurement will depend hugely on the understanding of 
the construct of interest under scrutiny. The TELER method constructs indicators 
according to clinical knowledge (258), which is obtained from experts in the field, from 
the healthcare literature and from the findings of specific research, such as interviews 
with clients.  
8.4 Translating medium of TELER 
All outcome measures require a translating medium. For instance, to measure 
temperature, mercury is embedded in a pre-calibrated transparent tube. Any alteration of 
temperature around this tube will result in a consequential movement of mercury upwards 
or downwards. Therefore, the mercury is considered a translating medium for 
temperature.  
A TELER indicator also consists of a translating medium and a measuring scale (342). 
Le Roux (342), p. 1, defines the translating medium as “an entity that converts the extent 
of an attribute to a point on a measuring scale”. The translating medium in a TELER 
indicator is observation. Thus, the TELER method facilitates the compatibility between 
observation and measurement, the two important pillars of science (75,271). This method 
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encourages clinicians to develop scientific scales. These should be scientific scales that 
can be tested empirically to be rejected or accepted (379). TELER indicators could be 
falsified10 through observation or experimentation (168). 
8.5 TELER indicators 
There are three types of indicators that can be constructed using the TELER method: 
functional, component or quiz-style indicators. The title of each of these indicators 
represents the goal to be achieved during interventions and is negotiated rather than 
imposed on the patient or their carers (258). The TELER indicators do not contradict the 
theory of measuring scales by enforcing an interval or ratio scale on qualitative structures 
(275).  For example, a TELER functional indicator uses an ordinal mathematical structure 
to measure a qualitative phenomenon, such as physical functioning. There are six 
clinically significant reference points [or TELER codes] in any TELER functional 
indicator. These codes are used to determine whether outcomes have happened by chance. 
Grocott (377) and Browne et al. (381) suggested that if there are five clinically significant 
improvements, the probability that the outcome happened by chance is less than 2.5%.  
TELER acknowledges the use of numerals, not numbers, to define the codes in each of 
TELER’s indicators, and uses acceptable statistical tests to analyse ordinal-level data. The 
TELER method mandates the utilisation of explicit clinical knowledge in the definition 
of an indicator. This is important to ensure that the definition contains different 
dimensions of a construct of interest and accounts for possible factors influencing that 
construct.  
The TELER function and component indicators aim to measure significant changes in a 
client over a given time period. The quiz-style indicator is time-independent; therefore, it 
can be used when a client is seen only once.  
8.6 TELER codes 
Typically, the TELER function or component indicators are a six-point ordinal scale that 
traces changes and no changes in different conditions (275). These six points are assigned 
to numerals 0 to 5. Code 0 in a TELER indicator means the presence of a problem that is 
relevant to the respondent and is amenable to change with the proposed intervention. 
                                                 
10 Falsifiability is the belief that for any hypothesis to have credence, it must be inherently disprovable before it can 
become accepted as a scientific hypothesis or theory (380). 
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Code 5 means the resolution of the problem in specific circumstances relevant to the 
population under examination. The remaining codes represent the various intermediate 
outcomes of the process of improvement (Chart 8.1). 
Chart 8.1: An example of a tracing change in a patient health status using a TELER indicator 
  
   
  
 
The TELER method generates indicators that have unique codes. For example, codes 
(units of measurement) in TELER functional indicators represent a hierarchical stepwise 
regain of functions which, as with the employment of clinical knowledge, might 
represent, as closely as possible, the patterns of recovery of functions following therapy 
(366). The TELER method assumes that each code in a TELER indicator represents one 
clinically significant change that is determined through clinical knowledge of experts or 
the living experience of the patients (275).  
Each code in a TELER indicator is based on the notion of using clinically significant 
changes over clinically significant periods as a measure of change in the patient health 
status. For example, Chart 8.1 represents a recovery pattern for patient X. This chart 
shows that there were fluctuations in the recovery pattern. The orange circle in the chart 
represents a point in time where a person who is carrying out the measurement, using the 
TELER form, must ensure that all of the conditions of a TELER code are satisfied before 
assigning that code to patient X. The definitions of the codes in a TELER indicator utilise 
a language that is easily understood by the respondents, the therapists and the managers. 
Each code in an indicator should be a unique marker ( ) on the recovery curve. This 
would make the outcome measurement using the TELER method easily interpreted. 
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The definitions of the codes are based on explicit knowledge of the condition, the 
theoretical mechanism of the intervention and the inclusion of patients’ experience of the 
trajectory of functional losses as a consequence of the presence of the condition. This 
ensures that the TELER indicators are sensitive in detecting changes in functional 
performance. It is important to note that “a TELER indicator serves the particular 
purpose of tracing change in a functional deficit and it does not measure the extent of a 
functional deficit” (LeRoux (342), p. 21). 
Codes in the TELER indicators represent clinically significant outcomes that are defined 
with reference to theoretical, scientific and clinical knowledge as well as patients’ and 
clinicians’ experience. These codes are represented by numerals and provide an ordinal 
level of measurement. Clinically significant changes are different from clinically 
significant outcomes. A clinically significant change is “the amount of clinical change 
that is required to achieve the next clinically significant outcome on the TELER indicator” 
(366), p. 260.  
Codes in any TELER indicator represent an ordinal scale of measurement; therefore, the 
amount of change between any two successive codes are not equal. It is not possible to 
quantify the amount of clinically significant change required to achieve one clinically 
significant outcome. However, the number of changes required to achieve a particular 
clinically significant outcome can be counted. The counting process does not require 
equality. For example, it is common to count how many people there are in a room with 
all of the inherent differences between them. Numbers can be used to count clinically 
significant changes and it could be subjected to arithmetic operations (382). 
8.7 Structure of the TELER form 
The TELER form is a composite of two elements: a system of clinical note making and 
TELER indicators (275). Grocott et al. (375), p. 13, stated that “the clinical note-making 
element comprises data that are routinely collected including patient identification 
numbers, demographic details, clinical history, diagnostic tests, diagnoses and medical 
and surgical interventions”. The clinical note-making element enables clinicians to trace 
clinically significant information in a systematic approach using a structured form, which  
also provides information such as the number of visits, the management plan and patients’ 
goals (275). “The clinical measurement element collects observational data through the 
TELER Indicator, a numerically formatted ordinal scale of patient outcomes at the point 
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of treatment and care. It records the relationship between the treatment and care given, 
how it was perceived by the patient and the outcomes in terms of clinically significant 
change” Grocott et al. (375), p. 13. 
The TELER method also includes software that generates indices (Table 8.4) that provide 
more information about the patient’s health status. The data generated from these 
individual indices can be aggregated to provide an informative conclusion to third parties, 
such as managers, commissioners or policymakers, about the quality of healthcare 
services offered to a group of patients (275).  
8.8 Summary 
The TELER method, theoretically, fulfils the requirement of an outcome measure of 
functional performance, the rules of levels of measurement and the qualifiers of 
measurement in a clinical context. Previous studies showed that the TELER method is 
promising, as it brought together clinicians, clients and researchers in the quest for the 
development of suitable outcome measures in different areas. Therefore, it was chosen to 
construct the new LBP measurement tool. This method encourages clinicians to firstly 
identify the desired outcome that is relevant and important to the patient. Thus, the next 
chapter describes a qualitative study that explores the impact of LBP on Jordanian 
individuals and determines the desired outcome following physiotherapy interventions.  
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Table 8.4: Definitions and values of TELER indices 
TELER 
index 
Definition Range Meaning 
Deficit index 
(DI) 
A measure for tracing change since admission in 
physiological, psychological or other clinically significant 
function presented by a patient. It shows the extent of 
functional loss and the potential for improvement. 
Range from 0 to 
100.  
The values are percentages in the range 0 to 100 where 0 denotes ‘no loss of function’ and 
100 denotes ‘complete loss of function’. 
Improvement 
index (II) 
A measure for tracing recovery of lost function between 
successive appointments. The number of lost treatment 
goals is the number lost before admission plus the 
number lost while under treatment 
Range from 0 to 
100.  
The values are percentages in the range 0 to 100 where 0 denotes ‘no recovery’ and 100 
denotes ‘full recovery’.  The value 0 also denotes the situation where loss of function under 
treatment had increased the value of the Deficit Index above its value on admission. 
Variability 
index (VI) 
A measure for tracing changes in a patient’s condition 
while the patient is under treatment. Variability is 
measured by reference to the changes that are 
deteriorations. In many contexts it can be assumed that 
variability denotes a lack of control of the recovery 
process and of the cost of treatment. 
Range from 0 to 
100.  
The values are percentages in the range 0 to 100 where 0 denotes ‘no variability’ and 100 
denotes ‘maximum variability’.  In many contexts, 0 denotes ‘complete control of the 
recovery process and minimum cost of treatment’ and 100 denotes ‘no control of the 
recovery process and maximum cost of treatment’.  
When the Variability Index is less than 50 it shows improvements exceeded deteriorations 
and the patient’s condition improved.  The smaller the Variability Index, the more complete 
the improvement.  A Variability Index of 0 shows all changes were improvements and vice 
versa. 
When the Variability Index is 50 it shows improvements balanced deteriorations and loss of 
function since admission was recovered.  
Effectiveness 
index (EI) 
A measure for tracing effectiveness in avoiding 
deterioration over a period of treatment. EI = 100 – VI.  
In many contexts it can be assumed that lack of 
effectiveness denotes a lack of control of the recovery 
process and of the cost of treatment. 
Range from 0 to 
100.  
The values are percentages in the range 0 to 100 where 0 denotes ‘no effectiveness in 
avoiding deterioration’ and 100 denotes ‘completely effective in avoiding deterioration.  In 
many contexts, 0 denotes ‘no control of the recovery process and maximum cost of 
treatment’ and 100 denotes ‘completely in control of the recovery process and minimum cost 
of treatment’. 
 A patient-specific measure that does not permit valid comparisons of patients. 
 The measure is based on the assumptions that a clinically significant change occurs over a clinically significant period, and the intervals between successive 
appointments are clinically significant periods or parts of such periods. 
 The information presented in this table is adopted from Le Roux (383). 
 The formula for calculating each of these indices is copyright-protected; therefore, they were not presented in this table. 
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Chapter 9: Determining the desired outcome – A qualitative study to 
explore patients’ perspective of living with LBP 
Key point in Chapter 9: 
- This chapter suggests that LBP is a multidimensional experience that includes 
aspects of pain, function, social limitation, psychological impact and spiritual 
issues. The patients’ understanding of their problem appears to underpin other 
aspects of the LBP experience, for example setting goals and concordance with 
therapy. Restoring physical abilities was identified in this chapter as ‘the desired 
outcome’ following physiotherapy interventions. 
9.1 Introduction 
This chapter presents the findings of a qualitative study that explored the impact of LBP 
on people’s lives. The study was conducted in Jordan. The study forms the second part of 
the second phase in this thesis. Life goals11 that were identified by Jordanian individuals 
with LBP as important following physiotherapy interventions were used in the next 
chapter to construct the new Arabic outcome measure.  
A recent meta-synthesis of qualitative research by Snelgrove and Liossi (384) showed 
that the majority of the qualitative studies were conducted in Scandinavia and North 
America. Thus, little is known about the impact of LBP on people who are living in Jordan 
and whether or not there is any difference between their experience and the experience of 
other populations in different countries. Furthermore, the first phase of this research 
programme identified a number of studies that strongly recommend future qualitative 
research to investigate individual perceptions of functional abilities and pain and to 
understand the impact of LBP on a patient’s quality of life in their own words (385).  It 
is noted that the quantitative approach dominates the LBP literature (386-388). This 
research programme has identified a gap in the literature: despite the high prevalence and 
level of disability associated with LBP worldwide (3), and specifically in Jordan (92,93), 
little is known about the impact of LBP on Jordanians’ physical abilities, emotions, 
psychological status and social functions (5,384). Therefore, the aim of the study 
presented in this chapter is to explore the experience of living with LBP and determine 
the desired outcome. The identification of life goals that are important to individuals with 
                                                 
11 Mawson et al. (372), p. 524, defines life goals as “A measurable, meaningful and achievable activity that is jointly 
(patient, carer, therapist) identified and agreed, contextually based on the patients’ clinical needs, their social and 
environmental background, a state which the individual seeks to obtain, maintain or avoid”. 
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LBP is of great importance in building up the theoretical framework for a pertinent 
outcome measure in the following stages of this thesis. 
9.2 Qualitative study design 
A qualitative method was used for this stage of the study to explore the impact of LBP on 
individuals’ lives and identify the concepts required to develop the new measurement 
tool.  
Usually, the first step when designing qualitative research is to select and justify an 
ontological and epistemological premises for the collection of qualitative data (388,389). 
The researcher conducted a rigorous review of the qualitative methodology to understand 
and adopt suitable approaches within this study. These positions were explained in detail 
in the following subsections. 
9.2.1 Ontology and epistemology 
Ontology is defined as “the nature of the social world and what can be known about it” 
(Ritchie and Lewis (389), p. 1). This research programme adopted the critical realism 
position, as it acknowledges that whilst an external reality exists it is only accessible and 
understood through human experience and understanding. LBP is therefore likely to be 
understood through individual interpretations and socially constructed meanings, which 
could be explored using subjective words and descriptions (389,390).  
The second requirement when designing a qualitative study is to understand the different 
epistemological schools within the qualitative literature. Ritchie and Lewis ((389), p. 1) 
define epistemology as “the nature of knowledge and how it can be acquired”. Positivism 
and interpretivism are two of the schools which are commonly reported within health 
services research (389,390). The positivists approach is more commonly aligned with 
quantitative research (389,390). The positivists approach considers the world independent 
of  the researcher’s perspectives and considers that it is possible to conduct objective and 
value-free investigation (389). Conversely, the interpretivism approach is more 
commonly aligned with qualitative research (389,390). The interpretivist position 
requires the researcher to directly interact with the social world and context of the 
phenomenon in question. In contrast to positivism, interpretivism accepts that the 
researcher and participant interact with each other in generating the data and its 
interpretation.  
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The extent to which this interaction influences study findings is monitored using 
reflexivity. This helps to ensure that the findings are grounded in the data and not the 
researcher’s pre-conceived knowledge. It is appropriate to explore and understand a 
human experience using an interpretivist approach that captures both the researcher's and 
the participants' understanding (389).  
Interpretivist and pragmatic approaches were adopted in this qualitative study for the 
following reasons. Firstly, many studies had indicated that LBP is a complex, 
multidimensional condition (biological, psychological and social dimensions); thus, it 
requires an in-depth understanding of different patients living with different problems and 
life contexts (389). Secondly, interpretivism might provide a scientific and systematic 
method to achieve a thick description and detailed interpretations around individual 
reality. 
It is possible that some of these commonly used outcome measures within the LBP field 
were developed based on exploratory qualitative studies. However, this research 
programme identified only one back-disability measure that was constructed according 
to the findings of a qualitative study, but that qualitative research was not published in a 
peer-reviewed journal. The critical review in the previous phase suggested that many of 
these commonly used outcome measures within the LBP field were primarily constructed 
according to the views of expert professional knowledge rather than the perspectives and 
experiences of people with LBP. Some of these measures, such as the RMDQ, ODI or the 
VAS, did not take into consideration exploring patients or physiotherapy perspectives 
during the construction phase when developing these scales. This further justifies the need 
for the qualitative exploration presented here. The qualitative study presented here helps 
to understand different perspectives of LBP from different points of view.  
This research programme aimed to construct a new outcome measure that addresses 
patients’ views as well as concepts used in the current scales. Clinicians and patients are 
those who observe and experience the impact of LBP on quality of life. Thus, their 
knowledge was the basis for constructing the LBP TELER indicators through the 
qualitative study and nominal group techniques in Chapter 11. 
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9.3 Methods 
Semi-structured in-depth interviews and thematic framework analysis methods were used 
in this qualitative study (390). The following subsection will review in detail the setting, 
sampling, recruitment and data collection methods, method of analysis and measures of 
quality of data interpretation. 
9.3.1 Aim 
The purpose of this qualitative study was to explore the perceptions and perspectives of 
the impact of LBP on the lives of Jordanian people following physiotherapy interventions 
for LBP and to determine the desired outcomes for measurement. 
9.3.2 Research questions 
The key research questions were as follows: 
 What are the extent and nature of the impact of LBP on the quality of life of Jordanian 
people with LBP? 
 What is the desired outcome of physiotherapy interventions for people in Jordan with 
LBP? 
9.3.3 Setting 
This qualitative study took place at the Ministry of Health/Jordan hospitals that a have 
physiotherapy department that treats individuals with LBP. These were Albashir, 
Altoutanji, King Abdallah and Alkarak hospitals. 
9.3.4 Sampling method 
Purposive sampling was adopted in this study to ensure that the participants recruited will 
enable this study to answer the research questions. Furthermore, purposive sampling was 
selected to ensure a wide range in terms of important characteristics, e.g. different ages, 
genders, occupations (working or not working due to LBP) and stages of LBP. Individuals 
who met the inclusion/exclusion criteria (Table 9.1) were invited to take part in this study 
by the hospital admission team. Senior physiotherapists who were responsible for 
allocating the cases to the physiotherapy team reviewed each patient’s referral form and 
checked whether or not the patient could be invited to the study.  
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Table 9.1: Inclusion and exclusion criteria of the qualitative study 
Inclusion criteria Exclusion criteria 
 Participants who consider LBP as their main 
complaint.  
 Participants’ greater than18 years old, this is 
important because they will be primarily responsible 
for their participation in this study and able to 
consent. 
 Participants who are referred to physiotherapy by 
rehabilitation or orthopaedics physicians to 
represent typical practice in Jordan. 
 Those who agree to take part in the study 
voluntarily.  
 Any participant who is unable to communicate in 
Arabic or English as the main researcher is able to 
communicate in these languages. 
 Any patient who is not clinically or medically 
stabilised. 
 Any patient who is unable to provide consent. 
9.3.5 Recruitment method 
Recruitment was carried out in four settings in three different locations, rural and urban, 
in order to achieve a diverse sampling frame. The director of studies sent a letter 
[Appendix A] to the study hospitals or clinics in Jordan. Those who agreed to take part 
in this research were asked to distribute information sheets [Appendix B] to patients 
primarily complaining of LBP in the relevant hospitals and orthopaedic clinics. 
Administrators who were working in these hospitals or clinics approached potential 
participants and gave them information sheets once they were referred to see a 
physiotherapist. One week later, patients who took the information sheets were asked by 
the physiotherapist or administrator if they would like to take part in this research. Patients 
who agreed to participate voluntarily were asked to complete and sign a consent form 
(Appendix C) prior to the interview. 
Those participants who agreed to take part were contacted by the main researcher to 
arrange an interview at their convenience. Prior to the interview, consent was verified.  
Recruitment continued until the point of data saturation; this is where further analysis 
does not reveal new themes from the data (391,392).  
9.3.6 Data collection method 
The researcher used in-depth interviews to explore the patients’ perspectives of the impact 
of LBP on their life and to identify the most desired outcome for them following 
physiotherapy treatment. This method of data collection was used because it offered the 
opportunity for a detailed understanding and an insightful exploration of the impact of 
LBP. In addition, in-depth interviews are preferable when individual participants’ 
experience and views might differ, if there is a possibility that participants know each 
other and that it would impede their contribution, or if there are some issues of status or 
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power (389,390). The researcher used semi-structured interview as the method of 
collecting data because it provides an acceptable level of flexibility, using an interview 
guide developed with reference to the literature (Appendix D). The interview topic guide 
contained fairly general questions that were asked of all participants but also allowed the 
researcher to probe and explore additional topics. The emphasis was on exploring the 
interviewees’ understanding of their LBP, their concerns and beliefs about the impact of 
LBP on their life, and the desired outcome following physiotherapy interventions.  
All interviews were carried out in meeting rooms within the hospitals at times close to 
the participants’ sessions. They were asked to sign consent forms prior to interviews. All 
interviews were audio-recorded using an electronic audio recorder that was locked with 
a password. All audio files were transferred to a computer that was locked with a 
password. Each audio file was assigned a unique number to maintain the anonymity of 
participants through the research. The names of the participants, the demographic data 
and their unique numbers were stored in a secure electronic file accessible using a 
password. 
9.3.7 Data analysis 
Data was recorded, transcribed, coded, and analysed using the Arabic language. However, 
results were translated into English by two researchers according to well-established and 
rigorous guidelines (393,394) to enable the communication of the results to the 
supervisory team. Appendix E presents a summary of the qualifications of the translators 
and few examples of translation validation. These conceptual translations were reviewed 
by two independent researchers from the University of Jordan: Dr Rasha Okasheh and Dr 
Jennifer Muhaidat, who have a good command in Arabic and English languages, and both 
had a PhD in physiotherapy. 
Figure 9.1 shows a graphical representation of the stages of conceptual translation 
recommended. 
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Figure 9.1: Conceptual translation between Arabic and English 
  
From Beaton et al. (394) 
Framework analysis was used to interpret and construct general themes obtained from 
these inductive and deductive approaches used simultaneously (390,391). Boyatzis (395) 
defines a theme as “a pattern found in the information that at minimum describes and 
organises possible observations and at maximum interprets aspects of the phenomenon”. 
Framework analysis was used because it has a clear structure and allows an in-depth 
understanding of the phenomenon of what is important to participants using their own 
words (396).  
The process of thematic framework analysis includes five stages as described by Ritchie 
and Spencer (397), p. 173-194. 
1. Familiarisation: The researcher audio-recorded all interviews and transcribed them 
verbatim; the researcher listened to these interviews many times to familiarise himself 
with points raised during the interview. 
2. Identifying a thematic framework: an initial theoretical framework was developed at 
this stage from the literature and from emerging issues during the familiarisation stage. 
This framework was flexible and subject to refinement to accommodate emerging new 
themes during subsequent stages of analysis. 
3. Indexing: this stage applied a thematic framework directly into the transcribed text using 
either textual or numerical codes to identify particular fragments of data which are 
directly related to different themes. 
4. Charting: headings from the thematic framework were used to develop charts; similar 
codes obtained from different interviews’ transcripts were gathered to allow the 
opportunity for cross-sectional comparison between different participants. 
5. Mapping and interpretation: the researcher at this stage searched for patterns, 
explanations, concepts and associations within the transcribed text, aided by plots or 
visual displays. 
Stage I: 
Translation
Stage II: 
Synthesis
Stage III:
Back translation
Stage IV:
Expert committee review
 Review all reports 
 Reach consensus on 
discrepancies (ALL) 
 Two translations by Thamer Altaim and Nancy Ali 
into targeted language [English] 
 Synthesize translated document into one document [Thamer Altaim] 
 Resolve any discrepancies with translators’ reports 
 Dr Rasha Okasheh and Dr Jennifer Muhaidat  
 Create 2 back translations 
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A thematic framework was developed based on themes found in this study. The thematic 
framework was continuously revisited and modified through analysis. Subthemes were 
merged if they provided a similar meaning. For example, hopelessness codes and 
depression codes were merged under the subtheme depression. Following the 
familiarisation stage, a thematic chart was developed and data generated from the 
patients’ interviews was mapped across all of the themes. This chart was continuously 
reviewed and modified to prevent any data loss. Data gathered in this qualitative study 
was rich; however, to achieve the aim of constructing a new outcome measure in this 
research programme, only those themes that were related to the development of the new 
TELER indicators were subject to more analysis. The identification of these themes 
related to the impact of LBP on people’s lives and desired outcome after therapy. These 
indicators are required to detect and measure clinically significant changes that are 
important to the patients and induced by physiotherapy interventions. 
9.3.8 Rigour of the qualitative study 
This qualitative study includes tables and diagrams to illustrate how the themes were 
identified from the raw data; this helps to demonstrate and assess the rigour of the analysis 
(398). A researcher from Sheffield Hallam University [NA], who is a physiotherapist 
holding a Master’s degree and who understands both languages, independently analysed 
10 transcripts to verify the main themes identified. The interviewer [TA] kept a reflective 
blog of any additional information that related to the theoretical or practical issues that 
happened during the interviews. 
Reflexivity is “a term used in research methodology to refer to reflectiveness among 
social researchers about the implications of the knowledge of the social world they 
generate of their methods, values, biases, decisions, and mere presence in the very 
situations they investigate” (Bryman (390), p. 715). In qualitative research it is important 
for the researcher to demonstrate that they are reflexive throughout analysis in order to 
show that the findings are grounded in the data, and not the preconceived ideas and beliefs 
of the researcher. Several techniques were used in this study to ensure that the researcher 
was reflexive and could demonstrate trustworthiness of the analysis. The researcher 
adhered to the criteria of trustworthiness while carrying out the thematic framework 
analysis: dependability, confirmability, credibility and transferability (Table 9.2). These 
criteria are of great importance to ensure the rigour and improve the quality of qualitative 
studies (399). 
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Table 9.2: Establishing trustworthiness 
Criteria Explanation Techniques used to meet the criteria 
Credibility This item reflects the precision of the results 
obtained to truthfully reflect participant 
perspectives. 
Two independent researchers from the university 
of Jordan, who are physiotherapists scrutinised 
the transcripts and the identified themes and 
subthemes.  
Iterative discussions round data interpretation 
Transferability The ability to transfer obtained results to 
similar research setting or enhance the 
ability to generalise the results obtained to 
other similar clinical setting. 
Continuously challenging the identified themes 
and/or subthemes during interviews. 
Member checking and feedback strategies to 
enhance verification within the interview. 
Keep full description of the research context and 
the assumptions that were central to the research. 
Dependability The ability to show how exactly the research 
was conducted and report the research 
design to allow the ability to replicate results 
if the research is repeated. 
Keeping a reflective journal and field notes which 
can be added to the collected data. 
Confirmability The requirement to control and limit the 
researcher bias by conveying the results to 
reflect what was reported by participants. 
Reflexivity to aid self-reflections as an attempt to 
monitor researcher bias. 
Reflections on research and a critical comparison 
with previous literature 
Adapted from Tod (399) with citation to Lincoln and Guba (1985), and Ritchie and Lewis (389). 
9.4 Findings of the qualitative study 
Forty Jordanian people with LBP referred to physiotherapy took part in this qualitative 
study. This study included a heterogeneous sample that provided a good representation 
of different age groups range between 22 and 74 years old (Table 9.3). Interviews lasted 
between 6 and 44 minutes. However, the majority of interviews lasted for around 12 
minutes. Data saturation was achieved after interviewing the first 10 participants in the 
middle of Jordan. However, interviews were conducted in four different settings. Each 
setting was treated separately at the beginning of the data collection phase in this 
qualitative study; thus, data saturation was examined separately in each clinical setting. 
Data analysis of interviews showed that no differences between themes emerged from the 
data collected in different settings; therefore, data from different settings were merged 
with each other later on in the analysis. There were approximately an equal number of 
men and women were interviewed in this study. 
Those who took part in this study, across the three geographical settings, were of a mixed 
background, including Bedouin, farmers and city dwellers. This provided a range of 
participants in terms of ethnicity and culture. Furthermore, the sample included people 
from two main religions in Jordan: Islam and Christianity. 
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Analysis of the data shows that LBP is a multidimensional experience that includes 
aspects related to physical functioning, social functioning, mood and spiritual practices. 
Eleven themes and 43 subthemes emerged from the patients’ interviews. A conceptual 
framework that describes these themes and the interactions between them is presented in 
Figure 9.2. 
The following sections will present the main findings of this qualitative study and 
describe the LBP experience from the patients’ perspective. This section is divided into 
seven subheadings (Figure 9.2). These subheadings are as follows: 
 Impact of LBP on physical functioning 
 Impact of LBP on psychological state 
 Impact of LBP on social functioning 
 Impact of LBP on spiritual practices 
 Coping with pain 
 Evaluating health status and determining life goals 
 Vigilance 
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Table 9.3: Participants’ demographics 
Middle of Jordan Occupation Social status 
LBP - 01 63 Male Imam Married 
LBP - 02 48 Female Housewife Married 
LBP - 03 45 Female Housewife Married 
LBP - 04 43 Female Housewife Married 
LBP - 05 47 Male Dustman (Municipality of great Amman) Married 
LBP - 06 52 Female Housewife Married 
LBP - 07 37 Female Dressmaker Married 
LBP - 08 51 Female Housewife Married 
LBP - 09 57 Male Retired teacher Married 
LBP -10 54 Female Housewife Married 
LBP -11 45 Female Housewife Widow 
LBP -12 27 Female Midwife Married 
LBP -13 43 Male Senior Nurse Married 
LBP -14 59 Male Bus driver Married 
LBP -15 42 Female Nurse Married 
LBP -16 46 Male Senior accountant (Ministry of Finance) Married 
North of Jordan 
LBP - 17 60 Female Religious studies teacher Married 
LBP - 18 47 Female School supervisor Married 
LBP - 19 45 Male Chef (Ministry of Health) Married 
LBP - 20 59 Male Olive oil factory (Manager) Married 
LBP - 21 22 Male Programmer Single 
LBP - 22 23 Male Med. Engineer Single 
LBP - 23 52 Female Retired mathematics teacher Married 
LBP - 24 40 Male General services (Ministry of Health) Married 
LBP - 25 50 Male Customs Married 
LBP - 26 24 Male Delivery driver Single 
LBP - 27 23 Female Pharmacist (student) Single 
South of Jordan 
LBP - 28 64 Male Retired accountant Married 
LBP - 29 31 Male Physiotherapists Married 
LBP - 30 39 Female Housewife Married 
LBP - 31 74 Male Publisher Married 
LBP - 32 47 Male Electrical engineer Married 
LBP - 33 44 Female General services (Ministry of Education) Married 
LBP - 34 40 Female Housewife Married 
LBP - 35 37 Female Housewife Married 
LBP - 36 63 Male Retired head teacher Married 
LBP - 37 33 Male Carpenter Married 
LBP - 38 70 Male Retired (unknown) Married 
LBP - 39 45 Female Housewife Married 
LBP - 40 60 Female Housewife Married 
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Figure 9.2: A conceptual framework representing the impact of LBP on people’s lives 
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9.4.1 Subsection one: The impact of LBP on people’s lives 
9.4.1.1 Impact of LBP on physical functioning 
All participants said that LBP was affecting their physical ability to perform various daily 
activities (Table 9.4). Participants indicated that different physical activities aggravated 
their pain or would further deteriorate their condition. However, three participants said 
that certain positions, such as lying down, or doing certain physical activities, such as 
walking or running, would help them to reduce their pain. 
LBP 21 [patient ID] – 18 [paragraph no.]: “Walking helps me to decrease my pain. I 
will only feel exhaustion, muscle fatigue from walking. In fact, I don’t feel pain at all 
when I run”. 
Different physical activities had variable influences on people’s perceptions and 
experience of pain. Participants stated that some activities helped them to reduce their 
pain and be more active. These physical activities include walking or lying down for a 
short period of time after standing up for a long time. Data generated from the patients’ 
interviews showed that the speed of the movement is affected by LBP and individuals 
with LBP require more time to perform each of the physical activities listed in Table 9.4. 
Generally, it seems that the performance of daily activities is an important factor that 
tends to aggravate the perception of pain. Participants reported that spending more time 
on a task tends also to aggravate their LBP symptoms. This means that sleeping, standing 
or even walking for a long period of time would aggravate patients’ symptoms. However, 
alternating between different positions seems to help to ease LBP symptoms.  
LBP 32 - 10: “Standing, I mean standing for a long time in a queue or anything like 
that, I will feel stressed because I can’t stand that long. I can’t, I need to keep moving. 
I will feel annoyed because of long standing”. 
Participants described how LBP negatively affected the speed of their movements, 
balance and equilibrium. Participants reported that they needed extra time to change their 
position. 
LBP 6 - 9: “When I sit down, I mean I am sitting down right now; it will take me 10-
15 sec to stand up and shake your hand. It will take a long time”.
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Table 9.4: Impact of LBP on people’s life 
Theme: Physical 
functioning 
ICF code Number 
(%)* 
Participants’ quotations LBP had negative  impact 
on: 
Lying down for a 
long period of 
time 
d4150, 
b1343, 
b1342, 
10 (25%) “I get the pain if I sleep on my back for more than 15 minutes” (LBP 12-10). Sleeping, resting 
Turning in bed d4100 4 (10%) “If I want to turn (in bed) I can’t turn over. If I want to sleep on my back, but I find it difficult to sleep 
on my back” (LBP 8-18). 
Sleeping, getting out of bed 
Getting out of 
bed 
d4100 13(32.5%) “When I’m getting out of bed in the morning … I feel that both of my legs are heavy and I feel 
pain”(LBP 18-6). 
Sitting, standing 
Sitting d4103, 
d4153 
28 (70%) “I can’t sit down properly for a long period of time” (LBP 31-16). Work, waiting for something, 
move towards standing 
Standing d4104, 
d4154 
29(72.5%) “Sometime I can’t stand up because of the severe pain” (LBP 19-4). Work, waiting for something, 
walking 
Bending and 
rotating the trunk 
d4105, 
d4102, 
d4152 
19(47.5%) Bending: “My biggest problem is when I need to bend over. I mean it is painful” (LBP 23-6). 
Rotation: “I can’t turn my trunk around to the right or to the left” (LBP 28-20). 
Work, lifting 
Walking and 
running 
d4559, 
d4501 
d4500 
26(65%) “This (LBP) will limit your abilities to use your legs, you can’t walk or move around” (LBP 28-10). Work, social life 
Squatting d4101, 
d4151 
5(12.5%) “I have these problems (pain and fatigue) when I use the squat toilet” (LBP 8-4). Pray, work, using the toilet, 
lifting 
lifting d4309, 
d4301 
26(65%) “lifting and moving patients around, I mean we have a lot of patients who need to be moved from the 
bed to the stretcher and from the stretcher back to the bed, and all of this will increase my pain” (LBP 
13-44). 
Work, social functioning, 
carry shopping bags 
Climbing 
up/down the 
stairs 
d4551 4(10%) “Going down the stairs or up to the roof will make me feel fatigued as well” (LBP 8-4). Work, social functioning 
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Theme: Psychological issues 
Anxiety b1522 24(60%)  “I am afraid that over a sudden I will not be able to move, stand up or sit down … I mean that I suffer 
disability, osteoporosis or a fracture in the spinal column without warning. I mean your doctor should 
warn you about this problem” (LBP 02-32). 
Vigilance, fear of movement, 
productivity, employment 
Depression b1529, 
b1265 
11(27.5%)  “Yeah sure, this problem makes me feel hopeless, anxious and depressed. I always feel as I have 
permanent disability. I try to overcome this disability, which I am suffering from at the moment. 
However, I can’t forget it” (LBP 02-12). 
Adherence to therapy, 
productivity, social 
functioning 
Anger b152 22 (55%) “I want to go to work, or get something done or go somewhere, can you see what I am talking about 
…I become nervous and yell at one of my children to do it”(LBP11-20). 
Social functioning, work 
Theme: Social functioning 
Family d9205, 
d7702 
18 (45%) “This problem has an impact on my relationship with my wife” (LBP 5-18). Sexual life, pregnancy, 
looking after family 
Work d859, 
d8451, 
d8500, 
d8502 
28 (70%) “This problem affects my ability to walk or work at home” (LBP 18- 6). Productivity, income, salary 
Interaction with 
other people 
d9205, 
d7504 
e3 
10 (40%) “I feel shy to interact with other people or to visit them (fear of sudden pain while in a social event)” 
(LBP 30-4). 
Loneliness, visiting family or 
friends, psychology 
Dependence e310, e315, 
e320, e325, 
22(55%) “There are so many things like washing or rinsing …I think to myself, I need one of my children to 
come and help me, so I postpone my work till they come back” (LBP 35-30). 
Productivity, self-confidence, 
physical activities 
Loneliness d9205, 
d7504 
23 (57.5%) “All of this is affecting my mood. I don’t want to be alone. I am afraid that if I felt angry on them they 
will leave me alone” (LBP 11-24). 
Social functioning, 
interaction with family 
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Participants mentioned that the impact of LBP on function affected their spiritual practice. 
It seems that these limitations in participants’ physical abilities have negative 
consequences on their ability to practise their worship. Physical activities, such as 
ablution and prostrating, were also reported to be affected by LBP. 
LBP 23 - 6: “It is not easy for me to raise my feet and wash them in ablution”. 
9.4.1.2 The impact of LBP on people’s psychological state 
Participants reported feeling anxious, depressed and angry, because of their LBP (Table 
9.4 and Figure 9.3). They described how limitations in performing different physical 
activities seemed to have a negative effect on mood. However, participants also reported 
that these psychological issues that were related to LBP, such as anxiety, negatively 
affected people’s ability to perform different physical activities, thus highlighting a 
cyclical pattern. 
Figure 9.3: The impact of limitation in physical functioning on mood 
 
  
• Inability to work
• Inability to look after family
• Dependance on other people 
on the majority of aspects of 
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• Failure to meet daily demands 
• Feeling disabled
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active in comparison 
to peers.
• Pismistics feelings 
about the recovery.
• Hoplesness
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9.4.1.2.1 Anxiety 12 
Approximately 60% of participants reported that they experienced anxiety because of 
LBP (Table 9.4). Participants’ interviews revealed that some participants tend to make 
extra effort and preparation before doing different tasks to avoid aggravating their LBP 
symptoms later on.  
LBP 21 - 12: “I need to plan everything before sleeping. I plan everything so I don’t 
wake up with back pain the next morning”. 
Most participants tended to be in a constant state of worry about doing a physical activity, 
such as moving around, which they believe can worsen their health conditions. 
Furthermore, they expressed their concern of ending up confined to a wheelchair, because 
of paralysis or suffering from spinal fractures. Participants perceived their bodies as 
fragile and that they might break their bones if they do certain physical activities too 
much. 
LBP 02 - 32: “I am afraid that all of a sudden I will not be able to move, stand up or 
sit down … I mean that I suffer disability, osteoporosis or a fracture in the spinal 
column without warning. I mean your doctor should warn you about this problem”. 
It appeared that the participants did not have an adequate understanding of their LBP 
problem. Participants chose phrases such as cracked bones and the bones in my spine are 
fusing to each other, which might indicate that they are worried to some extent about their 
physical abilities in the future. They reported unrealistic worries regarding problems such 
as a spinal fracture or osteoporosis and sought to prevent these. This highlights a 
distinction between fear and anxiety. Usually, fear is evoked by an immediate and/or 
realistic threat. Fear is considered to be an appropriate reaction to an apparent danger. 
However, participants in this study who suffered from chronic LBP and high levels of 
anxiety feared their movements and adopted several protective mechanisms to prevent 
further unrealistic deterioration in their health status and physical functioning. 
LBP 21- 26: “I am prepared to stop playing football if it will further deteriorate my 
problem and increase the pain”. 
                                                 
12 The national collaborating centre for mental health defines anxiety as “worry and apprehension that is out of 
proportion to the circumstances. The worries are typically widespread, involve everyday issues and have a shifting 
focus of concern. The affected person finds these worries difficult to control, and this can result in decreased 
occupational and social functioning.” ((400), p. 13). The previous definition stated that anxiety is a state of unrealistic 
worry about future events or situations that is only individually seen as threatening.  
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Another participant suggested that she is narrowing the space between her feet while 
walking to prevent further damage to her spine. 
LBP 12 - 19: “when I decide to walk, I say to myself be cautious about your back, so I 
walk while I am in fear of doing something that will increase my problem. To avoid 
this I do not let my feet go away from each other … that far, I walk slowly with small 
steps to prevent any deteriorations”. 
Generally, the majority of the participants were pessimistic and expecting the worst to 
come. This might happen as a result of the absence of patient education, or agreeing a 
long-term plan with healthcare providers, such as their physiotherapists. Furthermore, this 
state of over-thinking, unrealistic worries and difficulties returning back to a normal life 
might cause those who reported anxiety to experience various episodes of depression. 
9.4.1.2.2 Depression 13 
Approximately 27.5% of participants said that they felt depressed because of LBP (Table 
9.4). Many participants tended to compare their current physical status with what they 
were used to before feeling pain in the lower back. Those people reported a feeling that 
they were now disabled because of their LBP.  
LBP 02 - 12: “Yeah sure, this problem makes me feel hopeless, anxious and 
depressed. I always feel as I have permanent disability. I try to overcome this 
disability, which I am suffering from at the moment. However, I can’t forget it”. 
Some of the younger participants compared themselves with those who are older, but are 
more active. They used these comparisons as indicators of their functional limitations. 
These comparisons give them the feeling that they lost something important and this loss 
has fed into their feeling of depression. 
LBP 27 - 20: “I became so depressed, I feel so old. I cannot do the activities that 
people of my age do”. 
Many participants indicated that they did not expect improvements, and they felt 
hopeless. Participants thought that they would not get any better, and they were prone to 
despair and giving into the pain. 
                                                 
13 The World Health Organization (WHO) defines depression as “a common mental disorder that presents with depressed mood, 
loss of interest or pleasure, decreased energy, feelings of guilt or low self-worth, disturbed sleep or appetite, and poor concentration. 
Moreover, depression often comes with symptoms of anxiety. These problems can become chronic or recurrent and lead to 
substantial impairments in an individual’s ability to take care of his or her everyday responsibilities” ((401), p. 1). 
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One participant (LBP 28 - 24) indicated that he had lost his faith in all therapeutic 
techniques. He said:  
“What I can do about it, I am literally hanging on to a straw. I mean those who are 
drowning are hanging on to a straw … I tried everything, and nothing is working”.  
He has attended physiotherapy sessions and taken his medications. However, he is still 
convinced that he is unable to perform many simple daily activities, such as walking, 
because of LBP. He asked his doctor whether he could undergo surgery or not. His doctor 
advised him to do therapeutic exercises and avoid surgery. Emotional volatility therefore 
occurred as a result of the clash between their desire to be active and their inability to be 
active. Thus, many participants felt hopeless and in need of help from others. Their 
inability to perform certain functions made them dependent and reliant on help from other 
people. This hopelessness was seen to lead to despair, which, in turn, led the participants 
to surrender to the pain and accept it as part of the reality of their lives.  
LBP 13 - 8: “I feel that I am depressed (because of this pain)…pain accompanies me 
and I am stressed at work … so I get depressed, you give up and surrender to the pain, 
so you can get things done”. 
This hopelessness also made the participants with LBP seek out a quick cure regardless 
of the consequences that they might encounter later on; surgery was seen as a solution, 
with the only alternative being ‘hanging to hope by a thread’. 
LBP 08 - 10: “I want to have an operation no matter what the outcome is, even if I am 
paralysed”. 
A few participants reported that they felt hopeless and they believed that only surgical 
interventions would help them. This was later linked to the lack of knowledge and 
misunderstanding of the cause of LBP and the various interventions available to them to 
manage the LBP problem. 
LBP 08 -10: “because of all the pain I have been through, ah I want to undergo a 
surgery…and get it over with”. 
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9.4.1.2.3 Anger 14 
Around 22 participants in this study described feeling angry because of not being able to 
perform various physical activities. They expected themselves to be able to work, look 
after their families and live the rest of their lives independently. However, physical 
limitations, fear of movements and failure to meet daily demands resulted in anger for 
some participants. 
LBP 11 - 20: “I want to go to work, or get something done or go somewhere, can you 
see what I am talking about …I become nervous and yell at one of my children to do it 
for me”. 
People with high levels of anger reported being easily agitated. A few participants 
expressed their concern regarding turning this anger on their families or those who were 
close to them within their social circle.  
LBP 02 - 28: “Some time the pain severity makes you angry and you can’t tolerate 
anything. You do not like anyone to talk to you. You ask people to leave you alone not 
to express your nervousness in front of them”. 
9.4.1.3 The impact of LBP on social functioning 
Many participants reported that LBP affected their social life (Table 9.4 and Figure 9.4), 
with some reporting that their family life was negatively affected by LBP. However, they 
felt that their families were supporting them and they were a source of comfort, empathy 
and motivation.  
LBP 01 - 40: “My relationship with my wife is normal and I am really thankful to god. 
My wife understands that I am in pain and she supports me. She hoped that one day I 
will be cured”. 
  
                                                 
14 Videbeck (402) defines anger as: “a strong, uncomfortable, emotional response to a real or perceived provocation. 
Anger results when a person is frustrated, hurt, or afraid”. 
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Other participants indicated that their families were overprotective. This may be because 
those families were not provided with enough information about LBP. Alternatively, it 
may be due to the Arabic culture, where family members can be overprotective, especially 
with elderly people. 
LBP 02 - 18: “I notice that when I try to lift something heavy, my children don’t let me 
carry it. They help me. My husband asks me not to lift something because it will affect 
me, he also asks me not to go out even though that I enjoy walking”. 
 
Figure 9.4: The impact of the limitation in physical functioning on social functioning 
 
 
Participants in this study said that they faced problems performing certain functions, such 
as going out and visiting other family members, because of the existence of pain in their 
lower back. Four of the older participants felt that they were unable to visit their sons and 
daughters, and carry their grandchildren, which left them feeling helpless and frustrated. 
LBP 8 - 8: “I can’t go shopping with my daughters. They ask me to come out but I 
can’t. I can’t walk. I can’t visit them anymore. I feel that I am lying down on the bed 
all the day sleeping”. 
 
Family
Work
DependenceLoneliness
Interaction with other people
Limitation 
in the 
physical 
abilities 
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Participants expressed grief, indicating that these losses in their functional ability had 
negatively affected their productivity and made them dependent on other family members 
to help them with their daily activities. Furthermore, these losses in physical ability had 
negatively affected their sexual lives.  
LBP 20 - 12: “I admit that this problem affected my sexual relationship with my wife. 
I can’t have sex with my wife. I feel sever pain in the lower back”. 
Moreover, some participants described how avoiding meeting or interacting with friends, 
anxiety, depression and anger made them feel lonely. Some participants therefore limited 
their social interaction. 
LBP 6 -13: “I don’t like people to come and visit me. I try to avoid people and hope 
they will not visit me at all. They know that I don’t like people to come and visit me. 
My sister stopped visiting me as they know that I can’t stand up with them or sit down 
with them for a long period of time”. 
9.4.2 Subsection two: The experience of living with LBP 
Participants said that maintaining their functional abilities is important to them. They had 
the desire to be normal, but at the same time they worried too much about preventing 
further damage to their body. Therefore, some participants took action to minimise the 
chance of doing something that would aggravate their pain in the future. 
LBP 12 - 18: “The pain may strike all of a sudden…sometimes I walk with the fear 
that some lightening will strike down my back, and it will hurt…I take fearful short 
steps because I am afraid of the shooting pain”. 
People who took part in this study reported that the presence of LBP affected all of their 
daily activities. Thus, they identified some key strategies to ‘self-manage’ their LBP 
symptoms. Participants stated that they have become more vigilant to prevent aggravating 
their pain. Furthermore, participants said that they took medications to cope with their 
LBP problem. 
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9.4.2.1 Coping with pain 
Participants identified some key strategies to cope with pain (Table 9.5). Taking 
medication and understanding their pain are two of these strategies which helped them to 
adapt and resume their life. It seemed that participants developed an understanding of the 
trajectory of LBP over time. Furthermore, the majority of participants pointed out that 
LBP is an incurable and recurrent condition. Some participants preferred to take 
analgesics when they felt pain and others preferred to be more active and do therapeutic 
exercises when they felt pain in the lower back. 
LBP 6 - 43: “I don’t like to come here because now I know how to manage this pain 
by myself, these exercises that I am doing”. 
9.4.2.2 Evaluating health status and determining life goals 
Findings have illustrated how many participants reported that pain in the lower back 
affected their physical abilities. Thus, many participants (> 60%) consider restoring 
physical abilities or reducing pain as their main goals (Table 9.5). More than 25 
participants consider evaluating their perception of pain and their ability to perform 
physical activity following physiotherapy sessions to be a key marker to monitor the 
success or failure of physiotherapy interventions. 
9.4.2.3 Vigilance 
Participants described a state of being constantly alert, anxious and vigilant. They tended  
to watch out and be careful all the time. Furthermore, patients’ overall attitude was to 
avoid activities that could aggravate their pain (Table 9.5). 
Generally, the majority of participants believed in the following statement: ‘Prepare 
yourself, pre-load up on medications before you get moving and expect pain because it is 
going to strike and when it does, just quit’.  
Such agitation forced patients to spend ample time and energy planning their movements 
and activities in advance in order to guard against any symptom aggravation.  
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9.4.3 Subsection three: LBP patients’ knowledge about LBP 
Participants’ understanding of the cause of their problem, the consequences of having 
LBP and the source of information are three different factors that influence the 
management process for LBP (Table 9.6 and Figure 9.2). Participants’ understanding of 
their own LBP problem seems to have a great influence on their potential participation in 
more physical activities. However, misconceptions, myths related to LBP and misleading 
advice to avoid physical activity tended to negatively affect LBP symptoms. 
There were many sources of information which were identified by those who participated 
in this study (Table 9.6); however, some of these sources for the management of LBP 
were found to be contradictory. Participants described why they felt hopeless and failed 
to find anything to potentially stop the LBP affecting their life. They described how they 
tried traditional medicine and how it aggravated their symptoms and made them suffer 
more pain in their back. Respondents revealed that their hopelessness and despair left 
them vulnerable and willing to try different remedies, most of which rather aggravated 
their pains. 
LBP 6 - 27: “People told me to see someone who treats patients using traditional 
Arabic medicine15. He caused me an increase of my pain and I was afraid to be 
disabled”. 
It is vital to say that participants reported being confused due to the contradictory advice 
they received from their physicians about how to manage their LBP problem. Some 
physicians recommended undergoing surgery, and others asked patients to avoid surgery 
as much as they could and adhere to physiotherapy interventions.  
LBP 8 - 10: “A doctor who is well known here in Amman told my daughters that 
physiotherapy will not help me. He said that it would decrease pain for a short period 
of time. He recommended a surgery for me. The doctor here in this clinic didn’t 
recommend a surgery when he saw my neck images. Another doctor here asked me to 
sleep on my back for 40 days. If that didn’t help me then I need to consider the 
surgery”. 
  
                                                 
15 Traditional Arabic medicine is not related to the prophetic medicine. 
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Young participants expressed their concerns of losing career opportunities, early 
retirement or losing their current work because of these limitations in their functional 
abilities. They were fearful of the future, persistently questioning whether their pain 
would increase or they would improve.  
LBP 22 - 16: “I am worried that I am still in young age … I didn’t even start the 
practical real life. This problem affects the psychological part of my life. Sometime I 
can’t do what my employer asks me to do. I am worried that I will not be able to 
continue to do this work in the future”. 
9.4.3.1 Spiritual beliefs around LBP 
Participants reported that their spiritual beliefs play an important role in their life (Table 
9.6). They thought that God would help them and they had complete faith in God to cure 
them. Some of those participants said that they did not have faith in physiotherapy or 
healthcare services. They completely relied on their relationship with God. Participants 
enthusiastically stressed the fact that their spiritual beliefs were a cornerstone in their 
lives. They believed that their unwavering faith in God was the only salvage, cure from 
pains and that no healthcare services could ever measure up to God’s healing powers. 
LBP 6 - 3: “I could not do surgery and I resorted to praying…I know that I have a 
strong relation with the Lord… I was confident that this relation will save me…and 
that I will be able to do this mission … doctors told me to go for surgery, otherwise I 
will be paralysed... but I resorted to the Lord”. 
9.4.4 Desired outcome 
Generally, participants agreed that restoring physical functioning is an important life goal. 
They indicated that they monitor any changes in their health status by tracing changes in 
their physical abilities and their pain (Table 9.5). They clearly indicated that any success 
in their treatment will be reflected directly on their abilities to perform daily tasks and 
activities.   
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Table 9.5: The experience of living with LBP  
Themes and Sub-
theme 
ICFDH code Number (%)* Participants’ quotations  
Theme: Vigilance b1300, b1263   Vigilance had 
negative  impact on: 
Preventing further 
deterioration 
d175, d1751, 
b1266 
19 (47.5%) “I look after myself to avoid any further deterioration” (LBP36-18). Function 
Do it right d177, b1266 13 (32.5%) “Right movement will help me and wrong movements will affect me” (LBP28-20). Function 
Thinking before 
doing 
d163, d177 18 (45%) “Now I think a thousand times before doing anything” (LBP21-16). Function 
Hiding the problem b1260 11 (27.5%) “I don’t let other people know that I have back pain. I feel shy” (LBP19-22). Function, 
psychology, social life 
Theme: Coping with pain People used it to 
Sub-theme: 
Medications 
e1101 1(2.5%) “If I don’t take these analgesics my pain will increase and I my health status will deteriorate, I will 
feel numbness and pain” (LBP5-11). 
Decrease pain and 
increase physical 
activities 
Sub-theme: 
Adaptation 
Personal 
factors 
12 (30%) “I suffered for one month or one month and a half, and then I realised and understood that it [pain] 
is decreased. Don’t forget that this pain experience is something normal with my life style. I adapted 
to this” (LBP29-4). 
Increase physical 
activities, work 
Theme: Evaluating health status People want to 
Sub-theme: 
Restoring functions 
Many codes 
(Table 9.3). 
30 (75%) “This is the fourth session. I start to notice that physiotherapy helped me to be able to sit down and 
stand up again without a problem. I noticed that I will find problems in standing up following a long 
sitting. This is eased up. I noticed this” (LBP18-26). 
Increase their 
physical activities 
Sub-theme: 
Reducing pain 
b2801 25 (62.5%) “They asked me yesterday wither I am improving or not. I told her not. I felt severe pain in the right 
side of my body and in the bum. I went home yesterday with severe pain” (LBP6-25). 
Reduce pain to be 
able to perform 
activities of daily 
living 
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Table 9.6: Patient knowledge about LBP  
Theme: Understanding 
1st level sub-
theme 
2nd level sub-
theme 
ICF codes Number (%) Participants’ quotations 
Cause   
 
Pathological 
problem 
 
 9 (22.5%)  “At the beginning I thought that I have cancer, but when I did the MRI. The images showed that I have a 
problem between the fourth and the fifth vertebrae” (LBP1-38). 
Physiological 
change 
 5 (12.5%) “Firstly, I got married in a young age and the first pregnancy happened when I was 17. I mean at the age 
when your body is building up. I believe this and the difficult life circumstances are what caused me this 
pain” (LBP8-2). 
Nature of work  15 (37.5%) “the nature of my life and work require me to lift heavy objects … I suffered from this pain in the lower back 
after working like this for 7 years” (LBP29-2). 
Mechanical  9 (22.5%) “The problem started 10 years ago … when I tried to lift a heavy object … a gas heater. I tried to move it 
from one room to another … I felt severe pain in my back and that's what I believe caused my disc problem” 
(LBP18-2). 
Consequences Disability  27 (67.5%) “I am afraid of disability, to lose the ability to move around” (LBP28-40). 
Surgery  5 (12.5%) “I don’t want to undergo a surgery. I want to avoid the risks of anaesthesia and surgery” (LBP29-20). 
Further 
deterioration 
 17 (42.5%) “What I am afraid of? … As I said, not to mention that I am getting older, I have five discs. I am afraid that 
my problem is deteriorating and my pain will increase” (LBP19-52). 
Source of 
Information 
Health professions d115 31 (77.5%) “I went to a private doctor and he told me that I have inflammation” (LBP17-8). 
Family d115 1 (2.5%) "One year between me and my sister, I mean we are approximately in the same age. She told me that 
nothing  helped her except hydrotherapy and the things that they ask us to do in it" (LBP17-36). 
Friends d115 9 (22.5%) “I asked other people who did the surgery if they recommend it or not” (LBP02-20) 
Internet/Media d166, d110 3 (7.5%) “I mean I read a lot of these articles which talk about spine problems in newspapers or magazines. I read 
anything which is related to the spine, pain in the back or these problems related to the spine deviation. I 
also watch these TV shows which invite speakers who are specialists in the spine. I like to watch these 
shows. I want to understand what going on with me. What cause me this pain? I mean they have mentioned 
a lot of these symptoms which is similar to my symptoms" (LBP2-32). 
Theme: Spiritual beliefs 
This is my destiny d9300  10 (25%) "Although I have severe pain, but this is God’s will and again praise is to Allah…This is 
my life and I should accept God’s will" (LBP1-6) 
Psychology, 
understanding 
God will help me d9300 23 (57.5%) "Our hope in God not in physiotherapy…it is God’s will" (LBP17-24). Psychology, 
understanding 
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9.5 Discussion 
Previous studies have pointed out that the majority of episodes of LBP are self-limited 
(403,404). However, the recurrence of LBP is very common (104,403). All of those who 
took part in this study indicated that they had experienced several episodes of LBP in the 
past. Thus, they were considered to have chronic LBP within this context. The inclusion 
of people who have chronic as well as acute LBP might provide a sample with richer 
experience about the impact of LBP on people’s life. 
The findings indicate the complex impact of LBP on individuals’ physical abilities, 
psychological status, social functioning, and spiritual practice. This study also focused on 
identifying life goals that were important to individuals with LBP following 
physiotherapy management in order to develop a valid, reliable and culturally sensitive 
measurement tool for individuals with LBP in Jordan within the next sections of this 
research programme. 
9.5.1 The impact of LBP on physical abilities 
Participants said that they had the desire to be normal, but, at the same time, they worried 
about preventing further damage to their body. The findings of this Jordanian qualitative 
study suggested that participants saw their body as fragile and were scared to participate 
in many physical activities and further increase the damage to their body structures. These 
concerns of preventing further damage to a fragile body were also reported by Stenberg 
et al. (405), who conducted a qualitative study with people who had LBP. Stenberg et al. 
(405) indicated that fear of increased damage led to vigilance regarding physical activity, 
resulting in a preference for rest and being cautious when starting to exercise. Miles et al. 
(406) proposed that in chronic LBP, the body becomes the object of an activity instead of 
the means through which this activity was achieved. 
9.5.2 The impact of LBP on psychological status 
This Jordanian qualitative study reported that fear of movement made participants take 
actions to minimise the chance of doing something that would further damage their body 
and, consequently, aggravate their LBP symptoms in the future. Physical restrictions 
associated with LBP, the uncertainties about the cause, or the course of the LBP problem 
affected individuals’ psychological state. These restrictions in their physical abilities and 
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doubts around their future were described as leading to depression, anxiety and anger 
(407,408). Furthermore, anxiety was linked to fear of movement and hypervigilance16 
(407,410).  
Previous studies showed that hypervigilance is directed towards the intention to avoid 
physical movement and escape situations that require a high level of physical abilities. A 
helpful treatment option may be to challenge false beliefs about pain and to enhance 
individuals’ understanding that a meaningful life is possible despite pain (411,412).  
Vlaeyen and Linton (413) developed a model where the pain beliefs and experience lead 
to two contrasting behavioural responses: avoidance or confrontation of reality (Figure 
9.5). Fear of movement was a component of avoidance behaviour which led to less 
physical activity, aggravating pain symptoms, deconditioning17 and disuse of the body, 
and disability (Figure 9.5). On the contrary, confrontation with the fear of movement 
directly, towards less fear of pain, decreased pain over time. These findings were similar 
to the findings in this qualitative study. 
Figure 9.5: Cognitive-behavioural model of fear of movement/(re)injury 
 
The model proposed by Vlaeyen and Linton (413) showed that pain catastrophising18 may 
serve as a precursor of pain-related fear of movement. Therefore, the identification of 
catastrophic cognitions is important in order to prevent the development of chronic pain, 
fear-avoidance behaviours, depression and, consequently, disability (411).  
  
                                                 
16 Mackworth et al. (409) defined vigilance as “the predisposition to attend to a certain class of events, or the readiness 
to select and respond to a certain kind of stimulus from the external or internal environment”. 
17 Gillis et al. (414) define deconditioning as “a complex process of physiological change following a period of inactivity, 
bedrest or sedentary lifestyle”. 
18 “Although the defining criteria for catastrophizing have never been explicitly stated, there is general consensus that 
catastrophizing involves an exaggerated negative orientation toward noxious stimuli.” (Sullivan et al.(415). 
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9.5.3 The impact of LBP on social life 
This current study suggests that limitations in functional abilities also affected personal 
relationships and interactions with other people. These findings were also consistent with 
the findings of a recent qualitative study by Hawthorne et al. (416), who proposed that 
social isolation associated with LBP could lead to many problems, such as maladaptive 
responses, work loss, being tense with others, and sexual dysfunction. Men who took part 
in this study said that they were more willing to tolerate their LBP symptoms caused by 
their occupation and hide their pain from others. It seems that they tolerated their pain 
because this was linked to their social role as a reliable employee and breadwinner. This 
finding is supported in a study where men also reported that they were willing to tolerate 
pain caused by their work because this was connected to their social role as a dependable 
worker and breadwinner (417). A study by Ashby et al. (386) reported that these 
limitations in individuals’ physical abilities could lead to financial constrictions, social 
isolation, and the desire to hide the LBP symptoms from others. Furthermore, it seems 
that depression and hypervigilance may affect social relationships and lead to social 
isolations (386).  
The findings of this study indicated how fear of movement could lead to limited 
participation in social activities and this, in turn, negatively affects relationships with their 
spouse, children and friends, all of which are the basis for individuals’ coping and support. 
These changes might lead to relationship breakdown, which, in turn, might cause more 
social consequences (418). Therefore, attention has to be directed towards the 
complicated interactions between individuals and their social context in how the 
fluctuation patterns deeply rooted in their LBP problem shape the oscillation between 
hope and despair (407). 
9.5.4 The impact of LBP on spiritual practice 
Participants indicated that anxiety, caused by LBP, challenged their self-confidence to 
perform usual daily activities, such as praying. Bandura (419,420) suggested a model 
where self-efficacy or self-confidence was hugely dependent on individuals’ abilities to 
perform various tasks or meet specific situational demands (Table 9.7). The existence of 
pain or the apprehension of pain due to performing an activity that might aggravate the 
LBP symptoms could negatively affect self-confidence to maintain a position or perform 
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dynamic movements. This was also reported in a study where individuals reported that 
LBP challenged their self-confidence to perform their spiritual practices, which require 
individuals to maintain a position for a certain period of time or perform different 
dynamic movements (421). 
Table 9.7: Summary of models used in this chapter 
Model Author Definition and explanation 
Fear-avoidance 
model 
Vlaeyen (413) This model emphasizes the importance of fear that physical activity will 
cause pain and (re)injury 
Self-efficacy 
model 
Bandura (14,15) “to an individual belief in his or her ability to perform certain physical 
tasks or meet specific situational demands.” 
Sense of 
coherence model 
Antonovsky 
(422), p.19 
“a global orientation that expresses the extent to which one has a 
pervasive, enduring though dynamic feeling of confidence that: 
The stimuli deriving from one's internal and external environments in the 
course of living are structured, predictable and explicable; the resources 
are available to one to meet the demands posed by these stimuli; and 
these demands are challenges, worthy of investment and engagement.” 
9.5.5 The impact of patients’ knowledge on the rehabilitation process 
Fear and avoidance attitudes have been linked to erroneous and extraneous beliefs, which 
led to fear of movement or kinesiophobia19 (386). It seems that early in the LBP 
experience, individuals quickly identify those movements that aggravate their LBP 
symptoms and accordingly avoid such movements (386).  Fear of movement could be 
due to an incorrect interpretation by the individual of the cause of LBP (424,425). 
Examples of such incorrect beliefs held by participants in this qualitative study were  that 
a past injury could lead to damaging intervertebral discs. People believe that only surgery 
could fix the back pain problem or, most often, they believe that staying active could be 
the cause of potential further damage to the intervertebral disc, which leads to more pain 
and to paralysis. Participants who took part in this study had incorrect beliefs and 
explanations regarding the cause of their LBP. This lack of an explanatory model that 
tells them what is wrong with their back and their spine might significantly influence the 
rehabilitation process (426).  Therefore, participants’ experiences indicate that it is 
recommended that healthcare professionals working in this setting explore individuals’ 
knowledge. Patients’ knowledge is not static and will be influenced by the source of 
information, individuals’ beliefs and their interpretations of information passed to them 
by others (386). Avoidance behaviour and pain-related anxiety could be reinforced by 
advice from family members, colleagues, friends, and even therapists about the cause of 
                                                 
19 “An irrational and debilitating fear of physical movement and activity resulting from a feeling of vulnerability to painful 
injury or (re) injury.” Kori et al. (423) 
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pain and how to terminate the LBP problem (427-430). These interpretations had become 
part of the participant’s own explanatory model of LBP. Furthermore, the 
misunderstanding of the medical language accentuates the need to confirm understanding 
with the individual who suffers from LBP. The early identification of misunderstandings, 
fear of movements and its impacts could help health professionals to achieve better 
outcomes and the process of rehabilitation will be more effective (386,426).  
9.5.6 Self-management and coping with pain 
It appears that individuals’ knowledge and their understanding of the LBP problem help 
them to enhance their ability to cope with pain. Antonovsky (422) developed the sense of 
coherence model in 1979; he indicated in his model that individuals who cope with life 
stressors have a good understanding of their problem. Usually, individuals seek to be in 
control of their problem and try to find explanations of things that are happening to them. 
Furthermore, in his model, Antonovsky stated that comprehensibility, manageability, and 
meaningfulness are three key components to a successful coping strategy. The last 
component, meaningfulness, is the most important key factor in this model because 
individuals can only successfully self-manage their condition and cope with pain if they 
are working to achieve a meaningful and important life goal. This notion supports the 
overall aim of this thesis of developing a measurement tool that generates meaningful 
information that might help individuals with LBP to learn more about their problems and 
self-manage them.  
9.6 A reflection on the qualitative study 
This subsection reflects on the conduct and process of the qualitative study. It highlights 
aspects of the study which might have impacted upon the rigour of the findings. The 
majority of those who agreed to participate in this study engaged in the interview and 
responded to all questions. However, some issues emerged during the period of data 
collection which required being addressed to avoid any negative effect on the quality of 
the data gathered. During the recruitment stage, three participants initially agreed to 
participate in the qualitative study; however, they changed their mind later on prior to the 
commencement of their interviews. Two participants indicated that they were busy and 
did not have time to be interviewed. One participant refused to have the interview audio-
recorded and later requested a withdrawal from the qualitative study.  
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The interviewer made all efforts to ensure that during the recruitment stage, each 
participant understood that participation in this study was completely voluntary and each 
participant had the right to withdraw from the interview, even without giving a reason; 
however, no one decided to withdraw. Each participant was given an information sheet 
two weeks prior to the interview. These information sheets explain the purpose of the 
study, the role of the participants and their rights before, during and after the interviews. 
Some participants approached the interviewer following the completion of the interviews 
and expressed their concerns with regard to the quality of their treatment. Allmark et al. 
(431) conducted a review about the ethical issues during the in-depth interviews. This 
review recommends that interviewers disclose their professional background to the 
interviewees and resist any temptation to switch between the research and therapy during 
the data collection phase.  
Participants were assured that this study was conducted for research purposes and was 
not related to their therapy. The interviewer had taken patients’ concerns into 
consideration and stressed within each of the interviews that participation within this 
study would not affect the quality of the treatment, either positively or negatively. 
Participants were assured that their concerns would be included in the final report of this 
qualitative study. Participants were informed at the beginning of the recruitment stage 
that the overarching goal of this study is to develop an outcome measure that might assist 
them and their healthcare providers to take evidence-based decisions during their therapy. 
This evidence-based practice will enhance the overall quality of healthcare services 
provided to them. 
Another important issue was related to the furniture available within the interview room. 
One of the participants indicated that sitting down would increase his pain and he 
preferred to be interviewed while he was lying down on his back in one of the closed 
treatment rooms within the hospital. A room was booked for the purpose of this interview. 
However, the main researcher took into consideration that some of the participants might 
feel uncomfortable while sitting down for a long period of time to be interviewed. This 
had an impact on the focus of the interview, as participants might have ended up being 
preoccupied with sitting as something that aggravates their pain. Thus, each participant 
within the following interviews was asked if he/she wanted to take a break and perform 
some stretching or exercises. 
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Participants were encouraged to talk about their personal experiences of living with LBP. 
Some of the participants focused on their negative experiences. The majority of those 
participants provided an extensive and moving account about the impact of LBP on their 
physical abilities, social life, mood and spiritual life. Some of those participants became 
upset and distressed when they were talking about the impact of LBP on their life. The 
review by Allmark et al. (431) suggested that the interviewer should plan strategies in 
advance to deal with these stress situations. The interviewer reflected on his clinical 
practice as a registered physiotherapist; these issues were easily addressed and settled. 
This did not significantly affect the thread of the discussion and participants returned to 
talk about their experience with LBP with less emotional distress. Notes were written 
during the interviews to avoid repetition, to document the points discussed throughout the 
interview and to maintain the thread of the discussion. The interviewer assured those 
participants that their identity would be kept confidential throughout the research. 
Richards and Schwartz (432) pointed out that maintaining confidentiality is important 
while conducting a qualitative study and later on during writing up the final report. 
Therefore, pseudonyms were used in this qualitative study. 
All efforts were made to keep the participant focused, in order to be able to discuss their 
lived experience with LBP. However, some of those participants indicated that they 
suffered from other chronic problems in their spine, such as neck pain. The main 
researcher gently asked them to focus on LBP in their discussion. 
Finally, there were extra layers of translation in this qualitative study. The accuracy of 
the translation process might affect responses of participants or lead to unintentional 
omission of certain words that might be important later on in the items construction stage. 
This was taken into consideration and this research programme followed the instructions 
of two translation guidelines in order to preserve words and expression reported by 
participants. Two researchers were involved in the translation process and the two 
reviewers from the University of Jordan reviewed more than 50% of the translated 
quotations and they recommended minor changes to the English text to preserve 
meanings. The reviewers concerns were related to the word selection. It is important to 
note at this stage that even though text was translated from Arabic into English, this 
research programme only used the Arabic text in the construction stage of the TELER 
indicators. Therefore, this was not considered an issue that might affect the development 
phase. This subsection indicates that a variety of steps were taken to i) enhance the clarity 
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in describing the research process and ii) maintain the rigour of this study. 
9.7 Examining the quality of this study 
The criteria of trustworthiness were used in this research (Table 9.2). The following 
subsection describes in detail how ethics of research, credibility, transferability, 
dependability and confirmability were achieved in this qualitative study. 
Ethics: This qualitative study was approved by the Sheffield Hallam University Research 
Ethics Committee (Appendix F), the Jordanian University of Science and Technology 
Hospital (Appendix G) and the Jordanian Ministry of Health Ethics Committees 
(Appendix H). 
Credibility:  Semi-structured interviews were used in this study, which meant that the 
interviewer was not tied to the topic guide. The topic guide assisted only as a beginning 
point from which to start discussion of the subject. This enabled exploration of the 
participants’ views about the impact of LBP on their lives as they arose, the discovery of 
which was the main aim of this research. Credibility was improved by extended 
involvement in data collection and analysis. In order to avoid any biases of the interviewer 
influencing the analysis, the development of the themes went through the five stages of 
framework analysis. At each stage, the researcher scanned the data and evolving themes 
were examined against them, as was described in the methods. While this was happening, 
the data analysis was exposed to the supervisory team so that ‘quality control’ occurred. 
Transferability: In order to provide triangulation, respondents were from four hospital 
sites. Participants were only LBP patients with dominance of chronic problems. 
Demographic details were given in Table 9.3. 
Dependability: The fact that the interviewees knew that the researcher was not involved 
in their management might have helped them to be more comfortable to talk about their 
experience of living with LBP. As outlined previously, the data analysis was examined 
and re-examined by the author of this thesis and the supervisory team to ensure that the 
themes identified were exhaustive and thorough. Good qualitative research should be in 
tune with previous studies (433); other qualitative studies reported similar findings and 
there was no contradiction between this research and other studies, thus endorsing the 
reliability of the current study. However, this qualitative study provided more themes, 
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such as the ones related to spirituality and sources of information, which was not reported 
by other studies. 
 Confirmability: The majority of those who were invited agreed to take part in this study. 
It is, therefore, logical to assume that they represent a variety of perspectives, a range of 
participants and that they resemble the targeted population. Furthermore, there were equal 
numbers of male and female participants, avoiding over-representation of one group. As 
outlined earlier, this study followed a structured research process and the conclusion was 
warranted by the data. Within the limits of the resources available, everything was carried 
out to ensure a credible, dependable, transferable and confirmable collection and analysis 
of the data that the participants offered. 
9.8 Strengths and limitations of the qualitative study 
This study has a relatively large sample size in comparison to other qualitative studies 
and research in a similar area (5,366). This point was considered one of the strengths of 
the study because it allowed the inclusion of a more diverse sample, which enabled the 
exploration of similarities and differences between diverse participants and those from 
four different regions. This study followed a structured approach not only in the analysis 
of qualitative data but also in the process of translation, which adds to the strength of this 
study. 
Despite all efforts to enhance the quality of this research, there were some limitations. 
For example, this study was limited to individual interviews and did not utilise other 
methods of data collection, such as focus groups. A focus group might provide a broader 
range of information and different insights into a complex problem in comparison to semi-
structured interviews. However, it was difficult to encourage a range of participants to 
take part in a focus group because they were busy with other commitments. Furthermore, 
it is logical to assume that participants who were recruited from the same physiotherapy 
clinic knew one another and that it would impede their contribution in answering the 
research questions (389,390). 
Due to the nature of this research and the large sample size, participants were not asked 
to validate their transcripts, which could be considered one of the limitations of this 
research. However, towards the end of each interview the researcher gave each 
interviewee a short feedback summary of what they said in the interview to confirm that 
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the points mentioned in the interview represent their view and experience of living with 
LBP. Compared with a suggested checklist by Seale (434) for evaluating the quality of 
qualitative study, this study performs reasonably highly.  
9.9 What this qualitative study add to the current LBP literature  
The findings of this study fit with the concepts of the bio-psychosocial model (435,436). 
However, this study showed that spiritual life was also affected by LBP and recommends 
adding this dimension to the existing bio-psychosocial model. Individuals with LBP said 
that their spiritual life was important to them and made them cope with LBP. This study 
is the first to provide in-depth details about the impact of LBP on physical activities. It 
appears from the findings of this study that limitations in functional abilities affect other 
dimensions of the LBP experience, such as mood, social functioning, and praying. 
Furthermore, the findings showed that many activities, such as squatting, kneeling, and 
being prostrate, were affected by LBP. Current commonly used measures of function do 
not address such activities adequately (210). The findings of this study also supported the 
concepts of the cognitive-behavioural model regarding fear of movement/(re)injury 
(413). The study findings indicate that individuals’ knowledge could influence people’s 
ability to perform different physical activities. It seems that any misconception about what 
causes the LBP problem or any misunderstanding of the medical language could 
strengthen avoidance behaviours and lead to fear of movement. Therefore, this study 
emphasises the need to verify that patients do not have misconceptions or 
misunderstandings before the beginning of the rehabilitation process in order to avoid any 
negative impact on rehabilitation.  
The findings of this study make an important contribution of understanding LBP patients’ 
perspectives by exploring and identifying their life goals. The author of this thesis is not 
aware of any study that explores life goals that are important to individuals with LBP. 
This is the first qualitative study in Jordan to explore LBP patients’ perspectives and 
identify their life goals in order to design a measurement tool suitable to be used with 
Jordanian individuals who complain about LBP in a clinical setting. 
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9.10 Conclusion 
This qualitative study makes an important contribution to understanding the complexity 
of the LBP experience as a pre-cursor to the development of a culturally sensitive clinical 
outcome measurement tool for individuals receiving physiotherapy management for LBP. 
This qualitative study showed that LBP has a huge impact on an individual’s ability to 
perform different daily activities, especially sitting, standing, lifting, bending and rotating 
the trunk. It is clear from the participants’ narrative that restoring functions is a key 
feature to the success of therapy. Fear of movement due to individuals’ erroneous beliefs 
around the cause of their LBP problem and their misinterpretations of the medical 
language led to kinesiophobia. The findings support the need to develop a measurement 
tool for individuals with LBP which reflects changes in their physical abilities. The tool 
also needs to take into consideration that patients’ knowledge plays a key role in 
preventing fear of movement and associated behaviours.  Knowledge can help individuals 
to cope with pain, self-manage their condition, and continue their life. Therefore, the 
physical functioning theme and subthemes that emerged from this qualitative study will 
form the basis of TELER’s physical functioning indicators in the next section of this 
research programme.  
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Chapter 10: Combining outcome components into one measure – 
generating TELER codes from patients’ narrative 
Key point in Chapter 10: 
- The TELER LBP indicators were constructed using the findings of the qualitative 
study, along with scientific and clinical knowledge. The Nominal Group 
Technique ensured face and content validity of the TELER LBP indicators. 
10.1 Introduction 
Findings of the qualitative study [Chapter 9] indicated that LBP significantly affects many 
dimensions related to a patient’s quality of life. It seems that LBP affects a patient’s 
functional performance and leads to many limitations in social participation, ability to 
work and spiritual practice. Furthermore, the qualitative study suggested that these 
limitations in functional performance might lead to depression, anger and fear of 
movements.  
It appears from the findings of this study that individuals with LBP were concerned about 
their physical functioning. This was confirmed in a recent qualitative study conducted in 
Australia which explored individuals with LBP goals after physiotherapy (363). Gardner 
et al. (363) suggested that goals related to physical functioning were identified by 
individuals with LBP as important after physiotherapy. Therefore, the following 
subsections aim to describe the process of identifying and formulating the TELER codes 
for each physical activity identified from the findings of the qualitative study. 
10.2 Item selection 
Findings of the qualitative analysis identified two sets of activities that were challenging 
and important at the same time to individuals with LBP. These sets were maintaining a 
posture for a certain period of time and dynamic movements. These activities were further 
divided as follows: 
Set 1: The maintenance of a position (static posture): 
 Lying down  Squatting 
 Sitting  Bending forward 
 Standing  
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Set 2: Changing position (dynamic movements): 
 Rolling in bed  Standing to squatting 
 Getting out of bed  Walking 
 Lying down to sitting  Running 
 Sitting to standing  Going up stairs 
 Standing to walking  Going down stairs 
 Standing to pending forward  Lifting weights 
10.3 Generating item codes 
The next step after identifying the ‘desired outcome’ was to generate TELER codes for 
each of the TELER indicators. A first draft of TELER codes was generated from: 
 Patients’ narratives  Clinical knowledge 
 Movement analysis studies  Experts’ opinion 
The process of generating TELER codes involves standardising and refining codes’ 
descriptors to conform to the requirements of the TELER method of measurement (342). 
These requirements are as follows: 
1. Each TELER code must have a unique meaning. 
2. The language used in a TELER code’s descriptor must provide a singular meaning. This is 
achieved by ensuring that each statement in a TELER code’s descriptor means one thing and 
is not perceived differently by different individuals. 
3. A standardised language must be used in the formulation of the codes’ descriptors to allow 
for a wider application. 
4. Statements that rely on feelings must be avoided and replaced by observable characteristics. 
5. Codes provide an ordinal level of measurement. This is important to ensure that codes 
represent as closely as possible the different stages of the recovery process. 
Tables 10.1, 10.2 and 10.3 show some examples of using different approaches in the 
development of TELER codes’ descriptors. 
Table 10.1: An example of how a TELER [generic activity] functional indicator was constructed from 
LBP patients’ narratives 
Participants’ quotation TELER code’s descriptor 
LBP 28-20 “I can’t turn my trunk around to the right or to the left because 
of this pain”. 
Code 0: Pain prevents named 
activity 
LBP 28-10 “This [LBP] will limit your abilities to use your legs, you can’t 
walk or move around”. 
Code 1: Pain interrupts named 
activity, unable to resume 
LBP 28-30 “I can’t stand up quickly if I am lying or sitting down at home, 
you feel as there is a spasm in your leg. However, this pain will go away 
once I warm up … the pain becomes less … much less”. 
Code 2: Pain interrupts named 
activity, able to resume 
LBP 26-62 “I feel it [pain] while I am getting out of the car, and when I step 
down from the car, continuously, when I’m handing out the [news]papers 
as I told you, every morning, it increases with movement”. 
Code 3: Pain during named activity, 
able to continue without interruption 
LBP 12-04 “no problems while I am sleeping but I can’t move my back when 
I first get up in the morning, I need some time to be able to move about”. 
Code 4: Pain after completion of 
named activity 
LBP 21-18 “In fact, I don’t feel pain at all when I run”. Code 5: Pain free throughout named 
activity, no pain after 
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Table 10.2: An example of how a TELER functional indicator was constructed from movement 
analysis study 
Movement analysis of sitting to standing TELER codes TELER code’s descriptor 
 
Code 0 Unable to stand from sitting 
 
Code 1 Able to forward flex trunk 
 
Code 2 Able to forward flex trunk, shift 
bottom to edge of chair and 
transfer weight over feet 
 
Code 3 Able to initiate push up from chair 
 
Code 4 Able to rise from chair using 
hands 
 
Code 5 Stands independently from sitting 
without using hands 
The sequence of events described in this table is reported by many movement analysis studies, such as 
Millington et al. (437) and Schwenk et al. (438). 
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Table 10.3: An example of how a TELER LBP component indicator was constructed from clinical 
knowledge 
I have difficulties to maintain the following positions 
for [specify time]: 
TELER code TELER code’s descriptor 
Lying down on back Code 0 All problems present 
Sitting Code 1 4 problems present 
Standing Code 2 3 problems present 
Squatting Code 3 2 problems present 
Bending forward Code 4 1 problem present 
 Code 5 0 problems present 
 
The TELER codes in Tables 10.1 and 10.2 were very similar to the codes in existing 
TELER indicators (WC0051 and ST0278, respectively), which are located in the TELER 
online library (439). The TELER online library contains more than 1400 indicators that 
were validated by different qualitative studies and expert panels in the healthcare field 
(440). These indicators measure various dimensions of health-related quality of life, 
including the impact of pain on physical functioning. It is logical to assume that this 
online library might include indicators relevant to this research programme, ready to be 
modified according to the findings of the qualitative study and validated by expert in the 
next stages in this research programme.  
The TELER library was searched manually and electronically for indicators that could be 
potentially used with individuals with LBP. These indicators were examined and checked 
to ensure that they were appropriate to be used in the measurement of functional 
performance. The selected indicators were continuously compared to the findings of the 
qualitative study. The purpose of this comparison was to ensure that the selected 
indicators reflect desired outcomes that are important to individuals with LBP in Jordan. 
In total, 36 physical functioning indicators were identified from the TELER online library 
and were extracted to a Word® document [Appendix I]. Each of these indicators was 
individually examined to check whether it contradicted the findings of the qualitative 
study or not. Any indicator located in the TELER online library which contradicted 
patients’ narrative was excluded from the validation stage [Chapter 11]. The author of 
this thesis literally translated the first draft of TELER LBP indicators from the English 
language to the Arabic language in preparation of being  validated by experts in the next 
stage [Appendix J]. The Arabic standard language was used in the translation to allow for 
a wider application in Jordanian physiotherapy clinics.  
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10.4 Conclusion 
The first draft of the TELER LBP indicators represented a wide range of activities that 
were identified earlier in a qualitative study as important to individuals with LBP. The 
initial pool of indicators was prepared to be validated using the consensus method in the 
next stage of this research programme. The next chapter describes the methods used to 
validate the first draft of TELER physical functioning indicators.  
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Chapter 11: Item calibration and validation of TELER LBP indicators 
– Expert validation 
Key point in Chapter 11: 
- The nominal group technique used in this chapter facilitated the process of 
identifying issues in the pre-testing version of the TELER LBP indicators. The 
participants suggested few changes in the pre-testing version to enhance the 
readability of the indicators, omitting some indicators that did not represent the 
construct ‘physical functioning’ and replacing them with other indicators. 
11.1 Introduction 
Thirty-six indicators were selected in the previous stage to form the first draft of the 
TELER LBP questionnaire. The selected indicators included different response choices 
that match, as closely as possible, different stages of the recovery process. The aim of the 
following subsections is to describe the methods used to refine, standardise and validate 
the TELER LBP indicators by Jordanian experts in the field of physiotherapy. 
11.2 Methods 
A consensus method was adopted in this stage in order to scrutinise and validate the first 
draft of the TELER LBP questionnaire. Consensus methods are typically used in health 
services research for problem identification, development of solutions and establishing 
priorities (441,442). Four methods of consensus are often used in the health services 
research (441). These are the Delphi approach, focus groups, brainstorming sessions and 
nominal group technique (NGT) (also known as expert panel technique). Table 11.1 
presents a comparison between these methods. 
Table 11.1:  A comparison of group decision-making processes 
Attribute 
Decision-making process 
Delphi Focus groups Brainstorming NGT 
Face-to-face group meeting process No Yes Yes Yes 
Generates a large number of ideas Yes Maybe Maybe Yes 
Avoids focusing on a single series of thought Yes Yes No Yes 
Encourages equal input from all participants Yes No No Yes 
Highly structured process Yes Maybe No Yes 
Allowing participants to change their opinions Maybe No No Yes 
Avoids ‘quick’ decision-making Yes No No Yes 
High degree of task completion Yes Maybe No Yes 
Provision of immediate feedback No Maybe Maybe Yes 
Measures the relative importance of ideas generated Yes No No Yes 
Generate consensus No No No Yes 
Adapted from Potter et al. (441) 
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The comparison in Table 11.1 indicates that the nominal group technique (NGT) can 
provide a systematic method and environment to facilitate discussion, constructive 
criticism and improvement to the translated TELER LBP indicators. Thus, the NGT was 
selected as more appropriate for use in this research than the other consensus methods. 
Box 11.1 shows the NGT protocol that was followed in this research programme. 
Box 11.1: The nominal group technique protocol 
1. Introduction and explanation: The facilitator welcomed the participants and explained the purpose and 
procedure of the meeting. This included an oral presentation of the TELER method [~15 minutes]. 
 
2. Silent generation of ideas: The facilitator provided each participant with a sheet of paper with the question to 
be addressed and asked them to write down all ideas that came to their mind when considering the question. 
During this period, he asked participants not to consult or discuss their ideas with others [~5–10 minutes]. 
 
3. Sharing ideas: The facilitator invited participants to share the ideas they have generated. The facilitator 
recorded each idea on a PowerPoint® slide using the words spoken by the participant. The round-robin process 
continued until all ideas were presented. There was no debate about items at this stage and participants were 
encouraged to write down any new ideas that might arise from what others shared. This process ensured that all 
participants got an opportunity to make an equal contribution and provided a written record of all ideas generated 
by the group [~15–30 minutes]. 
 
4. Group discussion: Participants were invited to seek verbal explanation or further details about any of the ideas 
that colleagues had produced that might not be clear to them. The facilitator’s task was to ensure that each person 
was allowed to contribute and that discussion of all ideas was thorough without spending too long on a single idea. 
It was important to ensure that the process was as neutral as possible, avoiding judgment and criticism. The group 
suggested new items for discussion and combined items into categories, but no ideas were eliminated [~30–45 
minutes]. 
 
5. Voting and ranking: This involved prioritising the recorded ideas in relation to the original question. Following 
the voting and ranking process, immediate results in response to the question were available to participants, so 
the meeting concluded having reached a consensus. 
 
Consensus was considered to be reached if a certain format received the most votes. 
Adapted from Potter et al. (441). 
The NGT was used in this research programme in order to achieve the following 
objectives: 
 To review the translated version of the selected TELER indicators from English to 
Arabic. 
 To validate the modified TELER’s indicators. This was achieved by examining the 
construct, the content, and the clinical knowledge underpinning the TELER’s functional 
indicators. 
 To ensure that the codes in the indicators are representing clinically significant outcomes 
that are induced by physiotherapy interventions. 
 To ensure that the hierarchical stepwise regain of physical abilities in TELER’s indicators 
is a valid representation of improvement (or deterioration) in physical functioning. 
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11.2.1 Sampling 
Purposive sampling was used in the recruitment of the expert panel. Individuals who met 
the inclusion/exclusion criteria were invited to take part in the NGT meetings (Table 
11.2). Purposive sampling was selected because, in comparison to other methods such as 
convenience sampling, purposive sampling allows participants to be recruited in a 
strategic manner that befits the research goals (390). Selecting purposive sampling was 
important in order to achieve a wide range of different expertise and experiences required 
to inform the development of the TELER LBP indicators.  
Physiotherapists who were identified by the Jordanian Physiotherapy Society as experts 
in the management of LBP and met the inclusion and exclusion criteria (Table 11.2) were 
invited to take part in the nominal group meeting. A letter [Appendix K] explaining the 
aim of the research was sent to the selected physiotherapists. Participants were given one 
week to indicate whether or not they were interested in taking part in the NGT. The 
invitation letter included a mobile phone number that the participant could use in case 
they wanted more information or wanted to reply to the invitation letter. Once the 
participants agreed to take part in the study, they were sent the original version, the 
translated version of the first draft of the TELER LBP questionnaire and a questionnaire 
to assess the validity of each TELER LBP indicator [Appendix L], as well as the 
information sheets and consent forms [Appendix M]. They were asked to review and 
document their comments and suggestions on the translated version. Those who did not 
respond to the invitation letter through a phone call were approached one week later and 
were asked whether they would be willing to consent to take part in the scientific meeting 
or not. 
Table 11.2: Inclusion and exclusion criteria 
Inclusion criteria Exclusion criteria 
 Practicing musculoskeletal physiotherapists to 
represent typical practice. 
 Participants must have at least three years of 
experience in the management of LBP. This is 
important to ensure that the participants have an 
adequate knowledge about LBP and the 
trajectory of the condition. 
 Willing to participate voluntarily in this research. 
 Unable to communicate in Arabic or English 
languages.  
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11.2.2 Confidentiality 
The researcher followed Sheffield University protocols regarding confidentiality issues 
and complied with the requirements of data protection (443). Confirmation was given to 
participants that any given data would be coded so that their privacy was maintained 
throughout the study. In addition, information sheets clearly stated that electronic data, 
such as audio recordings, would be kept on a secure laptop using a complex password 
and that the laptop would not be left unattended at any stage. Field notes taken during the 
study were kept in a locked briefcase or a secure locker at the researcher’s living place. 
 11.3 Results 
Eighteen physiotherapists were invited to take part in this stage. Twelve physiotherapists 
agreed to take part in the validation stage. Table 11.3 shows the field of expertise and 
years of experience for each participant. The last two physiotherapists in Table 11.3 acted 
as facilitators in the NGT meetings; therefore, their votes were not included in the final 
voting round. Furthermore, the LBP-11 field of expertise lay in the pulmonary 
rehabilitation field and not musculoskeletal physiotherapy. Physiotherapists who agreed 
to take part in this stage scrutinised the first draft of the TELER LBP indicators in one of 
six sessions over two weeks. These sessions lasted between one and four hours. 
Table 11.3: Expert panel characteristics 
Participant number Field Years of 
experience 
Place of work 
LBP-01 Musculoskeletal physiotherapist 23 years Al Bukhari Center 
LBP-02 Musculoskeletal physiotherapist 5 years Islamic Hospital 
LBP-03 Musculoskeletal physiotherapist 4 years Spine Care Center 
LBP-04 Musculoskeletal physiotherapist 4 years Spine Care Center 
LBP-05 Musculoskeletal physiotherapist 3 years Spine Care Center 
LBP-06 Musculoskeletal physiotherapist 3 years Spine Care Center 
LBP-07 Musculoskeletal physiotherapist 4 years Physio Medic Center 
LBP-08 Musculoskeletal physiotherapist 9 years Red Cross and Red Crescent 
Societies 
LBP-09 Musculoskeletal physiotherapist 3 years Altamiouz 
LBP-10 Musculoskeletal physiotherapist 9 years Albashir Hospital 
LBP-11 Academic with TELER method 
experience, Physiotherapist 
5 years The University of Jordan 
LBP-12 PhD student with TELER 
method experience; 
Musculoskeletal physiotherapist 
2 years; 7 years The University of Sheffield 
The initial results of the voting stage are presented in Table 11.4, which indicates that 
experts were able to identify concerns regarding a number of indicators. These concerns 
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were regarding the complexity of language, which might compromise clarity. Other 
concerns were the inclusion of concepts that are not relevant to the domain of physical 
functioning and the inclusion of physical activities that cannot be induced by 
physiotherapy interventions alone. A full list of their recommendations and suggestions 
is presented in Appendix N. 
Table 11.4: The initial results of the votes in the nominal group technique 
Title of the TELER indicator 
Q1* Q2* Q3* Q4* Q5* 
Y D N Y D N Y D N Y D N Y D N 
1. General function (not hierarchical) 5 0 5 4 0 6 4 1 5 1 3 6 1 3 6 
2. Pain free activity 9 0 1 0 1 9 1 0 9 1 0 9 1 0 9 
3. Independent toileting 1 1 8 0 0 10 8 0 2 3 0 7 1 0 9 
4. Washing independently 1 4 5 2 2 6 5 1 4 3 3 4 5 1 4 
5. Return to sporting activity 8 0 2 0 0 10 2 0 8 2 0 8 1 0 9 
6. Sciatic referral anaesthesia, pain, 
paraesthesia 
4 1 5 2 1 
7 
5 1 
4 
4 1 
5 
1 
1 
8 
7. Ability to perform functions after the 
onset of lower back pain 
1 6 3 1 6 
3 
3 5 
2 
0 7 
3 
1 
5 
4 
8. Sleep without disruption due to pain 8 0 2 0 2 8 2 0 8 0 0 10 0 0 10 
9. Sleep normally (not hierarchial) 8 1 1 0 1 9 0 1 9 0 1 9 0 1 9 
10. Sleep pain free 7 2 1 0 3 7 1 2 7 0 4 6 0 0 10 
11. Bed mobility 7 0 3 2 0 8 3 0 7 0 0 10 0 0 10 
12. Lying to sitting over edge of bed 8 0 2 0 1 9 2 0 8 0 1 9 0 1 9 
13. Lying to sitting on bed 3 3 4 1 1 8 4 0 6 1 1 8 1 1 8 
14. Get out of bed (not hierarchial) 6 1 3 1 0 9 3 0 7 1 1 8 0 1 9 
15. Transfer lying to standing pain free 2 0 8 2 0 8 5 0 5 8 0 2 4 0 6 
16. Sitting to standing 9 0 3 0 1 9 3 0 7 0 1 9 0 1 9 
17. Stand to sit 5 1 4 2 0 8 4 1 5 0 0 10 1 0 9 
18. Floor sitting to standing 8 0 2 1 0 9 2 0 8 0 0 10 0 1 9 
19. Sit pain free 6 2 2 0 0 10 2 6 2 2 1 7 0 0 10 
20. Stand pain free 8 0 2 0 0 10 2 0 8 2 0 8 0 0 10 
21. Trunk movement pain free 5 0 5 0 0 10 5 0 5 2 0 8 0 0 10 
22. Standing to squatting 9 0 1 2 0 8 0 0 10 1 0 9 1 0 9 
23. Squatting into standing 5 0 5 2 0 8 5 0 5 1 0 9 1 0 9 
24. Walk a distance outdoors 1 1 8 2 1 7 8 0 2 7 0 3 3 0 7 
25. Walking without pain in the lower back 7 0 3 1 0 9 0 1 9 0 0 10 0 0 10 
26. Walk independently (not hierarchial) 8 2 0 0 1 9 0 3 7 0 3 7 0 1 9 
27. Walk independently with normal gait 5 1 4 1 1 8 4 1 5 2 1 7 0 1 9 
28. Functional walking 7 0 3 1 0 9 3 0 7 1 0 9 0 0 10 
29. Run in one direction on even ground 
without pain or limp or leg tiring 
5 0 5 1 1 
8 
5 1 
4 
1 1 
8 
1 
1 
8 
30. Run on uneven ground, change 
direction and pace with no problems 
afterwards 
6 0 4 1 0 
9 
4 0 
6 
0 1 
9 
0 
1 
9 
31. Jog pain free 1 2 7 1 0 9 7 0 3 2 0 8 3 0 7 
32. Climb stairs pain free 5 0 5 2 0 8 5 0 5 1 0 9 1 0 9 
33. Ascends stairs 6 0 4 0 0 10 4 0 6 0 0 10 0 0 10 
34. Use stairs pain free 6 0 4 0 0 10 4 0 6 0 0 10 0 0 10 
35. Descend stairs 6 0 4 1 0 9 4 0 6 1 0 9 1 0 9 
36. Lift weight 4 1 5 3 0 7 5 0 5 2 0 8 2 0 8 
* These questions are extracted from the workbook in Appendix L.  
Q: Question / Y: yes / N: No / D: Don’t know  
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The expert panel suggested that the first indicator in the TELER LBP questionnaire does 
not include all activities that are affected by LBP and important to Jordanian individuals. 
The NGT participants acknowledged the presence of other indicators in the same 
questionnaire, such as items 7, 14, 26 and 28, which cover some of these activities. They 
recommended replacing these indicators with one generic indicator. In response to the 
expert panel comments, a TELER quiz-style questionnaire was developed (Table 11.5). 
The LBP quiz-style questionnaire is considered important for three reasons. Firstly, it is 
designed to be filled by individuals with LBP in the first session while they are waiting 
to see the physiotherapist. This might enhance the partnership between the patient and 
their physiotherapist by ensuring the active participation of both parties in the 
measurement process. Secondly, the quiz-style questionnaire will form a point of control 
where the physiotherapist will measure only desired outcomes that are important to the 
patient. This is important to reduce the number of items without losing precision. Thirdly, 
the last question in the quiz-style questionnaire is important as a last resort to avoid any 
unintentional omission of activities that are important to individuals with LBP but are not 
included in the list above. This question is also important to ensure that the list of activities 
generated from the qualitative study is comprehensive.  
The experts identified a few indicators that were not related to the domain of physical 
functioning [Appendix N]. For example, the panel suggested the exclusion of item 6 
because it represents an impairment indicator, not a physical functioning indicator. Items 
3, 4 and 5 were also excluded from the TELER LBP questionnaire because they included 
activities that are beyond the scope of physiotherapy in Jordan. The participants also 
indicated that some of the codes in these indicators cannot be falsified and the activities 
in items 3 and 4 can be performed in at least two different positions. This violated one 
assumption of the TELER method which mandates that the language used in each TELER 
code descriptor must provide a singular meaning. 
11.4 Summary  
In summary, 12 indicators were excluded from the first draft of the TELER LBP 
questionnaire and five new indicators were added to the pre-testing draft (Appendix O). 
The group of experts reviewed all indicators in the pre-testing draft, verified their 
adherence to the TELER method assumptions and accepted the pre-testing draft for 
clinical testing. This stage ensured the face and content validity of the pre-testing draft of 
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the TELER LBP questionnaire. It is important to note at this stage that the quiz-style 
questionnaire and five indicators in the pre-testing draft are not located in the TELER 
online library. These new indicators are as follow: G2, H1, H2, L2 and L3. The next 
chapter describes the methods used in the clinical testing phase. 
 Table 11.5: Quiz-style LBP questionnaire 
Do you have any problem when performing the following 
activities due to your pain in the lower back? Please place 
a mark (e.g. X) next to these affected activities. 
No Yes Irrelevant 
to me 
For 
physiotherapist 
use 
1.  Sleeping continuously    A1 
2.  Bed mobility    B1 
3.  Getting up from lying to sit on the edge of bed    B2 
4.  Getting up from lying to sit on bed (long sitting)    B3 
5.  Getting out of bed without help    C1 
6.  Standing straight up from sitting    D1 
7.  Sitting from standing    D2 
8.  Standing straight up from sitting on the floor    D3 
9.  Sitting for a long period of time    E1 
10. Standing straight up for a long period of time    F1 
11. Bending the trunk forward from standing    G1 
12. Raising the trunk upwards to the upright position from 
bending forward 
   G2 
13. Squatting from standing straight up and maintaining 
squatting 
   H1 
14. Standing straight up from squatting and maintaining 
standing 
   H2 
15. Walking in general    I1 
16. Walking inside house    I2 
17. Walking outside house    I3 
18. Walking without help    I4 
19. Jogging    J1 
20. Running in one direction on even ground    J2 
21. Using the stairs in general    K1 
22. Ascending of one step    K2 
23. Ascending the whole staircase    K3 
24. Descending of one step    K4 
25. Descending the whole staircase    K5 
26. Lifting an object upwards    L1 
27. Carrying an object and walking    L2 
28. Lowering a carried object on the ground from standing    L3 
29. Do you have an activity other than those listed above 
which is affected by low back pain? 
   M1 
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Phase 3: Clinical testing 
Chapter 12: Determination of the usefulness of TELER LBP indicators: Piloting the TELER 
LBP Questionnaire 
Chapter 13: Overall discussion 
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Overview of phase 3: Clinical testing 
The aim of the third phase of this thesis is to examine the clinical utility and measurement 
properties of the TELER LBP questionnaire in the evaluation of functional performance 
outcomes following musculoskeletal rehabilitation in individuals with LBP. The 
evaluation process of the new outcome measure adheres to the theoretical specifications 
of the theory of measurement [Chapter 5] and the standards of measurement in a clinical 
context [Chapter 6] derived during the phase of conceptualisation. The TELER LBP 
questionnaire was developed according to the following principles: 
 The TELER LBP questionnaire is a patient-reported outcome measure. 
 The TELER LBP questionnaire is a measurement tool of individualised outcomes. 
 The TELER LBP questionnaire measures the construct functional performance. 
 The TELER LBP questionnaire was designed to be used in a clinical context to evaluate 
the outcomes of complex interventions [musculoskeletal rehabilitation]; however, 
because this measurement tool fulfils the requirements of measurement theory, it can be 
used in a research setting using an appropriate research design. 
 The title of each indicator in the TELER LBP questionnaire defines a treatment goal. 
 Each code in the TELER LBP questionnaire represents a clinically significant outcome. 
 The codes in any TELER LBP functional indicator are arranged to represent a hierarchical 
stepwise regain of function. 
 The codes in any TELER LBP component indicator are used for managerial purposes to 
identify problems and if necessary to direct towards other functional indicators.   
 The TELER LBP questionnaire traces changes [improvement or deteriorations] and a 
lack of change in functional performance. 
These principles have an implication on the methods used to evaluate the clinical utility 
and measurement properties of the TELER LBP questionnaire in a clinical setting. The 
following chapter describes these methods in detail. 
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Chapter 12: Determination of the usefulness of TELER LBP 
indicators – Piloting the TELER LBP Questionnaire 
Key points in Chapter 12: 
- The TELER LBP questionnaire is a valid, reliable and responsive measurement 
tool that provides informative information to a person with LBP, a clinician, 
researchers, managers and commissioners. 
 
- Jordanian physiotherapists indicated that the TELER LBP indicators informed 
their clinical decision more than the current outcome measures that they used in 
their clinics. 
 
- This study showed that the quality of outcomes was good and the majority of LBP 
patients improved. It is unclear whether or not patients improved because of 
physiotherapy interventions; however, no patient experienced exacerbation of 
symptoms while attending physiotherapy sessions. Therefore, it is logical to 
assume that physiotherapy interventions somehow helped individuals with LBP 
to achieve their goals. 
 
12.1 Introduction 
This section explains the methods used to pilot the TELER LBP questionnaire in 
Jordanian physiotherapy clinics. During the process of formulating the questionnaire’s 
components, an expert committee systematically examined the TELER LBP indicators to 
ensure that each statement in the questionnaire was valid [Chapter 11]. The expert 
committee agreed that the items in the TELER LBP questionnaire represented the 
different aspects of the construct ‘functional performance’ which were identified in a 
qualitative study as important to Jordanian individuals with LBP [Chapter 9]. The 
previous stage in this research programme [Chapter 11] was important in order to 
establish the face and content validity of the pre-testing version of the questionnaire. 
However, a pilot phase was necessary to test the remaining measurement properties 
described in Chapter 6 in this thesis and clinical utility. The following subsections 
describe the statistical tests used to analyse construct validity, internal consistency, inter-
rater reliability, sensitivity, and floor and ceiling effects. The following subsections also 
describe the methods used to analyse the TELER indices at the level of the individuals as 
well as the level of the group. 
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12.2 Methods 
12.2.1 Study design 
A prospective multisite cohort study design was conducted in the third phase of this 
research programme. The study was conducted between the 1st of February 2014 and the 
1st of June 2014. Figure 12.1 describes the different stages and methods used in this study.  
12.2.2 Validity: Face, content and construct validity 
12.2.2.1 Face and content validity 
Validity refers to the extent to which a measurement tool measures the phenomenon it is 
assumed to measure and it is not a fixed property as it is purpose and setting-specific 
(295).  There are four types of validity: criterion, face, content and construct validity. 
Criterion validity is assessed by comparing the results of one outcome measure with an 
established (benchmark) one that examines the same phenomenon (444). Chapter 7 in this 
thesis indicated a lack of a so-called “gold standard outcome measure” in the LBP field; 
therefore, criterion validity was not assessed in this study. Face, content and construct 
types of validity were assessed.  
Content validity reflects a judgement on whether or not the items of a scale are sensible 
and comprehensively cover the domain of interest (91). Face validity simply refers to 
whether, on the face of the scale’s items, the instrument appears to be examining the 
desired qualities. A NGT was carried out in the previous phase to examine the face and 
content validity of the TELER LBP indicators. Physiotherapists who participated in these 
meetings reviewed each indicator separately and voted to be included or excluded from 
the clinical testing phase (300). 
Face and content validity were reviewed qualitatively in the previous phase in this 
research programme [Chapter 11] because they were dependent on the judgment of the 
experts whether or not the TELER LBP questionnaire was appropriate for the intended 
purpose. This form of validation is known as ‘validity by assumption’, which simply 
means that an instrument is considered suitable to measure a particular attribute because 
an expert said it is (445). 
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Figure 12.1: An outline of the different levels and methods used in the analysis of the TELER LBP questionnaire 
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12.2.2.2: Construct validity 
Construct validity refers to the extent to which an instrument measures the phenomenon 
that it is designed to measure (91). There are two common forms of construct validity: 
convergent validity and divergent validity. Statistical tests for convergent and divergent 
validities involve calculating all of the pairwise correlation coefficients between scores 
obtained by two scales. A cross-sectional design was used in this study to test convergent 
construct validity. This type of validity assesses the extent to which a measure result 
[TELER LBP Questionnaire] agrees with another measurement tool that is designed to 
measure the same construct (446). In the case of the absence of a ‘gold standard outcome 
measure’, it is acceptable to assess construct validity with scales that closely measure 
either the same outcome (convergent validity) or other outcomes, such as pain (divergent 
validity). For the purpose of assessing convergent validity in this study, the total score 
generated by the TELER LBP questionnaire was paired with the total score of the Quebec 
Back Pain Disability Scale (QBPDS). The QBPDS was selected because it is a self-report 
Likert scale that measures functional status in individuals with LBP with reference to 
‘today’ on a 20-item scale with six response categories each. The items in the QBPDS 
were generated from a qualitative study similar to the study conducted in this thesis. 
Furthermore, even though the scaling methods used in each measure were different, there 
were six response choices in each of these questionnaires. The author of this thesis took 
into account the different polarities in each response system [Code 0 in the TELER LBP 
questionnaire represents the worst-case scenario and a total score of 100 in the QBPDS 
represents the worst-case scenario]. In order to test the construct validity of the TELER 
LBP questionnaire, the QBPDS was cross-culturally adapted from its original language 
into the Arabic language. The author of this thesis described the methods used in the 
cross-cultural adaptation process and the results in a separate study (96). 
The probability distribution of the QBPDS and the TELER LBP questionnaire was 
calculated in order to permit direct comparison between scores. Table 12.1 shows the 
probability distribution of the QBPDS and how the scores were converted to a TELER 
patient outcome indicator. It is important to note at this stage that each participant selected 
a different number of items from the TELER LBP questionnaire. Therefore, Table 12.2 
shows the different calculations of the TELER patient outcome indicator of the TELER 
LBP questionnaire. 
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Table 12.1: Probability distribution for the Quebec Back Pain Disability Scale 
 
Total 
score 
Total number 
of response profiles 
Probability 
(Total score) 
Cumulative 
Probability 
(Total score) 
TELER 
indicator 
code 
0 1 0.00000000 0.00000000 
5 
1 20 0.00000000 0.00000000 
2 210 0.00000000 0.00000000 
3 1,540 0.00000000 0.00000000 
4 to 8 3,324,394 0.00000000 0.00000000 
9 to 13 571,929,735 0.00000016 0.00000016 
14 to 18 29,458,359,810 0.00000806 0.00000821 
19 to 23 673,488,403,411 0.00018421 0.00019242 
24 to 28 7,392,268,461,208 0.00202187 0.00221429 
29 to 33 48,336,595,257,548 0.01322060 0.01543489 
34 20,603,519,692,320 0.00563529 0.02107018 
35 26,591,929,631,212 0.00727319 0.02834337 
36 to 41 330,130,346,526,476 0.09029432 0.11863769 
4 42 91,194,381,588,680 0.02494268 0.14358036 
43 111,767,706,801,150 0.03056971 0.17415008 
44 to 49 1,087,781,537,506,860 0.29752035 0.47167043 
3 50 207,154,825,093,824 0.05665915  
51 to 56 1,087,781,537,506,860 0.29752035 0.47167043 
57 111,767,706,801,150 0.03056971 0.17415008 
2 58 91,194,381,588,680 0.02494268 0.14358036 
59 to 64 330,130,346,526,476 0.09029432 0.11863769 
65 26,591,929,631,212 0.00727319 0.02834337 
1 
66 20,603,519,692,320 0.00563529 0.02107018 
67 to 71 48,336,595,257,548 0.01322060 0.01543489 
72 to 76 7,392,268,461,208 0.00202187 0.00221429 
77 to 81 673,488,403,411 0.00018421 0.00019242 
82 to 86 29,458,359,810 0.00000806 0.00000821 
87 to 91 571,929,735 0.00000016 0.00000016 
92 to 96 3,324,394 0.00000000 0.00000000 
97 1,540 0.00000000 0.00000000 
98 210 0.00000000 0.00000000 
99 20 0.00000000 0.00000000 
100 1 0.00000000 0.00000000 
Total 3,656,158,440,062,980 1.00000000   
 
- Mr Le Roux the author of the TELER method carried out the calculations in this table. 
- The cut-off points in this table were based on the first and second standard deviations from the 
mean.
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Table 12.2: Calculating the TELER patient outcome indicator of the TELER LBP questionnaire 
 Number of TELER indicators in each TELER LBP questionnaire 
Patient 
Outcome 
Indicator 
Code 
2 Indicators 3 Indicators 4 Indicators 5 Indicators 6 Indicators 7 Indicators 8 Indicators 9 Indicators 10 Indicators 11 Indicators 
1 0  0 or 1 0 to 3 0 to 4 0 to 6 0 to 8 0 to 10 0 to 12 0 to 14 0 to 16 
2 1 or 2 2, 3 or 4 4, 5 or 6 5 to 8 7 to 10 9 to 12 11 to 15 13 to 17 15 to 19 17 to 21 
3 3 to 7 5 to 10 7 to 13 9 to 16 11 to 19 13 to 22 16 to 24 18 to 27 20 to 30 22 to 33 
4 8 or 9 11, 12 or 13 14, 15 or 16 17 to 20 20 to 23 23 to26 25 to 29 28 to 32 31 to 35 34 to 38 
5 10 14 or 15 17 to 20 21 to 25 24 to 30 27 to 35 30 to 40 33 to 45 36 to 50 39 to 55 
Patient 
Outcome 
Indicator 
Code 
 
12 Indicators 13 Indicators 14 Indicators 15 Indicators 16 Indicators 17 Indicators 18 Indicators 19 Indicators 20 Indicators  
1 0 to 18 0 to 20 0 to 22 0 to 24 0 to 26 0 to 28 0 to 30 0 to 32 0 to 35  
2 19 to 24 21 to 26 23 to 28 25 to 30 27 to 33 29 to 35 31 to 37 33 to 39 36 to 43  
3 25 to 34 27 to 38 29 to 41 31 to 44 34 to 46 36 to 49 38 to 52 40 to 55 44 to 56  
4 35 to 41 39 to 44 42 to 47 45 to 50 47 to 53 50 to 56 53 to 59 56 to 62 57 to 64  
5 41 to 60 45 to 65 48 to 70 51 to 75 54 to 80 57 to 85 60 to 90 63 to 95 65 to 100  
 
- Mr Le Roux the author of the TELER method carried out the calculations in this table. 
- The area shaded in grey denotes the total score. 
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The correlation between the TELER LBP questionnaire and the QBPDS was assessed 
using Spearman’s correlation (rs). Equation 12.1 shows the formula used in calculating 
Spearman rho. Spearman rho is a nonparametric measure of statistical dependence 
between two variables; however, this test does not show the percentage of variability in 
observations explained by the dependent variables. To put it in simple words, it concerns 
how dependent variables [observations] in the QBPDS predict outcomes [functional 
performance] in individuals with LBP. In order to examine the relationships between the 
dependent variable and predicted outcomes, R2 (coefficient of determination) was used 
(447). Equation 12.2 shows the formula used to calculate R2. A relationship was regarded 
as unacceptable if R2 < 50, regarded as good if R2 was 51%–65%, regarded as moderately 
good if R2 = 66%–80% and regarded as very good if R2 > 81%. SPSS® 22 software was 
used to calculate Spearman rho and Excel® 2013 in the calculation of R2. 
Equation 12.1: Spearman rho 
𝑟𝑠 = 1 −
6∑𝑑𝑖
2
n(𝑛2 − 1)
 
where (n) denotes number of pairs and (di) denotes the difference between ranks (295). 
Equation 12.2: Coefficient of determination 
𝑅2 = ((
1
𝑁
) ∙
∑[(𝑥𝑖 − 𝑥 ) ∙ (𝑦𝑖 − ŷ)]
(σx ∙ σy)
)2 
where N is the number of observations used to fit the model, Σ is the summation symbol, xi is the x value 
for observation i, x̄ is the mean x value, yi is the y value for observation i, ŷ is the mean y value, σx is the 
standard deviation of x, and σ y is the standard deviation of y. 
12.2.3 Reliability: Inter-rater reliability testing 
Dunn ((448), p. 59) defines reliability as “the consistency of scores obtained under the 
theoretical concept of repeated testing of the same individual on the same test under 
identical conditions”. Thus, reliability generally refers to the degree of stability of a 
particular measure’s score over time or across different examiners (263). Inter-rater 
reliability testing was used in this study to examine the agreement between two observers 
who were measuring functional performance using the TELER LBP indicators. Intra-rater 
reliability testing was not tested in this research due to the unpredictable and fluctuating 
nature of pain and function over time, which makes it near impossible to obtain similar 
results from repeated measurements over a long interval [Chapter 4]. 
 194 
 
A reliable measure ensures objectivity by providing a measurement that is not influenced 
by the experience, emotions or personal opinions of the assessor (263,300). A concurrent 
design was used to assess inter-rater reliability of the TELER LBP questionnaire. Two 
physiotherapists repeated the measurement on the same patient using the same TELER 
indicators. The level of agreement between the two observers was determined using 
weighted kappa (KW) statistics (449). Weighted kappa was selected because it assesses 
the agreement between two observers using a predefined table of weights — the higher 
the weight, the higher the agreement. Equation 12.3 shows the formula used in calculating 
weighted kappa values. There is no consensus in the literature regarding how to interpret 
the values of the KW; however, this research programme supports the idea of using 
probabilities in the interpretation of the values of statistical tests. This is because it takes 
into consideration the possibility of reaching a wrong conclusion by chance, usually this 
error in interpretation should not exceed 5%. The probability distribution in Table 12.1 
was used in dividing the intervals of KW values as follows:  an agreement was regarded 
as very poor if KW < 20, regarded as moderately poor if KW = 21%–35%, regarded as 
poor if KW = 36%–50% regarded as good if KW = 51%–65%, regarded as moderately 
good if KW = 66%–80% and regarded as very good if KW > 81%. This classification was 
also used in the interpretations of Chronbach’s alpha values below. Epidat® 3.1 software 
was used for the analysis. 
Equation 12.3: Weighted kappa 
𝐾𝑊 = 1 −
∑𝑤𝑓𝑜
∑𝑤𝑓𝑐
 
where ( ∑𝒘𝒇𝒐) is the total weighted observed frequencies and ( ∑𝒘𝒇𝒄 ) is the total 
weighted chance frequencies (295). 
12.2.4 Reliability: Internal consistency testing 
Internal consistency demonstrates the extent to which items measure the various aspects 
of the same characteristic and nothing else (295). The most common approach to examine 
homogeneity includes looking at the correlation between all items in a measurement tool. 
The statistic used to test internal consistency is Cronbach’s coefficient alpha (450). 
Equation 12.4 shows the formula used in calculating Cronbach’s alpha (α). A 
homogeneity level was regarded very poor if (α < 20), regarded moderately poor if (α = 
21% – 35%), regarded poor (α = 36% – 50%) regarded good if (α 51%-65%), regarded 
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moderately good if (α = 66% – 80%) and regarded very good if (α > 81%). Epidat 3.1 
software was used for the analysis. 
Equation 12.4: Cronbach’s coefficient alpha 
𝛼 =
K
K − 1
 (1 −
∑ 𝜎𝑌𝑖
2𝐾
𝑖=1
𝜎𝑋
2 ) 
where K is number of component, X=Y1+Y2+…+YK, 𝜎𝑋
2is the variance of the observed total test scores 
and 𝜎𝑌𝑖
2  is the variance of component i for the current sample of persons . 
12.2.5 Responsiveness: Interpretability and sensitivity 
There are two important characteristics when assessing responsiveness of any outcome 
measure: sensitivity and interpretability [Chapter 6]. In order to ensure both of these 
characteristics in the TELER LBP questionnaire, the codes in the TELER LBP indicators 
were developed specifically to resemble, as closely as possible, the most important phases 
in the patterns of functional recovery of the activities identified in the qualitative study 
[Chapter 9]. The TELER indicators were also designed to correspond to clinically 
significant changes in the performance of physical activities that are experienced by the 
patients and observed by the physiotherapists.  
Any changes in a patient’s physical abilities might be attributed to physiotherapy 
interventions, natural progress of the condition or other unknown factors. In order to 
attribute changes in the patient’s physical abilities to the intervention, a different study 
design is needed. 
The decision that a clinically significant change has occurred and been captured by a 
measurement tool is based on two criteria: clinical knowledge and observation (451). 
Therefore, the evaluation of responsiveness in this study was based on the assumption 
that a physiotherapist has the necessary skills to notice a clinically significant change 
when it has occurred and document it. It is important to note that the codes in the TELER 
LBP questionnaire were defined specifically to be mutually exclusive and exhaustive. For 
the purpose of assessing interpretability, a qualitative method was used in this study to 
explore physiotherapists’ perspective after using the TELER LBP questionnaire. 
Participants were asked whether or not they found the scores of the questionnaire to be 
easy to interpret and informed their clinical decision. Semi-structured in-depth interviews 
and framework analysis methods were used in this qualitative study. The same criteria 
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used in Chapter 9 to establish trustworthiness were followed in this small qualitative 
study. The interview topic guideline is presented in Box 12.1. All participants were asked 
the same questions. 
Box 12.1: Interview topic guideline 
 
For the purpose of assessing the second criterion, sensitivity, the differences in the 
distribution between change and no change recorded in the TELER form were compared 
against changes and no changes recorded in the QBPDS. 
 The null hypothesis: there is no statistical difference between the ‘distribution of changes 
and no change’ recorded on the TELER LBP questionnaire and the ‘distribution of change 
and no change’ recorded on QBPDS. 
 The alternative hypothesis: there is a statistical difference between the ‘distribution of 
changes and no change’ recorded on the TELER LBP questionnaire and the ‘distribution 
of change and no change’ recorded on QBPDS. 
 Level of confidence: 95%, p-value: 0.05. 
The distributions were tested using Chi-square statistics. Equation 12.5 shows the formula 
used in the Chi-square test. It is important to note that each code in a TELER indicator 
represents a minimal clinically significant change, where 19 points were required in the 
QBPDS to consider it to be one clinically significant change (452). 
  
Good morning/afternoon Mr/Mrs … Thank you very much for taking part in this study. My name is 
Thamer Altaim and I am a research student at the University of Sheffield in the United Kingdom. You 
are invited to take part in this study because you have used the TELER LBP questionnaire in the 
measurement of functional performance in individuals with LBP. Please note that this interview will 
be audio-recorded. This interview might take up to 10 minutes of your time. Any information or 
details discussed within this interview will be kept secure and confidential. Any topics discussed will 
not be shared with anyone except for the supervisory team in the United Kingdom for study 
purposes. All data will be destroyed five years following the completion of this study. 
 
 Can you please start off by telling me, just briefly, about your experience of using the 
TELER LBP questionnaire in the clinic? 
 Do you think that the TELER LBP questionnaire helped you to take informed decisions? 
Why? 
 Do you think that the information generated by the TELER LBP indicators is easy to 
interpret? 
 Do you recommend using the TELER LBP questionnaire in your clinic? Why? 
 Can you tell me more about the time required to fill in the questionnaire? Initial assessment 
session? Follow-up sessions? 
 
Is there anything else about your experience of using the questionnaire which you would like to talk 
to me about before we finish up? 
Thank you very much for your time. Have a nice day. 
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Equation 12.5: Chi-square 
𝑋2 =
∑(𝑂 − 𝐸)2
𝐸
 
where (O) represents the observed frequency and (E) represents the expected frequency. 
The sensitivity and the specificity of the TELER LBP indicators were further tested in 
this thesis using the Receiver Operator Characteristics (ROC) method. This method was 
applied to each TELER indicator separately because each patient selected a different 
range of indicators. The Area Under the Curve (AUC) was interpreted as the probability 
of correctly discriminating between an ‘improved’ and ‘clinically stable’ patient outcome 
based on the changes in the TELER LBP indicators. The data collected from the inter-
rater reliability stage were used as a point of verification where two physiotherapists 
confirm whether or not the patient has improved. An AUC value of <0.5 is considered 
unacceptable, a value of between 0.5 and 0.60 is considered poor and a value of between 
0.61 and 0.7 is considered acceptable. Good is between 0.71 and 0.8, very good between 
0.81 and 0.9, excellent between 0.91 and 0.99 and 1 is regarded as perfect. SPSS® 22 
software was used for the analysis. 
12.2.6 Responsiveness: Floor and ceiling effects 
A cross-sectional design was used in this study to assess the floor and ceiling effects in 
the TELER LBP questionnaire. Each TELER LBP indicator was assessed to detect 
whether or not it precluded the reporting of the most favourable or worst physical ability. 
A floor effect was considered if more than 15% of the participants responded at the worst 
end of the response scale. Similarly, a ceiling effect was considered if more than 15% of 
participants responded at the optimal end of the scale (453). 
12.2.7 TELER analysis at the level of the individual: Monitoring changes in a 
client’s physical abilities 
Two types of analysis were performed at the level of the individual in this study: 
quantitative and qualitative. The quantitative analysis was further divided into two parts; 
the first part consisted of counting clinically significant improvement between initial 
appointments until the discharge session to monitor changes in a client’s physical 
abilities. This analysis was important to help physiotherapists to determine whether or not 
to continue the current physiotherapy programme or change some of the interventions to 
promote improvements in patients’ physical abilities. 
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12.2.8 TELER analysis at the level of the individual: Monitoring the patient’s 
outcome 
The second part of the quantitative analysis at the level of the individual provided 
descriptions of the patient’s outcome in terms of four TELER indices numbers: deficit 
index, improvement index, variability index and effectiveness index (383). Excel® 2013 
software was used to calculate the TELER indices. Table 12.3 shows the definitions and 
meaning of values of each TELER index used in this study.  
The formula for these indices is only available to the registered TELER users (439). The 
hypothesis in this part of this study was that ‘multimodal physiotherapy treatment’ should 
help individuals with LBP to restore their lost ‘functional abilities’ and help individuals 
with LBP to achieve their goals of treatment (300). Therefore, the outcomes of 
physiotherapy received by a patient were based on the analysis of the data of two TELER 
indices: improvement index and variability index.  
Three categories were used to describe patient outcomes: poor, satisfactory and good. The 
cut-off points for each category (poor, satisfactory and good) of patient outcomes were 
based on the classification provided by LongHand Data Limited (383) as follows: 
Improvement index 
 An improvement index of a value from 0 to 33 is defined as low improvement.  
 An improvement index of a value from 34 to 67 is defined as moderate improvement.  
 An improvement index of a value from 68 to 100 is defined as high improvement.  
Variability index 
 A variability index of a value from 0 to 25 is defined as stable condition. 
 A variability index of a value from 25 to 50 is defined as marginally stable 
condition. 
 A variability index of a value from 51 to 100 is defined as unstable condition. 
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Table 12.3: Definitions and values of TELER indices 
TELER index Definition Range Meaning 
Deficit index 
(DI) § 
“is a patient specific measure for tracing change since 
admission in physiological, psychological or other clinically 
significant function presented by a patient, and does not 
permit valid comparisons of patients.  The measure traces 
change between successive appointments in functional 
ability”. 
Range from 0 to 100.   0 denotes ‘no loss of function’. 
 100 denotes ‘complete loss of function’. 
Improvement 
index (II) § 
“is a patient specific measure for tracing recovery of lost 
function between successive appointments, and does not 
permit valid comparisons of patients”. 
Range from 0 to 100.   0 denotes ‘no recovery’. 
 100 denotes ‘full recovery’. 
Variability 
index (VI) § 
“is a patient specific measure for tracing changes in a 
patient’s condition while the patient is under treatment and 
does not permit valid comparisons of patients”. 
Range from 0 to 100.   0 denotes ‘no variability’ or ‘complete control of the recovery process and minimum 
cost of treatment’ 
 100 denotes ‘maximum variability’ or ‘no control of the recovery process and maximum 
cost of treatment’.   
Effectiveness 
index (EI) § 
“is a patient specific measure for tracing effectiveness in 
avoiding deterioration over a period of treatment”. 
Range from 0 to 100.   0 denotes ‘no effectiveness in avoiding deterioration’  
 100 denotes ‘completely effective in avoiding deterioration’.   
 In many contexts, 0 denotes ‘no control of the recovery process and maximum cost of 
treatment’ and 100 denotes ‘completely in control of the recovery process and minimum 
cost of treatment’. 
§: A patient specific measure and it does not permit valid comparisons of patients.  The measure is based on the assumptions that a clinically significant change occurs over 
a clinically significant period, and the intervals between successive appointments are clinically significant periods or parts of such periods. 
These definitions were sighted in Le Roux (383)
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The improvement and variability indices were selected because they were related to each 
other. For example, when the variability index is less than 50% it shows that 
improvements exceeded deteriorations and that the patient’s condition improved (383).  
The smaller the variability index, the more complete the improvement. Le Roux (383), p. 
3, stated: “A variability index of 0 shows all changes were improvements and vice versa. 
When the Variability Index is 50 it shows improvements balanced deteriorations and loss 
of function since admission was recovered”. A patient outcome was described as good, 
satisfactory or good according to the definitions of the improvement and variability 
indices.  
 Good patient outcome 
1. Either high or moderate improvement.  
 The value of the improvement index is 68-100.  
 The value of the improvement index is 34-67.  
2. The patient‘s clinical condition was stable.  
 The value of the variability index is 0-25.  
Satisfactory patient outcome  
1. Either moderate or low improvement.  
 The value of the effective index is 34-67.  
 The value of the effectiveness index is 0-33.  
2. The patient‘s clinical condition was marginally unstable.  
 The value of the variability index is 25-50.  
 
Poor patient outcome  
1. Either moderate or low improvement.  
 The value of the improvement index is 34-67.  
 The value of the improvement index is 0-33.  
2. The patient‘s clinical condition was unstable.  
 The value of the variability index is 50-100.   
12.2.9 TELER analysis at the level of the individual: Linking the TELER form 
[part 3] to clinical notes [part 4] 
A TELER clinical note section [Part 4 in Appendix Q] was added to the TELER 
questionnaire in order to encourage physiotherapists, who participated in this research, to 
avoid focusing on managing the LBP symptoms without taking into consideration the 
wider view of the LBP patient and their concerns. The clinical notes in part four in the 
questionnaire were designed to obtain as much description of other health conditions that 
might affect a patient’s physical abilities to help make informed decisions. The 
framework method was used in the analysis of the qualitative data. The analysis only 
involved the charting of responses across the framework used in the qualitative study in 
the second phase of this research programme. The framework was used to organise the 
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data collected from the clinical notes to identify links between these records and changes 
or the lack of change in the scores of the TELER indicators. 
12.2.10 TELER analysis at the level of the group – quantitative analysis at the 
level of functional problems presented 
The collated TELER data were analysed quantitatively at the level of the group using the 
TELER patient outcome indicator20 and TELER indices to provide informative evidence 
about the quality of treatment to the managers. The analysis of the TELER data at the 
level of the group aimed to provide descriptions of the overall extent of the group 
functional loss on admission, potential for improvement and the overall extent of the 
group change on discharge. The analysis was also carried out to test the following 
hypothesis: 
The experimental hypothesis [1]: the number of LBP patients who presented in the initial 
assessment session with a high level of disability is statistically significant. This is 
because Chapter 1 in this thesis suggested that individuals with LBP who are severely 
affected by their problems seek medical attention. Therefore, it is logical to assume that 
the majority of participants in this study are likely to select lower codes that indicate that 
they were severely affected by LBP at the initial assessment session.  
The null hypothesis [1]: the number of LBP patients who presented early with a high level 
of disability is not statistically significant. This means that there is no difference at the 
initial assessment session between patients. 
The experimental hypothesis [2]: the number of LBP patients who restored their lost 
functions at the discharge session is statistically significant. Chapter 1 also suggested that 
LBP is a self-limiting condition lasting less than three months regardless of treatment; 
therefore, it is logical to assume that the majority of patients are likely to experience 
improvements (454) and this will be reflected in the mode of TELER codes. 
The null hypothesis [2]: the number of LBP patients who restored their lost functions at 
the discharge session is not statistically significant. This means that there is no difference 
at the discharge session between patients who improved and those who are severely 
disabled. 
                                                 
20 Le Roux (383), p. 4, defined TELER patient indicator as “a patient specific measure for tracing the number of 
treatment goals achieved”. 
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12.2.11 Acceptability 
This part of the current study examined whether or not the TELER LBP questionnaire 
was acceptable to the study participants. Questionnaire acceptability was assessed in 
terms of the response rate by counting the number of individuals who refused to continue 
the process of measurement or did not complete some of the indicators in the 
questionnaire (455).  Physiotherapists recorded all refusal cases on a separate sheet and 
provided a summary of reasons behind why patients decided not to complete the 
questionnaire. 
12.2.12 Feasibility 
This part assessed the impact of collecting and processing the information from the 
TELER LBP questionnaire on staff working in physiotherapy clinics involved in this 
research. The feasibility was assessed in terms of the time required to administer and 
process the questionnaire. Physiotherapists were asked to report the time required to 
complete the questionnaire in the initial assessment session and in follow-up sessions. 
Semi-structured in-depth interviews and thematic framework analysis methods were used 
in this study (390). Physiotherapists were encouraged to discuss any concerns that they 
had around the burden of collecting information using the TELER LBP questionnaire. 
12.2.13 Clinical settings 
This study took place at three private physiotherapy centres in Amman, Jordan. These 
were Spine Care Jordan, Islamic Hospital and Physio Medic. These physiotherapy centres 
were selected because they were specialised centres for managing musculoskeletal spinal 
problems, including LBP [Appendix R]. 
12.2.14 Sample characteristics 
12.2.14.1 Physiotherapists 
A purposive sampling method was used in the recruitment of physiotherapists. 
Individuals who met the inclusion/exclusion criteria (Table 12.4) were invited to take part 
in the clinical testing study. 
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12.2.14.2 Individuals with LBP 
Individuals who met the inclusion/exclusion criteria (Table 12.4) were invited to take part 
in this study by the clinic’s admission team. Convenience sampling was adopted in this 
study because it was flexible, quick and gave access to the majority of LBP patients who 
were referred to the physiotherapy clinics involved in this study. 
Table 12.4: Inclusion and exclusion criteria 
 Inclusion criteria Exclusion criteria 
Physiotherapists  Practicing musculoskeletal physiotherapists to 
represent typical practice. 
 Participants must have at least three years of 
experience in the management of LBP. This is 
important to ensure that the participants have an 
adequate knowledge about LBP and the 
trajectory of the condition. 
 Participants must have adequate understanding 
of the TELER method. A workshop was 
conducted before the commencement of the 
clinical testing study. 
 Willing to participate voluntarily in this research. 
 Unable to communicate in the 
Arabic or English languages.  
Individuals with 
LBP 
 Participants who consider low back pain as their 
main complaint.  
 Participants’ greater than18 years old, this is 
important because they will be primarily responsible 
for their participation in this study and able to 
consent. 
 Participants who are referred to physiotherapy by 
rehabilitation or orthopaedics physicians to 
represent typical practice in Jordan. 
 Those who agree to take part in the study voluntarily.  
 Any participant who is unable to 
communicate in Arabic. This is 
important because this 
questionnaire was developed for 
individuals with LBP in Jordan. 
 Any patient who is not clinically 
or medically stabilised. 
 Any patient who is unable to 
provide consent. 
 12.2.15 Recruitment 
Individuals who were complaining about LBP and commencing a musculoskeletal 
rehabilitation programme in the private physiotherapy clinics involved were invited to 
take part in this study. Physiotherapists who agreed to take part in this study approached 
individuals with LBP who met the inclusion/exclusion criteria and asked them whether 
or not they were interested in taking part in this research. Those who showed interest in 
taking part in this research were given information sheets and consent forms at the initial 
assessment session [Appendix S]. Due to the nature of this research, participants were 
asked to sign the consent form before the beginning of their physiotherapy programme 
and they were assured that they had the right to withdraw at any time from this study 
without any negative consequences on their physiotherapy programme. Those who 
refused to take part in this study in the initial assessment session continued the usual 
admission protocol implemented in the clinic. 
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12.2.16 Data collection 
A baseline measurement using the TELER LBP questionnaire [Appendix Q] was 
performed at the beginning of the physiotherapy programme. The measurement of 
functional status was performed at the beginning of each follow-up session to reflect as 
many changes as possible in an individual’s physical abilities. The purpose of using the 
TELER LBP questionnaire in this study was to measure changes between consecutive 
physiotherapy sessions in physical abilities and was based on the assumptions that a 
clinically significant change occurs over a clinically significant period, and the intervals 
between consecutive sessions were clinically significant periods or parts of such periods. 
Patients were assessed using the TELER LBP questionnaire at initial assessment, during 
follow-up and at the discharge sessions in accordance with the policies followed in these 
clinics involved. This also included a full range of pathoanatomical, pathophysiological 
and pain assessments. Few examples of these instruments used in these clinics are 
presented in Appendix T. 
12.2.16.1 Initial assessment session 
Individuals with LBP who agreed to take part in this study were given the TELER LBP 
quiz-style indicator and the translated QBPDS [Appendix Q]. Participants were 
encouraged to answer all questions and return questionnaires to their physiotherapists 
before the commencement of their therapy. The TELER quiz-style indicator directed 
physiotherapists to select only these indicators [Part 2 in Appendix Q] relevant to the 
patient. The second part of the TELER LBP questionnaire contained a list of indicators 
that were specifically designed for people with LBP. Physiotherapists used a special 
TELER form [Part 3 in Appendix Q] to document their observations for each of the 
selected TELER LBP indicators. 
12.2.16.2 Follow-up sessions 
Functional performance was measured at the beginning of each follow-up physiotherapy 
session using the selected TELER LBP indicators and the QBPDS. Patients’ desired 
outcomes were re-evaluated in another physiotherapy session half-way through the 
programme using the quiz-style indicator to ensure the inclusion of all important goals to 
each individual patient.  
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Inter-rater reliability was assessed in one of the follow-up sessions. It was important to 
include patients with various levels of limitations in functional performance. Two 
physiotherapists measured functional performance for an individual with LBP using the 
second and third parts of TELER LBP questionnaire. For the purpose of inter-rater 
reliability testing, a sequential design was selected where one physiotherapist measured 
the functional performance of an individual with LBP, followed by to another 
physiotherapist who performed the measurement of the functional performance using the 
same indicators. It was important to decrease the chance of any changes in a patient’s 
physical abilities and to reduce the possibility of one of them influencing the judgment of 
the other observer. 
12.2.16.3 Discharge session 
Functional performance was measured at the discharge session using the selected TELER 
LBP indicators and the QBPDS. Physiotherapists were encouraged to document any 
comment they had in the clinical notes section [Part 4 in Appendix Q]. 
12.2.17 Ethics 
The ethics committee of Al-Bashir Hospital approved the clinical testing study [Appendix 
U]. The ethics committee of Al-Bashir Hospital is recognised by the University of 
Sheffield’s Research Ethics Committee as having in place sufficiently robust ethics 
review procedures. 
12.3 Results 
Eight musculoskeletal physiotherapists and 30 consecutive individuals with LBP who 
fulfilled the eligibility criteria entered into the study between the 23rd of January and the 
15th of May 2014. Table 12.5 describes the characteristics of physiotherapists who 
participated in this study.  Table 12.6 shows the demographic data of the LBP patients 
who completed the baseline assessment using the TELER LBP questionnaire. The median 
age was 47.5 and the mode was 30. The sample in this study included a variety of age 
groups (20–79 years), occupations and social statuses. Indicators were selected by LBP 
patients according to their relevance and importance to them. 
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Table 12.5: Physiotherapists 
Name Field Years of 
experience 
Place of work 
LBP-01 Musculoskeletal physiotherapist 23 years Spine Care Center 
LBP-02 Musculoskeletal physiotherapist 5 years Islamic Hospital 
LBP-03* Musculoskeletal physiotherapist 4 years Spine Care Center 
LBP-04* Musculoskeletal physiotherapist 4 years Spine Care Center 
LBP-05* Musculoskeletal physiotherapist 3 years Spine Care Center 
LBP-06* Musculoskeletal physiotherapist 3 years Spine Care Center 
LBP-07* Musculoskeletal physiotherapist 4 years Physio Medic Center 
LBP-08 Musculoskeletal physiotherapist 9 years Kaboushi Center 
* Physiotherapists who were interviewed after the completion of the clinical testing study.  
12.3.1 Face validity and content validity 
Face validity and content validity of the TELER LBP questionnaire were checked by the 
NGT. The expert committee systematically reviewed the pre-testing version of the 
TELER LBP questionnaire and concluded that it was valid. 
12.3.2 Construct validity 
Construct validity was examined by Spearman rho and R2 (456). Changes recorded in the 
TELER LBP questionnaire and on the QBPDS were converted to a TELER patient 
outcome indicator (POI) (Table 12.7). This was important in order to compensate between 
the differences in the number of items in both questionnaires. The Spearman rho between 
the TELER LBP questionnaire and the QBPDS was rs = 0.46 (p<0.05). Therefore, the 
correlation between both questionnaires was considered moderate. However, the 
coeffcient of determination (R2) was 23.9%; suggesting the existence of another variable 
than observations.  
It is important to note that the TELER LBP questionnaire was not designed to replicate 
precisely the QBPDS. Thus, the correlation value and coefficient of determination were 
not expected to be perfect.  
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Table 12.6 Individuals with LBP 
Participant ID Age Occupation Gender Social 
status 
Number of 
indicators 
Number of 
sessions 
CTS-01 27 Translator Female Single 14 8 
CTS-02 75 Housewife Female Married 7 7 
CTS-03 64 Contractor Male Married 14 8 
CTS-04 30 Researcher Male Married 10 8 
CTS-05 50 Lawyer Male Married 6 5 
CTS-06 49 Businessman Male Married 17 9 
CTS-07 76 Engineer Male Married 19 21 
CTS-08 40 Businessman Male Married 9 6 
CTS-09 63 Professor Male Married 6 11 
CTS-10 37 Electrician Male Married 20 10 
CTS-11 79 Retired Male Married 7 12 
CTS-12 20 Student Female Single 17 3 
CTS-13 58 Housewife Female Married 16 10 
CTS-14 42 Driver Male Married 12 10 
CTS-15 59 Retired Male Married 8 10 
CTS-16 58 Chef Male Married 15 8 
CTS-17 39 Senior 
Lecturer 
Male Single 4 6 
CTS-18 30 Mechanics Male Married 11 5 
CTS-19 43 Missing Male Single 13 5 
CTS-20 73 Housewife Female Widow 15 5 
CTS-21 55 Housewife Female Married 13 4 
CTS-22 46 Housewife Female Married 13 6 
CTS-23 38 Accountant Male Married 20 12 
CTS-24 70 Retired Male Married 13 11 
CTS-25 50 Lawyer Male Married 12 10 
CTS-26 34 Missing Male Married 5 6 
CTS-27 38 Painter Male Married 12 5 
CTS-28 34 Carpenter Male Married 13 6 
CTS-29 56 Retired Male Married 16 9 
CTS-30 42 Driver Male Married 14 10 
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Table 12:7: A comparison between changes recorded on the TELER LBP questionnaire and QBPDS 
Patient-ID Total score of 
TELER in session 
X 
Total score of 
TELER in session 
Y 
Total score of 
QBPDS in 
session X 
Total score of 
QBPDS in 
session Y 
POI of TELER 
in session X 
POI of TELER 
in session Y 
POI of QBPDS 
in session X 
POI of QBPDS 
in session Y 
Net change 
of TELER  
Net change 
of QBPDS 
CTS-01 32 54 55 12 3 5 3 5 2 2 
CTS-03 35 51 65 48 3 5 1 3 2 2 
CTS-04 30 50 9 8 3 5 5 5 2 0 
CTS-06 26 68 83 22 1 5 1 5 4 4 
CTS-07 3 78 92 46 1 5 1 3 4 2 
CTS-08 13 17 53 37 3 3 3 4 0 1 
CTS-10 39 98 57 1 2 5 2 5 3 3 
CTS-13 34 42 65 66 3 3 1 1 0 0 
CTS-14 14 48 33 13 1 5 5 5 4 0 
CTS-15 13 31 67 58 2 5 1 2 3 1 
CTS-16 38 56 25 28 3 5 5 5 2 0 
CTS-17 7 15 9 1 3 4 5 5 1 0 
CTS-18 28 43 48 47 3 5 3 3 2 0 
CTS-19 33 65 34 0 3 5 5 5 2 0 
CTS-20 33 64 60 34 3 5 2 5 2 3 
CTS-21 38 41 62 50 3 4 2 3 1 1 
CTS-23 17 70 86 36 1 5 1 4 4 3 
 Sessions X and Y denote physiotherapy sessions. Session X does not denote the initial assessment session and Session Y does not denote the discharge session; however, 
Session X was conducted before Session Y. Both questionnaires were used in Session X as well as in Session Y. 
 POI: Patient Outcome Indicator. The POI of the QBPDS was determined using the numbers in Table 12.1. The POI of the TELER LBP questionnaire was determined using 
the numbers in Table 12.2. 
 The red boxes denote a disagreement between the results of the two questionnaires, where one of them records a change / lack of change and the other one does not record a 
similar pattern. 
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12.3.3 Inter-rater reliability 
Six physiotherapists from the sample of eight physiotherapists available examined a 
sample of 18 LBP patients from one clinic [Spine Care Centre] using the TELER LBP 
questionnaire. Each patient was assessed by two physiotherapists within 30 minutes of 
each other on the same day. It is important to note that each patient in this study selected 
a different number of TELER LBP indicators. Therefore, the data presented in this 
subsection represent a range of Kw. Physiotherapists agreed in seven cases (Kw = 1). 
Physiotherapists slightly disagreed in 11 cases (Kw = 0.94, Range: 0.4579–1); however, 
their disagreement was only in the range of one unit of measurement [one TELER code]. 
Even with this slight disagreement between physiotherapists, the inter-rater reliability of 
the TELER LBP questionnaire was considered very good. It is important to note that the 
disagreement was always with the second observer ratings. The second observer was not 
responsible for delivering physiotherapy to the patient. 
12.3.4 Internal consistency 
Different correlation matrices of different combinations of TELER LBP indicators 
revealed a high degree of internal correlations. Cronbach alpha coefficients were all 
positive and ranged between 0.84 and 0.99, mode = 0.98 and median = 0.96. Therefore, 
the homogeneity between the TELER indicators was considered very good. 
12.3.5 Responsiveness: Interpretability and sensitivity 
Five physiotherapists (Table 12.5) were interviewed after the completion of the data 
collection process. All participants (100%) indicated in the semi-structured interviews 
that the TELER LBP indicators helped them to make informed decisions during the 
physiotherapy session without any undue delay. Participants suggested that the scores 
generated by the TELER LBP indicators were easy to interpret. 
LBP-03: “I believe the items [in the questionnaire] helped us and directed us to understand these 
problems that are important to the patient. I mean if you are running a physiotherapy programme 
and you get back to these indicators and check the numbers with the patient, you might notice 
that two or maybe three of them didn’t change or one of them is showing deterioration! This 
[documentation] system helped us to precisely know where exactly is the problem and think about 
what we can do to solve the problem. When I compare this with my questions around pain intensity 
and pain location, this information will not show me what is the impact of the problem! I believe 
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these indicators helped us to think more and directed us to focus the therapy on these problems 
that are important to the patient. This system also helped us to take the decision on whether or 
not to refer the patient to a specialist”. 
Chi-square was used in this study to assess the differences in the distribution of clinically 
significant changes and no change recorded on the TELER LBP questionnaire and 
QBPDS. Table 12.8 and Table 12.9 show the calculations of the Chi-square for each 
questionnaire. The results [9.94] suggest that the TELER is statistically significant at the 
95% level, and the result [0.52] for QBPDS is not [Tabulated X2 = 3.481, df = 1, p-value 
= 0.05]. 
Table 12.8: Distribution of observed and expected values resembling the distribution of changes and 
no changes on TELER 
 
TELER 
  Observed Probability Expected (O  E)2  E 
Improvement 15 0.5 8.5 4.97 
No improvement 2 0.5 8.5 4.97 
Total 17 1.0 17.0 9.94 
 
Table 12.9: Distribution of observed and expected values resembling the distribution of changes and 
no changes on QBPDS 
 
QBPDS 
  Observed Probability Expected (O  E)2  E 
Improvement 10 0.5 8.5 0.26 
No improvement 7 0.5 8.5 0.26 
Total 17 1.0 17.0 0.52 
Degree of freedom in both tables = 1, p-value = 0.05, 95% confidence level 
Since the calculated X2 is bigger than the tabulated X2 [9.94>3.481, respectively], the null 
hypothesis was rejected and the alternative hypothesis was accepted. This indicated a 
difference between observed and expected improvement and no improvement recorded 
in the TELER LBP indicators but not in the QBPDS. This was further confirmed through 
the ROC curve method (Table 12.10) for each TELER indicator. The AUC ranged 
between 0.99 and 1 indicating excellent to perfect sensitivity and specificity. It is clear 
from the results that the TELER LBP indicators are more sensitive to change than the 
QBPDS. 
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Table 12.10 Calculation of the Area Under the Curve for each TELER LBP indicator using the 
Receiver Operator Method 
Indicators 
Area Under 
Curve 
Interpretation 
No 
problem 
Problems 
present 
Std. 
Error 
p-value 
Confidence 
interval 
A1 1 Perfect 14 70 0 0  
B1 0.992 Excellent 25 59 0.01 0 0.972-1 
B2 1 Perfect 37 76 0 0 1-1 
B3 1 Perfect 26 46 0 0 1-1 
C1 1 Perfect 11 59 0 0 1-1 
D1 1 Perfect 16 67 0 0 1-1 
D2 1 Perfect 15 44 0 0 1-1 
D3 1 Perfect 16 43 0 0 1-1 
E1 1 Perfect 14 97 0 0 1-1 
F1 1 Perfect 10 113 0 0 1-1 
G1 0.994 Excellent 21 87 0.007 0 0.981-1 
G2 1 Perfect 9 72 0 0 1-1 
H1 1 Perfect 5 38 0 0 1-1 
H2 1 Perfect 2 28 0 0.02 1-1 
I1 1 Perfect 10 73 0 0 1-1 
I2 1 Perfect 2 61 0 0.017 1-1 
I3 0.991 Excellent 9 92 0 0.008 0.975-1 
I4 1 Perfect 4 44 0 0.001 1-1 
J1 1 Perfect 4 35 0 0.001 1-1 
J2 1 Perfect 3 36 0 0.004 1-1 
K1 1 Perfect 2 84 0 0.016 1-1 
K2 1 Perfect 8 26 0 0 1-1 
K3 1 Perfect 2 51 0 0.017 1-1 
K4 1 Perfect 2 19 0 0.023 1-1 
K5 1 Perfect 3 34 0 0.005 1-1 
L1 1 Perfect 9 67 0 0 1-1 
L2 1 Perfect 10 58 0 0 1-1 
L3 0.99 Excellent 13 52 0.011 0 1-1 
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12.3.6 Responsiveness: Floor and ceiling effects 
Floor and ceiling effects were examined by calculating the number of patients who 
obtained the lowest or highest possible scores. Table 12.11 shows the scores recorded on 
the TELER LBP questionnaire at the initial assessment and discharge sessions. There was 
no floor effect; however, there was a ceiling effect (23.3%). The TELER LBP 
questionnaire can be used with people who are severely affected by LBP. It is logical to 
assume that the ceiling effect means that participants restored their lost functional abilities 
and that they do not require more physiotherapy sessions; therefore, this information 
might be of great importance when it comes to the decision on discharging the patient. 
Table 12.11: TELER LBP questionnaire scores at the initial assessment and discharge sessions 
Patient-ID Initial session Discharge session Floor and ceiling effects 
CTS-01 30/70 54/70 Non 
CTS-02 20/35 32/35 Non 
CTS-03 35/70 57/70 Non 
CTS-04 30/50 50/50 Highest 
CTS-05 17/30 25/30 Non 
CTS-06 26/85 68/85 Non 
CTS-07 3/90 78/95 Non 
CTS-08 13/30 23/30 Non 
CTS-09 9/30 29/30 Non 
CTS-10 39/100 98/100 Non 
CTS-11 6/35 32/35 Non 
CTS-12 26/85 26/85 Non 
CTS-13 20/80 40/80 Non 
CTS-14 14/60 48/60 Non 
CTS-15 13/40 31/40 Non 
CTS-16 38/75 56/75 Non 
CTS-17 5/20 17/20 Non 
CTS-18 25/55 43/55 Non 
CTS-19 33/65 65/65 Highest 
CTS-20 33/75 62/75 Non 
CTS-21 38/65 41/65 Non 
CTS-22 34/65 59/65 Non 
CTS-23 17/100 70/100 Non 
CTS-24 31/65 65/65 Highest 
CTS-25 35/60 60/60 Highest 
CTS-26 11/25 18/25 Non 
CTS-27 37/60 60/60 Highest 
CTS-28 36/65 65/65 Highest 
CTS-29 41/80 80/80 Highest 
CTS-30 13/70 62/70 Non 
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12.3.7 Monitoring changes in a client’s physical abilities 
The numbers of improvements or deteriorations on all indicators used by patient CTS-07 
are presented  in Table 12.12. This participant was selected as an example throughout this 
study because he selected a high number of indicators (n=19) that were used in more than 
20 sessions. Data above the dashed line represent neither an improvement nor a 
deterioration, and data below the dashed line resemble a clinically significant change that 
was reported by the patient and observed by the therapist. Data below the thick orange 
line resemble a statistical and clinical significant change in TELER functional indicators. 
Data below the thick blue lines resemble a statistically and clinically significant change 
in TELER component indicators. The calculation of statistical significance at the level of 
the individual was based on calculating the probability of chance occurrence of 
improvement, deterioration and no change in a TELER functional indicator or component 
indicator. A statistically significant change has a probability of happening which is very 
small to be explained by chance (275). 
Table 12.12: The significance of the number of improvements or deteriorations recorded on TELER 
Codes on 
discharge 
Codes on admission 
 0 1 2 3 4 5 
0       
1       
2 2      
3 4      
4 3      
5 7 3     
Similar tables of data distribution were developed for each participant [Appendix V]. A 
summary of Appendix V is presented in Table 12.13. Table 12.13 indicates that the 
majority of participants experienced both clinically significant changes and statistically 
significant changes (n=28). The mode of clinically significant changes was 20 (range: 0–
75) and of statistically significant changes was 6 (range: 0–15). 
  
 214 
 
Table 12.13: Summary of clinically significant changes versus statistically significant changes 
Patient-ID 
Numbers of clinically 
significant changes 
Numbers of statistically 
significant changes 
CTS-01 24 3 
CTS-02 12 3 
CTS-03 22 5 
CTS-04 20 5 
CTS-05 8 1 
CTS-06 42 7 
CTS-07 75 15 
CTS-08 10 1 
CTS-09 20 5 
CTS-10 59 13 
CTS-11 26 6 
CTS-12 0 0 
CTS-13 20 3 
CTS-14 34 7 
CTS-15 18 2 
CTS-16 17 1 
CTS-17 12 2 
CTS-18 18 3 
CTS-19 32 6 
CTS-20 29 2 
CTS-21 5 0 
CTS-22 25 6 
CTS-23 53 10 
CTS-24 34 6 
CTS-25 25 4 
CTS-26 7 1 
CTS-27 23 2 
CTS-28 29 4 
CTS-29 39 6 
CTS-30 49 13 
 
12.3.8 Monitoring the quality of patient outcomes at the level of the individual 
Patient outcome was described in terms of the number of clinically significant 
improvements at the end of the physiotherapy programme. Table 12.14 shows that from 
admission until the discharge session, 26 participants have a good-quality outcome, two 
participants have a satisfactory outcome and two participants have a poor outcome. 
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Table 12.14: Summary of TELER indices used to determine the quality of physiotherapy services 
Measure 
Patient ID 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
Deficit Index 
Start 57 43 50 40 43 69 97 57 70 61 83 69 75 77 68 
End 23 9 19 0 17 20 18 23 3 2 9 69 50 20 23 
Improvement Index End 60 80 63 100 62 71 87 59 95 97 90 0 33 74 67 
Variability Index End 7 0 13 0 0 10 0 19 5 0 0 0 19 17 15 
Effectiveness Index End 93 100 83 100 100 90 100 81 95 100 100 100 81 83 85 
Quality of physiotherapy End G G G G G G G G G G G P S G G 
 
Measure 
Patient ID 
16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 
Deficit Index 
Start 49 75 55 49 56 42 48 83 52 42 65 38 45 49 81 
End 25 15 22 0 17 37 9 30 0 0 28 0 0 0 11 
Improvement Index End 49 80 60 100 69 11 81 64 100 100 50 100 100 100 86 
Variability Index End 30 7 5 0 9 0 0 0 0 0 0 0 0 0 2 
Effectiveness Index End 70 93 95 100 91 100 100 100 100 100 100 100 100 100 98 
Quality of physiotherapy End S G G G G P G G G G G G G G G 
G: denotes Good Patient Outcomes, S denotes Satisfactory Patient Outcomes, and P denotes Poor Patient Outcomes. 
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The TELER form of patient CTS-07 [Appendix W] was used here as an example to 
describe changes in outcomes at the individual level. The form shows that 15 out of the 
19 indicators recorded clinically and statistically significant changes in outcomes which 
are important to this patient between initial assessment and discharge sessions (n=21). 
This means that there is sufficient statistical evidence to indicate that these observed 
patterns of changes were not due to chance and it is highly likely due to something else. 
The TELER form of participant CTS-07 shows that the deficit index on admission was 
97%, indicating a high loss of functions due to LBP. The deficit index on discharge was 
18%, indicating that the patient restored 79% of these lost functions. The variability index 
indicates that this participant has a stable pattern of improvements, which, in turn, 
suggested that the patient outcome was good. 
12.3.9 Linking the TELER form to clinical notes 
Clinical notes were linked qualitatively to the TELER form to seek explanations for the 
lack of improvement or full recovery from the patient or the physiotherapist perspectives. 
Clinical notes contained valuable information that was related to contextual factors and 
factors related to the impact of LBP on physical abilities. The clinical notes of participant 
CTS-07 were used here as an example. The TELER form showed that this participant did 
not achieve a full recovery at the discharge session in nine out of the 19 goals that he 
identified earlier in the initial assessment session as important to him. The clinical notes 
indicated that he was complaining, beside LBP, about osteoarthritis in his hips and knee 
joints, which prevented full improvements in his abilities to stand up from sitting, to bend 
forward, to stand up from kneeling, and walking (four indicators), climbing the stairs and 
lifting weights. Clinical records of other participants also indicated that fear of movement, 
obesity and other health conditions, such as arthritis, prevented a full recovery. 
12.3.10 Results of quantitative analysis at the level of functional problems 
presented 
The data recorded on the TELER forms were analysed at the level of the group using the 
TELER patient outcome indicator and the TELER indices. It is important to note that the 
TELER indices facilitated the analysis at both the level of the individual and group. Table 
12.15 shows the median, the mode and the mean for each TELER index. The mean for 
the patient outcome indicator shows a change between the initial assessment session and 
 217 
 
discharge session. The mean of the Deficit Index shows a moderate to large (42.97%) 
improvement. This was further confirmed by the Improvement Index, which shows that 
72.93% of the deteriorations experienced before the start of the physiotherapy programme 
were recovered. The Variability Index shows that the pattern of improvement was stable 
between the initial assessment session and the discharge session. The median and the 
mood show that the distribution for all variables was symmetrical at the end. The Deficit 
Index at the end shows that the deficit at the start was recovered. However, Table 12.15 
does not show the number of patients who did not change even after the commencement 
of the physiotherapy programme. Thus, Table 12.16 was developed to show the number 
of patients who improved, did not change or those who experienced deteriorations. Table 
12.17 shows the distribution of the patients on the patient outcome indicator at the start 
and at the end. 
Table 12.15: Outcome per patient by the type of measurement 
 
 
 
 
 
 
 
 
 
Table 12.16: Number of patients by the type of change 
 
  
Measure 
Type of measurement 
Median Mode Mean 
Patient Outcome 
Indicator 
At start 3 3 2.33 
At end 5 5 4.7 
Deficit Index 
At start 56.5 49 59.6 
At end 17 0 16.63 
Improvement Index At end 77 100 72.93 
Variability Index At end 0 0 5.27 
Effectiveness Index At end 100 100 94.23 
Measure 
Outcome 
Improved No change Deteriorated Total 
Deficit Index 29 (96.67%) 1 (3.33%) 0 (0%) 30 (100%) 
 218 
 
Table 12.17: Number of patients by the Patient Outcome Indicator code at the start and end 
 
 
 
 
 
 
The distribution of codes in Table 12.17 shows a concentration on code 3 at the start of 
the physiotherapy programme, which might indicate that the majority of participants were 
not suffering from a severe disability. However, the results [X2 = 119.65] of the chi-square 
test in Table 12.18 suggest that the number of LBP patients who presented with a high 
level of disability in the initial assessment session is statistically significant [Tabulated 
X2 = 9.488, df = 4, p-value = 0.05]. Therefore, the first null hypothesis is rejected and the 
first experimental hypothesis is accepted. 
Table 12.17 shows that the majority of participants (n=25) achieved code 5 at the 
discharge session. The result [1008.12] of the chi-square test in Table 12.18 suggests that 
the number of LBP patients who restored their lost functions at the discharge session is 
statistically significant [Tabulated X2 = 9.488, df = 4, p-value = 0.05]. Table 12.19 shows 
the distribution of codes in the patient outcome indicator which were used in the 
calculation of chi-square. For the seek of completeness of analysis, a chi-square test was 
used to determine whether improvement, deteriorations and the lack of change were 
statistically significant events or were random events. Table 12.20 confirms this 
conclusion and shows that the number of patients who improved at the discharge session 
is statistically significant and it is unlikely due to chance. Therefore, the second null 
hypothesis is rejected and the second experimental hypothesis is accepted. 
  
Indicator 
code 
Number Percent 
At start At end 
At 
start 
At end 
1 9 1 30% 3.3% 
2 4 0 13.3% 0% 
3 15 1 50% 3.3% 
4 2 3 6.7% 10% 
5 0 25 0% 83.4% 
Total 30 30 100.0 100.0 
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Table 12.18: Chi-square analysis of the number of patients by codes of patient outcome indicators 
at the start and end 
Indicator 
code 
p 
At start  At end 
Observed 
(O) 
Expected 
(E) 
(O – 
E)2/E 
Observed 
(O) 
Expected 
(E) 
(O – 
E)2/E 
1 0.0197 9 0.591 119.646 1 0.591 0.283 
2 0.1446 4 4.338 0.026 0 4.338 4.338 
3 0.6714 15 20.142 1.313 1 20.142 18.192 
4 0.1446 2 4.338 1.260 3 4.338 0.413 
5 0.0197 0 0.591 0.591 25 0.591 1008.12 
Total 1.0000 30 30.000 122.837 30 30.000 1031.535 
A significance level of 95% confidence was set before calculation, P<0.05 
 
Table 12.19: Number of patients by codes of patient outcome indicators at the start and end 
Code at 
end 
Code at start 
1 2 3 4 5 Total 
1 1     1 
2      0 
3 1     1 
4 1  2   3 
5 6 4 13 2  25 
Total 9 4 15 2 0 30 
 
Table 12.20: Analysing data at the level of the group to show improvement, deterioration and the 
lack of change 
State p Observed (O) Expected (E) (O – E)2/E 
Improvement 0.333 29 9.99 36.17 
Deterioration 0.333 0 9.99 9.99 
Lack of change 0.333 1 9.99 8.09 
Total 0.999 30 29.97 54.25 
 
12.3.11 Acceptability 
Five physiotherapists were interviewed after the completion of the clinical testing study. 
All participants found the questionnaire to be useful and informed their clinical decision. 
Due to the limitations in time and resources patients were not interviewed after the 
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completion of the study. This step was considered to be assessed after the completion of 
this thesis. However, physiotherapists were asked to report all cases that refused to 
continue their assessment using the TELER questionnaire. All individuals with LBP, 
except for two who initially agreed to participate in this study, continued to use it until 
the discharge session. The two who refused to be assessed using the TELER LBP 
questionnaire indicated that the measurement process took a considerable interval of the 
time (>20 minutes) allocated for their treatment. Thus, they asked not to be measured 
using the TELER LBP questionnaire. 
12.3.12 Feasibility 
Participants (five physiotherapists) indicated that the measurement process took a long 
period of time (>15 minutes) in comparison to the existing tools, such as the VAS (less 
than 1 minute). Participants agreed that the TELER LBP questionnaire was more 
informative and it was measuring a construct other than pain intensity. They indicated 
that the time allocated for measurement decreased dramatically after the initial assessment 
session. They indicated that once they determined the goals of treatment using the TELER 
quiz-style indicators, the number of items dropped considerably between the initial 
assessment session and follow-up sessions. The participants also indicated that they 
gained more experience after using the TELER questionnaire in the follow-up sessions. 
Thus, the time required to fill in the questionnaire dropped significantly from more than 
20 minutes to less than 5 minutes.  
Participants said that the time required to fill in the questionnaire was also determined by 
the number of items in the questionnaire. Three physiotherapists indicated that patients 
found some indicators that represent a movement analysis of an activity difficult to 
understand.  
LBP-04: “It took me some time to fill up the questionnaire in the initial assessment 
session, but once I familiarised myself with the content, things got easier and it took me 
less time to assess patients. I really wished that it [the questionnaire] was short and 
concise. It took me at least 15 minutes to explain the questionnaire to the patient and then 
allow him to select the questions relevant to his problem, but then once you identify these 
questions the time drops to 5 minutes. I always verify that the patient understands what 
he selected”. 
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12.4 Discussion 
The objectives of this study were to examine the measurement properties and clinical 
utility of the TELER LBP questionnaire in terms of its validity, reliability and 
responsiveness, as well as judging the outcome measure capability to inform clinical 
decision-making when used in individuals with LBP in a clinical context and research. In 
order to assist clinical decision-making, an outcome measure must provide meaningful 
answers to the following questions (90,457,458): 
 What is the functional status of a patient? 
 Has a patient’s functional status changed? 
Clinical knowledge and observations were used in this study to answer these questions. 
It is important to note at this stage that the primary purpose of this clinical testing study 
was not to establish the effectiveness of current physiotherapy interventions used in the 
Jordanian physiotherapy clinics; instead, the aim was to measure changes in the construct 
functional performance. Therefore, interpretations drawn from the study were based on 
TELER evaluation, not attribution.  
In TELER evaluation, clinicians assume that the treatment is effective; therefore, they 
compare the observed patterns of change or the lack of change to the expected pattern of 
change or the lack of change in order to examine measurement properties and clinical 
utility (366). In TELER attribution, the TELER indicators are incorporated into an 
appropriate research design to identify the cause of an observed pattern of change or a 
lack of change. The process of attribution is required to determine whether or not an 
observed pattern of change or the lack of change is unlikely to have occurred by chance. 
Therefore, clinicians use specific study designs to control for as many known treatment-
like effects as possible. This is important to validate the conclusion that the observed 
pattern of change can be attributed to the treatment in the context of the clinical trial (296). 
12.4.1 Validity 
In comparison to the ODI (357), RMDQ (274) and QBPDS (279), the TELER LBP 
indicators were based on sound conceptual models of functional status and appropriate 
methods of item selection and development. Most current LBP outcome measures have 
no conceptual framework (279). The face validity and content validity of the TELER LBP 
indicators were established via a triangulation of methods using semi-structured 
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interviews with LBP patients [Chapter 9], an NGT with musculoskeletal physiotherapists 
[Chapter 11] and linking the concepts in the TELER LBP indicators to the ICF core sets 
for LBP (175). A structured guideline was followed to link the concepts in the indicators 
to the ICF categories (459). Table 12.19 shows a comparison between the ICF categories 
in three of the most commonly used back-disability measures and in the TELER LBP 
indicators. It is clear in Table 12.19 that the TELER LBP indicators represent a wider 
range of functional performance outcomes relevant to LBP patients than other back-
disability scales. This enables the TELER LBP indicators to be more tailored to the 
different levels of disability which might be encountered among individuals with LBP. 
Grocott and Campling (374), p. 32, suggested that “the validity of TELER indicators is 
predicated on the use of sound clinical knowledge and evidence to underpin the 
definitions of the indicators. Ensuring validity of the indicators is ongoing. With new 
knowledge the indicators are revised. Patients’ experiences are captured from their own 
perspectives. The reliability of the data collected depends on training, accurate 
assessment and data recording skills”. These recommendations were considered during 
the process of designing the manual of the TELER LBP questionnaire [Appendices Y and 
Z]. The manual of the TELER LBP indicators was designed to reflect recent clinical and 
scientific knowledge and enhances the clarity of the definitions of the indicators. 
Convergent construct validity has been used to examine the capacity of measures of LBP 
to provide accurate representations of the attributes of interest (252). The results showed 
that the TELER LBP questionnaire correlated moderately (r = 0.46) with QBPDS. This 
was expected because the TELER LBP indicators were developed using clinical and 
scientific knowledge, whereas the items in the QBPDS relied heavily on statistical 
calculations during the process of their development (279). This was confirmed through 
the coefficient of determination (R2), which showed that scores of the QBPDS were not 
explained by observations. This means that there is an unknown variable that is affecting 
the QBPDS scores other than observation.
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Table 12.21: Linking the TELER LBP indicators to the ICF categories 
Scale ODI (15 ICF categories) RMDQ (20 ICF categories) QBPDS (17 ICF categories) TELER LBP indicators (26 ICF categories) 
ICFDH 
codes 
b 134 (Sleep function)*,  
b 280 (Sensation of Pain), 
d 230 (Carrying out daily routine)**, 
d 4153 (Maintaining a sitting position)**, 
d 4154 (Maintaining a standing position)*, 
d 430 (Lifting and carrying objects)**, 
d 4500 (Walking short distances)*, 
d 4501 (Walking long distances)**, 
d 5 (Self-care), 
d 7702 (Sexual relationship), 
d 9 (Community, social and civic life), 
d 920 (Recreation and leisure), 
e 1101 (Drugs), 
e 1150 (General products and technology for  
             personal use in daily living), 
e 1201 (Assistive products and technology for  
             personal indoor and outdoor mobility and  
             transportation)**, 
b 1302 (Appetite), 
b 134 (Sleep function)*, 
b 152 (Emotional function), 
b 28013 (Pain in back), 
d 230 (Carrying out daily routine)**, 
d 410 (Changing basic body position)**, 
d 4102 (Kneeling)**, 
d 4105 (Bending)**, 
d 4106 (Shifting the body’s centre of gravity), 
d 4154 (Maintaining a standing position)*, 
d 450 (Walking), 
d 4500 (Walking short distances)*, 
d 4551 (Climbing)**, 
d 465 (Moving around using equipment)**, 
d 540 (Dressing), 
d 5402 (Putting on footwear)**, 
d 570 (Looking after one’s health), 
d 845 (Acquiring, keeping and terminating a job), 
d 850 (Remunerative employment), 
e 3 (Support and relationship), 
b 134 (Sleep function)*, 
d 2100 (Undertaking a simple tasks), 
d 410 (Changing basic body position)**, 
d 4105 (Bending)**, 
d 4153 (Maintaining a sitting position)**, 
d 4154 (Maintaining a standing position)*, 
d 430 (Lifting and carrying objects)**, 
d 4450 (Pulling), 
d 4451 (Pushing), 
d 4454 (Throwing), 
d 4500 (Walking short distances)*, 
d 4501 (Walking long distances)**, 
d 4551 (Climbing)**, 
d 4552 (Running)**, 
d 470 (Using transportation), 
d 5402 (Putting on footwear)**, 
d 640 (Doing housework), 
 
b134 (Sleep function[A1])*, 
d 230 (Carrying out daily routine [M1])**, 
d 410 (Changing basic body position [B2, B3, C1,  
           D1, D2])**, 
d 4100 (Changing basic body position- [B1])**, 
d 4101 (Squatting [H1, H2]), 
d 4102 (Kneeling [D3])**, 
d 4103 (Sitting [C1, D1, D2, D3]), 
d 4104 (Standing [C1, D1, D2, D3, H1, H2]), 
d 4105 (Bending [G1, G2])**, 
d 4150 (Maintaining a lying position [A1]), 
d 4153 (Maintaining a sitting position [E1])**, 
d 4154 (Maintaining a standing position [F1])*, 
d 4300 (Lifting [L1])**, 
d 4301 (Carrying in the hands [L1, L2, L3]), 
d 4305 (Putting down objects [L3]), 
d 4500 (Walking short distances [I1, I2,  I3])*, 
d 4501 (Walking long distances [I3])**, 
d 4502 (Walking on different surfaces [I1]), 
d 4503 (Walking around obstacles [I1]), 
d 455 (Moving around [J1]), 
d 4551 (Climbing [K1, K2, K3, K4, K5])**, 
d 4552 (Running [J2])**, 
d 4600 (Moving around within the home [I2]), 
d 4602 (Moving around outside the home and  
             other buildings [I3]), 
d 465 (Moving around using equipment [I4])**, 
e 1201 (Assistive products and technology for  
            personal indoor and outdoor mobility and  
            transportation [I4])**, 
Adapted from Wang et al. (210) 
ODI: Oswestry disability index; RMDQ: Roland-Morris disability questionnaire; QBPDS: Quebec back pain disability scale; ICFDH: International Classification of Function, Disability and Health. 
*: The ICF code is shared between the ODI, RMDQ, QDBS and TELER LBP indicators. 
**: The ICF code is shared between at least two scales. 
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12.4.2 Reliability 
A highly reliable measurement tool has the potential to show greater validity and 
sensitivity to change (460,461). This study suggests that the inter-rater reliability and the 
internal consistency of the TELER LBP questionnaire were excellent. Table 7.2 shows 
the psychometric properties of three commonly used back-disability scales. The inter-
rater reliability of these measures was not tested. The value of Cronbach's alpha, the 
coefficient of reliability, of the TELER LBP questionnaire was higher than the values of 
current LBP measures. The results support further testing concerning the potential 
superiority of the TELER LBP questionnaire over other LBP measures. Further testing in 
different settings and a larger population would provide an evidence that supports the 
findings of this study. 
Errors in measurement were reduced in this study by ensuring that the observer had 
adequate knowledge, training and skills in identifying and documenting a real change 
when it happened in a systematic and consistent manner. Consistency was ensured by 
defining TELER codes using statements that have a singular meaning, so it can be 
interpreted in one way only. Measurements in this study were jointly performed by LBP 
patients and physiotherapists. Physiotherapists received training on the TELER method 
by an expert who educated them about the concepts and showed them how to use the 
TELER software, entry of data and producing of patients’ reports.  
Further examination of the findings of the inter-rater reliability testing suggested that the 
second observer who was not responsible for looking after the patients was always 
recording one code fewer than the first observer [the physiotherapist who was responsible 
for delivering interventions] when disagreement was recorded. One explanation could be 
that the second observer was stricter when verifying scores than the first observer who 
maybe was more optimistic and inclined to discharge the patient. These findings require 
further investigation in future research. 
12.4.3 Responsiveness 
The pilot study applied two different methods for evaluating the TELER LBP 
questionnaire’s ability to detect change accurately. The findings of these tests showed 
that the TELER LBP questionnaire was sensitive to change or the lack of change more 
than the QBPDS. In comparison to TELER, 19 points are required to overcome the 
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standard error of measurement in the QBPDS. A change between two successive codes 
in a TELER indicator represents a minimal detectable change and each code in a TELER 
indicator denotes a clinically significant outcome (342). The clinical knowledge of many 
experts was used in the construction of codes to ensure that they were mutually exclusive 
and exhaustive. These factors minimised measurement errors in the TELER LBP 
indicators. The TELER LBP indicators were more responsive to change than the QBPDS 
because the latter lacked precision. The definitions of TELER codes allowed the 
recording of more clinically significant changes than QBPDS. This is because the codes 
represent clinically significant outcomes that are meaningful to the individuals with LBP 
and healthcare professionals; therefore, these changes could be observed, recognised and 
recorded. 
12.4.4 Clinical utility 
One of the limitations of the current LBP measures is that they were developed for group 
decision-making in a research context rather than individual patient decision-making in a 
clinical context (252). The results of this study showed that 29/30 LBP patients 
experienced clinically significant changes and 28/30 experienced at least one statistically 
significant change. The QBPDS was used also in this study, but it did not provide similar 
information that could be used to inform the process of clinical decision-making.   
The TELER indices used in the quantitative analysis at the level of the individual provide 
means for interpreting patients’ outcomes with reference to management records, 
performance records and clinical notes. These indices guided clinical decision-making by 
identifying accurately undesirable outcomes such as a deterioration or a lack of change. 
The TELER software provided session-by-session (longitudinal follow-up) measurement 
of changes in functional performance during physiotherapy. It is the responsibility of the 
clinician to respond to the recorded changes, whether an improvement or deterioration. 
The response might be in the form of maintaining treatment, altering treatment or 
withdrawing treatment. 
Linking clinical notes and patient records to the performance record helped in identifying 
contextual factors that might influence functional performance, which included personal 
and environmental factors. It also enabled clinicians to generate explanations of changes 
experienced by the patient.  
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Quantitative analysis at the level of the group showed that by the end of physiotherapy 
all participants had experienced either an improvement or no change. There was a 
statistically significant difference in the distribution of TELER codes at the beginning of 
physiotherapy and at the discharge session. These patterns of clinically significant 
changes happened in the majority of patients (n = 28). Within the limitations of an 
observational study, it is difficult to attribute these changes only to physiotherapy 
interventions. However, the only things that participants had in common during the period 
of this study were LBP [the condition] and physiotherapy interventions [management]; 
therefore, it is likely that these patterns of changes in functional performance outcomes 
are induced by physiotherapy interventions. This hypothesis requires further testing in a 
different study design (e.g. randomised control trial) to establish a causal relationship 
between physiotherapy interventions and improvement in functional performance in 
individuals with LBP. 
The quantitative analysis at the level of the group showed that the majority of participants 
achieved good outcomes and the pattern of improvement was relatively stable. This might 
suggest that patients confronted their pain, were able to cope with their LBP symptoms 
and remained active during the study period. The Variability Index indicated that 
instability was frequently associated with old age. The pattern of recovery was 
heterogeneous across the group with some LBP patients experiencing a small 
improvement in all indicators and others experiencing a large improvement in a small 
number of indicators. 
12.5 Conclusion 
This study has contributed to the knowledge about the pattern of recovery and trajectory 
of LBP in Jordanian individuals with LBP. The quantitative and qualitative analyses of 
the data collected in this study showed that the TELER LBP questionnaire is valid, 
reliable, responsive to change and provided useful information that helped in clinical 
decision-making. The TELER LBP questionnaire was found to be a useful clinical tool 
that possesses the potential to be used in both research and clinical contexts. 
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Chapter 13: The overall discussion 
Key points in Chapter 13: 
- There were many objectives identified at the different phases in this thesis; these 
have been synthesised in this chapter into five clear objectives in order to have a 
clear structure of the new knowledge developed in this thesis. 
 
- This chapter aims to critically review the methods used in this research 
programme to support the conclusion that a new outcome measure of functional 
performance for individuals with LBP was developed following a rigorous 
research process, which was underpinned by the theory of measurement and 
clinical knowledge. 
 
- This chapter considers the implications of research that has been conducted with 
reference to each aim or objective stated in this thesis. 
 
- The extent to which new knowledge (Box 13.1) has been produced is considered 
alongside some recommendations for further research in this field. 
 
Box 13.1: Summary of the main contributions of this thesis 
 
13.1 Purpose of the thesis 
In the context of a prevalent, costly and poorly understood condition, the aim of this thesis 
was to develop an appropriate outcome measure that will help individuals with LBP and 
assist clinicians to better understand the clinical course of the condition. It also aims to 
help them make informed decisions on whether to continue treatment, change 
interventions, discharge the patient or refer him or her to other services. This research 
This thesis has: 
 Provided an up-to-date in-depth understanding of LBP and its management.  
 Provided an in-depth understanding of the theory underpinning measurement of LBP in 
a clinical context. 
 Developed a theoretical framework for the measurement of LBP in a clinical context. 
 Developed a comprehensive and in-depth understanding of the impact of LBP on 
Jordanian individuals with LBP, and determined clinically significant outcomes 
following physiotherapy. 
 Developed a new LBP outcome measure of functional performance that is valid, reliable 
and responsive to change or lack of change that will enable the development of further 
knowledge in the field when used in research or clinical contexts. 
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was conducted on the backdrop of an ongoing strategic plan at the Ministry of Health in 
Jordan to significantly enhance health services research and stimulate an evidence-based 
practice paradigm to deliver high quality health services (20,21). These challenges could 
not be met without the development of an appropriate outcome measures that will provide 
informative data about the outcome of treatment (19,462). The findings of this research 
suggest that the overarching aim has been met with indications of the potential superiority 
of the characteristics of the new outcome measure in comparison to the current LBP 
‘assessment tools’. 
Underpinning the overarching aim were several objectives. The amount to which each 
has been accomplished and the implications of the work that has been conducted will now 
be considered in turn. 
13.1.1 Objective one  
To provide an up-to-date in-depth understanding of LBP and its management.   
This thesis began with an exploration of the impact of LBP on the healthcare systems and 
on individuals living in the Middle East, especially in Jordan. To achieve this objective, 
a rigorous systematic review was conducted in Chapter 1 to identify epidemiological 
studies that examined the prevalence and natural history of LBP in the Middle East and 
worldwide. The initial search did not retrieve any population-based epidemiological 
studies conducted in Jordan or any of the surrounding Arabic countries. The updated 
systematic review in the first chapter of this thesis concluded that there were no 
significant differences in the reported prevalence of LBP among countries in different 
continents; therefore, it is suggested that the prevalence of LBP in Jordan is unlikely to 
be different from the rest of the world. However, the natural history of the condition was 
different among countries, and until this stage, there has been no study that investigated 
the natural history or the clinical course of LBP in Jordan. A recent study suggests that 
there were different recovery pattern, and that the current understanding of LBP and its 
consequences would be supported by detailed knowledge of the clinical course of LBP 
and the factors linked to its transition from trivial to burdensome condition (463). The 
acquisition of this detailed knowledge of the course of the condition and associated factors 
requires an appropriate outcome measure that traces change in the individual patient. This 
work filled this gap by developing a new measurement tool, the TELER LBP 
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questionnaire, which is appropriate for measuring the impact of pain on functional 
performance in a clinical context. 
In addition to this, the quality assessment list used to review the articles included in the 
systematic review showed that majority of the epidemiological studies used inappropriate 
outcome measures, which might distort the current understanding of LBP. To understand 
these shortcomings in the musculoskeletal field, Chapters 2–4 in the first phase were 
dedicated to understanding the impact of LBP on individuals’ lives and on the critically 
reviewed management models of LBP, models of pain and functioning. This modern and 
in-depth knowledge of LBP and its management provided a sound theoretical framework 
that was used later on in the second and third phases to develop the TELER LBP 
questionnaire.  
The findings of phase one suggests that LBP is a self-limiting condition, but that 
recurrence is common. A small proportion of individuals severely affected by the 
condition accounts for most health- and disability-related costs. Low back pain affects an 
individual’s physical abilities, which in turn affects other aspects of quality of life, such 
as mood and social functioning. Due to this, LBP is considered a highly diverse condition, 
and there is mounting evidence supporting targeted multidisciplinary interventions for its 
management. 
13.1.2 Objective two  
To provide an in-depth understanding of the theory underpinning measurement of LBP 
in a clinical context. 
The findings of the first section in the conceptualisation phase suggest that a clinical 
measurement tool is required. The second section in the conceptualisation phase is 
dedicated to determining the required characteristics in a measurement tool to be suitable 
for use in a clinical context. This objective is achieved in Chapters 5 and 6. Chapter 5 
suggests that the construct functional status can be evaluated in the initial assessment 
session to examine an individual’s physical abilities, and in follow-up sessions, to trace 
changes in the patient’s health status. In comparison to the other dimensions of quality of 
life, only the changes in functional status can be reported by individuals with LBP and 
observed by clinicians. An analytical framework of this construct was identified earlier 
in Chapter 4. This framework suggested that the level of functional performance varies 
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between patients, and that each patient performs at a different level across a continuum 
of performance (Connectivity). This means that an individual who possesses a higher 
functional capacity can perform more tasks than another person who possesses less 
functional capacity, who also in turn can perform more tasks than a patient with a disorder 
that affects any of the components of functional status (216). This thesis suggests that 
there is a symmetry between the mathematical structure of the construct ‘functional 
performance’ and the characteristics of an ordinal scale of measurement (connectivity, 
transitivity and asymmetry). The Guttman scaling method can be used to construct ordinal 
scales that describe recovery patterns of physical activities. The theoretical framework of 
clinical measurement in a clinical context developed at the end of the conceptualisation 
phase is based on these findings. The standards of measurement in a clinical context are 
identified in Chapter 6. 
Chapter 6 suggests that clinical measurement tools should possess, apart from adequate 
psychometric properties, the ability to measure clinically significant changes in the 
construct of interest at the level of the individual, detect early deterioration and provide 
clinically informative data that will enable the process of making swift and decisive 
decisions related to the management of the condition. 
The theoretical principles of measurement in a clinical context identified in Chapters 5 
and 6 are used in Chapter 7 to critically review current LBP instruments for measuring 
pain and disability. It is unclear whether or not the questions in the current scales reflect 
what is important to individuals with LBP. It seems that these measurement tools lack an 
appropriate conceptual framework, which negatively affect their validity. Regardless of 
the psychometric properties of the current LBP measures, some of the items in these 
measures are inappropriate because some of the items, for example each question within 
the ODI, lack specificity by measuring more than one thing at the same time. Moreover, 
the response choices in the current measures are not suitable for use in a clinical setting. 
Current LBP scales provide data (meaningless numbers) that cannot be used readily to 
inform clinical decision-making. 
The conceptualisation phase indicated that the current LBP outcome measures were not 
suitable for use in clinical musculoskeletal settings for many reasons. Hence, the purpose 
of the following phases in this research programme was to create a new valid, reliable 
and sensitive measurement tool that is suitable for use in a clinical musculoskeletal 
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context. It is important to note that the first phase did not only identify the need for 
developing a new outcome measure, but also helped to shape and construct a new 
theoretical framework that offered a basis and stimulus upon which to conduct further 
useful research. 
13.1.3 Objective three 
To develop a theoretical framework for measurement in research and clinical contexts 
In comparison to the rising number of documents that provide guidance on the 
development and evaluation of complex interventions, such as the framework developed 
by the Medical Research Council (296), no document provided similar guidance on the 
development of outcome measures that trace changes in a clinical context. This thesis 
responded to this gap by demonstrating an example of a rigorous process for developing 
a clinical measurement tool that can be easily transferred to other areas in the healthcare 
field. This thesis has enhanced the knowledge in the area of measurement in a clinical 
musculoskeletal context by reviewing models of functioning and developing a new 
framework for the measurement of functional performance in individuals with LBP. This 
was achieved through the consideration of the theoretical knowledge of LBP and its 
management and models of functioning in the conceptualisation phase, which in turn 
enabled the selection of appropriate methods in the development and clinical testing 
phases. 
The TELER method was used in the development phase because it fulfilled the theoretical 
underpinning identified in the conceptualisation phase. This method has a clear 
conceptual framework for developing outcome measures for both the research and clinical 
contexts. A lesson learnt in this work is that it is the responsibility of the user (a clinician 
or a researcher) to ensure that the definition of the TELER indicator represents an 
individualised outcome using their clinical knowledge.  
In the TELER method, it is important to distinguish between a clinically significant 
outcome and a clinically significant change. A clinically significant outcome is the 
construct of interest, and it should be defined from the perspective of the patient. A 
clinically significant change is the change experienced by the patient and observed by the 
clinician in the clinically significant outcome. In this thesis, clinical significant changes 
were defined according to experts’ opinion and theoretical established knowledge, and 
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not according to patients’ opinion for two main reasons. Firstly, different patients have 
different LBP experiences. It is illogical to assume that all LBP patients have experienced 
the full trajectory of change from complete loss of functioning to maximum functioning. 
It is highly unlikely that patients might arrive at a consensus around the recovery pattern. 
Secondly, it is illogical to assume that individuals with LBP are able to fully remember 
all stages of functional loss as they developed. 
13.1.4 Objective four 
To gain a comprehensive understanding of the impact of LBP on Jordanian individuals 
with LBP 
This objective was achieved in Chapter 9 using qualitative methods. When developing a 
new outcome measure, it is necessary to explore and determine the desired outcome. As 
was indicated earlier in the conceptualisation phase, there was no study that explored the 
impact of LBP on Jordanian individuals; therefore, a qualitative study was conducted as 
part of this doctoral programme. People from the north, middle and south of Jordan were 
interviewed. Participants represented a heterogeneous sample of the Jordanian 
population. The study followed a rigorous research process to ensure the trustworthiness 
of the findings. The findings of the qualitative study suggested that i) LBP is a 
multidimensional experience and ii)  LBP impacts on functional performance and is 
affected by other constructs, such as social functioning, mental functioning and spiritual 
practices. This qualitative study suggested that spirituality played a key role in coping 
with LBP. The qualitative study indicated that restoring physical functioning emerged as 
a main theme on the thematic chart. The narratives of the patients were used to determine 
clinically significant outcomes. They were also used in the construction of the TELER 
LBP questionnaire. 
13.1.5 Objective five 
To develop a new LBP outcome measure of functional performance that is valid, 
reliable and responsive and that informs clinical decisions in a clinical context 
This objective was met in Chapters 11 and 12. The validity of the TELER LBP indicators 
was ensured by adequate theoretical conceptualisation of the construct and empirical 
qualitative evidence. This included referring to the experience of functional limitations 
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by individuals with LBP and the clinical perspectives of experts. Nominal group 
technique was used as a valid method of item selection and reduction that preserved 
patients’ perspectives [Chapter 11]. The clinical testing study presented evidence of the 
validity, reliability and responsiveness of the TELER LBP questionnaire. It was also 
interesting to find some indications that support the superiority of the measurement 
properties of the TELER LBP indicators in comparison to the current LBP scales. 
Statistical tests showed excellent reliability, sensitivity to change and high specificity. 
The TELER functional indicators provided detailed information about patient functional 
status at the individual level. This information identified whether the patient was 
improving, deteriorating or did not change during treatment. According to these 
information, different clinical actions were taken. TELER LBP indicators provided a 
longitudinal trace of changes, which enabled individuals with LBP to detect any 
deterioration or lack of change when it occurred. Evidence of clinically significant change 
was established through the observation of that change. 
Measurement at the individual level provided LBP patients and clinicians with important 
information for making informed clinical decisions in response to the observed and 
documented changes in functional performance. Appropriate measurement of 
physiotherapy outcomes in a clinical context enables therapists to notice deteriorations 
once they happen and to act on them. The TELER LBP questionnaire provided useful 
information, such as clinical characteristics of the group of LBP patients and the overall 
outcome of treatment at the managerial level.  
In the authors’ knowledge, the TELER LBP questionnaire is the only measurement tool 
in the musculoskeletal field that enables the calculation of a quantitative estimation of the 
variability of the clinical condition at the individual level. 
13.2 A reflection on the appropriateness of the methods used in this research 
In the world of patient-centred care in physiotherapy practice, the development of a tool 
for measuring outcomes in clinical settings requires an innovative approach. The 
traditional approaches for outcome measure development depend heavily on experts’ 
knowledge and on the use of statistical tests to construct new outcome measures. This 
study adopted the stance that expertise on the impact of LBP (clinical significant 
outcomes) lay not only in the musculoskeletal literature and experts’ opinions, but also 
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within the individuals with LBP. It is these people who observe and experience changes 
in their physical abilities, and their knowledge has been kept in the forefront during all 
stages of the process of instrument development. The second phase in this research 
programme started with an exploration of a suitable method of measurement in the 
physiotherapy literature. The TELER method was selected for many reasons. Firstly, it 
was selected because it was specifically designed to trace changes in the desired outcome 
at the individual level, as well as on the group level. Secondly, it facilitated a partnership 
between the observer who is recording the scores and the respondent who is experiencing 
the health problem and reporting the change. Thirdly, this method was grounded in the 
patients’ narratives, and it fulfilled the theoretical underpinnings identified during the 
conceptualisation phase. Fourthly, it has been used in other studies in the field of 
physiotherapy, particularly in the measurement of individualised outcome. 
The TELER indicators were developed from patients’ narratives, movement analysis 
studies and amending existence TELER indicators. A NGT was then used in the fourth 
step in this research programme to examine the face and content validity of the first draft 
of the TELER LBP questionnaire.  
The new TELER LBP questionnaire was then piloted in the Jordanian physiotherapy 
clinics. A rigorous research process that examined different measurement properties 
using a combination of qualitative and quantitative methods was adopted. The findings 
of the clinical testing study indicated that the pre-testing version of the TELER LBP 
questionnaire was valid, reliable and responsive to change at the individual and group 
level. A qualitative study conducted after the completion of the clinical testing phase 
concluded that the TELER LBP questionnaire provided informative data that guided the 
decision-making process, and recommended using the new outcome measure in the 
physiotherapy clinics in Jordan. 
13.3 Limitations of the clinical testing study 
The TELER LBP indicators were validated from the perspective of clinicians involved in 
the development of the measurement tool phase. It is highly unlikely that this will affect 
the validity of the TELER LBP questionnaire because it was originally developed from 
the patients’ narratives.  
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The findings of the clinical testing study were based on a prospective longitudinal follow 
up of cohort of individuals with LBP over a period of four months. Causality could not 
be established between physiotherapy interventions and changes in the patients’ 
functional status. Establishing causality requires implementing the TELER LBP 
questionnaire in an appropriate research design, such as a randomised controlled trial. 
The findings of the clinical testing study were limited by the small sample size and lack 
of randomisation, which limited the generalisability of the findings or of the establishment 
of a causal relationship between physiotherapy and improvement in the patient’s 
functional performance. It is important to note that the sample size was a true 
representation of the actual number of individuals with LBP at the sites of clinical testing. 
The aim is to evaluate the measurement properties of the newly developed TELER LBP 
questionnaire within a real clinical context. It is important to interpret the findings within 
the context and design of the clinical testing study. The sample size and the study design 
provide a realistic insight on the physiotherapy practice in Jordan 
13.4 Recommendations for future directions 
Future research includes four main directions. These are developing new TELER LBP 
indicators, implementing the TELER LBP in different appropriate research designs, using 
the questionnaire in a larger population to examine the clinical course patterns of 
functional recovery in a larger sample of individuals with LBP and comparing the TELER 
LBP indicators with existing measures.  
13.4.1 Developing new TELER LBP indicators 
The validity, reliability and responsiveness of the TELER LBP indicators were 
established using a combination of quantitative and qualitative methods. The codes in the 
TELER LBP indicators are the only available descriptions in the musculoskeletal 
literature concerning the patterns of functional recovery in a population of individuals 
with LBP. It is plausible that new patterns of functional recovery might emerge in the 
future. The conceptualisation phase suggests that LBP is a heterogeneous condition and 
that the recovery patterns of individuals with LBP might differ. A possible solution to 
overcome such a situation is provided by the flexibility of the TELER method. Grocott 
and Campling (374) suggested that the validity of the TELER indicators is an ongoing 
process; with the emergence of new knowledge, the TELER codes are revised.  
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13.4.2 Implementing the TELER LBP in different appropriate research designs 
The TELER LBP questionnaire can be implemented in appropriate research designs, such 
as a randomised controlled trial, to evaluate the causal chain links between physiotherapy 
interventions and improvements in the outcomes of individuals with LBP. This might 
enhance the current understanding of how complex interventions work and what is the 
effect of these interventions on the construct of functional status (296). 
13.4.3 Examining the clinical course patterns of functional recovery in a larger 
sample size of individuals with LBP 
Variations in the clinical course are a recognised clinical feature of LBP (463). Low back 
pain might be better understood by the recognition of these variations. One approach to 
recognise these variations is through the identification of clinical course patterns. A 
prospective observational cohort study might identify LBP trajectories using the TELER 
LBP questionnaire over one year, and compare the findings obtained using different 
analytical approaches. 
13.4.4 Comparing the TELER LBP indicators with existing measures 
The clinical testing study presented an evidence that indicated the superiority of the 
TELER LBP questionnaire in comparison to the QBPDS. Further comparisons against 
other LBP assessment tools in different populations might support this conclusion and 
add more weight to the evidence that support the superiority of the measurement 
properties of the new measurement tool developed in this research programme. 
13.5 Dissemination and communication of the research findings 
The findings of the systematic review has been submitted to a peer-reviewed journal. 
 Altaim, T., Littlewood, C., Mawson, S. (2015). Examining the impact of research design 
on low back pain prevalence rates. Systematic Reviews Journal. (In the review process). 
The findings of the qualitative study were communicated in an oral presentation in 
national and international conferences. 
 Altaim, T., Littlewood, C., Tod, A., Mawson, S. (2013). Exploring the multidimensional 
experience of people with low back pain: A qualitative study. PhysiotherapyUK 2013. 
Chartered Society of Physiotherapy. 
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 Altaim, T., Littlewood, C., Tod, A., Mawson, S. (2013). Exploring the multidimensional 
experience of people with low back pain: A qualitative study. JPTS scientific day. 
Jordanian Physiotherapy Society. 
 Altaim, T., Littlewood, C., Tod, A., Mawson, S. (2014). Development and measurement 
properties testing of the TELER LBP questionnaire. ScHARR PGR conference. Sheffield 
University. 
The findings of the cross-cultural adaptation of the QBPDS was published in a peer-
reviewed journal. 
 Altaim, T., Littlewood, C. (2011). Cross cultural adaptation of the Quebec Back Pain 
Disability Scale from English into Arabic. International Journal of Physiotherapy and 
Rehabilitation. 1 (2) 4-13. 
A journal publication plan: 
 Altaim, T., Littlewood, C., Tod, A., Mawson, S. (2015). Exploring the impact of LBP on 
Jordanian people’s lives: A qualitative study. Physiotherapy. 
 Altaim, T., Littlewood, C., LeRoux, A., Mawson, S. (2015). The TELER LBP 
questionnaire: conceptualisation and development. Physiotherapy. 
  Altaim, T., Littlewood, C., LeRoux, A., Mawson, S. (2015). The TELER LBP 
questionnaire: measurement properties. Physiotherapy. 
13.6 Conclusion 
This research programme offers a new and valuable insight into the understanding of 
measurement in a clinical context. This was achieved through robust, rigorous and 
interlinked research methods. This thesis did not only succeed in developing a new LBP 
outcome measure of functional performance for individuals with LBP, but also developed 
a new theoretical framework of measurement in a clinical context that can be used in other 
areas in the field of physiotherapy.   
The measurement tool developed in this thesis was validated to be used in clinical settings 
but it also has the potential to be used in a research context to generate new knowledge in 
the field of physiotherapy. Regardless of the advancements achieved in this thesis, it is 
clear that there are still many unanswered questions. Nevertheless, a solid base upon 
which further knowledge can be developed has been established. 
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Appendix E: A summary of the qualifications of the translators and few examples of translation validation 
Name Research background Familiar with the requirements of translation Translation phase 
Thamer Altaim Musculoskeletal physiotherapists, (MSc) Yes, used the translation guidelines in previous research 1,2,3 and 4 
Nancy Ali Musculoskeletal physiotherapists, (MSc) Yes, she was involved in cross-cultural adaptation studies 1, 2 and 4 
Dr Rasha Okasheh Cardiopulmonary physiotherapist, (PhD) Yes, she was involved in cross-cultural adaptation studies 3 and 4 
Dr Jennifer Muhaidat Musculoskeletal physiotherapists, (MSc) Yes, but she does not have any previous experience 3 and 4 
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Appendix I: The first draft of the TELER LBP 
indicators 
 
Generic indicators 
1- General function (not hierarchical) 
 Walk without feeling pain in the lower 
back 
 Stand and sit safely, without feeling 
pain in the lower back 
 Lift object independently, without 
feeling pain in the lower back 
 Sleep undisturbed. 
 Managing clothing without feeling pain 
in the lower back 
0. Unable to do any 
1. Able to do 1 
2. Able to do 2 
3. Abel to do 3 
4. Able to do 4 
5. Able to do all 
2- Pain free activity* (from pain prevents) 
* Specify in the notes 
0. Pain prevents named activity 
1. Pain interrupts named activity, unable to 
resume 
2. Pain interrupts named activity, able to 
resume 
3. Pain during named activity, able to 
continue without interruption 
4. Pain after completion of named activity 
5. Pain free throughout named activity, no 
pain after 
3- Independent toileting (not hierarchical) 
 Maintain sitting 
 Sit to stand 
 Stepping 
 Stand to adjust clothes 
 Stand to sit 
0. Unable to do any 
1. Able to do 1 
2. Able to do 2 
3. Able to do 3 
4. Able to do 4 
5. Able to do all 
 
 
 
 
 
4- Washing independently (not 
hierarchical) 
 Wash hands 
 Wash face 
 Wash feet 
 Wash head 
 Wash the hand from the fingers to the 
elbow 
0. Does none independently 
1. Does one independently# 
2. Does two independently 
3. Does three independently 
4. Does four independently 
5. Does all independently 
 
5- Return to sporting activity 
0. Unable to exercise 
1. Return to physiotherapy exercises only 
2. Return to pre-sport training 
3. Return to sporting activity controlled and 
paced 
4. Return to sporting activity, unable to 
complete 
5. Return to full sporting activity - no problems 
6- Sciatic referral anaesthesia (x) pain (y) 
paraesthesia (z) 
0. [] in sciatic disturbance to include foot 
1. [] in sciatic distribution to lower leg, not 
beyond 
2. [] into buttock and thigh, not beyond 
3. [] into buttock, not beyond 
4. [] into back 
5. [] free 
7- Ability to perform functions after the 
onset of lower back pain 
0. Pain (24 hrs) 
1. Pain free in lying 
2. Pain free in standing or walking 
3. Pain free in forward flexion or sitting 
4. Pain free in functional activities 
5. Pain free in daily activities 
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Lying in bed 
8- Sleep without disruption due to pain 
0. Unable to sleep due to pain  
1. Wakes up due to pain, unable to go back to 
sleep 
2. Wakes up due to pain, goes back to sleep 
3. Pain does not interrupt sleep 
4. No pain on going to sleep, pain on waking up 
5. Sleep pain free 
9- Sleep normally (not hierarchical) 
 Difficulty getting off to sleep 
 Wakes frequently 
 Unable to adopt usual sleep position 
 Pain on waking am 
 Requires pain killers to sleep 
0. All problems present 
1. 4 problems present 
2. 3 problems present 
3. 2 problems present 
4. 1 problem present 
5. 0 problems present 
10- Sleep pain free 
0. Unable to sleep due to pain 
1. Pain does not prevent but interrupts sleep, 
unable to go back to sleep 
2. Pain does not prevent but interrupts sleep, 
able to go back to sleep 
3. Pain does not prevent and does not interrupt 
sleep 
4. Sleeps pain free but pain on waking 
5. Sleeps pain free, no pain on waking 
Bed mobility 
11- Bed mobility (not hierarchical) 
 Able to bend hips and knees 
 Able to maintain hips and knees in 
flexion 
 Able to lift bottom 
 Able to shift bottom across 
 Able to shift shoulders and head 
Across 
0. Unable to achieve any 
1. Able to achieve 1 
2. Able to achieve 2 
3. Able to achieve 3 
4. Able to achieve 4 
5. Able to achieve all 
 
 
 
 
 
 
 
12- Lying to sitting over edge of bed 
0. Cannot move functionally in bed 
1. Can achieve crook lying 
2. Can achieve modified bridge to move 
sideways 
3. Can role into side lying (with knees bent) 
4. Can roll into side lying and achieve forearm 
support 
5. Can achieve sitting on edge of bed (by 
dropping legs over side and pushing up with 
arm) 
13- Lying to sitting on bed 
0. Unable to sit from lying 
1. Able to lift and turn head and upper trunk 
2. Able to move arm and rotate upper trunk 
through midline 
3. Able to extend supporting arm, rotate lower 
trunk and lift legs off bed 
4. Able to transfer weight onto bottom 
5. Able to get to sitting and release arms 
Getting out of bed 
14- Get out of bed (not hierarchical) 
 Sit to stand to get out of bed 
 Move forward to edge of bed 
 Push up into sitting 
 Roll onto side 
 Each with arm turn head and bend leg 
0. Unable to do any 
1. Able to do 1 
2. Able to do 2 
3. Able to do 3 
4. Able to do 4 
5. Able to do all 
15- Transfer lying to standing pain free 
0. Unable to achieve pain free position 
1. Able to achieve pain free position in lying 
with support of one 
2. Able to achieve pain free position in lying 
independently 
3. Able to transfer lying to standing pain free 
4. Standing pain free 
5. Lying to standing pain free 
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Sitting to standing 
16- Sitting to standing 
0. Unable 
1. Able to move forwards on chair or bed 
2. Able to transfer weight over feet 
3. Able to lift bottom off chair or bed 
4. Able to extend knees, hips or trunk 
5. Able to extend knees, hips and trunk 
17- Stand to sit 
0. Sits down with no control 
1. Brings weight forwards, from standing 
position 
2. Bends hips and knees 
3. Hands reach to chair arms 
4. Lowers smoothly onto chair 
5. Moves hips to back of chair to adjust sitting 
posture 
18- Floor sitting to standing 
0. Unable to transfer weight in side sitting 
1. Able to transfer weight in side sitting 
2. Able to transfer weight forwards over knees 
3. Able to extend hips into high kneeling and 
place non weight bearing foot on the floor 
4. Able to transfer weight onto foot and extend 
hip and knee 
5. Able to stand 
 
Maintaining sitting 
19- Sit pain free 
0. Unable to sit due to pain 
1. Pain interrupts sitting for (Specify time), 
unable to continue 
2. Pain interrupts sitting for (Specify time) but 
able to continue 
3. Able to sit pain free for (Specify time) but 
pain afterwards 
4. Able to sit pain free for (Specify time) but 
discomfort afterwards 
5. Able to sit for (Specify time) without 
discomfort 
Maintaining standing 
20- Stand pain free 
0. Unable to stand for (Specify time) due to 
pain 
1. Pain interrupts standing for (Specify time), 
unable to continue 
2. Pain interrupts standing for (Specify time) but 
able to continue 
3. Able to stand pain free but pain afterwards 
4. Able to stand for (Specify time) pain free but 
discomfort afterwards 
5. Able to stand for (Specify time) without 
discomfort 
Standing to bending forward 
21- Trunk movement pain free 
0. Unable to bend the trunk forward because of 
pain 
1. Pain when initiating bending, pain free at 
standing 
2. Pain when trunk flexed, but not fully 
3. No pain when trunk flexed, but not fully 
4. Pain when trunk fully flexed 
5. Full active range of trunk movement forward, 
pain free 
Standing into squatting 
22- Standing to squatting 
0. Able to bend head forward 
1. Able to bend the trunk forward 
2. Able to bend hip 
3. Able to bend knees 
4. Able to bend ankles 
5. Able to maintain a squatting position 
independently 
 
23- Squatting into standing 
0. No extension possible in knees and hip 
1. Knees extended 
2. Hips extended 
3. Trunk extension lumbar lordosis 
4. Trunk extension - upper trunk in alignment 
5. Head in neutral flexion or extension 
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Walking 
24- Walk a distance outdoors 
0. Unable to walk to door without feeling pain 
(during or after) 
1. Able to walk to inside room without feeling 
pain 
2. Able to walk to toilet without feeling pain 
3. Able to walk length of corridor without feeling 
pain 
4. Able to walk all necessary distances indoors, 
pain free 
5. Able to walk all necessary distances 
outdoors, pain free 
25- Walking without pain in the lower 
back 
0. Unable to initiate sitting to standing in 
preparation for walking due to pain in the 
lower back 
1. Able to initiate sitting to standing in 
preparation for walking but unable to walk 
due to pain in the lower back 
2. Pain in the lower back interrupts walking and 
cannot resume 
3. Pain in the lower back interrupts walking but 
can resume 
4. Able to walk with no interruption, with the 
presence of pain in the lower back 
5. Able to walk, without pain in the lower back 
 
26- Walk independently (not hierarchial) 
 Walk forwards 
 Walk backwards 
 Walk sideways 
 Walk in circle 
 Walk around obstacles 
0. Unable to achieve any 
1. Able to achieve 1 
2. Able to achieve 2 
3. Able to achieve 3 
4. Able to achieve 4 
5. Able to achieve all 
27- Walk independently with normal gait 
(from unable to walk - flexed hip and 
knees) 
0. Unable to walk 
1. Walks with flexed hip and knees and support 
from 2 people 
2. Walks with flexed hip and knees and support 
from 1people 
3. Walks with flexed hip or knees, stick and 
helper present 
4. Walks with trunk almost straight, alone 
5. Walks with normal gait independently 
 
28- Functional walking (not hierarchial) 
 Walk in different directions 
 Change directions 
 Walk on different everyday surfaces 
 Able to negotiate slopes 
 Able to negotiate confined spaces 
0. Unable to do 1 
1. Able to do 1 
2. Able to do 2 
3. Able to do 3 
4. Able to do 4 
5. Able to do all 
Running 
29- Run in one direction on even ground 
without pain or limp or leg tiring* 
* Specify in the notes the agreed distance 
0. Unable to jog or run in one direction on even 
ground 
1. Able to jog or run in one direction on even 
ground with severe painful limp 
2. Able to jog or run in one direction on even 
ground with severe limp but no pain 
3. Able to run in one direction on even ground 
with slight limp and no pain 
4. Able to run in one direction on even ground 
without limp or pain but leg tires 
5. Able to run in one direction on even ground 
without pain or limp or leg tiring 
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30- Run on uneven ground, change 
direction and pace with no problems 
afterwards* 
* Specify in the notes the agreed distance 
0. Able to run at a consistent pace in one 
direction on even ground 
1. Able to run on even ground and change pace 
but has difficulty changing direction 
2. Able to run on even ground, change pace and 
change direction but has difficulty afterwards 
3. Able to run on even ground, change pace and 
direction with problems afterwards 
4. Able to run on even ground, change pace and 
direction with no problems afterwards 
5. Ability to run on uneven ground, change 
direction and pace with no problems 
afterwards 
31- Jog pain free 
* Specify in the notes 
0. Unable to walk the required distance* without 
pain 
1. Able to walk the required distance without pain 
2. Able to jog the required distance without pain 
3. Able to change the pace of jogging without 
pain 
4. Able to change the direction of jogging without 
pain 
5. Able to jog the required distance pain free 
Going up stairs 
32- Climb stairs pain free 
0. Pain prevents climbing stairs 
1. Pain prevents climbing stairs but can walk on 
flat pain free 
2. Pain interrupts climbing stairs and cannot 
resume without support 
3. Pain interrupts climbing stairs but can resume 
without support 
4. Pain during climbing stairs but can complete 
without interruption 
5. Pain free during climbing stairs 
33- Ascends stairs 
0. Unable to place foot on step 
1. Able to transfer weight onto 1 foot, maintain 
hip and knee alignment and place non 
weight bearing foot on step 
2. Able to transfer weight onto placed foot 
placed on step 
3. Able to extend weight bearing hip and knee 
4. Able to flex non weight bearing hip and knee 
5. Able to place other foot on step 
34- Use stairs pain free 
0. Unable to weight bear pain free 
1. Able to weight bear pain free 
2. Pain inhibits going up and down stairs 
3. Pain inhibits going up stairs but does not 
inhibit going down stairs 
4. Pain does not inhibit going up stairs 
5. Pain free up and down stairs 
35- Descend stairs 
0. Unable to place foot on lower step 
1. Able to place foot and transfer weight onto 1 
leg 
2. Able to place non weight bearing foot onto 
lower step 
3. Able to transfer weight onto foot placed on 
lower step 
4. Able to flex hip, knee and ankle of rear leg 
5. Able to place other foot onto lower step 
Lifting 
36- Lift weight 
0. Unable to bend trunk due to pain 
1. Able to bend trunk without pain 
2. Able to lift 1 KG without pain 
3. Able to lift 2.5 KG without pain 
4. Able to lift 5 KG without pain 
5. Able to lift X KG without pain 
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 الظهر أسفلمؤشرات عامة لمستويات الحركة عند مرضى الم 
 
 مؤشر حركة عام (غير تصاعدي) -1
 المشي من غير الاحساس بألم في أسفل الظهر 
أمن من غير الشعور بألم في  والجلوس بشكلالوقوف  
 أسفل الظهر
حمل الأوزان بشكل مستقل من غير الشعور بألم في  
 ل الظهرأسف
 النوم من غير إزعاج* 
التحكم بلبس الملابس** من غير الشعور بألم في أسفل  
 الظهر
 غير قادر على عمل أي منهم 0
 قادر على عمل واحدة 1
 قادر على عمل اثنتين 2
 قادر على عمل ثلاث 3
 قادر على عمل أربعة 4
 قادر على عملهم كلهم 5
و بألم أسفل الظهر ابسبب الشعور  وغير متقطع* النوم بشكل سلس 
 الشعور بهذا األم عند التقلب في النوم
** القدرة على لبس المعطف او الثوب او القميص او الجرابات 
 القصيرة او الطويلة
 
 القيام بنشاط* من غير الشعور بالألم في أسفل الظهر -2
 * يتم تحديده في صفحة الملاحظات
 النشاط المسمى الالم يمنع القيام ب 0
 غير المقدرة على المتابعة معالمسمى النشاط يقاطع الالم  1
 مع المقدرة على المتابعةالنشاط المسمى الالم يقاطع  2
مع المقدرة على المتابعة من النشاط المسمى خلال  بالألمالشعور  3
 غير مقاطعة
 النشاط المسمىمن بعد أكمال  بالألمالشعور  4
 بالألممع عدم الشعور  المسمى،النشاط عدم الشعور بالألم خلال  5
 لاحقا  
 
 استخدام دورة المياه بشكل مستقل -3
 المحافظة على الجلوس* 
 الوقوف من الجلوس 
 المتابعة 
 الوقوف لضبط الملابس 
 الجلوس من الوقوف 
 غير قادر على عمل أي منهم 0
 قادر على عمل واحدة 1
 قادر على عمل اثنتين 2
 قادر على عمل ثلاث 3
 قادر على عمل أربعة 4
 قادر على عملهم كلهم 5
المراحيض، العربي والافرنجي يرجى مراعاة ان هنالك نوعين من 
 (يتم تحديده في الملاحظات).
 الاغتسال بشكل مستقل -4
 غسل اليدين 
 غسل الوجه 
 غسل القدمين 
 غسل الرأس 
 غسل اليدين من الاصابع الى المرفق 
 غير قادر على عمل أي منهم 0
 قادر على عمل واحدة 1
 على عمل اثنتين قادر 2
 قادر على عمل ثلاث 3
 قادر على عمل أربعة 4
 قادر على عملهم كلهم 5
 
 العودة للنشاط الرياضي -5
 غير قادر على التمرين 0
 العودة الى تمارين العلاج الطبيعي فقط 1
 العودة الى التدريبات التحضيرية للرياضة 2
 بها**العودة الى النشاطات الرياضية بخطى محسوبة* ومتحكم  3
 العودة الى النشاط الرياضي ولكن مع غير القدرة على الاستكمال 4
 العودة الى النشاط الرياضي، من غير مشاكل 5
 
 )z) تنميل (y) الالم (xامتداد عرق النساء، الخدران ( -6
 [   ] في اضطراب عرق النساء ليشمل القدم 0
 [   ] في امتداد عرق النساء لأسفل الرجل، و ليس ما بعد 1
 [   ] في المؤخرة و الفخذ ، و ليس ما بعد 2
 [   ] في المؤخرة  ، و ليس ما بعد 3
 [   ] في الظهر 4
 [   ] ليس هنالك 5
 
 
 القدرة على القيام بالوظائف بعد حصول الم أسفل الظهر -7
 ساعة). 42الم متواصل ( 0
 الاستلقاء من غير الم 1
 الجلوس والوقوف من غير الم 2
 المالمشي من غير  3
 ثني الجذع الى الامام من غير ألم 4
 ممارسة النشاطات الحياتية* من غير ألم 5
 * تشمل صعود الدرج وحمل الاشياء
 
 الاستلقاء في السرير
 
 النوم من غير مقاطعة بسبب الالم -8
 غير قادر على النوم بسبب الالم 0
 استيقاظ من النوم بسبب الالم، غير قادر على العودة الى النوم 1
 استيقاظ من النوم بسبب الالم، ولكن أعود للنوم 2
 الالم لا يقاطع النوم 3
 ليس هنالك الم عند الخلود للنوم ولكن الالم عند الاستيقاظ 4
 نوم من غير الم 5
 
 النوم بشكل عادي -9
 صعوبة في الخلود للنوم 
 الاستيقاظ بشكل متكرر 
 عدم المقدرة على أخذ وضعية النوم الاعتيادية 
 ستيقاظ في الصبا الم عند الا 
 ضرورة أخذ مسكنات الالم للخلود للنوم 
 كل هذه المشاكل موجودة 0
 وجود أربعة مشاكل 1
 وجود ثلاثة مشاكل 2
 وجود مشكلتين 3
 وجود مشكلة واحدة 4
 لا يوجد أي من هذه المشاكل 5
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 النوم من غير الم -01
 غير قادر على النوم بسبب الالم 0
 ع النوم مع عدم المقدرة على العودة للنومالالم لا يمنع ولكنه يقاط 1
 الالم لا يمنع ولكنه يقاطع النوم مع المقدرة على العودة للنوم 2
 الالم لا يمنع ولا يقاطع النوم 3
 نوم من غير ألم ولكن هنالك الم عند الاستيقاظ 4
 نوم من غير الم والاستيقاظ من غير الم 5
 
 الحركة في السرير
 
 الحركة في السرير -11
 ادر على ثني الحوض والركبتينق 
 قادر على المحافظة على ثني الحوض والركبتين 
 قادر على رفع المؤخرة 
 قادر على تحريك المؤخرة للجانب 
 قادر على تحريك الكتفين والرأس للجانب 
 
 غير قادر على عمل أي منهم 0
 قادر على عمل واحدة 1
 قادر على عمل اثنتين 2
 قادر على عمل ثلاث 3
 على عمل أربعةقادر  4
 قادر على عملهم كلهم 5
 
 النهوض من الاستلقاء الى الجلوس على طرف السرير -21
 لا أستطيع اداء وظيفة النهوض من السرير 0
 استطاعة ثني الركبتين خلال الاستلقاء 1
 استطاعة رفع الجسم كجسر للتحرك الى الجانب 2
 تين).استطاعة الدوران الى النوم الى الجانب (مع ثني الركب 3
 استطاعة الدوران للنوم على الجانب مع الاستناد على الساعد 4
استطاعة الجلوس على طرف السرير (عن طريق إنزال القدمين  5
 الى الجانب ودفع الجسم للأعلى باليد).
 
 النهوض من الاستلقاء للجلوس على السرير -31
 عدم المقدرة على الجلوس من وضعية الاستلقاء 0
 وتدوير الرأس والجذع العلوي من الجسم المقدرة على رفع 1
المقدرة على تحريك اليد وتدوير الجزء العلوي من الجذع خلال  2
 خط المنتصف
القدرة على فرد اليد الدافعة للجسم، تدوير الجزء السفلي من الجذع  3
 ورفع القدمين عن السرير
 القدرة على تحميل الوزن على المؤخرة. 4
 ع الايدي عن السريرالقدرة على الجلوس ورف 5
 
 الخروج من السرير
  
 الخروج من السرير -41
 الوقوف من حالة الجلوس للخروج من السرير 
 التقدم للأمام الى حافة السرير 
 رفع الجسم للجلوس 
 الدوران للجانب (في السرير) 
 تدوير الرأس وثني الرجلين مع تثبيت اليدين 
 غير قادر على عمل أي منهم 0
 ةقادر على عمل واحد 1
 قادر على عمل اثنتين 2
 قادر على عمل ثلاث 3
 قادر على عمل أربعة 4
 قادر على عملهم كلهم 5
 
 تغير الوضعية من الاستلقاء الى الوقوف من دون الم -51
 غير قادر على تحقيق الوضعية من غير ألم 0
 قادر على تحقيق وضيعة الاستلقاء من غير ألم بمساعدة من أحد 1
 ة الاستلقاء من غير ألم وبشكل مستقلقادر على تحقيق وضعي 2
 المقدرة على التنقل بين الاستلقاء والوقوف من غير ألم 3
 الوقوف من غير ألم 4
 الوقوف من حالة الاستلقاء من غير الشعور بألم 5
 
 الوقوف من الجلوس
 
 الوقوف من الجلوس -61
 غير قادر 0
 قادر على التحرك للأمام من فوق الكرسي أو السرير 1
 ر على نقل الوزن فوق الاقدامقاد 2
 المقدرة على رفع المؤخرة من على الكرسي او السرير 3
 المقدرة على فرد أي من الحوض أو الركبتين أو الجذع. 4
 المقدرة على فرد الحوض والركبتين والجذع 5
 
 الجلوس من الوقوف -71
 استطاعة الجلوس ولكن من غير تحكم 0
 ضعية الوقوفاحضار وزن الجسم الى الأمام من و 1
 ثني الحوض والركبتين 2
 وضع اليدين على الكرسي 3
 إنزال الجسم بشكل سلس الى الكرسي 4
 تحريك الحوض الى ظهر الكرسي لأخذ وضعية الجلوس 5
 
 الوقوف من وضعية الجلوس على الأرض -81
 عدم المقدرة على نقل الوزن بوضعية الجلوس الجانبي. 0
 ية الجلوس الجانبيقادر على نقل وزن الجسم الى وضع 1
 قادر على تحريك الوزن الى الأمام فوق الركبتين 2
قادر على فرد الحوض الى الاعلى لأخذ وضعية الوقوف على  3
 الركب ومن ثم تحريك القدم غير محملة الوزن على الأرض
 المقدرة على تحميل الوزن على القدم وفرد الحوض والركبة 4
 القدرة على الوقوف 5
 
 لى وضعية الجلوسالمحافظة ع
 
 الجلوس بدون ألم -91
 غير قادر على الجلوس بسبب الألم 0
الالم يقاطع الجلوس لمدة (تحديد المدة الزمنية)، غير قادر على  1
 المتابعة
الالم يقاطع الجلوس لمدة (تحديد المدة الزمنية) ولكنني قادر على  2
 المواصلة
الزمنية) ولكن  قادر على الجلوس من غير ألم لمدة (تحديد المدة 3
 هنالك ألم يكون لاحقا  
قادر على الجلوس من غير ألم لمدة (تحديد المدة الزمنية) ولكن  4
 هنالك عدم ارتيا  يكون لاحقا  
 قادر على الجلوس لمدة (تحديد المدة الزمنية) من غير عدم الارتيا  5
 
 المحافظة على وضعية الوقوف
 
 الوقوف بدون ألم -02
 ف بسبب الألمغير قادر على الوقو 0
الالم يقاطع الوقوف لمدة (تحديد المدة الزمنية)، غير قادر على  1
 المتابعة
الالم يقاطع الوقوف لمدة (تحديد المدة الزمنية) ولكنني قادر على  2
 المواصلة
قادر على الوقوف من غير ألم لمدة (تحديد المدة الزمنية) ولكن  3
 هنالك ألم يكون لاحقا  
ف من غير ألم لمدة (تحديد المدة الزمنية) ولكن قادر على الوقو 4
 هنالك عدم ارتيا  يكون لاحقا  
 قادر على الوقوف لمدة (تحديد المدة الزمنية) من غير عدم الارتيا  5
 
 الانحناء للأمام من وضعية الوقوف
 
 تحريك الجذع من غير الشعور بالألم -12
 غير قادر على ثني الجذع للأمام بسبب الألم 0
يكون عند البدء بثني الجذع ولكن ليس هنالك ألم في وضعية  الالم 1
 الوقوف
 الشعور بالألم عند ثني الجذع، ولكن ليس بشكل كامل 2
 ليس هنالك الم عند ثني الجذع ولكن ليس بشكل كامل 3
 الشعور بالألم عند ثني الجذع بشكل كامل 4
 عدم الشعور بالألم عند ثني الجذع بشكل كامل للأمام 5
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 قرمزة من وضعية الوقوفال
 
 القرمزة من وضعية الوقوف -22
 قادر على ثني الرأس الى الأمام 0
 قادر على ثني الجذع الى الأمام 1
 قادر على ثني الحوض 2
 قادر على ثني الركبتين 3
 قادر على ثني مفصل الكاحل 4
 قادر على المحافظة على وضعية القرمزة بشكل مستقل 5
 
 الوقوف من وضعية القرمزة -32
 غير قادر على فرد الحوض والركبتين 0
 قادر على فرد الركبتين 1
 قادر على فرد الحوض 2
 قادر على فرد أسفل الظهر الى الاعلى 3
 قادر على فرد اعلى الظهر للوصول الى الاستقامة 4
 رفع الراس الى الاعلى بالوضعية المحايدة 5
 
 المشي
 
 مشي مسافة خارج البيت -42
الى الباب بدون الاحساس بالألم (خلال او غير قادر على المشي  0
 بعد).
 قادر على المشي داخل الغرفة من دون ألم 1
 قادر على المشي الى الغرفة المجاورة من دون ألم 2
 قادر على المشي في ممر البيت كاملا  (الكريدور) بدون ألم 3
 قادر على المشي كل المسافات داخل البيت، من دون ألم 4
 شي كل المسافات خارج البيت من دون ألمقادر على الم 5
 
 المشي من دون الم في أسفل الظهر -52
غير قادر على البدء بالوقوف من الجلوس للتحضير للمشي بسبب  0
 ألم أسفل الظهر
قادر على البدء بالوقوف من الجلوس للتحضير للمشي، ولكن غير  1
 قادر على المشي بسبب ألم أسفل الظهر
 طع المشي ولا أقدر المواصلةألم أسفل الظهر يقا 2
 ألم أسفل الظهر يقاطع المشي ولكن أستطيع المواصلة 3
 قادر على المشي بدون مقاطعة مع وجود الألم في أسفل الظهر 4
 قادر على المشي من دون ألم في أسفل الظهر 5
 
 المشي بشكل مستقل -62
 المشي الى الامام 
 المشي الى الخلف 
 المشي جانبيا   
 المشي خلال حلقة 
 المشي حول عوائق 
 
 غير قادر على عمل أي منهم 0
 قادر على عمل واحدة 1
 قادر على عمل اثنتين 2
 قادر على عمل ثلاث 3
 قادر على عمل أربعة 4
 قادر على عملهم كلهم 5
 
 المشي بشكل مستقل  -72
 غير قادر على المشي 0
 أمشي بمساعدة قاعدتين للدعم (شخصين). 1
 للدعم (شخص).أمشي بمساعدة قاعدة واحدة  2
 أمشي بمساعدة عكاز أو إطار للمشي 3
 أمشي بدون أي مساعدة ولكن بظهر ملتوي للأسفل أو الجانب 4
 أمشي بدون مساعدة أحد وبظهر معتدل 5
 
 أداء وظيفة المشي -82
 المشي في عدة اتجاهات 
 تغيير الاتجاهات 
 المشي على الأسطح المختلفة في الحياة اليومية 
 المنحدرات قادر على التعامل مع 
 قادر على التعامل مع الأماكن الضيقة 
 غير قادر على عمل أي منهم 0
 قادر على عمل واحدة 1
 قادر على عمل اثنتين 2
 قادر على عمل ثلاث 3
 قادر على عمل أربعة 4
 قادر على عملهم كلهم 5
 
 الركض
 الركض في اتجاه واحد على أرض مستوية بدون ألم* -92
 ملاحظات* تحدد المسافة في صفحة ال
غير قادر على الهرولة أو الركض في اتجاه واحد على أرض  0
 مستوية
قادر على الهرولة أو الركض في اتجاه واحد على أرض مستوية  1
 ولكن مع ألم شديد في الرجل
قادر على الهرولة أو الركض في اتجاه واحد على أرض مستوية  2
 مع عرج شديد من دون ألم
ركض في اتجاه واحد على أرض مستوية قادر على الهرولة أو ال 3
 مع عرج خفيف** بدون ألم
قادر على الهرولة أو الركض في اتجاه واحد على أرض مستوية  4
 بدون عرج ولا ألم ولكن أتعب بسرعة
قادر على الهرولة أو الركض في اتجاه واحد على أرض مستوية  5
 من دون ألم ولا تعب ولا عرج.
 صل خلال المشي** عرج خفيف بشكل غير متوا
 
الركض على سطح غير مستوي مع تغيير الاتجاه وسرعة  -03
 المشي وعدم وجود مشاكل لاحقا*ً
 يتم تحديد المسافة في صفحة الملاحظات* 
 الركض باتجاهات مختلفة 
 الركض على أرض غير مستوية 
 استطاعة تغيير سرعة الركض 
 الركض على أرض مستوية 
 الركض باتجاه واحد 
 عمل أي منهمغير قادر على  0
 قادر على عمل واحدة 1
 قادر على عمل اثنتين 2
 قادر على عمل ثلاث 3
 قادر على عمل أربعة 4
 قادر على عملهم كلهم 5
 
 الهرولة من دون ألم -13
 غير قادر على المشي المسافة المطلوبة* بدون ألم 0
 قادر على مشي المسافة المطلوبة* بدون ألم 1
 ادر على هرولة المسافة المطلوبةالألم يقاطع الهرولة ولكن ق 2
 قادر على تغيير سرعة الهرولة من دون ألم 3
 قادر على تغيير اتجاه الهرولة من دون ألم 4
 قادر على هرولة المسافة المطلوبة* بدون ألم 5
 
 صعود ونزول السلالم
 
 صعود السلالم بدون ألم* -23
 يتم تحديد كم درجة في صفحة الملاحظات *
 د الدرجاتالألم يمنع صعو 0
الألم يمنع صعود الدرجات ولكن أستطيع المشي بنفس الطابق بدون  1
 ألم
 الألم يقاطع صعود الدرجات ولا أستطيع المتابعة بدون مساعدة 2
 الألم يقاطع صعود الدرجات ولكنني أستطيع المتابعة بدون مساعدة 3
الألم موجود عند صعود الدرجات ولكنني أستطيع المواصلة من  4
 مقاطعة غير
 ليس هنالك ألم عند صعود الدرجات 5
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 صعود الدرجات* -33
 * يتم تحديد كم درجة في صفحة الملاحظات
 غير قادر على وضع القدم على الدرجة 0
قادر على نقل القدم على الدرجة وتحميل وزن الجسم على القدم  1
 الأخرى مع المحافظة على توازن الجسم
 دم الموضوعة على الدرجةقادر على نقل وزن الجسم على الق 2
 قادر على فرد الركبة الأمامية حاملة الوزن والحوض. 3
 قادر على ثني الحوض والقدم غير حاملة الوزن  4
 قادر على وضع القدم الأخرى على الدرجة 5
 
 استخدام السلالم* بدون ألم -43
 * يتم تحديد عدد الدرجات في صفحة الملاحظات
 بدون ألمغير قادر على تحميل وزن الجسم  
 غير قادر على صعود الدرج بدون ألم 
 غير قادر على نزول الدرج بدون ألم 
 غير قادر على المحافظة على التوازن بسبب الألم 
 احتاج مساعدة عند صعود الدرج بسبب الألم 
 
 كل هذه المشاكل موجودة 0
 وجود أربعة مشاكل 1
 وجود ثلاثة مشاكل 2
 وجود مشكلتين 3
 وجود مشكلة واحدة 4
 لا يوجد أي من هذه المشاكل 5
 
 نزول الدرجات* -53
 * يتم تحديد عدد الدرجات في صفحة الملاحظات
 غير قادر على وضع القدم على الدرجة السفلية 0
قادر على نقل القدم على الدرجة السفلية مع تحميل الوزن على القدم  1
 الأخرى
  قادر على وضع القدم غير حاملة الوزن على الدرجة السفلية 2
 قادر على نقل الوزن على القدم الموضوعة على الدرجة السفلية 3
 قادر على ثني الحوض والركبة والكاحل للقدم الخلفية 4
 قادر على وضع القدم الأخرى على الدرجة السفلية 5
 
 تحميل الأوزان
 
 تحميل الأوزان بدون ألم -63
 غير قادر على ثني الجذع بسبب الألم 0
 دون ألمقادر على ثني الحوض ب 1
ولكن لا أستطيع  (حدد الوزن الأقل بالكيلو غرام)قادر على رفع  2
 المواصلة بسبب الألم
 بدون ألم (حدد الوزن الأقل بالكيلو غرام)قادر على رفع  3
 بدون ألم (حدد الوزن المتوسط بالكيلو غرام)قادر على رفع  4
 بدون ألم (حدد الوزن الأكبر بالكيلو غرام)قادر على رفع  5
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Appendix K: Invitation to a scientific meeting 
 
 
 
 
 
Low back pain physical functioning indicators 
We have the pleasure of inviting you to participate in a scientific meeting on the 
“Development and validation of TELER physical functioning indicators for use in 
musculoskeletal rehabilitation for people with low back pain”.  
The meeting will take place on the 20th of December 2013 in the Jordanian Society of 
Physiotherapy, Tabarbour. 
Aim of the meeting 
The objective of this scientific meeting is to obtain experts opinion of a newly developed 
measurement tool that measures functional activities following physiotherapy. We are 
inviting academics and clinicians from physiotherapy clinics to participate and attend this 
meeting. Participants will be experts in the measurement, musculoskeletal physiotherapy, 
or the TELER method of measurement. 
Meeting Plan 
We are aiming to make the day interesting and useful to you as well as informative to us. 
The meeting will consist of three parts: 
1- A short presentation of the protocol by which the TELER physical functioning 
indicators were developed. 
2- An introduction to the TELER method of measurement. 
3- A structured discussion to generate consensus on the TELER physical functioning 
indicators. These indicators will then be tested in three private physiotherapy 
clinics in Amman. 
If you would like to participate in this meeting, we would be thankful if you could respond 
as soon as possible to Thamer Altaim (t.altaim@sheffield.ac.uk / 0785818800).  
We look forward to hearing from you soon. 
Yours sincerely, 
Thamer Ahmad Altaim 
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Appendix L: Topic guideline for experts’ meetings 
 
                                                                               
 
 
Scientific meeting: Development and validation of TELER physical functioning indicator 
for use in musculoskeletal rehabilitation for people with low back pain 
Consensus meeting: A questionnaire to assess the validity of the TELER physical functioning indicator for use in musculoskeletal rehabilitation 
for people with low back pain 
 
Thamer Ahmad Altaim 
 
 Please note that this questionnaire contains a working sheet for each TELER physical functioning indicator. 
 You will be given 5 minutes to complete each evaluation sheet during the meeting. 
 Please answer each question by placing a mark in the appropriate box. 
 In the case you answer (NO) or (Don’t know) for any of the questions, please answer the questions provided below the table. 
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TELER indicator Assessment of validity Yes No Don’t 
know 
1 
Q1: Does this TELER function indicator seems to measure what is intended to 
measure? 
   
Q2: Are there any codes that do not denote a clinically significant outcome, that is, an 
outcome that can be justified by reference to clinical or other relevant knowledge? 
   
Q3: Are there any codes that do not have one clinical meaning?    
Q4: Are there any codes that do not denote a clinically significant change between two 
successive codes, that is, a change that can be explained by reference to clinical or 
other relevant knowledge? 
   
Q5: Are there any codes that do not denote an improvement or lack of deterioration 
between two successive codes that requires a clinically significant amount of 
therapeutic input? 
   
 
If you have answered (Yes) or (DON’T KNOW) for any of the above question, please answer the following questions. 
It is important that you write down all your ideas and thoughts as these would form the bases for the next rounds of the validation process: 
Why have you answered Yes/don’t know? 
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
 
How would you change the code to satisfy what is required by the question? 
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
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Appendix M: Physiotherapists’ consent form for the expert validation 
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Appendix N: Summary of NGT suggestions and comments 
 
Indicator 1: 
 Physiotherapists who took part in the NGT suggested replacing this indicator with a quiz-style indicator 
that covers all activities identified, in the qualitative study, as important to Jordanian individuals with 
LBP. This quiz-style indicator will play a key role in facilitating the partnership process between a 
physiotherapist and an individual with LBP. It will document all functional outcomes that are important to 
a LBP patient and determines whether or not selected goals were achieved by the end of 
physiotherapy. The quiz-style indicator is also important as a control point to exclude these TELER 
indicators that are not important to the patient (reduce the number of TELER indicators in the TELER 
LBP questionnaire). 
 The NGT also recommended adding the following words: “Low back pain does not prevents …”, “Low 
back pain prevents …” and “ … due to low back pain” to clarify that any limitations in functional 
performance were because of LBP and not something else such as the inability to walk because of 
rheumatoid arthritis in the knees joints. 
 Participants suggested using the TELER clinical note system to document any other conditions that the 
patients might have other than LBP. 
 Participants pointed out that some of the LBP patients might restore all of their lost functions despite the 
fact that they continue to experience the symptoms of LBP. They suggested involving the patient in the 
measurement process and discussing the possibility of a discharge without reaching to code 5. 
 Participants suggested that the notes section in part 1 in the TELER LBP questionnaire could be used 
to document important information such as pain location or the presence of a carer. 
 The NGT recommended adding question 29 in part 1 in order to ensure that the list in the quiz-style 
questionnaire included all outcomes that are important to the patient and to ensure that this list does not 
limit choices. 
 Consensus reached in the first session to replace this indicator with a list of activities in the first part of 
TELER LBP questionnaire. 
Indicator 2: 
 The NGT consented that this TELER indicator is important for the measurement of any activity that 
therapists cannot break it down into components (movement analysis) because of the its nature (e.g. 
maintaining a position) or the differences between individuals in the performance of such an activity. 
 Participants recommended few changes to the Arabic translation to enhance clarity (e.g. code 5  مدع
هنم ءاهتنلاا دعب و طاشنلا للاخ ملأب روعشلا/ code 1ةعباتملا ىلع ةردقملا مدع عم ىمسملا طاشنلا عطاقي مللأا / code 
4:ىمسملا طاشنلا لامكإ دعب مللأاب روعشلا /  
 Participants agreed that each code was clear and provided a singular meaning. 
 Consensus reached in the first session to include the amended indicator in the TELER LBP 
questionnaire. 
Indicator 3: 
 Participants pointed out that some of the activities included in this indicator were covered in more 
details in other TELER indicators in the same questionnaire. 
 Participants identified redundancy and overlap between codes (e.g. standing). 
 There are two types of toilets in Jordan and the movements required to use each one of them are 
different. The codes in this indicator do not cover the movements necessary to use a squat toilet. 
 Participants found the words “managing clothes” a source of confusion as it carries more than one 
meaning and requires more clarifications. 
 Participants recommended excluding this indicator from the TELER LBP questionnaire. 
 Consensus reached in the first session to exclude this indicator. 
Indicator 4: 
 Participants indicated that all of the activities in this indicator can be performed in, at least, two different 
positions. For example, washing the feet can be performed over the bathroom sink (fully bending hip 
and knee joints/internal rotation in hip) or in the bathtub (partial bending of hip and full extension in knee 
joint). The neurodynamics in each position is different. 
 This might be a source of confusion as each choice in this indicator carry more than one meaning. 
 Consensus reached in the first session to exclude this indicator [9/10]. 
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Indicator 5: 
 One of the participants indicated that the sequence of events in this indicator is incorrect. He suggested 
that the activity in code 4 should come before the activity mentioned in code 3. This is because the 
activity in code 3 is more difficult to achieve more than the activity mentioned in code 4. 
 Participants consented that after reaching to code 1 the patient should be transferred to a sport 
medicine clinic. This is because the activities described in codes 2-5 require specialised training that is 
beyond physiotherapy management of LBP. 
 Two physiotherapists suggested that the description of code 3 is unclear and carry more than one 
meaning [controlled and paced]. 
 Consensus reached in the first session to exclude this indicator. 
Indicator 6: 
 Participants suggested that this TELER indicator represents an “impairment” rather than “functional 
performance”. It measures more than one construct at the same time which violate one of the principles 
of measurement in a clinical context. 
 Consensus reached in the first session to exclude this indicator. 
Indicator 7: 
 Consensus reached in the first session to replace this indicator with the LBP quiz-style questionnaire 
[10/10]. 
Indicator 8: 
 The codes in this indicator were similar to the codes in indicator 10. 
 Consensus reached in the first session to exclude this indicator. 
Indicator 9: 
 Participants indicated that there were similarity between this indicator and indicator 8. 
 One of the participants suggested to document whether the patient is under medication effect at the 
time of measurement of “functional performance”. 
 Consensus reached in the first session to exclude this indicator. 
Indicator 10: 
 Participants suggested the following changes: 
 Code 2: “Low back pain interrupts sleeping, unable to return back to sleep”. 
 Code 3: “Low back pain interrupts sleeping, able to return back to sleep”. 
 Code 4: “Low back pain does not interrupt sleeping, pain when waking up”. 
 Code 5: “Low back pain does not prevent sleeping”. 
 Participants checked the translation and amended the Arabic indicator to reflect the changes made 
above. 
 Consensus reached in the second session to include the amended indicator in the TELER LBP 
questionnaire. 
Indicator 11: 
 Participants suggested changing “ضوحلا لصفم” to “كرولا لصفم”. 
 Consensus reached in the second session to include the amended indicator in the TELER LBP 
questionnaire. 
Indicator 12: 
 Participants recommended changing code 4 to “دعاسلا مادختساب ىلعلأا ىلا مسجلا عفد”. 
 Consensus reached in the second session to include the amended indicator in the TELER LBP 
questionnaire. 
Indicator 13: 
 Participants recommended adding photos that demonstrate the activities described in each code. They 
suggested that this would enhance the clarity. 
 Consensus reached in the second session to include this indicator in the TELER LBP questionnaire. 
Indicator 14: 
 Participants recommended changing “ريرسلا ةفاح ىلا ماملأل مدقتلا” to “ ىلا لاقتنلاا ريرسلا ةفاح ”. 
 Participant found similarities between this component indicator and indicator 15. 
 Consensus reached in the first session to exclude this indicator. 
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Indicator 15: 
 Participants recommended the following amendments: 
 Code 0: “Low back pain prevents standing up”. 
 Code 1: “Low back pain does not prevent sitting over the edge of the bed [with help]”. 
 Code 2: “Low back pain does not prevent sitting over the edge of the bed [without help]”. 
 Code 3: “Low back pain does not prevent transferring between sitting and standing [without help]”. 
 Code 4: “Low back pain does not prevent maintaining a standing position [without support]”. 
 Code 5: “Low back pain does not prevent walking away from bed [without help]”. 
 Consensus reached in the second session to include the amended indicator in the TELER LBP 
questionnaire. 
Indicator 16: 
 Participants recommended the following amendments: 
 Code 0: “Low back pain prevents standing up from sitting position”. 
 Code 2: “مادقلأا قوف نزولا لقن ىلع رداق” to “ نزو لمح ىلع رداق مادقلأا ىلع مسجلا ”.  
 Adding to Code 4 “مهعيمج سيل”. 
 Code 5: “ةماقتساب فوقولا ةيعضو قيقحتل لماك لكشب عذجلا و نيتبكرلا و ضوحلا درف ىلع رداق”. 
 Participants agreed that the codes represent a recovery pattern and each code provide a singular 
meaning. 
 Consensus reached in the third session to include the amended indicator in the TELER LBP 
questionnaire. 
Indicator 17: 
 Participants reviewed the translation and recommended few changes to the language to enhance the 
clarity. 
 Participants agreed that the codes represent a recovery pattern and each code provide a singular 
meaning. 
 Consensus reached in the third session to include the amended indicator in the TELER LBP 
questionnaire. 
Indicator 18: 
 Participants reviewed the translation and recommended few changes to the language to enhance the 
clarity. 
 Participants recommended adding photos that demonstrate the activities described in each code. They 
suggested that this would enhance the clarity. 
 Consensus reached in the third session to include the amended indicator in the TELER LBP 
questionnaire. 
Indicator 19: 
 Participants reviewed the translation. They did not recommend any changes. 
 Participants agreed that the codes represent a recovery pattern and each code provide a singular 
meaning. 
 Consensus reached in the third session to include this indicator in the TELER LBP questionnaire. 
Indicator 20: 
 Participants reviewed the translation. They did not recommend any changes. 
 Participants agreed that the codes represent a recovery pattern and each code provide a singular 
meaning. 
 Consensus reached in the third session to include this indicator in the TELER LBP questionnaire. 
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Indicator 21: 
 Participants recommended the following amendments: 
 Changing the title “ملأب روعشلا نود نم ماملأا ىلا عذجلا كيرحت”. 
 Code 0: “Low back pain prevents bending the trunk forward”. 
 Code 1: “Low back pain does not prevent initiating forward bending, pain free at standing position”. 
 Code 2: “Low back pain prevents reaching to the mid-range of forward bending, unable to continue”. 
 Code 3: “Low back pain does not prevent reaching to the mid-range of forward bending; however, 
unable to fully forward bend the trunk”. 
 Code 4: “Low back pain when reaching to full forward bending”. 
 Code 5: “Low back pain does not prevent forward bending [feeling no pain]. 
 Participants recommended developing a new indicator that measure LBP patients to extend their back 
from a forward bending position. The new indicator was created in the same meeting and was validated 
by the participants. 
 Consensus reached in the third session to include the amended indicator in the TELER LBP 
questionnaire. 
Indicator 22: 
 Participants recommended the following amendments: 
 Changing “ةزمرق” to “ءاصفرق”. 
 Changing “ضوحلا لصفم” to “كرولا يلصفم”. 
 Code 0: “Low back pain prevents squatting”. 
 Code 1: “Low back pain does not prevent leaning forward in preparation of squatting”. 
 Code 2: “Low back pain interrupts bending the hips, knees and ankles joints, unable to continue”. 
 Code 3: “Low back pain interrupts bending the hips, knees and ankles joints, able to continue”. 
 Code 4: “Low back pain does not prevent squatting, unable to maintain this position due to low back 
pain”. 
 Code 5: “Low back pain does not prevent squatting and able to maintain this position”. 
 Consensus reached in the fourth session to include the amended indicator in the TELER LBP 
questionnaire. 
Indicator 23: 
 Participants recommended the following amendments: 
 Changing “ةزمرق” to “ءاصفرق”. 
 Changing “ضوحلا لصفم” to “كرولا يلصفم”. 
 Code 0: “Low back pain prevents standing up straight from squatting position”. 
 Code 1: “Low back pain interrupts extending the hips, knees and ankles joints, unable to continue”. 
 Code 2: “Low back pain interrupts extending the hips, knees and ankles joints, able to continue”. 
 Code 3: “Low back pain does not prevent raising the lower back upwards. 
 Code 4: “Low back pain does not prevent raising the upper back upwards to fully straighten up”. 
 Code 5: “Low back pain does not prevent standing up straight from squatting”. 
 Consensus reached in the fourth session to include the amended indicator in the TELER LBP 
questionnaire. 
Indicator 24: 
 Participants suggested limiting the activities in this indicator to walking inside the house. This was 
clarified in the title of the indicator [Walking a distance indoors]. 
 Participants recommended the following amendments: 
 Code 0: “Low back pain prevents walking to the door of the room”. 
 Code 1: “Low back pain does not prevent walking to the door of the room”. 
 Code 2: “Low back pain does not prevent walking to the next room”. 
 Code 3: “Low back pain does not prevent walking all distances indoors with the presence of 
symptoms”. 
 Code 4: “Low back pain does not prevent walking all distances indoors, pain after the completion 
of walking”. 
 Code 5: “Low back pain does not prevent walking all distances indoors, pain free during and after 
the completion of walking”. 
 Consensus reached in the fourth session to include the amended indicator in the TELER LBP 
questionnaire. 
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Indicator 25: 
 Participants suggested limiting the activities in this indicator to walking outside the house. This was 
clarified in the title of the indicator [Walking a distance outdoor]. 
 Participants recommended the following amendments: 
 Code 0: “Low back pain prevents walking to the door of the room”. 
 Code 1: “Low back pain does not prevent walking to the door of the room”. 
 Code 2: “Low back pain does not prevent walking to the next room”. 
 Code 3: “Low back pain does not prevent walking all distances indoors with the presence of 
symptoms”. 
 Code 4: “Low back pain does not prevent walking all distances indoors, pain after the completion 
of walking”. 
 Code 5: “Low back pain does not prevent walking all distances indoors, pain free during and after 
the completion of walking”. 
 Consensus reached in the fourth session to include the amended indicator in the TELER LBP 
questionnaire. 
Indicator 26: 
 Participants suggested that this component indicator is similar to indicator 28. 
 Consensus reached in the fourth session to exclude this indicator. 
Indicator 27: 
 Participants recommended the following amendments: 
 Code 0: “Low back pain prevents walking”. 
 Code 1: “Low back pain does not prevent walking with help from two bases of support [two 
individuals]”. 
 Code 2: “Low back pain does not prevent walking with help from one base of support [a person]”. 
 Code 3: “Low back pain does not prevent walking with help of stick”. 
 Code 4: “Low back pain does not prevent walking without support but with bent trunk”. 
 Code 5: “Low back pain does not prevent walking without support and with a straight back”. 
 Participants validated the translation. 
 Consensus reached in the fourth session to include the amended indicator in the TELER LBP 
questionnaire. 
Indicator 28: 
 Participants validated the translation. 
 Participants did not recommend any changes to this indicator. 
 Consensus reached in the fourth session to include the amended indicator in the TELER LBP 
questionnaire. 
Indicator 29: 
 Participants suggested that jogging and running were two different activities; therefore, they 
recommended splitting this indicator into two functional indicators. 
 Participants indicated that it is illogical to expect a LBP patient to limp without pain. 
 The recovery pattern is unclear especially between codes 3 and 4. 
 Participants recommended the following amendments: 
 Code 0: “Low back pain prevents jogging specify distance”. 
 Code 1: “Low back pain interrupts jogging specify distance, unable to continue”. 
 Code 2: “Low back pain interrupts jogging specify distance, able to continue”. 
 Code 3: “Low back pain during jogging specify distance, able to continue without interruption”. 
 Code 4: “Low back pain does not prevent jogging specify distance, pain in the lower back after the 
completion of the task”. 
 Code 5: “Low back pain does not prevent jogging specify distance”. 
 Consensus reached in the fifth session to include the amended indicator in the TELER LBP 
questionnaire. 
Indicator 30: 
 Participants indicated that there were an overlap between the first choice and the last choice in the list. 
 Consensus reached in the fifth session to exclude this indicator. 
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Indicator 31: 
 Participants recommended the following amendments: 
 Code 0: “Low back pain prevents running specify distance”. 
 Code 1: “Low back pain interrupts running specify distance, unable to continue”. 
 Code 2: “Low back pain interrupts running specify distance, able to continue”. 
 Code 3: “Low back pain during running specify distance, able to continue without interruption”. 
 Code 4: “Low back pain does not prevent running specify distance, pain in the lower back after the 
completion of the task”. 
 Code 5: “Low back pain does not prevent running specify distance”. 
Consensus reached in the fifth session to include the amended indicator in the TELER LBP questionnaire. 
Indicator 32: 
 Participants recommended the following amendments: 
 Code 0: “Low back pain prevents climbing up stairs”. 
 Code 1: “Low back pain interrupts climbing up stairs, unable to continue”. 
 Code 2: “Low back pain interrupts climbing up stairs, able to continue”. 
 Code 3: “Low back pain during climbing up stairs, able to continue without interruption”. 
 Code 4: “Low back pain does not prevent climbing up stairs, pain in the lower back after the 
completion of the task”. 
 Code 5: “Low back pain does not prevent climbing up stairs”. 
Consensus reached in the fifth session to include the amended indicator in the TELER LBP questionnaire. 
Indicator 33: 
 Participants validated the translation. 
 Participants did not recommend any changes to this indicator. 
 Consensus reached in the fifth session to include the amended indicator in the TELER LBP 
questionnaire. 
Indicator 34: 
 Participants recommended using this component indicator as a control point that direct to other 
indicators. 
 Participants validated the translation. 
 Participants did not recommend any changes to this indicator. 
 Consensus reached in the fifth session to include the amended indicator in the TELER LBP 
questionnaire. 
Indicator 35: 
 One of the participants suggested that in order to place the non-weight bearing in the lower steep, the 
patient should be able to bend the rear leg. Therefore, the descriptors of code 3 and 4 were reversed. 
 Consensus reached in the fifth session to include the amended indicator in the TELER LBP 
questionnaire. 
Indicator 36: 
 Participants recommended adding two functional indicators for carrying weights and lowering a carried 
weight. These indicators were constructed in the same session and were validated by physiotherapists. 
 Participants recommended changing weights in the codes to represent “objects” and not “kilograms”. 
 Consensus reached in the fifth session to include these indicators in the TELER LBP questionnaire. 
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Appendix O: TELER LBP indicators following the expert panel meetings 
 
A1 - Sleeps continuously without disruption due 
to low back pain (without taking medications) 
⓿ Unable to sleep due to pain*. 
❶ Wakes up from sleeping due to pain*, unable to 
go back to sleep due to this pain*. 
❷Wakes up from sleeping due pain*, but able to go 
back to sleep. 
❸ There is pain* but it doesn’t prevent and doesn’t 
interrupt sleep 
❹There is no pain* in going to sleep, but there is 
pain* on  waking up. 
❺ Pain* free in sleeping and in waking up. 
* Pain in the lower back 
A1 - نودب لصاوتم لكشب مونلا مللأا ببسب ةعطاقم   لفسأ يف
رهظلا  )تانكسملا ذخأ نودب و( 
⓿ ريغ رهظلا لفسأ يف مللأا ببسب مونلا ىلع رداق 
❶  لفسأ يف مللأا ببسب مونلا نم ظقيتساريغ هببسبو ،رهظلا 
مونلا ىلا ةدوعلا ىلع رداق 
❷  لفسأ يف مللأا ببسب مونلا نم ظقيتسال ،رهظلانك ع رداق ىل
مونلل ةدوعلا 
❸  دوجوم رهظلا لفسأ يف مللأالا هنكلو  عنميعطاقي لاو مونلا 
❹ سيل  مللأا نكلو مونلل دولخلا دنع رهظلا لفسأ يف ملأ كلانه
 دنعءاهتنلاا مونلا نم 
❺ مون  رهظلا لفسأ يف ملأ نودب لصاوتم  اقحلا لاو  دنع
ظاقيتسلاا 
B1 – Bed mobility (not hierarchical) 
 Able to bend hips and knees. 
 Able to maintain hips and knees in flexion 
 Able to lift bottom 
 Able to shift bottom across 
 Able to shift shoulders and head across 
⓿Unable to do any of the above mentioned 
activities* 
❶ Able to do one* 
❷ Able to do two* 
❸ Abel to do three* 
❹ Able to do four* 
❺ Able to do all 
*Due to low back pain 
B1 - ريرسلا يف ةكرحلا  )يدعاصت ريغ( 
•  كرولا يلصفم ينث ىلع رداقنيتبكرلاو 
•  كرولا يلصفم ينث ىلع ةظفاحملا ىلع رداقتبكرلاوني 
• ةرخؤملا عفر ىلع رداق 
• بناجلل ةرخؤملا كيرحت ىلع رداق 
•  ىلع رداق نيفتكلا كيرحتبناجلل سأرلاو 
⓿ *مهنم يأ قيقحت ىلع رداق ريغ 
❶ * ةدحاو قيقحت ىلع رداق 
❷ * نيتنثا قيقحت ىلع رداق 
❸ * ةثلاث قيقحت ىلع رداق 
❹ * ةعبرأ قيقحت ىلع رداق 
❺ رداق مهلك مهقيقحت ىلع 
رهظلا لفسأ ملأ ببسب * 
B2 – Lying to sitting over edge of bed 
⓿ Cannot move functionally in bed* 
❶ Can achieve crock lying** 
❷ Can achieve modified bridge to move sideways** 
❸ Can roll into side lying (with knees bent) ** 
❹ Push the body upwards supported on forearms** 
❺ Able to achieve sitting at the edge of the bed (by 
dropping legs over side and pushing the body 
upwards using arms) ** 
*Due to low back pain 
** Low back pain does not prevent this movement. 
B2 -  نم ضوهنلاءاقلتسلاا ريرسلا فرط ىلع سولجلا ىلا 
⓿  لاعيطتسأ  ريرسلا يف ةكرحلامللأا ببسب رهظلا لفسأ يف 
❶ ينث عيطتسأ بكرلا للاخ نيتءاقلتسلاا 
❷ عيطتسأ نيبناجلا ىلا كرحتلل رسجك مسجلا عفر 
❸ عيطتسأ )نيتبكرلا ينث عم( بناجلا ىلع مونلا ىلا نارودلا 
❹  ىلعلأل مسجلا عفددانتسلااب دعاسلا ىلع 
❺ عيطتسأ  لازنإ قيرط نع( ريرسلا فرط ىلع سولجلا قيقحت
 بناجلا ىلا نيمدقلامسجلا عفدو ىلعلأل )ديلاب 
B3 – Lying to sitting on bed 
⓿ Unable to sit in bed from lying due to low back 
pain 
❶ Able to lift and turn head and upper trunk** 
❷ Able to move arm under the body and rotate head 
and the upper trunk** 
❸ Able to extend the supporting arm, rotate lower 
trunk and lift legs off bed** 
❹ Able to transfer weight onto bottom** 
❺ Able to get into sitting and release/use/lift arms** 
** Low back pain does not prevent this movement. 
B3 -  نم ضوهنلاءاقلتسلاا  درف عم ريرسلا ىلع سولجلل
نيلجرلا 
⓿ ا ىلع سولجلا ىلع رداق ريغ ةيعضو نم ريرسلءاقلتسلاا 
رهظلا لفسأ ملأ ببسب 
❶  عفر ىلع رداقسأرلا ريودتو يولعلا عذجلاو مسجلا نم 
❷  مسجلا تحت ديلا كيرحت ىلع رداقءزجلا ريودتو  نم يولعلا
عذجلا 
❸  نم يلفسلا ءزجلا ريودت ،مسجلل ةمعادلا ديلا درف ىلع رداق
 عذجلانيمدقلا عفرو ريرسلا ىلع 
❹ ت ىلع رداق.ةرخؤملا ىلع نزولا ليمح 
❺  سولجلا ىلع رداقيديلأا عفرو ريرسلا نع 
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C1 – Get out of bed without help 
⓿ Unable to get out of bed due to low back pain 
❶ Able to achieve sitting over the edge of the bed 
with help 
❷ Able to achieve sitting over the edge of the bed 
without help 
❸ Able to transfer between sitting and standing 
without help 
❹ Able to maintain standing without support 
❺ Walking away from the bed without help 
C1 - ةدعاسم نودب ريرسلا نم جورخلا 
⓿ رهظلا لفسأ يف ملأ ببسب ريرسلا نم جورخلا ىلع رداق ريغ 
❶ ق ىلع رداةيعضو قيقحت سولجلا  ريرسلا فرط ىلع
 ةدعاسمب 
❷ رداق  سولجلا ةيعضو قيقحت ىلعةدعاسم نودبو 
❸ ىلع رداق  فوقولا ىلا سولجلا نم لقنتلاةدعاسم نودبو 
❹ ةدعاسم نودب فوقولا ةيعضو ىلع ةظفاحملا 
❺ يشملا ريرسلا نع  اديعب ةدعاسم نود نم 
D1 – Standing up straight from sitting 
⓿Unable to stand from sitting due to low back pain 
❶ Able to move forwards on bed or chair* 
❷ Able to transfer body weight over feet* 
❸ Able to lift bottom off bed or chair* 
❹ Able to fully extend hips, knees or trunk (not all of 
them) to achieve standing* 
❺ Able to fully extend hips, knees and trunk to 
achieve standing up straight* 
* Low back pain does not prevent this movement. 
D1 -  فوقولاةماقتساب سولجلا نم 
⓿ رهظلا لفسأ ملأ ببسب سولجلا نم فوقولا ىلع رداق ريغ 
❶ سركلا قوف نم ماملأل كرحتلا ىلع رداقريرسلا وأ ي 
❷ مادقلأا ىلع مسجلا نزو لمح ىلع رداق 
❸ ريرسلا وأ يسركلا ىلع نم ةرخؤملا عفر ىلع رداق 
❹  لكشب عذجلا وأ نيتبكرلا وأ ضوحلا نم يأ درف ىلع رداق
.)مهعيمج سيل( لماك 
❺ رداق  ضوحلا درف ىلعلكشب عذجلاو نيتبكرلاو قحتل لماك قي
 فوقولا ةيعضوةماقتساب 
D2 – Sitting from standing 
⓿Sits down with no control due to low back pain 
❶ Brings body weight forwards, from standing 
position 
❷ Bends hips and knees 
❸ Use arms to support sitting 
❹ Lowers smoothly onto bed or chair 
❺ Sitting completely/properly on the bed or chair 
D2 - فوقولا نم سولجلا 
⓿ رهظلا لفسأ ملأ ببسب مكحت نود نم سولجلا 
❶ فوقولا ةيعضو يف ماملأا ىلا مسجلا نزو راضحإ 
❷  كرولا يلصفم ينثنيتبكرلاو 
❸ مادختسا سولجلا ىلع ةدعاسملل نيديلا 
❹ لازنإ ريرسلا وأ يسركلا ىلا سلس لكشب مسجلا 
❺ سولجلا  لماك لكشبملأ نودبو 
D3 – Standing up straight from floor sitting 
⓿Unable to transfer weight in side sitting due to low 
back pain 
❶ Able to transfer weight in side sitting 
❷ Able to transfer weight forwards over knees (in 
order to achieve kneeling position). 
❸ Able to extend hips into high kneeling and place 
non weight bearing foot on the floor 
❹ Able to transfer weight onto the foot (forward) and 
extend the hip and knee 
❺ Able to stand up straight. 
D3 -  فوقولاةماقتساب ضرلأا ىلع سولجلا ةيعضو نم 
⓿ لجلا ةيعضوب نزولا لقن ىلع ةردقملا مدع ببسب يبناجلا سو
.رهظلا لفسأ ملأ 
❶ يبناجلا سولجلا ةيعضو ىلا مسجلا نزو لقن ىلع رداق 
❷  ةيعضو قيقحتل( نيتبكرلا قوف ماملأا ىلا نزولا لقن ىلع رداق
)بكرلا ىلع فوقولا 
❸  ةيعضو ذخلأ ىلعلأا ىلا كرولا يلصفم درف ىلع رداق
 بكرلا ىلع فوقولامث نمو لا ةلمحم ريغ مدقلا كيرحت ىلع نزو
ضرلأا 
❹  ةيماملأا مدقلا ىلع نزولا ليمحت ىلع رداقيلصفم درفو 
 كرولاةبكرلاو 
❺ رداق  فوقولا ىلعةماقتساب 
E1 – Sitting for (specify time) without pain in the 
lower back 
⓿Unable to sit for (specify time) due to low back 
pain 
❶ Pain interrupts sitting for (Specify time), unable 
to continue 
❷ Pain interrupts sitting for (Specify time) but able 
to continue 
❸ Able to sit pain free for (Specify time) but 
experiences pain afterwards 
❹ Able to sit pain free for (Specify time) but 
discomfort afterwards 
❺ Able to sit for (Specify time) without problems 
E1 - رهظلا لفسأ يف ملأ نودب )ةينمزلا ةدملا ددح( ةدمل سولجلا 
⓿ ( ةدمل سولجلا ىلع رداق ريغةينمزلا ةدملا ددح مللأا ببسب )
رهظلا لفسأ يف 
❶ ( ةدمل سولجلا عطاقي مللأاةينمزلا ةدملا ددح ىلع رداق ريغ ،)
ةعباتملا 
❷ ا عطاقي مللاا( ةدمل سولجلةينمزلا ةدملا ددح رداق يننكلو )
ةلصاوملا ىلع 
❸ ( ةدمل ملأ نود نم سولجلا ىلع رداقةينمزلا ةدملا ددح نكلو )
  اقحلا نوكي ملأ كلانه 
❹ ( ةدمل ملأ نود نم سولجلا ىلع رداقةينمزلا ةدملا ددح نكلو )
  اقحلا نوكي  ايترا مدع كلانه 
❺ رداق ( ةدمل سولجلا ىلعملا ددحةينمزلا ةدلكاشم نود نم ) 
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F1 – Stands up straight for (Specify time) without 
low back pain 
⓿Unable to stand up straight for (Specify time) due 
to pain 
❶ Pain interrupts standing up straight for (Specify 
time), unable to continue 
❷ Pain interrupts standing up straight for (Specify 
time) but able to continue 
❸ Able to stand up straight pain free for (Specify 
time) but experiences pain afterwards 
❹ Able to stand up straight for (Specify time) pain 
free but experiences discomfort afterwards 
❺ Able to stand up straight for (Specify time) without 
problems 
F1 -  فوقولاةماقتساب  يف ملأ نودب )ةينمزلا ةدملا ددح( ةدمل
رهظلا لفسأ 
⓿  فوقولا ىلع رداق ريغةماقتساب ( ةدمل ةدملا ددحةينمزلا )
ببسب رهظلا لفسأ يف مللأا 
❶  فوقولا عطاقي مللأاةماقتساب ( ةدملةينمزلا ةدملا ددح،) ريغ 
ةعباتملا ىلع رداق 
❷  فوقولا عطاقي مللأاةماقتساب ( ةدمل ةدملا ددحةينمزلاننكلو )ي 
ةلصاوملا ىلع رداق 
❸  فوقولا ىلع رداقةماقتساب ( ةدمل ملأ ريغ نم ةدملا ددح
ةينمزلانكلو )   اقحلا نوكي ملأ كلانه 
❹  فوقولا ىلع رداقةماقتساب ( ةدمل ملأ ريغ نم ةدملا ددح
ةينمزلانكلو )   اقحلا نوكي  ايترا مدع كلانه 
❺ رداق  فوقولا ىلعةماقتساب ( ةدملةينمزلا ةدملا ددح نود نم )
لكاشم 
G1 – Bend trunk forward without feeling pain in 
the lower back 
⓿Unable to bend the trunk forwards because of pain 
❶ Pain on initiating forward bending, pain free at 
standing position 
❷ Pain on forward bending (before reaching mid-
range of trunk movement), unable to continue 
❸ Pain on forward bending, able to continue but 
cannot fully bend the trunk 
❹ Pain when trunk is  fully flexed 
❺ Full active range of trunk movement forwards, 
without feeling pain in the lower back 
G1 -  لفسأ يف مللأاب روعشلا نود نم ماملاا ىلا عذجلا ينث
رهظلا 
⓿ رهظلا لفسأ يف مللأا ببسب ماملأل عذجلا ينث ىلع رداق ريغ 
❶  عذجلا ينثب ءدبلا دنع نوكي رهظلا لفسأ يف مللاايل نكلوس 
وقولا ةيعضو يف ملأ كلانهف 
❷  لوصولا لبق( عذجلا ينث دنع رهظلا لفسأ يف مللأاب روعشلا
 ،)ةكرحلا ىدم فصتنمللا نكلو ةلصاوملا عيطتسأ 
❸  عذجلا ينث دنع رهظلا لفسأ يف مللأاب روعشلا عيطتسأو
ةلصاوملا سيل نكلو لماك لكشب 
❹  لفسأ يف مللأاب روعشلادنع رهظلا  ينثعذجلا لماك لكشب 
❺ ينث ماك لكشب عذجلارهظلا لفسأ يف ملأ نودب ماملأل ل 
G2 - Raising the trunk upwards to the upright position 
from bending forwards without feeling pain in the 
lower back 
⓿ Unable to rise trunk upwards due to low back pain 
❶ Pain initiating on raising the trunk upwards, pain 
free when bending the trunk forwards. 
❷ Pain when raising the trunk upwards (before 
reaching mid-range of trunk movement), unable to 
continue 
❸ Pain when raising the trunk upwards, able to 
continue but cannot stand up upright 
❹ Pain when standing up upright. 
❺ Raises the trunk upward to stand up straight 
without feeling pain in the lower back 
G2 -  نود نم ماملأل ينثلا ةيعضو نم ىلعلأا ىلا عذجلا عفر
رهظلا لفسأ يف مللأاب روعشلا 
⓿ رهظلا لفسأ يف مللأا ببسب ىلعلأل عذجلا عفر ىلع رداق ريغ 
❶ ا عفرب ءدبلا دنع نوكي مللاا ىلعلأل عذجلسيل نكلو كلانه  ملأ
ماملأل عذجلا ينث ةيعضو يف 
❷  لبق( ىلعلأل عذجلا عفر دنع رهظلا لفسأ يف مللأاب روعشلا
 ،)ةكرحلا ىدم فصتنمل لوصولاسيل نكلو لماك لكشب 
❸  ىلعلأل عذجلا عفر دنع رهظلا لفسأ يف مللأاب روعشلا
ةلصاوملا عيطتسأو سيل نكلو لماك لكشب 
❹ ب روعشلا لفسأ يف مللأادنع رهظلا  فوقولاةماقتساب 
❺ عفر  فوقولا ةيعضول لوصولل ىلعلأل عذجلاةماقتساب ب نود
رهظلا لفسأ يف ملأ 
H1 – Squatting from standing up straight and 
maintaining the position without pain 
⓿ Unable to squat due to low back pain 
❶ Able to lean forwards in preparation of squatting 
❷ Pain* interrupts the ability to bend the hips, knees 
and ankle joints, unable to continue 
❸ Pain* interrupts the ability to bend the hips, knees 
and ankle joints, able to continue 
❹ Able to achieve squatting position, unable to 
maintain this position due to pain* 
❺ Able to maintain squatting position without feeling 
pain* 
* Pain in the lower back 
H1 -  فوقولا نم ءاصفرقلاةماقتساب  نودب اهيلع ةظفاحملا و
ملأ 
⓿  لفسأ ملأ ببسب ءاصفرقلا ةيعضو قيقحت ىلع رداق ريغ
رهظلا 
❶  ينث ىلع رداقماملأا ىلا عذجلا 
❷  كرولا يلصفم ينث ىلع ةردقلا عطاقي مللأا نيتبكرلاو
،لحاكلاو ةلصاوملا عيطتسأ لا 
❸  كرولا يلصفم ينث ىلع ةردقلا عطاقي مللأا نيتبكرلاو
،لحاكلاو ةلصاوملا عيطتسأ نكل 
❹  ءاصفرقلا قيقحت ىلع رداقلا نكلو  اهيلع ةظفاحملا عيطتسأ
رهظلا لفسأ ملأ ببسب 
❺ اقرد  ةيعضو ىلع ةظفاحملا ىلعملأ نودبو ءاصفرقلا  يف
رهظلا لفسأ 
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H2 – Standing up straight from squatting position 
⓿ Unable to stand up straight from a squatting 
position due to low back pain 
❶ Pain* interrupts the ability to extend the hips, 
knees and ankle joints, unable to continue. 
❷ Pain* interrupts the ability to extend the hips, 
knees and ankle joints, able to continue. 
❸ Able to raise the lower back upwards 
❹ Able to raise the upper back upwards to fully 
straighten up  
❺ Stands up straight from squatting without feeling 
pain* 
* Pain in the lower back 
H2 -  فوقولاةماقتساب ءاصفرقلا ةيعضو نم 
⓿ ريغ  فوقولا ىلع رداقةماقتساب  ببسب ءاصفرقلا ةيعضو نم
رهظلا لفسأ ملأ 
❶  كرولا يلصفم درف ىلع ةردقلا عطاقي مللأا نيتبكرلاو
،لحاكلاو ةلصاوملا عيطتسأ لا 
❷ دقلا عطاقي مللأا كرولا يلصفم درف ىلع ةر نيتبكرلاو
،لحاكلاو ةلصاوملا عيطتسأ نكل 
❸  عفر ىلع رداقلفسأ ىلعلاا ىلا رهظلا 
❹  ىلا لوصولل رهظلا ىلعأ عفر ىلع رداقةماقتسلاا فوقولاب 
❺ فوقولا ةماقتساب  لفسأ يف ملأ نودب ءاصفرقلا ةيعضو نم
رهظلا 
I1 -  Functional walking (not hierarchical) 
 Walk in different directions 
 Change directions 
 Walk on different everyday surfaces 
 Able to negotiate slopes 
 Able to negotiate confined spaces 
⓿Unable to do any of the above mentioned 
activities* 
❶ Able to do one* 
❷ Able to do two* 
❸ Abel to do three* 
❹ Able to do four* 
❺ Able to do all 
*Due to low back pain 
I1 - يشملا ةفيظو ءادأ 
•  ةدع يف يشملاتاهاجتا 
•  رييغتتاهاجتلاا 
• ةيمويلا ةايحلا يف ةفلتخملا حطسلأا ىلع يشملا 
• تاردحنملا عم لماعتلا ىلع رداق 
• ةقيضلا نكاملأا عم لماعتلا ىلع رداق 
⓿ مهنم يأ لمع ىلع رداق ريغ* 
❶ داقةدحاو لمع ىلع ر* 
❷ نيتنثا لمع ىلع رداق* 
❸ ثلاث لمع ىلع رداق* 
❹ ةعبرأ لمع ىلع رداق* 
❺ رداق مهلك مهلمع ىلع 
*  رهظلا لفسأ ملأ ببسب 
I2 -  Walk a distance indoors without low back 
pain 
⓿ Unable to walk to the door of the room without 
feeling pain in the lower back (during or after) 
❶ Able to walk inside a room without feeling pain 
❷ Able to walk to the next room without feeling pain 
❸ Able to walk all distances indoors with the 
presence of pain* 
❹ Able to walk all distances indoors pain* free, pain 
after the completion of walking. 
❺ Able to walk all distances indoors, pain* free 
during and after the completion of walking 
* Pain in the lower back 
I2 -  رهظلا لفسأ يف ملأ نودب تيبلا لخاد ةفاسم يشم 
⓿  مللأاب ساسحلإا نودب ةفرغلا باب ىلا يشملا ىلع رداق ريغ
هظلا لفسأ يف.)دعب وا للاخ( ر 
❶ رهظلا لفسأ يف ملأ نود نم ةفرغلا لخاد يشملا ىلع رداق 
❷  ملأب روعشلا نود نم ةرواجملا ةفرغلا ىلا يشملا ىلع رداق
رهظلا لفسأ يف 
❸  لخاد تافاسملا لك يشملا ىلع رداق،تيبلا  لفسأ ملأ دوجوب
رهظلا 
❹  لخاد تافاسملا لك يشملا ىلع رداق،تيبلا ملأ نودب 
كلومللأا ن  دعب نوكيءاهتنلاا يشملا نم 
❺ رداق  لخاد تافاسملا لك يشملا ىلع،تيبلا  ملأ كلانه سيل
 يشملا للاخدعب لاو ءاهتنلاا يشملا نم 
I3 – Walking outdoor without feeling pain in the 
lower back 
⓿ Unable to initiate walking outdoors due to low 
back pain. 
❶ Pain* interrupts walking outdoors, unable to 
resume 
❷ Pain* interrupts walking outdoors, able to resume 
❸ pain* during walking outdoors, able to continue 
without interruption 
❹ pain* after completion of walking outdoors 
❺ Pain* free throughout walking outdoors, no pain* 
afterwards 
* Pain in the lower back 
I3 - رهظلا لفسأ يف ملأ نودب تيبلا جراخ يشملا 
⓿ دبلا ىلع رداق ريغء  لفسأ ملأ ببسب تيبلا جراخ يشملاب
رهظلا 
❶  تيبلا جراخ يشملا عطاقي رهظلا لفسأ ملأعيطتسأ لاو 
ةلصاوملا 
❷  تيبلا جراخ يشملا عطاقي رهظلا لفسأ ملأسأ نكلوعيطت 
ةلصاوملا 
❸  يف مللأا دوجو عم ةعطاقم نودب تيبلا جراخ يشملا ىلع رداق
رهظلا لفسأ 
❹  للاخ ملأ كلانه سيليشملا جراخ ،تيبلا  رهظلا لفسأ يف مللأا
  اقحلا نوكي 
❺ رداق  ،رهظلا لفسأ يف ملأ نود نم تيبلا جراخ يشملا ىلع
كلانه سيلو   اقحلا ملأ 
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I4 - Walk independently 
⓿ Unable to walk due to low back pain 
❶ Walks with help from two bases of support (2 
people) 
❷ Walks with help from one base of support (1 
people) 
❸ Walks with the help of stick 
❹ Walks without support but with bent trunk 
❺ Walks independently, without help and with 
straight back 
I4 - ةدعاسم نودب يشملا 
⓿ يشملا ىلع رداق ريغ 
❶ .)نيصخش( معدلل نيتدعاق ةدعاسمب يشمأ 
❷ .)صخش( معدلل ةدحاو ةدعاق ةدعاسمب يشمأ 
❸  زاكع ةدعاسمب يشمأ 
❹  ةدعاسم يأ نودب يشمأرهظب نكلو لدتعم ريغ 
❺ يشمأ  ةدعاسم نودب ،لقتسم لكشبلدتعم رهظبو 
J1 – Jogging required distance* without pain** 
⓿ Pain in the lower back prevents jogging for a 
required distance* 
❶ Pain** interrupts jogging for a required distance*, 
unable to resume 
❷ Pain** interrupts jogging for a required distance*, 
able to resume 
❸ Feeling pain** during jogging for a required 
distance*, able to continue without interruption 
❹ Feeling pain** after completion of jogging for a 
required distance* 
❺ Pain* free throughout jogging for a required 
distance*, no pain afterwards 
* Specify in the notes 
** Pain in the lower back 
J1 -  ةلوره ةبولطملا ةفاسملاملأ نود نم 
⓿ ملأ نودب *ةبولطملا ةفاسملا ةلوره ىلع رداق ريغ**  لفسأ يف
رهظلا 
❶  عطاقي مللأاةفاسملا ةلوره  ىلع ةردقملا مدع عم ،*ةبولطملا
ةعباتملا 
❷  عطاقي مللأاةفاسملا ةلوره ىلع ةردقملا عم ،*ةبولطملا 
ةعباتملا 
❸  ةفاسملا ةلوره للاخ مللأاب روعشلا،ةبولطملا عباتملا عيطتسأ ة
ةعطاقم ريغ نم 
❹  ةفاسملا ةلوره دنع ملأ كلانه سيلةبولطملا مللأا نكلو  يف
ةلورهلا لامكإ دعب نوكي رهظلا لفسأ 
❺ رداق ةبولطملا ةفاسملا ةلوره ىلعنودب *  ملأ كلانه سيل ،ملأ
  اقحلا 
*   هديدحت متيتاظحلاملا ةحفص يف 
J2 – Runs in one direction on even ground 
without pain* 
⓿ Pain* prevents running in one direction on even 
ground 
❶ Pain* interrupts running in one direction on even 
ground, unable to resume 
❷ Pain* interrupts running in one direction on even 
ground, able to resume 
❸ Pain* during running in one direction on even 
ground, able to continue without interruption 
❹ Pain* after completion of running in one direction 
on even ground 
❺ Pain* free throughout running in one direction on 
even ground, no pain afterwards 
* Pain in the lower back 
J2 - *ملأ نودب ةيوتسم ضرأ ىلع دحاو هاجتا يف ضكرلا 
⓿ مللأا يف دحاو هاجتا يف ضكرلاب مايقلا عنمي رهظلا لفسأ ع ىل
ةيوتسم ضرأ 
❶ دحاو هاجتا يف ضكرلا عطاقي رهظلا لفسأ يف مللأا  ىلع
ةيوتسم ضرأ ةعباتملا ىلع ةردقملا مدع عم 
❷ دحاو هاجتا يف ضكرلا عطاقي رهظلا لفسأ يف مللأا  ىلع
ةيوتسم ضرأ ةعباتملا ىلع ةردقملا عم 
❸ دحاو هاجتا يف ضكرلا للاخ رهظلا لفسأ يف مللأاب روعشلا 
ةيوتسم ضرأ ىلع ،عيطتسأ ةعطاقم ريغ نم ةعباتملا 
❹  هاجتا يف ضكرلا لامكإ دعب رهظلا لفسأ يف مللأاب روعشلا
دحاو سم ضرأ ىلعةيوت 
❺ سيل  هاجتا يف ضكرلاب مايقلا للاخ رهظلا لفسأ يف ملأ كلانه
دحاو ةيوتسم ضرأ ىلع ءاهتنلاا دعبو هنم 
K1 – Using the stairs* 
 Unable to load body weight pain** free 
 Unable to go upstairs pain** free 
 Unable to go down-stairs pain** free 
 Unable to maintain balance due to pain** 
 Requires support to use stairs due to pain** 
⓿ All of these problems exist  
❶ Four problems exist  
❷ Three problems exist  
❸ Two problems exist  
❹ One problem exists  
❺ None of these problems exist  
* Specify the number of  steps in the notes 
** Pain in the lower back 
K1 - ملأ نودب *جردلا مادختسا 
تاظحلاملا ةحفص يف اهيلع قفتملا تاجردلا ددع ديدحت متي * 
• ملأ نودب مسجلا نزو ليمحت ىلع رداق ريغ 
• ملأ نودب جردلا دوعص ىلع رداق ريغ 
• ملأ نودب جردلا لوزن ىلع رداق ريغ 
• ب نزاوتلا ىلع ةظفاحملا ىلع رداق ريغمللأا ببس 
• مللأا ببسب جردلا مادختسا دنع ةدعاسم جاتحا 
⓿ ةدوجوم لكاشملا هذه لك 
❶ لكاشم ةعبرأ دوجو 
❷ لكاشم ةثلاث دوجو 
❸ نيتلكشم دوجو 
❹ ةدحاو ةلكشم دوجو 
❺ لا لكاشملا هذه نم يأ دجوي 
 
  
 315 
 
K2 – Climbing one step 
⓿Unable to place foot on step 
❶ Able to transfer weight onto 1 foot, maintain body 
balance and place non weight bearing foot on step 
❷ Able to transfer weight onto foot placed on step 
above 
❸ Able to extend weight bearing hip and knee 
❹ Able to flex non weight bearing hip and knee 
❺ Able to place other foot on the next step above 
K2 - ةدحاو ةجرد دوعص 
⓿ ةجردلا ىلع مدقلا عضو ىلع رداق ريغ 
❶  ةجردلا ىلع مدقلا لقن ىلع رداقنزو ليمحتو  ىلع مسجلا
مسجلا نزاوت ىلع ةظفاحملا عم ىرخلأا مدقلا 
❷ ةجردلا ىلع ةعوضوملا مدقلا ىلع مسجلا نزو لقن ىلع رداق 
❸  كرولا يلصفم درف ىلع رداقةلماح ةبكرلاو .نزولا 
❹  كرولا يلصفم ينث ىلع رداقريغ مدقلاو  نزولا ةلماح 
❺ رداق ةيلاتلا ةيولعلا ةجردلا ىلع ىرخلأا مدقلا عضو ىلع 
K3 – Ascending the whole staircase* 
⓿ Pain** prevents ascending the whole staircase 
❶ Pain** interrupts ascending the whole staircase, 
unable to resume 
❷ Pain** interrupts ascending the whole staircase, 
able to resume 
❸ Feeling pain in the lower back during ascending 
the whole staircase, able to continue without 
interruption 
❹ Feeling pain in the lower back after completion of 
ascending the whole staircase 
❺ Pain free throughout ascending the whole 
staircase, no pain afterwards 
* Specify in the notes 
** Pain in the lower back 
K3 -  ًلاماك جردلا دوعص 
* تاظحلاملا ةحفص يف ةجرد مك ديدحت متي 
⓿ جردلا دوعص عنمي مللأا 
❶ دلا دوعص عطاقي مللأا جرعيطتسأ لاو ةدعاسم نودب ةعباتملا 
❷  جردلا دوعص عطاقي مللأاعيطتسأ يننكلو  نودب ةعباتملا
ةدعاسم 
❸  نم ةلصاوملا عيطتسأ يننكلو جردلا دوعص دنع دوجوم مللأا
ةعطاقم ريغ 
❹  جردلا دوعص للاخ ملأ كلانه سيلكلانه نكلو   اقحلا نوكي ملأ 
❺ سيل  سيل ،جردلا دوعص دنع ملأ كلانه  اقحلا ملأ كلانه 
K4 – Descending one step 
⓿Unable to place foot on lower step due to pain 
❶ Able to transfer one foot on the lower step and 
loading body weight on the other leg 
❷ Able to flex hip, knee and ankle of rear weight 
bearing leg 
❸ Able to place non weight bearing foot onto the 
lower step 
❹ Able to transfer weight onto foot placed on the 
lower step 
❺ Able to place other foot onto the lower step 
K4 - ةدحاو ةجرد لوزن 
⓿  ببسب ةيلفسلا ةجردلا ىلع مدقلا عضو ىلع رداق ريغالألم 
❶ دلا ىلع مدقلا لقن ىلع رداق ىلع نزولا ليمحت عم ةيلفسلا ةجر
ىرخلأا مدقلا 
❷  كرولا يلصفم ينث ىلع رداقمدقلل لحاكلاو ةبكرلاو  ةلماح
نزولا 
❸ رداق  عضو ىلعريغ مدقلا  ةيلفسلا ةجردلا ىلع نزولا ةلماح 
❹  ةجردلا ىلع ةعوضوملا مدقلا ىلع نزولا لقن ىلع رداق
ةيلفسلا 
❺ رداق دلا ىلع ىرخلأا مدقلا عضو ىلعةيلفسلا ةجر 
K5 - Descending the whole staircase* 
⓿ Pain** prevents descending the whole staircase 
❶ Pain** interrupts descending the whole staircase, 
unable to resume 
❷ Pain** interrupts descending the whole staircase, 
able to resume 
❸ Feeling pain in the lower back during descending 
the whole staircase, able to continue without 
interruption 
❹ Feeling pain in the lower back after completion of 
descending the whole staircase 
❺ Pain free throughout descending the whole 
staircase, no pain afterwards 
* Specify in the notes 
** Pain in the lower back 
K5 - *ملأ نودب ًلاماك جردلا لوزن 
* تاظحلاملا ةحفص يف ةجرد مك ديدحت متي 
⓿ جردلا لوزن عنمي مللأا 
❶  جردلا لوزن عطاقي مللأاعيطتسأ لاو ةدعاسم نودب ةعباتملا 
❷  جردلا لوزن عطاقي مللأاعيطتسأ يننكلو ةدعاسم نودب ةعباتملا 
❸ لأا نم ةلصاوملا عيطتسأ يننكلو جردلا لوزن دنع دوجوم مل
ةعطاقم ريغ 
❹  جردلا لوزن للاخ ملأ كلانه سيلكلانه نكلو   اقحلا نوكي ملأ 
❺ سيل   اقحلا ملأ كلانه سيل ،جردلا لوزن دنع ملأ كلانه 
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L1 – Lifting objects without pain* 
⓿ Unable to bend trunk, hips, and lower limb due to 
pain* 
❶ Able to bend trunk, hips, and lower limb pain* 
free, but unable to lift (Specify a small size object 
for lifting) due to pain* 
❷ Able to lift the (Specify a small size object for 
lifting), unable to continue due to pain* 
❸ Able to lift (Specify a small size object for 
lifting), pain* free 
❹ Able to lift (Specify a medium size object for 
lifting), pain* free 
❺ Able to lift (Specify a large size object for 
lifting), pain* free 
* Pain in the lower back 
L1 - ملأ نودب  ماسجلأا عفر 
⓿ ىلع رداق ريغ  ينثعذجلا، كرولا يلصفمو ةيلفسلا فارطلأاو 
مللأا ببسب 
❶  عذجلا ينث ىلع رداقكرولا يلصفمو نودب ةيلفسلا فارطلأاو 
 ملأريغ نكلو  عفر ىلع رداق)لمحلل رغصلأا مسجلا ددح(  
❷  عفر ىلع رداق)لمحلل رغصلأا مسجلا ددح(  لا نكلوعيطتسأ 
مللأا ببسب ةلصاوملا 
❸  عفر ىلع رداق ددح()لمحلل رغصلأا مسجلا ملأ نودب 
❹  عفر ىلع رداق)لمحلل طسوتملا مسجلا ددح( ملأ نودب 
❺ رداق  عفر ىلع)لمحلل ربكلأا مسجلا ددح( ملأ نودب 
L2 – Carrying an object* for a certain distance*  
⓿ Pain* prevents carrying an object for a specified 
distance 
❶ Pain* interrupts carrying an object for a specified 
distance, unable to resume 
❷ Pain* interrupts carrying an object for a specified 
distance, able to resume 
❸ Feeling pain* during carrying an object for a 
specified distance, able to continue without 
interruption 
❹ Feeling pain* after completion of carrying an 
object a specified distance 
❺ Pain* free throughout carrying an object for a 
specified distance, no pain* afterwards *  
* Specify in the notes. 
L2 - *ةددحم ةفاسم *مسج لقن 
* تاظحلاملا ةحفص يف هديدحت متي 
⓿ نمي مللأاةددحم ةفاسم مسج لقن ع 
❶  ةددحم ةفاسم مسج لقن عطاقي مللأاعيطتسأ لاو نودب ةعباتملا 
ةدعاسم 
❷  ةددحم ةفاسم مسج لقن عطاقي مللأاعيطتسأ يننكلو عباتملا ة
ةدعاسم نودب 
❸  عيطتسأ يننكلو ةددحم ةفاسم مسج لقن دنع دوجوم مللأا
ةعطاقم ريغ نم ةلصاوملا 
❹ لقن للاخ ملأ كلانه سيل  ةددحم ةفاسم مسجكلانه نكلو  ملأ
  اقحلا نوكي 
❺ سيل  ملأ كلانه سيل ،ةددحم ةفاسم مسج لقن دنع ملأ كلانه
  اقحلا 
L3 – Lowering an object* 
⓿ Unable to lower a carried object from a standing 
position due to pain** 
❶ Able to bend trunk forwards and maintain 
carrying an object. 
❷Pain** interrupts the ability to bend hips, knees 
and ankles, unable to continue  
❸ Pain** interrupts the ability to bend hips, knees 
and ankles, able to continue 
❹ Pain* during lowering down a carried object  from 
a standing position, able to continue without 
interruption  
❺ Able to lower a carried object on the ground from 
a standing position, pain** free 
* Specify in the notes 
** Pain in the lower back 
L3 - فوقولا ةيعضو نم ضرلأا ىلع لومحم *مسج لازنإ 
⓿ عضو نم لومحملا مسجلا ليزنت ىلع رداق ريغ فوقولا ةي
رهظلا لفسأ يف مللأأ ببسب 
❶ مسجلا لمح ىلع ةظفاحملا عم ماملأا ىلا عذجلا ينث ىلع رداق 
❷  كرولا يلصفم ينث ىلع ةردقلا عطاقي مللأا نيتبكرلاو
،لحاكلاو ةلصاوملا عيطتسأ لا  
❸  كرولا يلصفم ينث ىلع ةردقلا عطاقي مللأا نيتبكرلاو
،لحاكلاو ةلصاوملا عيطتسأ نكل 
❹ ا ةيعضو نم ضرلأا ىلع لومحم مسج لازنإ دنع نوكي مللأ
 فوقولاعيطتسأ نكلو ةلصاوملا ةعطاقم نودب 
❺ رداق  ةيعضو نم ضرلأا ىلع لومحم مسج لازنإ ىلع
 فوقولاملأ نودبو رهظلا لفسأ يف 
M1 - Doing an activity* without feeling pain in the lower 
back 
* Specify in the notes 
⓿ Pain in the lower back prevents a named activity 
❶ Pain in the lower back interrupts a named activity, 
unable to resume 
❷ Pain in the lower back interrupts a named activity, 
able to resume 
❸ pain in the lower back during a named activity, able to 
continue without interruption 
❹ pain in the lower back after completion of a named 
activity 
❺ Pain free throughout a named activity, no pain 
afterwards 
M1 - رهظ لفسأ يف ملأ ريغ نم *طاشنب مايقلا 
تاظحلاملا ةحفص يف هديدحت متي * 
⓿ مللأا يف ب مايقلا عنمي رهظلا لفسأ شنلا()ىمسملا طا 
❶ ( عطاقي رهظلا لفسأ يف مللأا طاشنلا )ىمسملاعم  ةردقملا مدع
ةعباتملا ىلع 
❷ ( عطاقي رهظلا لفسأ يف مللأا )ىمسملا طاشنلا ىلع ةردقملا عم
ةعباتملا 
❸ ( للاخ رهظلا لفسأ يف مللأاب روعشلا ،)ىمسملا طاشنلا
عيطتسأ ةعطاقم ريغ نم ةعباتملا 
❹ لفسأ يف مللأاب روعشلا ( لامكإ دعب رهظلا)ىمسملا طاشنلا 
❺ سيل ( مايقلا للاخ ملأ كلانه)ىمسملا طاشنلا ءاهتنلاا دعبو مهن 
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Appendix P: The TELER LBP quiz-style questionnaire 
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Appendix Q: The pre-testing copy of the TELER LBP questionnaire 
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Appendix R: Spine Care Jordan Centre 
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Appendix S: Consent form and information sheet of clinical testing study 
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Appendix T: An example of a data collection form and instruments used in the Jordanian 
physiotherapy clinics involved in this research 
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Appendix U: Ethics approval letter from Al Bashir Hospital 
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Appendix V: Significance of number of improvement or deterioration on a TELER indicator (level of 
the individual)
CTS-01 
Codes on 
discharge 
Codes on admission 
 0 1 2 3 4 5 
0       
1       
2   1    
3  3 1 1   
4  1  1 1  
5  1 1 3   
 CTS-02 
Codes on 
discharge 
Codes on admission 
 0 1 2 3 4 5 
0       
1       
2   1    
3       
4       
5   3  3  
 CTS-03 
Codes on 
discharge 
Codes on admission 
 0 1 2 3 4 5 
0 2      
1       
2       
3   1    
4     1  
5  2 3  4 1 
CTS-04 
Codes on 
discharge 
Codes on admission 
 0 1 2 3 4 5 
0       
1       
2       
3       
4       
5  2 3  3 2 
 
CTS-05 
Codes on 
discharge 
Codes on admission 
 0 1 2 3 4 5 
0       
1       
2       
3  1     
4  1   2  
5    1 1  
 CTS-06 
Codes on 
discharge 
Codes on admission 
 0 1 2 3 4 5 
0       
1       
2 1      
3 1 2     
4 1 3 4    
5  1 1 2 1  
 CTS-07 
Codes on 
discharge 
Codes on admission 
 0 1 2 3 4 5 
0       
1       
2 2      
3 4      
4 3      
5 7 3     
CTS-08 
Codes on 
discharge 
Codes on admission 
 0 1 2 3 4 5 
0       
1       
2       
3 1  2    
4   1    
5    1 1  
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CTS-09 
Codes on 
discharge 
Codes on admission 
 0 1 2 3 4 5 
0       
1       
2       
3       
4   1    
5  3 2    
 CTS-10 
Codes on 
discharge 
Codes on admission 
 0 1 2 3 4 5 
0       
1       
2       
3       
4 1  1    
5  6 6 5 1  
 CTS-11 
Codes on 
discharge 
Codes on admission 
 0 1 2 3 4 5 
0       
1       
2       
3       
4 2 1     
5 1 2  1   
CTS-12 
Codes on 
discharge 
Codes on admission 
 0 1 2 3 4 5 
0 3      
1  7     
2   3    
3    3   
4     1  
5       
 
 
CTS-13 
Codes on 
discharge 
Codes on admission 
 0 1 2 3 4 5 
0 1      
1  1     
2 2 2 2    
3 1 1 1 2   
4 1 1  1   
5       
 CTS-14 
Codes on 
discharge 
Codes on admission 
 0 1 2 3 4 5 
0       
1       
2       
3 2 1     
4 4 1 1    
5    2 1  
 CTS-15 
Codes on 
discharge 
Codes on admission 
 0 1 2 3 4 5 
0       
1       
2  1     
3   1    
4 2  2    
5    2   
CTS-16 
Codes on 
discharge 
Codes on admission 
 0 1 2 3 4 5 
0       
1       
2       
3  1 4 1   
4   1 3 1  
5   1 1 1  
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CTS-17 
Codes on 
discharge 
Codes on admission 
 0 1 2 3 4 5 
0       
1       
2       
3       
4 1  1 1   
5 1      
 CTS-18 
Codes on 
discharge 
Codes on admission 
 0 1 2 3 4 5 
0       
1       
2  3     
3       
4  2  1   
5   1 1 3  
 CTS-19 
Codes on 
discharge 
Codes on admission 
 0 1 2 3 4 5 
0       
1       
2       
3       
4       
5  3 3 4 3  
CTS-20 
Codes on 
discharge 
Codes on admission 
 0 1 2 3 4 5 
0       
1  1     
2       
3  2     
4  1 3 1   
5   1 6   
 
 
CTS-21 
Codes on 
discharge 
Codes on admission 
 0 1 2 3 4 5 
0       
1  2     
2   1    
3   1 4   
4     3  
5    2   
 CTS-22 
Codes on 
discharge 
Codes on admission 
 0 1 2 3 4 5 
0       
1       
2       
3       
4  1 1 1 3  
5   5 2   
 CTS-23 
Codes on 
discharge 
Codes on admission 
 0 1 2 3 4 5 
0       
1       
2 2 1     
3 5 3     
4 2 2 1    
5 1 1   2  
CTS-24 
Codes on 
discharge 
Codes on admission 
 0 1 2 3 4 5 
0       
1       
2       
3       
4       
5 1 2 3 5 2  
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CTS-25 
Codes on 
discharge 
Codes on admission 
 0 1 2 3 4 5 
0       
1       
2       
3       
4       
5   4 5 3  
 CTS-26 
Codes on 
discharge 
Codes on admission 
 0 1 2 3 4 5 
0       
1       
2  1     
3 1  1    
4       
5     2  
 CTS-27 
Codes on 
discharge 
Codes on admission 
 0 1 2 3 4 5 
0       
1       
2       
3       
4       
5   2 7 3  
CTS-28 
Codes on 
discharge 
Codes on admission 
 0 1 2 3 4 5 
0       
1       
2       
3       
4       
5  1 3 7 2  
 
 
CTS-29 
Codes on 
discharge 
Codes on admission 
 0 1 2 3 4 5 
0       
1       
2       
3       
4       
5  3 3 8 2  
 CTS-30 
Codes on 
discharge 
Codes on admission 
 0 1 2 3 4 5 
0       
1       
2       
3       
4 2 6     
5 2 2 1 1   
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Appendix W: The TELER form of participant CTS-07 
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 Appendix X: Calculations of the probabilities of a statistical significant change in TELER component indicator 
 
Table 1.1 
Probability an outcome with a start code of  
0 is a random event by clinically significant period 
Code Outcome 
Clinically significant period  
1 2 3 4 5 
0 None of the functions 0.5000 0.4167 0.3472 0.3080 0.2785 
1 Any one of the functions 0.5000 0.4167 0.4028 0.3728 0.3513 
2 Code 1 + any of the 4 remaining functions  0.1667 0.1945 0.2176 0.2252 
3 Code 2 + any of the 3 remaining functions   0.0556 0.0833 0.1069 
4 Code 3 + any of the 2 remaining functions    0.0185* 0.0341* 
5 All 5 functions     0.0062* 
Total 1.0000 1.0001 1.0001 1.0002 1.0024 
* statistically significant (p  0.05 one tail) 
 
  
 348 
 
 
Table 1.2 
Probability an outcome with a start code of  
1 is a random event by clinically significant period 
Code Outcome 
Clinically significant period  
1 2 3 4 5 
0 None of the functions  0.3333 0.2778 0.2685 0.2483 
1 Any one of the functions  0.3333 0.3889 0.3425 0.3283 
2 Code 1 + any of the 4 remaining functions  0.3333 0.2222 0.2406 0.2309 
3 Code 2 + any of the 3 remaining functions   0.1111 0.1110 0.1292 
4 Code 3 + any of the 2 remaining functions    0.0370* 
0.0492
* 
5 All 5 functions     
0.0123
* 
Total  0.9999 1.0000 1.0006 0.9982 
* statistically significant (p  0.05 one tail) 
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Table 1.3 
Probability an outcome with a start code of  
2 is a random event by clinically significant period 
Code Outcome 
Clinically significant period  
1 2 3 4 5 
0 None of the functions    0.1111 0.1296 
1 Any one of the functions   0.3333 0.2222 0.2406 
2 Code 1 + any of the 4 remaining functions   0.3333 0.3333 0.2590 
3 Code 2 + any of the 3 remaining functions   0.3333 0.2222 0.2220 
4 Code 3 + any of the 2 remaining functions    0.1111 0.1110 
5 All 5 functions     0.0370* 
Total   0.9999 0.9999 0.9992 
* statistically significant (p  0.05 one tail) 
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Table 1.4 
Probability an outcome with a start code of  
3 is a random event by clinically significant period 
Code Outcome 
Clinically significant period  
1 2 3 4 5 
0 None of the functions      
1 Any one of the functions     0.1111 
2 Code 1 + any of the 4 remaining functions    0.3333 0.2222 
3 Code 2 + any of the 3 remaining functions    0.3333 0.3333 
4 Code 3 + any of the 2 remaining functions    0.3333 0.2222 
5 All 5 functions     0.1111 
Total    0.9999 0.9999 
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Appendix Y: Manual of TELER LBP questionnaire (English) 
 
Summary 
Measures: Functional performance 
Description: The TELER LBP questionnaire is a valid, reliable and responsive clinical measurement tool 
that traces changes in functional performance in individuals with low back pain (LBP). The questionnaire is 
divided into four sections: (a) the quiz-style indicators list, (b) the TELER LBP indicators, (c) the TELER 
form and (d) the clinical notes. 
A- The quiz-style indicators list 
The first part of the TELER LBP questionnaire includes a list of 29 quiz-style indicators. The first 
part is design specifically to be used in the initial assessment session to guide LBP patients to 
select only outcomes that are relevant to them. Following to the identification of the patient’s 
problems and goals, the physiotherapist should select from Part 2 of the questionnaire indicators 
that can be used to record the achievement of the goals, enabling the documentation of change in 
functional status that occurs during the physiotherapy treatment. 
B- The TELER LBP indicators 
These are unique ordinal scales that traces changes in the construct “functional performance”. 
C- The TELER form 
Part 3 is designed to trace change on a TELER LBP indicator in a LBP patient. This part provide 
information that can be readily used to inform clinical decision-making. 
D- The clinical notes 
This part is used to document important information that cannot be quantified such as other 
conditions that affect the patient health status or psychological factors such as fear of movement 
which might affect physical functioning. 
Measurement Properties: 
Reliability Inter-rater reliability : Yes (Excellent) 
Internal consistency: Yes (Excellent) 
Validity Face validity: Yes 
Content validity: Yes 
Construct validity: Yes 
Responsive to change Yes (Excellent) 
Sensitivity Yes (Excellent) 
Specificity Yes (Excellent) 
Measurement at the individual 
level 
Yes 
Measurement at the group level Yes 
 
Training: Medium (Requires training of how to use the TELER system). 
Equipment: Stop watch, objects of different weights, usual walking aid, and access to bed, chair and 
stairs. 
Space needed: Space for bed, chair, stairs, space for walking or running. 
Time to complete: 5 – 20 minutes 
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Good things about it:  
In a clinical context: The TELER LBP questionnaire can be used in the initial assessment session to 
identified limitations in activities of daily living. It also can be used in follow up sessions to trace changes in 
the construct functional performance. The TELER LBP questionnaire was designed specifically to provide 
information that is readily accessible and inform decision-making process whether to continue the current 
LBP management, change interventions, refer the patient to a specialist or discharge the patient. 
Quantitative data collected at the individual level can be aggregated to provide information to a clinic 
manager about the quality of service provided. 
In a research setting: The TELER LBP questionnaire can be used in appropriate research design to 
provide data that can analysed to determine whether an outcome is attributable to the therapeutic input or 
to spontaneous recovery. 
Limitations:  
 Ceiling effect for more able patients.  
 This questionnaire was validated in Jordan using an Arabic speaking sample of individuals with 
non-specific LBP. 
Clarity: 
Each code in any TELER LBP indicator provide a singular meaning which make the majority of these 
indicators clear and easy to understand; However, some people might find few of the functional indicators, 
especially the ones that represent a movement analysis, are difficult to understand and require more 
clarifications. Therefore, in order to facilitate understanding of these indicators, an image was attached to 
each code. The following pages in this manual show these TELER LBP indicators. 
Last updated: May 2015  
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B1- Bed mobility: not hierarchical (low back pain patients) 
TELER code TELER code’s descriptor Demonstration 
Choice Low back pain does not prevent bending hips and 
knees. 
 
 
Choice Low back pain does not prevent maintaining hips 
and knees in flexion 
 
Choice Low back pain does not prevent lifting bottom 
 
Choice Low back pain does not prevent shifting bottom 
across 
 
Choice Low back pain does not prevent shifting shoulders 
and head across 
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B2 - Lying to sitting over edge of bed (low back pain patients) 
TELER code TELER code’s descriptor Demonstration 
Code 0 Low back pain prevents moving functionally in bed 
 
Code 1 Low back pain does not prevent achieving crock 
lying 
 
Code 2 Low back pain does not prevent achieving modified 
bridge to move sideways 
 
Code 4 Low back pain does not prevent achieving rolling 
into side lying (with knees bent) 
 
Code 4 Low back pain does not prevent achieving pushing 
body upwards supported on forearms 
 
Code 5 Low back pain does not prevent achieving sitting 
at  the edge of the bed (by dropping legs over side 
and pushing the body upwards using arms) 
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B3 – Lying to sitting on bed (low back pain patients) 
TELER code TELER code’s descriptor Demonstration 
Code 0 Low back pain prevents siting in bed from lying 
 
Code 1 Low back pain does not prevent lifting and turning 
head and upper trunk 
 
Code 2 Low back pain does not prevent moving arm under 
the body and rotating head and the upper trunk 
 
Code 3 Low back pain does not prevent extending the 
supporting arm, rotating lower trunk and lifting legs 
off bed 
 
Code 4 Low back pain does not prevent transferring weight 
onto bottom 
 
Code 5 Low back pain does not prevent getting into sitting 
and lifting arms off bed 
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C1 – Get out of bed without help (low back pain patients) 
TELER code TELER code’s descriptor Demonstration 
Code 0 Unable to get out of bed due to low back pain 
 
Code 1 Able to achieve sitting over the edge of the bed 
with help 
 
Code 2 Able to achieve sitting over the edge of the bed 
without help 
 
Code 3 Able to transfer between sitting and standing 
without help 
 
Code 4 Able to maintain standing without support 
 
Code 5 Walking away from the bed without help 
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D1 – Standing up straight from sitting (low back pain patients) 
TELER code TELER code’s descriptor Demonstration 
Code 0 Low back pain prevents standing from sitting 
 
Code 1 Low back pain does not prevent moving forwards 
on bed or chair 
 
Code 2 Low back pain does not prevent transfering body 
weight over feet 
 
Code 3 Low back pain does not prevent lifting bottom off 
bed or chair 
 
Code 4 Low back pain does not prevent fully extending 
hips, knees or trunk (not all of them) to achieve 
standing 
 
Code 5 Low back pain does not prevent fully extending 
hips, knees and trunk to achieve standing up 
straight 
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D2 – Sitting from standing (low back pain patients) 
TELER code TELER code’s descriptor Demonstration 
Code 0 Sits down with no control due to low back pain 
 
 
Code 1 Low back pain does not prevent bringing body 
weight forwards, from standing position 
 
 
Code 2 Low back pain does not prevent bending hips and 
knees 
 
Code 3 Low back pain does not prevent using arms to 
support sitting 
 
Code 4 Low back pain does not prevent lowering smoothly 
onto bed or chair 
 
Code 5 Low back pain does not prevent sitting 
completely/properly on the bed or chair 
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D3 – Standing up straight from floor sitting (low back pain patients) 
TELER code TELER code’s descriptor Demonstration 
Code 0 Low back pain prevents transferring weight into 
side sitting  
 
 
Code 1 Low back pain does not prevent transferring weight 
into side sitting 
 
Code 2 Low back pain does not prevent transferring weight 
forwards over knees (in order to achieve kneeling 
position). 
 
 
Code 3 Low back pain does not prevent extending hips into 
high kneeling and placing non weight bearing foot 
on the floor 
 
Code 4 Low back pain does not prevent transferring weight 
onto the foot (forward) and extending the hip and 
knee 
 
Code 5 Low back pain does not prevent standing up 
straight. 
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G1 – Bend trunk forward (low back pain patients) 
TELER code TELER code’s descriptor Demonstration 
Code 0 Low back pain prevents bending the trunk forwards 
 
 
Code 1 Pain on initiating forward bending, pain free at 
standing position 
 
Code 2 Low back pain prevents forward bending (before 
reaching mid-range of trunk movement), unable to 
continue 
 
Code 3 Low back pain does not prevent forward bending, 
able to continue but cannot fully bend the trunk 
 
Code 4 Pain when trunk is fully flexed 
 
Code 5 Full active range of trunk movement forwards, 
without feeling pain in the lower back 
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G2 - Raising the trunk upwards to the upright position from bending forwards (low back pain patients) 
TELER code TELER code’s descriptor Demonstration 
Code 0 Low back pain prevents rising trunk upwards 
 
Code 1 Pain initiating on raising the trunk upwards, pain 
free when bending the trunk forwards 
 
Code 2 Low back pain interrupts raising the trunk upwards 
(before reaching mid-range of trunk movement), 
unable to continue 
 
 
Code 3 Low back pain interrupts raising the trunk upwards, 
able to continue but cannot stand up upright 
 
Code 4 Low back pain prevents standing up upright. 
 
Code 5 Low back pain does not prevents standing up 
upright. 
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H1 – Squatting from standing up straight and maintaining the position (low back pain patients) 
TELER code TELER code’s descriptor Demonstration 
Code 0 Low back pain prevents squatting 
 
Code 1 Low back pain does not prevent leaning forwards in 
preparation of squatting 
 
Code 2 Low back pain interrupts bending the hips, knees 
and ankle joints, unable to continue 
 
Code 3 Low back pain interrupts bending the hips, knees 
and ankle joints, able to continue 
 
Code 4 Low back pain does not prevent squatting, unable 
to maintain this position due to pain 
 
Code 5 Low back pain does not prevent squatting, able to 
maintain this position 
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H2 – Standing up straight from squatting position (low back pain patients) 
TELER code TELER code’s descriptor Demonstration 
Code 0 Low back pain prevents standing up straight from a 
squatting position 
 
Code 1 Low back pain interrupts extending the hips, knees 
and ankle joints, unable to continue. 
 
Code 2 Low back pain interrupts extending the hips, knees 
and ankle joints, able to continue 
 
Code 3 Low back pain does not prevent raising the lower 
back upwards 
 
Code 4 Low back pain doe not prevent raising the upper 
back upwards to fully straighten up  
 
 
Code 5 Low back pain does not prevent standing  up 
straight from squatting 
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I1 - Functional walking: not hierarchical (low back pain patients) 
TELER code TELER code’s descriptor Demonstration 
Choice Walk in different directions 
 
 
Choice Change directions 
 
 
Choice Walk on different everyday surfaces 
 
  
Choice Able to negotiate slopes 
 
Choice Able to negotiate confined spaces 
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I4 - Walk independently (low back pain patients) 
TELER code TELER code’s descriptor Demonstration 
Code 0 Low back pain prevents walking 
 
Code 1 Low back pain does not prevent walking with help 
from two bases of support (2 people) 
 
 
Code 2 Low back pain does not prevents walking with help 
from one base of support (1 people) 
 
Code 3 Low back pain does not prevent walking with the 
help of stick 
 
Code 4 Low back pain does not prevent walking (without 
support but with bent trunk) 
 
Code 5 Low back pain does not prevent walking 
independently (without help and with straight back) 
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K2 – Climbing one step (low back pain patients) 
TELER code TELER code’s descriptor Demonstration 
Code 0 Low back pain prevents placing foot on step 
 
Code 1 Low back pain does not prevent transferring weight 
onto 1 foot, maintaining body balance and placing 
non weight bearing foot on step 
 
Code 2 Low back pain does not prevent transferring weight 
onto foot placed on step above 
 
 
Code 3 Low back pain does not prevent extending weight 
bearing hip and knee 
 
Code 4 Low back pain does not prevent flexing non-weight 
bearing hip and knee 
 
Code 5 Low back pain does not prevent placing other foot 
on the next step above 
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K4 – Descending one step (low back pain patients) 
TELER code TELER code’s descriptor Demonstration 
Code 0 Low back pain prevents placing foot on lower step  
 
Code 1 Low back pain does not prevents transferring one 
foot on the lower step and loading body weight on 
the other leg 
 
 
Code 2 Low back pain does not prevent flexing hip, knee 
and ankle of rear weight bearing leg 
 
 
Code 3 Low back pain does not prevent placing non-weight 
bearing foot onto the lower step 
 
 
Code 4 Low back pain does not prevent transferring weight 
onto foot placed on the lower step 
 
 
Code 5 Low back pain does not prevent placing other foot 
onto the lower step 
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L1 – Lifting objects (low back pain patients)
 TELER code TELER code’s descriptor Demonstration 
Code 0 Low back pain prevents bending trunk, hips, and 
lower limbs 
 
Code 1 Low back pain does not prevent bending trunk, 
hips, and lower limb, but it prevents lifting (Specify 
a small size object for lifting) 
 
Code 2 Low back pain interrupt lifting (Specify a small 
size object for lifting), unable to continue due to 
pain 
 
Code 3 Low back pain does not prevent lifting (Specify a 
small size object for lifting) 
 
Code 4 Low back pain does not prevent lifting (Specify a 
medium size object for lifting) 
 
Code 5 Low back pain does not prevent lifting (Specify a 
large size object for lifting) 
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L3 – Lowering an object (low back pain patients) 
TELER code TELER code’s descriptor Demonstration 
Code 1 Low back pain prevents lowering a carried object 
from a standing position 
 
Code 1 Low back pain does not prevent bending trunk 
forwards and maintain carrying an object. 
 
 
Code 2 Low back pain interrupts bending hips, knees and 
ankles, unable to continue 
 
Code 3 Low back pain interrupts bending hips, knees and 
ankles, able to continue 
 
Code 4 Low back pain interrupts lowering down a carried 
object  from a standing position, able to continue 
without interruption  
 
Code 5 Low back pain does not prevents lowering a carried 
object on the ground from a standing position 
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 )cibarA( eriannoitseuq PBL RELET fo launaM :Z xidneppA
 
 (غير تصاعدي) الحركة في السرير - 1B
 رموز RELET الوصف العام لرمز RELET صور توضيحية لرموز RELET
 
 الخيار قادر على ثني مفصلي الورك والركبتين
 
 الخيار  لورك والركبتينقادر على المحافظة على ثني مفصلي ا
 
 الخيار  قادر على رفع المؤخرة
 
 الخيار  قادر على تحريك المؤخرة للجانب
 
 الخيار  قادر على تحريك الكتفين و الرأس للجانب
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 الى الجلوس على طرف السرير الاستلقاءالنهوض من  - 2B
  موزر RELET الوصف العام لرمز RELET صور توضيحية لرموز RELET
 
  0الخيار  رفي أسفل الظه بسبب الألمالحركة في السرير  أستطيعلا 
 
  1الخيار  الاستلقاءالركبتين خلال  أستطيع ثني
 
  2الخيار  رفع الجسم كجسر للتحرك الى الجانبين أستطيع
 
  3الخيار  الدوران الى النوم على الجانب (مع ثني الركبتين) أستطيع
 
  4الخيار  على الساعد الاستنادبدفع الجسم للأعلى 
 
تحقيق الجلوس على طرف السرير (عن طريق إنزال  أستطيع
  باليد) للأعلى ودفع الجسمالقدمين الى الجانب 
  5الخيار 
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 للجلوس على السرير مع فرد الرجلين الاستلقاءالنهوض من  - 3B
 رموز RELET الوصف العام لرمز RELET صور توضيحية لرموز RELET
 
 الاستلقاءغير قادر على الجلوس على السرير من وضعية 
 بسبب ألم أسفل الظهر
  0الخيار 
 
  1الخيار  من الجسم والجذع العلوي وتدوير الرأسقادر على رفع 
 
 العلوي من وتدوير الجزءقادر على تحريك اليد تحت الجسم 
 الجذع
  2الخيار 
 
لجزء السفلي من قادر على فرد اليد الداعمة للجسم، تدوير ا
 على السرير ورفع القدمينالجذع 
  3الخيار 
 
  4الخيار  قادر على تحميل الوزن على المؤخرة.
 
  5الخيار   عن السرير ورفع الأيديقادر على الجلوس 
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 الخروج من السرير بدون مساعدة - 1C
 رموز RELET الوصف العام لرمز RELET صور توضيحية لرموز RELET
 
  0الخيار  ر على الخروج من السرير بسبب ألم في أسفل الظهرغير قاد
 
الجلوس على طرف السرير  تحقيق وضعيةقادر على 
 بمساعدة
  1الخيار 
 
  2الخيار  وبدون مساعدةقادر على تحقيق وضعية الجلوس 
 
  3الخيار  وبدون مساعدةالتنقل من الجلوس الى الوقوف  قادر على
 
  4الخيار  لوقوف بدون مساعدةالمحافظة على وضعية ا
 
  5الخيار  المشي بعيدا عن السرير من دون مساعدة
 
 
  473
 
 من الجلوس باستقامةالوقوف  - 1D
 رموز RELET الوصف العام لرمز RELET صور توضيحية لرموز RELET
 
  0الخيار  غير قادر على الوقوف من الجلوس بسبب ألم أسفل الظهر
 
  1الخيار  من فوق الكرسي أو السريرقادر على التحرك للأمام 
 
  2الخيار  قادر على حمل وزن الجسم على الأقدام
 
  3الخيار  قادر على رفع المؤخرة من على الكرسي أو السرير
 
قادر على فرد أي من الحوض أو الركبتين أو الجذع بشكل 
 كامل (ليس جميعهم)
  4الخيار 
 
كامل لتحقيق  بشكل والركبتين والجذعقادر على فرد الحوض 
  باستقامةوضعية الوقوف 
  5الخيار 
 
  
  573
 
 الجلوس من الوقوف - 2D
 رموز RELET الوصف العام لرمز RELET صور توضيحية لرموز RELET
 
  0الخيار  الجلوس من دون تحكم بسبب ألم أسفل الظهر
 
  1الخيار  إحضار وزن الجسم الى الأمام في وضعية الوقوف
 
  2الخيار  والركبتينك ثني مفصلي الور
 
  3الخيار  اليدين للمساعدة على الجلوس استخدام
 
  4الخيار  الجسم بشكل سلس الى الكرسي أو السرير إنزال
 
  5الخيار   وبدون ألمالجلوس بشكل كامل 
 
  
  673
 
 من وضعية الجلوس على الأرض باستقامةالوقوف  - 3D
 رموز RELET  ز الوصف العام لرم RELET صور توضيحية لرموز RELET
 
عدم المقدرة على نقل الوزن بوضعية الجلوس الجانبي بسبب 
 ألم أسفل الظهر
  0الخيار 
 
  1الخيار  قادر على نقل وزن الجسم الى وضعية الجلوس الجانبي
 
قادر على نقل الوزن الى الأمام فوق الركبتين (لتحقيق 
 وضعية الوقوف على الركب)
  2الخيار 
 
مفصلي الورك الى الأعلى لأخذ وضعية  قادر على فرد
تحريك القدم غير محملة الوزن  ومن ثمالوقوف على الركب 
 على الأرض
  3الخيار 
 
 وفرد مفصليقادر على تحميل الوزن على القدم الأمامية 
 والركبةالورك 
  4الخيار 
 
  5الخيار   باستقامةقادر على الوقوف 
 
  
  773
 
 الشعور بالألم في أسفل الظهر ثني الجذع الى الامام من دون - 1G
 رموز RELET الوصف العام لرمز RELET صور توضيحية لرموز RELET
 
  0الخيار  غير قادر على ثني الجذع للأمام بسبب الألم في أسفل الظهر
 
 يسولكن لالالم في أسفل الظهر يكون عند البدء بثني الجذع 
 هنالك ألم في وضعية الوقوف
  1الخيار 
 
ور بالألم في أسفل الظهر عند ثني الجذع (قبل الوصول الشع
 أستطيع المواصلة ولكن لالمنتصف مدى الحركة)، 
  2الخيار 
 
وأستطيع الشعور بالألم في أسفل الظهر عند ثني الجذع 
 بشكل كامل ولكن ليس المواصلة
  3الخيار 
 
  4 الخيار بشكل كامل الجذعثني  الظهر عندالشعور بالألم في أسفل 
 
  5الخيار  ثني الجذع بشكل كامل للأمام بدون ألم في أسفل الظهر
 
  
 
 
 
 
  873
 
 رفع الجذع الى الأعلى من وضعية الثني للأمام من دون الشعور بالألم في أسفل الظهر - 2G
 رموز RELET الوصف العام لرمز RELET صور توضيحية لرموز RELET
 
أسفل  غير قادر على رفع الجذع للأعلى بسبب الألم في
 الظهر
  0الخيار 
 
ك ألم هنال ولكن ليسالالم يكون عند البدء برفع الجذع للأعلى 
 في وضعية ثني الجذع للأمام
  1الخيار 
 
الشعور بالألم في أسفل الظهر عند رفع الجذع للأعلى (قبل 
 بشكل كامل ولكن ليسالوصول لمنتصف مدى الحركة)، 
  2الخيار 
 
الظهر عند رفع الجذع للأعلى  الشعور بالألم في أسفل
 بشكل كامل ولكن ليس وأستطيع المواصلة
  3الخيار 
 
  4الخيار  باستقامةالوقوف  الظهر عندالشعور بالألم في أسفل 
 
بدون  باستقامةرفع الجذع للأعلى للوصول لوضعية الوقوف 
 ألم في أسفل الظهر
  5الخيار 
 
  
 
 
 
 
  973
 
 لمحافظة عليها بدون ألمو ا باستقامةالقرفصاء من الوقوف  - 1H
 رموز RELET الوصف العام لرمز RELET صور توضيحية لرموز RELET
 
غير قادر على تحقيق وضعية القرفصاء بسبب ألم أسفل 
 الظهر
  0الخيار 
 
  1الخيار  قادر على ثني الجذع الى الأمام
 
والركبتين الألم يقاطع القدرة على ثني مفصلي الورك 
 ستطيع المواصلةلا أ والكاحل،
  2الخيار 
 
والركبتين الألم يقاطع القدرة على ثني مفصلي الورك 
 لكن أستطيع المواصلة والكاحل،
  3الخيار 
 
 أستطيع المحافظة عليها ولكن لاقادر على تحقيق القرفصاء 
 بسبب ألم أسفل الظهر
  4الخيار 
 
 في القرفصاء وبدون ألمقادر على المحافظة على وضعية 
 أسفل الظهر
  5الخيار 
 
  
 
  
 
  083
 
 من وضعية القرفصاء باستقامةالوقوف  - 2H
 رموز RELET الوصف العام لرمز RELET صور توضيحية لرموز RELET
 
من وضعية القرفصاء بسبب  باستقامةغير قادر على الوقوف 
 ألم أسفل الظهر
  0الخيار 
 
والركبتين الألم يقاطع القدرة على فرد مفصلي الورك 
 لا أستطيع المواصلة الكاحل،و
  1الخيار 
 
والركبتين الألم يقاطع القدرة على فرد مفصلي الورك 
 لكن أستطيع المواصلة والكاحل،
  2الخيار 
 
  3الخيار  الظهر الى الاعلى أسفلقادر على رفع 
 
  4الخيار  بالوقوف الاستقامةقادر على رفع أعلى الظهر للوصول الى 
 
من وضعية القرفصاء بدون ألم في أسفل  قامةباستالوقوف 
 الظهر
  5الخيار 
 
  
 
 
 
  183
 
 أداء وظيفة المشي - 1I
 رموز RELET الوصف العام لرمز RELET صور توضيحية لرموز RELET
 
 الخيار  اتجاهاتالمشي في عدة 
 
 الخيار  الاتجاهاتتغيير 
  
 الخيار  اليومية المشي على الأسطح المختلفة في الحياة
 
 الخيار  قادر على التعامل مع المنحدرات
 
 الخيار  قادر على التعامل مع الأماكن الضيقة
 
  
  283
 
 المشي بدون مساعدة - 4I
 رموز RELET الوصف العام لرمز RELET صور توضيحية لرموز RELET
 
  0الخيار  غير قادر على المشي
 
  1الخيار  ).أمشي بمساعدة قاعدتين للدعم (شخصين
 
  2الخيار  أمشي بمساعدة قاعدة واحدة للدعم (شخص).
 
  3الخيار  أمشي بمساعدة عكاز
 
  4الخيار  غير معتدل ولكن بظهرأمشي بدون أي مساعدة 
 
  5الخيار   وبظهر معتدلأمشي بشكل مستقل، بدون مساعدة 
 
  383
 
 صعود درجة واحدة - 2K
 رموز RELET  لعام لرمز الوصف ا RELET صور توضيحية لرموز RELET
 
  0الخيار  غير قادر على وضع القدم على الدرجة
 
الجسم على  وتحميل وزنقادر على نقل القدم على الدرجة 
 القدم الأخرى مع المحافظة على توازن الجسم
  1الخيار 
 
  2الخيار  قادر على نقل وزن الجسم على القدم الموضوعة على الدرجة
 
  3الخيار  الوزن. والركبة حاملةصلي الورك قادر على فرد مف
 
  4الخيار  حاملة الوزن والقدم غيرقادر على ثني مفصلي الورك 
 
  5الخيار  قادر على وضع القدم الأخرى على الدرجة العلوية التالية
 
 
 
  483
 
 نزول درجة واحدة - 4K
 رموز RELET الوصف العام لرمز RELET صور توضيحية لرموز RELET
 
  0الخيار  مللأاادر على وضع القدم على الدرجة السفلية بسبب غير ق
 
قادر على نقل القدم على الدرجة السفلية مع تحميل الوزن 
 على القدم الأخرى
  1الخيار 
 
ة حامل والركبة والكاحل للقدمقادر على ثني مفصلي الورك 
 الوزن
  2الخيار 
 
  3الخيار  جة السفليةحاملة الوزن على الدر القدم غيرقادر على وضع 
 
  4الخيار  قادر على نقل الوزن على القدم الموضوعة على الدرجة السفلية
 
  5الخيار  قادر على وضع القدم الأخرى على الدرجة السفلية
 
  
  583
 
 ألم الأجسام بدونرفع  - 1L
 رموز RELET الوصف العام لرمز RELET صور توضيحية لرموز RELET
 
والأطراف  ومفصلي الورك ،جذعالغير قادر على ثني 
 بسبب الألم السفلية
  0الخيار 
 
والأطراف السفلية  ومفصلي الوركقادر على ثني الجذع 
(حدد الجسم الأصغر قادر على رفع  ولكن غيرألم  بدون
 للحمل)
  1الخيار 
 
 أستطيعولكن لا  (حدد الجسم الأصغر للحمل)قادر على رفع 
 المواصلة بسبب الألم
  2الخيار 
 
  3الخيار  بدون ألم (حدد الجسم الأصغر للحمل)قادر على رفع 
 
  4الخيار  بدون ألم (حدد الجسم المتوسط للحمل)قادر على رفع 
 
  5الخيار   بدون ألم (حدد الجسم الأكبر للحمل)قادر على رفع 
 
 
  683
 
 إنزال جسم* محمول على الأرض من وضعية الوقوف - 3L
 رموز RELET الوصف العام لرمز RELET صور توضيحية لرموز RELET
 
غير قادر على تنزيل الجسم المحمول من وضعية الوقوف 
 بسبب ألألم في أسفل الظهر
  0الخيار 
 
قادر على ثني الجذع الى الأمام مع المحافظة على حمل 
 الجسم
  1الخيار 
 
والركبتين الألم يقاطع القدرة على ثني مفصلي الورك 
 يع المواصلةلا أستط والكاحل،
  2الخيار 
 
والركبتين الألم يقاطع القدرة على ثني مفصلي الورك 
 لكن أستطيع المواصلة والكاحل،
  3الخيار 
 
الألم يكون عند إنزال جسم محمول على الأرض من وضعية 
 بدون مقاطعة المواصلة ولكن أستطيعالوقوف 
  4الخيار 
 
وضعية قادر على إنزال جسم محمول على الأرض من 
  في أسفل الظهر وبدون ألمالوقوف 
  5الخيار 
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